[
{"id":"1","list":"Alerts","symbol": "BBRY","name": "BlackBerry Limited - Common Stock","price": 7.75,"dollarChange": 0.8,"percentChange": 11.52,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/BBRY-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/BBRY-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/BBRY-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/BBRY-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/BBRY-1yr.php","open": 7.53,"high": 8.08,"low":7.47,"volume": 53837350,"avgVol": 4238614.116667,"sharesShort": 53711924,"shortPercent": 10.134325,"marketCap": 3688800000,"float": 530000000,"headlines":{"data":[{"title":"BlackBerry's profit beats expectations on software push","publication_date":"2017-04-01 02:54:27 +0000","url":"http://in.finance.yahoo.com/news/blackberrys-profit-beats-expectations-software-025427224.html","summary":"BlackBerry's profit beats expectations on software push"},{"title":"Stocks Post Strong First-Quarter Gains as Nasdaq Rockets 10%; Dow Jumps Nearly 5%","publication_date":"2017-04-01 00:30:00 +0000","url":"https://www.thestreet.com/story/14068142/1/stocks-post-strong-first-quarter-gains-as-nasdaq-rockets-10-dow-jumps-nearly-5.html?puc=yahoo&cm_ven=YAHOO","summary":"Stocks Post Strong First-Quarter Gains as Nasdaq Rockets 10%; Dow Jumps Nearly 5%"},{"title":"Full Show: Bloomberg Technology (03/31)","publication_date":"2017-03-31 23:55:34 +0000","url":"https://www.bloomberg.com/news/videos/2017-03-31/full-show-bloomberg-technology-03-31-video?cmpid=yhoo.headline","summary":"Full Show: Bloomberg Technology (03/31)"},{"title":"BlackBerry’s Chen Says Company’s Made Progress","publication_date":"2017-03-31 22:41:49 +0000","url":"http://finance.yahoo.com/video/blackberry-chen-says-company-made-224149938.html","summary":"BlackBerry’s Chen Says Company’s Made Progress"},{"title":"BlackBerry to license brand for new tablets, wearables and appliances","publication_date":"2017-03-31 22:09:22 +0000","url":"http://www.cnbc.com/id/104377987?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104377987","summary":"BlackBerry to license brand for new tablets, wearables and appliances"},{"title":"BlackBerry's profit beats expectations on software push","publication_date":"2017-03-31 21:30:53 +0000","url":"http://sg.finance.yahoo.com/news/blackberry-posts-smaller-quarterly-loss-113204957.html","summary":"BlackBerry's profit beats expectations on software push"},{"title":"CANADA STOCKS-TSX slips but BlackBerry tempers decline; index up on quarter","publication_date":"2017-03-31 21:13:31 +0000","url":"http://finance.yahoo.com/news/canada-stocks-tsx-slips-blackberry-211331524.html","summary":"CANADA STOCKS-TSX slips but BlackBerry tempers decline; index up on quarter"},{"title":"BlackBerry Finds Its Software Niche, Shares Jump On Earnings","publication_date":"2017-03-31 20:06:00 +0000","url":"http://www.investors.com/news/technology/blackberry-finds-its-software-niche-shares-jump-on-earnings/?src=A00220A","summary":"BlackBerry Finds Its Software Niche, Shares Jump On Earnings"},{"title":"[$$] BlackBerry Looks to Wide Range of Technology Options for Growth","publication_date":"2017-03-31 19:26:11 +0000","url":"https://www.wsj.com/articles/blackberry-earnings-beat-expectations-1490959690?mod=yahoo_hs","summary":"[$$] BlackBerry Looks to Wide Range of Technology Options for Growth"},{"title":"Stocks Mixed Friday With an Eye on Gains for the First Quarter","publication_date":"2017-03-31 19:19:00 +0000","url":"https://www.thestreet.com/story/14067778/1/stocks-trade-mixed-and-are-poised-the-end-march-the-same-way.html?puc=yahoo&cm_ven=YAHOO","summary":"Stocks Mixed Friday With an Eye on Gains for the First Quarter"},{"title":"BlackBerry's (BBRY) Q4 Loss Narrows, Revenues Fall Y/Y","publication_date":"2017-03-31 19:13:07 +0000","url":"http://finance.yahoo.com/news/blackberrys-bbry-q4-loss-narrows-191307079.html","summary":"BlackBerry's (BBRY) Q4 Loss Narrows, Revenues Fall Y/Y"},{"title":"BlackBerry Is Actually Looking Like a Reasonably Successful Software Company","publication_date":"2017-03-31 18:59:00 +0000","url":"https://www.thestreet.com/story/14068057/1/blackberry-is-actually-looking-like-a-reasonably-successful-software-company.html?puc=yahoo&cm_ven=YAHOO","summary":"BlackBerry Is Actually Looking Like a Reasonably Successful Software Company"},{"title":"Why Blackberry Ltd Stock Jumped Today","publication_date":"2017-03-31 18:27:00 +0000","url":"https://www.fool.com/investing/2017/03/31/why-blackberry-ltd-stock-jumped-today.aspx","summary":"Why Blackberry Ltd Stock Jumped Today"},{"title":"Blackberry Stock Soars on a Strong Earnings Beat","publication_date":"2017-03-31 18:16:02 +0000","url":"http://www.investopedia.com/-/blackberry-stock-soars-strong-earnings-beat/?partner=YahooSA","summary":"Blackberry Stock Soars on a Strong Earnings Beat"},{"title":"From Smartphones to Smart Enterprises, BlackBerry Expands Licensing Strategy for the Enterprise of Things","publication_date":"2017-03-31 18:00:00 +0000","url":"http://finance.yahoo.com/news/smartphones-smart-enterprises-blackberry-expands-180000862.html","summary":"[Marketwired] - BlackBerry Limited today shared new details on its broad licensing strategy which addresses the growing need for secure, connected devices and endpoints in today's Enterprise of Things."},{"title":"This is no early April Fool: BlackBerry shares surge as results top forecasts","publication_date":"2017-03-31 17:29:34 +0000","url":"http://www.siliconbeat.com/2017/03/31/no-early-april-fool-blackberry-shares-surge-results-top-forecasts/","summary":"This is no early April Fool: BlackBerry shares surge as results top forecasts"},{"title":"This is Why Shares of BlackBerry (BBRY) are Rallying Today","publication_date":"2017-03-31 17:19:05 +0000","url":"http://finance.yahoo.com/news/why-shares-blackberry-bbry-rallying-171905226.html","summary":"This is Why Shares of BlackBerry (BBRY) are Rallying Today"},{"title":"Today's charts: Blackberry shares soar; Credit Suisse falls on tax probe; Starbucks tests mobile order-only store","publication_date":"2017-03-31 17:12:56 +0000","url":"http://finance.yahoo.com/news/todays-charts-blackberry-shares-soar-credit-suisse-falls-on-tax-probe-starbucks-tests-mobile-order-only-store-171256563.html","summary":"Today's charts: Blackberry shares soar; Credit Suisse falls on tax probe; Starbucks tests mobile order-only store"},{"title":"BlackBerry narrows loss amid focus on services","publication_date":"2017-03-31 15:17:40 +0000","url":"http://uk.finance.yahoo.com/news/blackberry-narrows-loss-amid-focus-151740394.html","summary":"BlackBerry narrows loss amid focus on services"},{"title":"Blackberry Levels to Watch After Earnings","publication_date":"2017-03-31 15:00:00 +0000","url":"http://www.investopedia.com/news/blackberry-levels-watch-after-earnings-bbry-aapl/?partner=YahooSA","summary":"Blackberry Levels to Watch After Earnings"},{"title":"Dow Falls and Is on Track for First Monthly Loss Since Presidential Election","publication_date":"2017-03-31 14:58:00 +0000","url":"https://www.thestreet.com/story/14067577/1/stocks-open-lower-but-wall-street-is-poised-to-close-out-the-first-quarter-with-gains.html?puc=yahoo&cm_ven=YAHOO","summary":"Dow Falls and Is on Track for First Monthly Loss Since Presidential Election"},{"title":"Tech Today: Apple For Toshiba? BlackBerry Surges, Surging Chip Prices","publication_date":"2017-03-31 14:37:00 +0000","url":"http://blogs.barrons.com/techtraderdaily/2017/03/31/tech-today-apple-for-toshiba-blackberry-surges-surging-chip-prices/?mod=yahoobarrons&ru=yahoo","summary":"Tech Today: Apple For Toshiba? BlackBerry Surges, Surging Chip Prices"},{"title":"BlackBerry's profit surprise, Diageo downgraded to sell, DuPont asset deal","publication_date":"2017-03-31 14:28:29 +0000","url":"http://finance.yahoo.com/news/blackberrys-profit-surprise-diageo-downgraded-to-sell-dupont-asset-deal-142829911.html","summary":"BlackBerry's profit surprise, Diageo downgraded to sell, DuPont asset deal"},{"title":"BlackBerry (BBRY) Reports Narrower-than-expected Q4 Loss","publication_date":"2017-03-31 14:03:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LE7HBv8R79M/blackberry-bbry-reports-narrower-than-expected-q4-loss-cm768191","summary":"BlackBerry Limited BBRY based in Waterloo Canada was founded in 1984 The company operates in North America Europe Asia Middle East Latin America and Africa BlackBerry has an impressive record with respect to the bottom line The company has delivered positive surprises in each of"},{"title":"BlackBerry Stock Pops Following Earnings Beat","publication_date":"2017-03-31 13:31:00 +0000","url":"https://www.thestreet.com/story/14067403/1/blackberry-stock-pops-following-earnings-beat.html?puc=yahoo&cm_ven=YAHOO","summary":"BlackBerry Stock Pops Following Earnings Beat"},{"title":"Investors take a breath as stocks finish the best first quarter in four years","publication_date":"2017-03-31 13:14:18 +0000","url":"http://finance.yahoo.com/news/investors-take-a-breath-as-stocks-finish-the-best-first-quarter-in-four-years-131418358.html","summary":"Investors take a breath as stocks finish the best first quarter in four years"},{"title":"Why BlackBerry Is Maintaining a Presence in the Handsets Business","publication_date":"2017-03-31 13:05:51 +0000","url":"http://marketrealist.com/2017/03/why-blackberry-is-maintaining-a-presence-in-the-handsets-business/?utm_source=yahoo&utm_medium=feed","summary":"Why BlackBerry Is Maintaining a Presence in the Handsets Business"},{"title":"How BlackBerry Won Big in Q4","publication_date":"2017-03-31 13:05:16 +0000","url":"http://finance.yahoo.com/news/blackberry-won-big-q4-130516394.html","summary":"How BlackBerry Won Big in Q4"},{"title":"BlackBerry Surges 7%: FYQ4 Tops Street on Higher Software Sales","publication_date":"2017-03-31 13:03:00 +0000","url":"http://blogs.barrons.com/techtraderdaily/2017/03/31/blackberry-surges-7-fyq4-tops-street-on-higher-software-sales/?mod=yahoobarrons&ru=yahoo","summary":"BlackBerry Surges 7%: FYQ4 Tops Street on Higher Software Sales"},{"title":"Pre-Market Most Active for Mar 31, 2017 : WWAV, BBRY, MT, CARA, TRR, ELF, FMC, HMY, QQQ, MU, SORL, LULU","publication_date":"2017-03-31 12:59:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QVWViQkUQwI/pre-market-most-active-for-mar-31-2017-wwav-bbry-mt-cara-trr-elf-fmc-hmy-qqq-mu-sorl-lulu-cm768144","summary":"The NASDAQ 100 Pre Market Indicator is down 26 to 5 439 48 The total Pre Market volume is currently 12 120 055 shares traded The following are the most active stocks for the pre market session Whitewave Foods Company The WWAV is 0 51 at 56 16 with 8 762 690"},{"title":"Blackberry Holding On To Strong Gain In Afternoon Trading","publication_date":"2017-03-31 12:57:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IDTwXfHcNDs/blackberry-holding-on-to-strong-gain-in-afternoon-trading-20170331-00769","summary":"Blackberry Holding On To Strong Gain In Afternoon Trading"},{"title":"Stock Futures Slip as Wall Street Closes Out Mixed First Quarter","publication_date":"2017-03-31 12:37:00 +0000","url":"https://www.thestreet.com/story/14066325/1/stock-futures-slip-as-wall-street-closes-out-a-mixed-first-quarter.html?puc=yahoo&cm_ven=YAHOO","summary":"Stock Futures Slip as Wall Street Closes Out Mixed First Quarter"},{"title":"BlackBerry posts smaller quarterly loss as costs fall","publication_date":"2017-03-31 12:10:34 +0000","url":"http://finance.yahoo.com/news/blackberry-posts-smaller-quarterly-loss-112801284.html","summary":"BlackBerry posts smaller quarterly loss as costs fall"},{"title":"BlackBerry's profit beats expectations","publication_date":"2017-03-31 12:03:41 +0000","url":"http://finance.yahoo.com/news/blackberrys-profit-beats-expectations-120341454.html","summary":"BlackBerry's profit beats expectations"},{"title":"BlackBerry (BBRY) Reports Narrower-than-expected Q4 Loss","publication_date":"2017-03-31 11:58:11 +0000","url":"http://finance.yahoo.com/news/blackberry-bbry-reports-narrower-expected-115811640.html","summary":"BlackBerry (BBRY) Reports Narrower-than-expected Q4 Loss"},{"title":"BlackBerry Beats Earnings Estimates, Expects To Be Profitable Next Year","publication_date":"2017-03-31 11:46:20 +0000","url":"http://finance.yahoo.com/news/blackberry-beats-earnings-estimates-expects-114620993.html","summary":"BlackBerry Beats Earnings Estimates, Expects To Be Profitable Next Year"},{"title":"What to Watch Friday: BlackBerry's Results, Inflation Data","publication_date":"2017-03-31 11:35:00 +0000","url":"http://www.thestreet.com/video/14066852/what-to-watch-friday-blackberry-s-results-inflation-data.html?puc=yahoov&cm_ven=YAHOOV","summary":"What to Watch Friday: BlackBerry's Results, Inflation Data"},{"title":"BlackBerry reports 4Q loss","publication_date":"2017-03-31 11:28:34 +0000","url":"http://sg.finance.yahoo.com/news/blackberry-reports-4q-loss-112633987.html","summary":"BlackBerry reports 4Q loss"},{"title":"Free From Phones, BlackBerry Posts Profit, Says More to Come","publication_date":"2017-03-31 11:22:17 +0000","url":"https://www.bloomberg.com/news/articles/2017-03-31/freed-from-phones-blackberry-posts-profit-expects-more-to-come?cmpid=yhoo.headline","summary":"Free From Phones, BlackBerry Posts Profit, Says More to Come"},{"title":"BlackBerry's stock surges after reporting surprise adjusted profit","publication_date":"2017-03-31 11:16:45 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=74B0C61B-165C-4342-B6F9-4848F9263CBD&siteid=yhoof2","summary":"BlackBerry's stock surges after reporting surprise adjusted profit"},{"title":"7:12 am BlackBerry beats by $0.04, beats on revs; expects to be profitable on a non-GAAP basis and to generate positive free cash flow for FY18","publication_date":"2017-03-31 11:12:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#bbry","summary":"7:12 am BlackBerry beats by $0.04, beats on revs; expects to be profitable on a non-GAAP basis and to generate positive free cash flow for FY18"},{"title":"BlackBerry Reports Q4 Fiscal 2017 Results Above Analyst Consensus Revenue and EPS Estimates","publication_date":"2017-03-31 11:00:00 +0000","url":"http://finance.yahoo.com/news/blackberry-reports-q4-fiscal-2017-110000360.html","summary":"[Marketwired] - BlackBerry Limited , a global software leader in securing, connecting and mobilizing enterprises, today reported financial results for the three months and fiscal year ended February 28, 2017 ."},{"title":"Market Recon: Investors Get Something of a Wake-Up Call","publication_date":"2017-03-31 10:43:00 +0000","url":"https://www.thestreet.com/story/14067216/1/market-recon-investors-get-something-of-a-wake-up-call.html?puc=yahoo&cm_ven=YAHOO","summary":"Market Recon: Investors Get Something of a Wake-Up Call"},{"title":"BlackBerry Ltd. (BBRY) Has Surged To A 3-Month High On Q4 Results","publication_date":"2017-03-31 09:50:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7TimL0E-dvc/blackberry-ltd-bbry-has-surged-to-a-3month-high-on-q4-results-20170331-00581","summary":"BlackBerry Ltd. (BBRY) Has Surged To A 3-Month High On Q4 Results"},{"title":"BlackBerry Q4 Loss Narrows, Expects Adj. Profit In FY18","publication_date":"2017-03-31 08:34:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xaEcPud_t2M/blackberry-q4-loss-narrows-expects-adj-profit-in-fy18-20170331-00435","summary":"BlackBerry Q4 Loss Narrows, Expects Adj. Profit In FY18"},{"title":"BlackBerry Expects To Be Profitable On Non-GAAP Basis In FY18 - Quick Facts","publication_date":"2017-03-31 07:19:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1lfm2VU9KxI/blackberry-expects-to-be-profitable-on-nongaap-basis-in-fy18--quick-facts-20170331-00299","summary":"BlackBerry Expects To Be Profitable On Non-GAAP Basis In FY18 - Quick Facts"},{"title":"[$$] Ford Hires BlackBerry Employees to Work on Connected Cars","publication_date":"2017-03-31 04:11:10 +0000","url":"https://www.wsj.com/articles/ford-hires-blackberry-employees-to-work-on-connected-cars-1490879191?ru=yahoo?mod=yahoo_itp","summary":"[$$] Ford Hires BlackBerry Employees to Work on Connected Cars"},{"title":"How to Trade BlackBerry Ltd (BBRY) Stock Around Q4 Earnings","publication_date":"2017-03-30 21:01:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KQ_56cOI0I0/how-to-trade-blackberry-ltd-bbry-stock-around-q4-earnings-cm768039","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips BlackBerry Ltd NASDAQ BBRY is far far removed from its heyday of being a dominant smartphone provider Most high profile personalities had a BlackBerry touting two points of interest security and the"},{"title":"These 5 Dow Stocks Are Near Buy Points: Investing Action Plan","publication_date":"2017-03-30 20:30:58 +0000","url":"http://www.investors.com/research/investing-action-plan/5-dow-average-stocks-that-are-near-buy-points-investing-action-plan/?src=A00220A","summary":"These 5 Dow Stocks Are Near Buy Points: Investing Action Plan"},{"title":"[$$] Blackberry Earnings: What to Watch","publication_date":"2017-03-30 20:25:47 +0000","url":"https://www.wsj.com/articles/blackberry-earnings-what-to-watch-1490905544?mod=yahoo_hs","summary":"[$$] Blackberry Earnings: What to Watch"},{"title":"Ford Hiring 400 BlackBerry Engineers In Connected Car Push: Report","publication_date":"2017-03-30 20:21:39 +0000","url":"http://www.investors.com/news/ford-hiring-400-blackberry-engineers-report/?src=A00220A","summary":"Ford Hiring 400 BlackBerry Engineers In Connected Car Push: Report"},{"title":"Pre-Market Earnings Report for March 31, 2017 : BBRY, SFUN, SORL, QRHC","publication_date":"2017-03-30 20:19:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R7EG1nyiZTw/pre-market-earnings-report-for-march-31-2017-bbry-sfun-sorl-qrhc-cm768004","summary":"The following companies are expected to report earnings prior to market open on 03 31 2017 Visit our Earnings Calendar for a full list of expected earnings releases BlackBerry Limited BBRY is reporting for the quarter ending February 28 2017 The"},{"title":"Blackberry Poised to Tumble on Weak Fundamentals","publication_date":"2017-03-30 18:36:28 +0000","url":"http://finance.yahoo.com/tumblr/blog-blackberry-poised-to-tumble-on-weak-fundamentals-183639060.html","summary":"Blackberry Poised to Tumble on Weak Fundamentals"},{"title":"What to Expect From BlackBerry Earnings","publication_date":"2017-03-30 15:45:11 +0000","url":"http://finance.yahoo.com/news/expect-blackberry-earnings-154511919.html","summary":"What to Expect From BlackBerry Earnings"},{"title":"[$$] Ford Hires BlackBerry Employees to Work on Connected Cars","publication_date":"2017-03-30 15:40:34 +0000","url":"https://www.wsj.com/articles/ford-hires-blackberry-employees-to-work-on-connected-cars-1490879191?mod=yahoo_hs","summary":"[$$] Ford Hires BlackBerry Employees to Work on Connected Cars"},{"title":"BlackBerry (BBRY) Focuses on Software to Regain Lost Glory","publication_date":"2017-03-30 14:12:04 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x03DGqRfBp4/blackberry-bbry-focuses-on-software-to-regain-lost-glory-cm767628","summary":"Canadian handset manufacturer 160 BlackBerry Ltd BBRY had been grappling with declining sales in its handset business following which it exited the smartphone business However the company s software business has failed to build hope among investors so far The company scheduled to"},{"title":"Ford Hires 400 BlackBerry Employees for Connected Cars Work","publication_date":"2017-03-30 14:10:36 +0000","url":"https://www.bloomberg.com/news/articles/2017-03-30/ford-hires-400-blackberry-employees-to-work-on-connected-cars?cmpid=yhoo.headline","summary":"Ford Hires 400 BlackBerry Employees for Connected Cars Work"},{"title":"Ford Hires Former BlackBerry Employees to Further Mobile Engineering Efforts","publication_date":"2017-03-30 14:01:00 +0000","url":"https://www.thestreet.com/story/14065832/1/ford-hires-former-blackberry-employees-to-further-mobile-engineering-efforts.html?puc=yahoo&cm_ven=YAHOO","summary":"Ford Hires Former BlackBerry Employees to Further Mobile Engineering Efforts"},{"title":"BlackBerry (BBRY) Focuses on Software to Regain Lost Glory","publication_date":"2017-03-30 12:04:12 +0000","url":"http://finance.yahoo.com/news/blackberry-bbry-focuses-software-regain-120412593.html","summary":"BlackBerry (BBRY) Focuses on Software to Regain Lost Glory"},{"title":"Preview: BlackBerry, freed of handsets, looks to software for return to glory","publication_date":"2017-03-30 10:01:25 +0000","url":"http://sg.finance.yahoo.com/news/preview-blackberry-freed-handsets-looks-100125791.html","summary":"Preview: BlackBerry, freed of handsets, looks to software for return to glory"},{"title":"BlackBerry, freed of handsets, looks to software for return to glory","publication_date":"2017-03-30 09:34:55 +0000","url":"http://sg.finance.yahoo.com/news/blackberry-freed-handsets-looks-software-093455947.html","summary":"BlackBerry, freed of handsets, looks to software for return to glory"},{"title":"BlackBerry Shifts Focus to Software Development","publication_date":"2017-03-29 20:01:00 +0000","url":"https://www.thestreet.com/story/14064820/1/blackberry-shifts-focus-to-software-development.html?puc=yahoo&cm_ven=YAHOO","summary":"BlackBerry Shifts Focus to Software Development"},{"title":"BlackBerry, freed of handsets, looks to software for return to glory","publication_date":"2017-03-29 19:20:23 +0000","url":"http://sg.finance.yahoo.com/news/blackberry-freed-handsets-looks-software-192023244.html","summary":"BlackBerry, freed of handsets, looks to software for return to glory"},{"title":"How to Trade BlackBerry Ltd (BBRY) Stock Ahead of Q4 Earnings","publication_date":"2017-03-28 17:58:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZjHkodGEq9s/how-to-trade-blackberry-ltd-bbry-stock-ahead-of-q4-earnings-cm766804","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips It s hard to believe that the once ubiquitous BlackBerry handset is a thing of the past But it s a reality that BlackBerry Ltd NASDAQ BBRY investors have had to make peace with along with a 10 year over year"},{"title":"Can BlackBerry (BBRY) Spring a Surprise in Q4 Earnings?","publication_date":"2017-03-28 16:02:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hKruiMlhBq8/can-blackberry-bbry-spring-a-surprise-in-q4-earnings-cm766667","summary":"Canadian handset manufacturer 160 BlackBerry Limited BBRY is slated to release fourth quarter fiscal 2017 results on Mar 31 before the market opens In the last quarter the company reported a loss of 1 cent per share narrower than the Zacks Consensus Estimate of a loss of 4"},{"title":"Samsung Looks to Avoid Another Battery Blunder","publication_date":"2017-03-28 14:38:21 +0000","url":"http://marketrealist.com/2017/03/samsung-looks-to-avoid-another-battery-blunder/?utm_source=yahoo&utm_medium=feed","summary":"Samsung Looks to Avoid Another Battery Blunder"},{"title":"Can BlackBerry (BBRY) Spring a Surprise in Q4 Earnings?","publication_date":"2017-03-28 13:49:01 +0000","url":"http://finance.yahoo.com/news/blackberry-bbry-spring-surprise-q4-134901608.html","summary":"Can BlackBerry (BBRY) Spring a Surprise in Q4 Earnings?"},{"title":"How Suing Nokia over Patent Violations Can Impact BlackBerry","publication_date":"2017-03-28 11:37:13 +0000","url":"http://marketrealist.com/2017/03/how-suing-nokia-over-patent-violations-can-impact-blackberry/?utm_source=yahoo&utm_medium=feed","summary":"How Suing Nokia over Patent Violations Can Impact BlackBerry"},{"title":"Does It Matter That BlackBerry’s OS Market Share Is Almost Gone?","publication_date":"2017-03-27 20:35:43 +0000","url":"http://marketrealist.com/2017/03/does-it-matter-that-blackberrys-os-market-share-is-almost-gone/?utm_source=yahoo&utm_medium=feed","summary":"Does It Matter That BlackBerry’s OS Market Share Is Almost Gone?"},{"title":"How BBM Enterprise Could Impact BlackBerry’s Software Business","publication_date":"2017-03-27 19:05:43 +0000","url":"http://marketrealist.com/2017/03/how-bbm-enterprise-could-impact-blackberrys-software-business/?utm_source=yahoo&utm_medium=feed","summary":"How BBM Enterprise Could Impact BlackBerry’s Software Business"},{"title":"Why Alibaba Group Holding Ltd (BABA) Stock Is Worth Every Penny","publication_date":"2017-03-27 18:59:48 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e6cgIjlUExU/why-alibaba-group-holding-ltd-baba-stock-is-worth-every-penny-cm766156","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Since taking my own advice in November and putting some shares of Alibaba Group Holding Ltd 160 NYSE BABA into my retirement account I ve gotten a 16 gain On some days like Mar 23 BABA stock is 160 the star"},{"title":"Why BlackBerry Ltd (BBRY) Stock Is Only Worth a Short-Term Nibble","publication_date":"2017-03-27 17:59:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MUk75EYlYeg/why-blackberry-ltd-bbry-stock-is-only-worth-a-short-term-nibble-cm766093","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips For better or for worse 2016 was the year of the comeback We saw it in sports when the Chicago Cubs clawed back three down in the World Series to emerge victorious In the markets embattled companies like Micron"},{"title":"How a Budget BlackBerry Device Can Impact Apple","publication_date":"2017-03-27 17:12:45 +0000","url":"http://marketrealist.com/2017/03/how-a-budget-blackberry-device-can-impact-apple/?utm_source=yahoo&utm_medium=feed","summary":"How a Budget BlackBerry Device Can Impact Apple"},{"title":"BlackBerry Ltd (BBRY) Finds Life After Smartphones","publication_date":"2017-03-27 13:41:54 +0000","url":"http://finance.yahoo.com/news/blackberry-ltd-bbry-finds-life-134154888.html","summary":"BlackBerry Ltd (BBRY) Finds Life After Smartphones"},{"title":"Week Ahead: Financials, Health Care on Edge as Obamacare Escapes GOP Axe","publication_date":"2017-03-25 19:25:00 +0000","url":"https://www.thestreet.com/story/14058969/1/week-ahead-financials-health-care-on-edge-as-obamacare-escapes-gop-axe.html?puc=yahoo&cm_ven=YAHOO","summary":"Week Ahead: Financials, Health Care on Edge as Obamacare Escapes GOP Axe"},{"title":"Week Ahead On Wall Street: It's Beginning To Look A Lot Like Brexit","publication_date":"2017-03-25 14:00:00 +0000","url":"http://www.forbes.com/sites/laurengensler/2017/03/25/week-ahead-brexit-begins-samsung-galaxy-s8-trump-border-wall/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix","summary":"Week Ahead On Wall Street: It's Beginning To Look A Lot Like Brexit"},{"title":"Prem Watsa's Place in the Benjamin Graham Universe","publication_date":"2017-03-24 16:42:29 +0000","url":"http://finance.yahoo.com/news/prem-watsas-place-benjamin-graham-164229263.html","summary":"Prem Watsa's Place in the Benjamin Graham Universe"},{"title":"BlackBerry Ltd (BBRY) Stock Is in ‘Wait-And-See’ Mode","publication_date":"2017-03-23 19:02:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7S_5V_bz7Jc/blackberry-ltd-bbry-stock-is-in-wait-and-see-mode-cm764880","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Canada based mobile phone company 160 BlackBerry Ltd NASDAQ BBRY used to be an undisputed giant in the cell phone market Back in 2009 its namesake phones which were considered indispensable to its"},{"title":"How a Deal with Gemalto Could Impact Microsoft’s Mobile Business","publication_date":"2017-03-23 13:05:43 +0000","url":"http://marketrealist.com/2017/03/how-a-deal-with-gemalto-could-impact-microsofts-mobile-business/?utm_source=yahoo&utm_medium=feed","summary":"How a Deal with Gemalto Could Impact Microsoft’s Mobile Business"},{"title":"How BlackBerry Stock Compares to Moving Averages","publication_date":"2017-03-23 11:36:35 +0000","url":"http://marketrealist.com/2017/03/how-blackberry-stock-compares-to-moving-averages/?utm_source=yahoo&utm_medium=feed","summary":"How BlackBerry Stock Compares to Moving Averages"},{"title":"How Will BlackBerry’s Major Business Segments Perform in 4Q17?","publication_date":"2017-03-22 14:37:23 +0000","url":"http://marketrealist.com/2017/03/how-will-blackberrys-major-business-segments-perform-in-4q17/?utm_source=yahoo&utm_medium=feed","summary":"How Will BlackBerry’s Major Business Segments Perform in 4Q17?"},{"title":"Brand Licensing Could Be a Key Revenue Driver for BlackBerry","publication_date":"2017-03-22 13:07:18 +0000","url":"http://marketrealist.com/2017/03/brand-licensing-could-be-a-key-revenue-driver-for-blackberry/?utm_source=yahoo&utm_medium=feed","summary":"Brand Licensing Could Be a Key Revenue Driver for BlackBerry"},{"title":"BlackBerry Ltd. breached its 50 day moving average in a Bearish Manner : BBRY-US : March 22, 2017","publication_date":"2017-03-22 12:10:37 +0000","url":"http://www.capitalcube.com/blog/index.php/blackberry-ltd-breached-its-50-day-moving-average-in-a-bearish-manner-bbry-us-march-22-2017/","summary":"BlackBerry Ltd. breached its 50 day moving average in a Bearish Manner : BBRY-US : March 22, 2017"},{"title":"What Are the New Markets for BlackBerry’s Licensing Services?","publication_date":"2017-03-22 11:37:29 +0000","url":"http://marketrealist.com/2017/03/what-are-the-new-markets-for-blackberrys-licensing-services/?utm_source=yahoo&utm_medium=feed","summary":"What Are the New Markets for BlackBerry’s Licensing Services?"},{"title":"Why BlackBerry Is Targeting the CPaaS Space","publication_date":"2017-03-21 16:35:43 +0000","url":"http://marketrealist.com/2017/03/why-blackberry-is-targeting-the-cpaas-space/?utm_source=yahoo&utm_medium=feed","summary":"[at Market Realist] - Instant messaging is quickly becoming the primary mode of communication in enterprises. Blackberry has the capabilities to provide secure and encrypted messaging services."},{"title":"How BlackBerry Is Expanding Its Embedded Software Business","publication_date":"2017-03-21 15:05:43 +0000","url":"http://marketrealist.com/2017/03/how-blackberry-is-expanding-its-embedded-software-delivery/?utm_source=yahoo&utm_medium=feed","summary":"How BlackBerry Is Expanding Its Embedded Software Business"},{"title":"What Do Analysts Expect from BlackBerry in Fiscal 4Q17?","publication_date":"2017-03-21 13:14:21 +0000","url":"http://marketrealist.com/2017/03/what-do-analysts-expect-from-blackberry-in-fiscal-4q17/?utm_source=yahoo&utm_medium=feed","summary":"What Do Analysts Expect from BlackBerry in Fiscal 4Q17?"},{"title":"BlackBerry Receives the First FedRAMP Authorization for Crisis Communication Software","publication_date":"2017-03-21 13:00:00 +0000","url":"http://finance.yahoo.com/news/blackberry-receives-first-fedramp-authorization-130000674.html","summary":"[Marketwired] - BlackBerry Limited , today announced its crisis communication software-as-a-service, BlackBerry AtHoc, has received Federal Risk and Authorization Management Program Authorization. This authorization certifies ..."},{"title":"BlackBerry May Be Spreading Itself Too Thin","publication_date":"2017-03-20 17:51:00 +0000","url":"http://www.forbes.com/sites/greatspeculations/2017/03/20/blackberry-may-be-spreading-itself-too-thin/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix","summary":"BlackBerry May Be Spreading Itself Too Thin"},{"title":"BlackBerry to Announce Year-End and Fourth Quarter Fiscal 2017 Results on Friday, March 31, 2017","publication_date":"2017-03-17 21:30:00 +0000","url":"http://finance.yahoo.com/news/blackberry-announce-end-fourth-quarter-213000124.html","summary":"[Marketwired] - BlackBerry Limited will be reporting results for the year-end and fourth quarter of fiscal 2017 on March 31, 2017. A conference call and live webcast will be held beginning at 8 a.m. ET, which can be accessed ..."},{"title":"BlackBerry Expands Embedded Software Delivery with New Partner Program","publication_date":"2017-03-16 19:09:19 +0000","url":"http://finance.yahoo.com/news/blackberry-expands-embedded-software-delivery-190919698.html","summary":"[Marketwired] - BlackBerry Limited today announced the addition of a new specialized Value-Added Integrator program that will build a worldwide network of experts trained on BlackBerry QNX and Certicom technologies. The ..."},{"title":"[video]Stop Wondering What Is Going on With Under Armour","publication_date":"2017-03-14 15:00:00 +0000","url":"https://www.thestreet.com/story/14042017/1/stop-wondering-what-is-going-on-with-under-armour.html?puc=yahoo&cm_ven=YAHOO","summary":"[video]Stop Wondering What Is Going on With Under Armour"},{"title":"Stop Wondering What Is Going on With Under Armour","publication_date":"2017-03-14 13:00:00 +0000","url":"http://realmoney.thestreet.com/articles/03/14/2017/stop-wondering-what-going-under-armour?puc=yahoo&cm_ven=YAHOO","summary":"Stop Wondering What Is Going on With Under Armour"},{"title":"Log Into Facebook Inc (FB) Stock For Free Money","publication_date":"2017-03-13 19:05:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mt1AildFfjM/log-into-facebook-inc-fb-stock-for-free-money-cm760172","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips I have shared many successful Facebook Inc NASDAQ FB trade ideas Most of those were designed as slow trades yet they ve yielded fast profits like this this one last month Today I want to share one that is"},{"title":"A Bullish Case For BlackBerry As An 'Anti-Trend Play'","publication_date":"2017-03-13 16:03:37 +0000","url":"http://finance.yahoo.com/news/bullish-case-blackberry-anti-trend-160337941.html","summary":"A Bullish Case For BlackBerry As An 'Anti-Trend Play'"},{"title":"3 Big Stock Charts for Thursday: CA, Inc. (CA), Autodesk, Inc. (ADSK) and Alexion Pharmaceuticals, Inc. (ALXN)","publication_date":"2017-03-09 19:16:17 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3tbYbk45z4M/3-big-stock-charts-for-thursday-ca-inc-ca-autodesk-inc-adsk-and-alexion-pharmaceuticals-inc-alxn-cm758770","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips We re starting to see more technical snags in the bull market that initiated after the results of the election in November All sectors are beginning to see dealers take profits or worse knock stocks out of"},{"title":"Should You Buy BlackBerry Ltd (BBRY) Stock? 3 Pros, 3 Cons","publication_date":"2017-03-09 15:16:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MhEBE3dEfJ8/should-you-buy-blackberry-ltd-bbry-stock-3-pros-3-cons-cm758529","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips At what point does a corporate turnaround simply become a busted company For investors in BlackBerry Ltd 160 NASDAQ BBRY patience must be running thin by this point BlackBerry has been in full on turnaround"},{"title":"BlackBerry (BBRY) is Oversold: Can It Recover?","publication_date":"2017-03-09 14:15:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VGanjENjZvU/blackberry-bbry-is-oversold-can-it-recover-cm758351","summary":"BlackBerry Limited BBRY has been on a bit of a cold streak lately but there might be light at the end of the tunnel for this overlooked stock And for technical investors there is some hope when looking at BBRY given that according to its RSI reading of 27 88 it is now in oversold"},{"title":"BlackBerry (BBRY) is Oversold: Can It Recover?","publication_date":"2017-03-09 12:08:12 +0000","url":"http://finance.yahoo.com/news/blackberry-bbry-oversold-recover-120812058.html","summary":"BlackBerry (BBRY) is Oversold: Can It Recover?"},{"title":"CIA Listed BlackBerry's Car Software as Possible Target","publication_date":"2017-03-08 19:12:50 +0000","url":"https://www.bloomberg.com/news/articles/2017-03-08/cia-listed-blackberry-s-car-software-as-possible-target-in-leak?cmpid=yhoo.headline","summary":"CIA Listed BlackBerry's Car Software as Possible Target"},{"title":"Netflix, Inc. (NFLX) Stock Wins When Everyone Stays Home","publication_date":"2017-03-07 22:13:01 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D0vnnEvORhA/netflix-inc-nflx-stock-wins-when-everyone-stays-home-cm757598","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips What do the pizza and big box retail industries have to do with 160 Netflix Inc NASDAQ NFLX and the performance 160 of NFLX stock going forward Source Apple Surprisingly a lot Domino s Pizza Inc"},{"title":"RadioShack To Kodak; These Companies Fell From Grace The Hardest","publication_date":"2017-03-07 19:44:25 +0000","url":"http://finance.yahoo.com/news/radioshack-kodak-companies-fell-grace-194425040.html","summary":"RadioShack To Kodak; These Companies Fell From Grace The Hardest"},{"title":"This is how much Google’s Play Store has added to its bottom line","publication_date":"2017-03-06 23:22:37 +0000","url":"http://www.bizjournals.com/sanjose/news/2017/03/06/google-android-play-store-revenue-apple-app-store.html?ana=yahoo","summary":"This is how much Google’s Play Store has added to its bottom line"},{"title":"Should I Buy BlackBerry Ltd (BBRY)? 3 Pros, 3 Cons","publication_date":"2017-03-06 23:12:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wMsR1e4uP24/should-i-buy-blackberry-ltd-bbry-3-pros-3-cons-cm756926","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips The collapse of BlackBerry Ltd NASDAQ BBRY has been stunning But in the tech world such things do happen with regularity Source WEi WEi via Flickr Yet BBRY stock is still far from dead Hey if anything it"},{"title":"BlackBerry is Now Oversold","publication_date":"2017-03-06 18:13:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mDfwn-GeeqI/blackberry-is-now-oversold-cm756719","summary":"Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on"},{"title":"Nokia Corp (ADR) (NOK) Hopes Old Phone Revival Can Help NOK Stock","publication_date":"2017-03-03 23:13:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r22w1FnKrhs/nokia-corp-adr-nok-hopes-old-phone-revival-can-help-nok-stock-cm756239","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips The high tech world is still buzzing after Nokia Corp ADR NYSE NOK and BlackBerry Ltd NASDAQ BBRY showed off new handsets at last weekend s Mobile World Conference However I m not sure nostalgia"},{"title":"Will the Galaxy S8 Save Samsung?","publication_date":"2017-03-03 19:34:42 +0000","url":"http://finance.yahoo.com/news/galaxy-s8-save-samsung-193442102.html","summary":"Will the Galaxy S8 Save Samsung?"},{"title":"BlackBerry's M&A head Mackey says left company in February","publication_date":"2017-03-02 21:57:57 +0000","url":"http://sg.finance.yahoo.com/news/blackberrys-m-head-mackey-says-204717596.html","summary":"BlackBerry's M&A head Mackey says left company in February"},{"title":"Goldman Irks Bankers With New Rules on Mobile Perks","publication_date":"2017-03-02 20:18:12 +0000","url":"http://finance.yahoo.com/news/goldman-reins-mobile-perks-irking-201812667.html","summary":"Goldman Irks Bankers With New Rules on Mobile Perks"},{"title":"BlackBerry's M&A head Mackey says left company in February","publication_date":"2017-03-02 19:59:39 +0000","url":"http://sg.finance.yahoo.com/news/blackberrys-m-head-mackey-says-193339783.html","summary":"BlackBerry's M&A head Mackey says left company in February"},{"title":"Vintage Western phone brands resurrected by Chinese players","publication_date":"2017-03-02 14:27:38 +0000","url":"http://finance.yahoo.com/news/vintage-western-phone-brands-resurrected-142738230.html","summary":"Vintage Western phone brands resurrected by Chinese players"},{"title":"11 Ways The Cell Phone Has Evolved Since The Nokia 3310","publication_date":"2017-03-01 19:20:25 +0000","url":"http://finance.yahoo.com/news/11-ways-cell-phone-evolved-192025490.html","summary":"11 Ways The Cell Phone Has Evolved Since The Nokia 3310"},{"title":"Why Nokia Corp (ADR) (NOK) Stock Should Move Higher in 2017","publication_date":"2017-02-28 21:50:32 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KUzc0DyUzfQ/why-nokia-corp-adr-nok-stock-should-move-higher-in-2017-cm754517","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Nokia Corp ADR 160 NYSE NOK is in back in favor on the stock markets again The company reported fourth quarter results where revenue missed consensus estimates but earnings of 0 04 per share still"},{"title":"Apple Stock Gets Two Price-Target Increases, Hovers Near High","publication_date":"2017-02-28 21:29:58 +0000","url":"http://www.investors.com/news/technology/click/apple-stock-gets-two-price-target-increases-hovers-near-high/","summary":"Apple Stock Gets Two Price-Target Increases, Hovers Near High"},{"title":"Play Tesla Inc (TSLA) Stock Before It Swings Back North","publication_date":"2017-02-28 17:50:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N7zA0Fvc7uM/play-tesla-inc-tsla-stock-before-it-swings-back-north-cm754311","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Tesla Inc NASDAQ TSLA initially rose after hours following an earnings report that raised as many questions as it answered However TSLA stock then succumbed to selling pressures and ultimately fell some 7"},{"title":"Go Long United Parcel Service, Inc. (UPS) Stock","publication_date":"2017-02-28 17:49:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MUBpsti5DW0/go-long-united-parcel-service-inc-ups-stock-cm754306","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Transportation stocks as represented by the 160 iShares Dow Jones Transport Avg ETF NYSEARCA IYT have rallied about 1 6 between last Friday and yesterday Monday Feb 27 This might"},{"title":"New Strong Buy Stocks for February 28th","publication_date":"2017-02-28 16:53:25 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ymz2AhU7KVE/new-strong-buy-stocks-for-february-28th-cm754292","summary":"Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today The Bank of N T Butterfield amp Son Limited NTB This provider of various specialized financial services has witnessed the Zacks Consensus Estimate for its current year earnings increased 0 6 over the last 30"},{"title":"BlackBerry Ltd (BBRY) Stock or Twilio Inc (TWLO): Which Is a Better Buy?","publication_date":"2017-02-28 15:49:15 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8E5y7jPcS3k/blackberry-ltd-bbry-stock-or-twilio-inc-twlo-which-is-a-better-buy-cm754194","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips This is a choice between BlackBerry Ltd NASDAQ BBRY a company with a storied past in hardware that has pivoted in recent times to software and Twilio Inc NYSE TWLO a company whose cloud based"},{"title":"New Strong Buy Stocks for February 28th","publication_date":"2017-02-28 14:12:02 +0000","url":"http://finance.yahoo.com/news/strong-buy-stocks-february-28th-141202681.html","summary":"New Strong Buy Stocks for February 28th"},{"title":"BlackBerry Markets Super Secure New Phone","publication_date":"2017-02-28 09:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kNxc0RE0fFs/blackberry-markets-super-secure-new-phone-20170228-01108","summary":"BlackBerry Markets Super Secure New Phone"},{"title":"[$$] Do Nokia, BlackBerry Still Pack a Punch?","publication_date":"2017-02-28 05:14:37 +0000","url":"https://www.wsj.com/articles/nokia-blackberry-ring-a-bell-but-can-they-still-pack-a-punch-1488201192?ru=yahoo?mod=yahoo_itp","summary":"[$$] Do Nokia, BlackBerry Still Pack a Punch?"},{"title":"How This High School Hit the Lottery With Snap Investment -- Tech Roundup","publication_date":"2017-02-27 21:36:00 +0000","url":"https://www.thestreet.com/story/14017668/1/how-this-high-school-hit-the-lottery-with-snap-investment-tech-roundup.html?puc=yahoo&cm_ven=YAHOO","summary":"How This High School Hit the Lottery With Snap Investment -- Tech Roundup"},{"title":"5 Reasons to Buy General Electric Company (GE) Stock","publication_date":"2017-02-27 20:49:25 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ioHAxmErHyc/5-reasons-to-buy-general-electric-company-ge-stock-cm753798","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors looking for a reasonably valued stock that is poised to benefit from the Trump presidency and the improvement of the global economy should buy General Electric Company NYSE GE 160 From Trump s energy"},{"title":"Alibaba Group Holding Ltd (BABA) Will Try to Dominate India","publication_date":"2017-02-27 19:50:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/glDZLyyZ74o/alibaba-group-holding-ltd-baba-will-try-to-dominate-india-cm753785","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips While China s e commerce market is still growing Alibaba Group Holding Ltd NYSE BABA and its affiliate Ant Financial are already looking south to India Last year Morgan Stanley predicted that the"},{"title":"Under Armour Inc (UA) Stock Offers the Easiest Profits Ever","publication_date":"2017-02-27 18:49:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FLRLUP_b7Tk/under-armour-inc-ua-stock-offers-the-easiest-profits-ever-cm753744","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Lost in the collapse of Under Armour Inc NYSE UA stock over the past year is an odd divergence between two classes of stock Shares of UAA stock Class A have traded at a substantial premium to UA stock Class C"},{"title":"[$$] Do Nokia, BlackBerry Still Pack a Punch?","publication_date":"2017-02-27 18:04:32 +0000","url":"https://www.wsj.com/articles/nokia-blackberry-ring-a-bell-but-can-they-still-pack-a-punch-1488201192?mod=yahoo_hs","summary":"[at The Wall Street Journal] - Licensing partners hope the answer is yes as they roll out new phones bearing the respected names at the Mobile World Congress."},{"title":"3 Stocks to Watch on Monday: Tesla Inc (TSLA), Alphabet Inc (GOOGL) and BlackBerry Ltd (BBRY)","publication_date":"2017-02-27 17:49:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/re6YZTIiA04/3-stocks-to-watch-on-monday-tesla-inc-tsla-alphabet-inc-googl-and-blackberry-ltd-bbry-cm753698","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips The U S stock market enters Monday s trading with major indices at all time highs and naturally many individual stocks in the same position However experts are increasingly warning about overvalued issues"},{"title":"What You Need To Know About KEYone, Blackberry's New Device","publication_date":"2017-02-27 17:24:17 +0000","url":"http://finance.yahoo.com/news/know-keyone-blackberrys-device-172417296.html","summary":"What You Need To Know About KEYone, Blackberry's New Device"},{"title":"BlackBerry Returns With the KEYone Smartphone","publication_date":"2017-02-27 17:06:49 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=D93F2155-3712-4D7E-9A3B-2BD073A7E551&siteid=yhoof2","summary":"BlackBerry Returns With the KEYone Smartphone"},{"title":"Apple Is Slowly but Surely Blowing Companies Away","publication_date":"2017-02-27 14:00:00 +0000","url":"http://realmoney.thestreet.com/articles/02/27/2017/apple-slowly-surely-blowing-companies-away?puc=yahoo&cm_ven=YAHOO","summary":"Apple Is Slowly but Surely Blowing Companies Away"},{"title":"BlackBerry, Chinese Device Maker TCL Team Up for New Handheld Device","publication_date":"2017-02-27 13:02:00 +0000","url":"https://www.thestreet.com/story/14016693/1/blackberry-and-chinese-device-maker-tcl-team-up-for-new-handheld-device.html?puc=yahoo&cm_ven=YAHOO","summary":"BlackBerry, Chinese Device Maker TCL Team Up for New Handheld Device"},{"title":"BlackBerry and Nokia Attempt Comebacks With Some Throwbacks","publication_date":"2017-02-27 11:05:00 +0000","url":"http://www.investopedia.com/news/blackberry-and-nokia-attempt-comebacks-some-throwbacks-bbry-nok/?partner=YahooSA","summary":"[at Investopedia] - The new phones were unveiled over the weekend at the Mobile World Congress in Barcelona."},{"title":"TCL carries flickering BlackBerry flame with new phone launch","publication_date":"2017-02-26 03:24:05 +0000","url":"http://sg.finance.yahoo.com/news/tcl-carries-flickering-blackberry-flame-032405084.html","summary":"[Reuters] - Blackberry Ltd may have exited the device business, but fans of the pioneering email machine need not despair as Chinese smartphone maker TCL Communication has introduced its first Blackberry-licensed phone with the physical keyboard that was long its key allure. The KEYone combines a touch display with a physical keyboard to give users more useable space for typing than a typical 5.5-inch all-touch smartphone, along with BlackBerry Ltd's security and software, TCL said. TCL cut the new brand-licensing deal in December with BlackBerry Ltd., which now focuses on making the security software that was another key factor underpinning the Canadian company's phenomenal success in the pre-smartphone era and sustained it with corporate users as the world moved on to smartphones with other features."},{"title":"China's TCL brings back physical keyboard in new BlackBerry","publication_date":"2017-02-25 22:50:49 +0000","url":"http://uk.finance.yahoo.com/news/chinas-tcl-brings-back-physical-225049190.html","summary":"China's TCL brings back physical keyboard in new BlackBerry"},{"title":"TCL carries flickering BlackBerry flame with new phone launch","publication_date":"2017-02-25 19:06:46 +0000","url":"http://sg.finance.yahoo.com/news/tcl-carries-flickering-blackberry-flame-190646350.html","summary":"[Reuters] - Blackberry Ltd (BB.TO) may have exited the device business, but fans of the pioneering email machine need not despair as Chinese smartphone maker TCL Communication (TCCLF.PK) has introduced its first Blackberry-licensed phone with the physical keyboard that was long its key allure. The KEYone combines a touch display with a physical keyboard to give users more useable space for typing than a typical 5.5-inch all-touch smartphone, along with BlackBerry Ltd's security and software, TCL said. TCL cut the new brand-licensing deal in December with BlackBerry Ltd., which now focuses on making the security software that was another key factor underpinning the Canadian company's phenomenal success in the pre-smartphone era and sustained it with corporate users as the world moved on to smartphones with other features."},{"title":"TCL carries flickering BlackBerry flame with new phone launch","publication_date":"2017-02-25 19:05:02 +0000","url":"http://sg.finance.yahoo.com/news/tcl-carries-flickering-blackberry-flame-190502039.html","summary":"[Reuters] - Blackberry Ltd (BB.TO) may have exited the device business, but fans of the pioneering email machine need not despair as Chinese smartphone maker TCL Communication (TCCLF.PK) has introduced its first Blackberry-licensed phone with the physical keyboard that was long its key allure. The KEYone combines a touch display with a physical keyboard to give users more useable space for typing than a typical 5.5-inch all-touch smartphone, along with BlackBerry Ltd's security and software, TCL said. TCL cut the new brand-licensing deal in December with BlackBerry Ltd., which now focuses on making the security software that was another key factor underpinning the Canadian company's phenomenal success in the pre-smartphone era and sustained it with corporate users as the world moved on to smartphones with other features."},{"title":"BlackBerry refuses to say die, launches new $549 device with a physical keyboard and Android OS","publication_date":"2017-02-25 19:00:00 +0000","url":"http://www.cnbc.com/id/104304932?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104304932","summary":"BlackBerry refuses to say die, launches new $549 device with a physical keyboard and Android OS"},{"title":"[video]Here's What to Expect From the Mobile World Congress Next Week","publication_date":"2017-02-24 18:55:00 +0000","url":"https://www.thestreet.com/story/14015736/1/here-s-what-to-expect-from-the-mobile-world-congress-next-week.html?puc=yahoo&cm_ven=YAHOO","summary":"[video]Here's What to Expect From the Mobile World Congress Next Week"},{"title":"Apple Inc. Fesses Up to iPhone 6 Battery Issue, Releases Fix","publication_date":"2017-02-24 18:51:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a1d2Xox6mS0/apple-inc-fesses-up-to-iphone-6-battery-issue-releases-fix-cm752995","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips If it seems as though Apple Inc NASDAQ AAPL has been fighting with battery issues with the iPhone 6 and iPhone 6s for months that s because it has Source Apple There was a limited recall of iPhone"},{"title":"BlackBerry Ltd. – Value Analysis (NASDAQ:BBRY) : February 24, 2017","publication_date":"2017-02-24 18:45:37 +0000","url":"http://www.capitalcube.com/blog/index.php/blackberry-ltd-value-analysis-nasdaqbbry-february-24-2017/","summary":"BlackBerry Ltd. – Value Analysis (NASDAQ:BBRY) : February 24, 2017"},{"title":"BlackBerry Ltd. breached its 50 day moving average in a Bearish Manner : BBRY-US : February 23, 2017","publication_date":"2017-02-23 12:32:12 +0000","url":"http://www.capitalcube.com/blog/index.php/blackberry-ltd-breached-its-50-day-moving-average-in-a-bearish-manner-bbry-us-february-23-2017/","summary":"BlackBerry Ltd. breached its 50 day moving average in a Bearish Manner : BBRY-US : February 23, 2017"},{"title":"[$$] Smartphones to find their voice again at MWC in Barcelona","publication_date":"2017-02-23 05:00:16 +0000","url":"http://www.ft.com/cms/s/4052c266-f917-11e6-9516-2d969e0d3b65,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","summary":"[at Financial Times] - The mobile industry may have almost lost its voice in recent years, in the age of the data-focused smartphone, but next week's Mobile World Congress in Barcelona could mark a comeback for talking into ..."},{"title":"First Week of BBRY December 15th Options Trading","publication_date":"2017-02-22 19:52:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fjPacN3Kgog/first-week-of-bbry-december-15th-options-trading-cm751562","summary":"Investors in BlackBerry Ltd Symbol BBRY saw new options begin trading this week for the December 15th expiration One of the key data points that goes into the price an option buyer is willing to pay is the time value so with 296 days until expiration the newly trading contracts represent"},{"title":"BlackBerry's fall from grace, in one chart","publication_date":"2017-02-21 22:54:29 +0000","url":"http://finance.yahoo.com/news/blackberrys-fall-grace-one-chart-225429545.html","summary":"BlackBerry's fall from grace, in one chart"},{"title":"Gilead Sciences, Inc. (GILD) Stock Has Caught a Cold","publication_date":"2017-02-21 22:06:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iJD3PXxHWe0/gilead-sciences-inc-gild-stock-has-caught-a-cold-cm750930","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech stocks are ramping this month but not all drug companies are joining in the bullish festivities Unfortunately for shareholders of Gilead Sciences Inc NASDAQ GILD the California based"},{"title":"Top 3 Tech Stocks Under $10","publication_date":"2017-02-21 21:07:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ss9_YJGy4B8/top-3-tech-stocks-under-10-cm750845","summary":"Here at Zacks we don t generally classify stocks as cheap or expensive and rather than looking at the stock s face value we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors That being said low priced stocks"},{"title":"Top 3 Tech Stocks Under $10","publication_date":"2017-02-21 19:23:07 +0000","url":"http://finance.yahoo.com/news/top-3-tech-stocks-under-192307592.html","summary":"Top 3 Tech Stocks Under $10"},{"title":"The Precipitous Fall Of The Blackberry In One Graph","publication_date":"2017-02-21 18:41:58 +0000","url":"http://finance.yahoo.com/news/precipitous-fall-blackberry-one-graph-184158191.html","summary":"The Precipitous Fall Of The Blackberry In One Graph"},{"title":"Apple Could Introduce Apple Pencil 2 with New iPad","publication_date":"2017-02-21 15:36:01 +0000","url":"http://marketrealist.com/2017/02/apple-could-introduce-apple-pencil-2-with-new-ipad/?utm_source=yahoo&utm_medium=feed","summary":"Apple Could Introduce Apple Pencil 2 with New iPad"},{"title":"[$$] Pager alert! Vodafone sells beeper unit to Capita","publication_date":"2017-02-20 15:10:32 +0000","url":"http://www.ft.com/cms/s/99e92b22-f759-11e6-9516-2d969e0d3b65,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","summary":"[at Financial Times] - Vodafone is finally getting out of pagers, the beeping business that seems archaic in the age of smartphones, but is still beloved, in dwindling numbers, by birdwatchers, coastguards and medics. Professional ..."},{"title":"The Snapchat (SNAP) IPO Will Be a Bust, But You Should Buy It Anyway","publication_date":"2017-02-17 19:53:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7DpDOgdS9JM/the-snapchat-snap-ipo-will-be-a-bust-but-you-should-buy-it-anyway-cm749816","summary":"InvestorPlace Stock Market News Stock Advice amp Trading Tips Snapchat s NYSE SNAP IPO has mainstream media sounding alarm bells Fortune wrote that Snapchat Likely the Most Expensive Big Tech IPO Ever the Wall Street Journal said a shadow looms over its IPO"},{"title":"Top 10 Stocks Under $20","publication_date":"2017-02-17 19:19:07 +0000","url":"http://finance.yahoo.com/news/top-10-stocks-under-20-191907356.html","summary":"Top 10 Stocks Under $20"},{"title":"Billionaire Prem Watsa’s Fairfax Financial Holdings Boosts Stakes in Kennedy-Wilson, U.S. Bancorp, Johnson & Johnson","publication_date":"2017-02-17 16:55:41 +0000","url":"http://www.insidermonkey.com/blog/billionaire-prem-watsas-fairfax-financial-holdings-boosts-stakes-in-kennedy-wilson-u-s-bancorp-johnson-johnson-557919/","summary":"Billionaire Prem Watsa’s Fairfax Financial Holdings Boosts Stakes in Kennedy-Wilson, U.S. Bancorp, Johnson & Johnson"},{"title":"Apple Struggles to Appeal to the Android Community","publication_date":"2017-02-17 14:07:29 +0000","url":"http://marketrealist.com/2017/02/apple-struggles-to-appeal-to-the-android-community/?utm_source=yahoo&utm_medium=feed","summary":"Apple Struggles to Appeal to the Android Community"},{"title":"Nokia’s Move Could Complicate Apple’s Recovery in China","publication_date":"2017-02-17 14:05:51 +0000","url":"http://marketrealist.com/2017/02/nokias-move-could-complicate-apples-recovery-in-china/?utm_source=yahoo&utm_medium=feed","summary":"Nokia’s Move Could Complicate Apple’s Recovery in China"},{"title":"It’s Complicated: Apple’s Recent Push in India","publication_date":"2017-02-16 14:06:01 +0000","url":"http://marketrealist.com/2017/02/its-complicated-apples-recent-push-in-india/?utm_source=yahoo&utm_medium=feed","summary":"It’s Complicated: Apple’s Recent Push in India"},{"title":"BlackBerry Launches Patent Lawsuit Against Nokia","publication_date":"2017-02-15 16:10:00 +0000","url":"http://www.investopedia.com/news/blackberry-launches-patent-lawsuit-against-nokia/?partner=YahooSA","summary":"[at Investopedia] - BlackBerry filed a patent infringement suit against Nokia, seeking an undisclosed amount of money."},{"title":"Today's Research Reports on Trending Tickers: Kraft Heinz and BlackBerry","publication_date":"2017-02-15 14:45:00 +0000","url":"http://finance.yahoo.com/news/todays-research-reports-trending-tickers-144500146.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 15, 2017 / U.S. markets continued to rise off their record highs Tuesday after Federal Reserve Chairwoman hinted that the central bank could raise short-term interest ..."},{"title":"BlackBerry Slaps Nokia With A Patent Infringement Lawsuit","publication_date":"2017-02-15 13:25:19 +0000","url":"http://finance.yahoo.com/news/blackberry-slaps-nokia-patent-infringement-132519018.html","summary":"BlackBerry Slaps Nokia With A Patent Infringement Lawsuit"},{"title":"BlackBerry Files Patent-Infringement Suit Against Nokia","publication_date":"2017-02-14 19:57:16 +0000","url":"http://www.bloomberg.com/news/articles/2017-02-14/blackberry-files-patent-infringement-suit-against-nokia?cmpid=yhoo.headline","summary":"BlackBerry Files Patent-Infringement Suit Against Nokia"},{"title":"BlackBerry Ltd (BBRY) Might Actually Make Money Again Someday","publication_date":"2017-02-13 19:18:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XJXPKsqRu_w/blackberry-ltd-bbry-might-actually-make-money-again-someday-cm747252","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Remember BlackBerry Ltd 160 NASDAQ BBRY Yes BBRY 160 is still in the game It s 160 in a minor league a software and services league but it s 160 still trying to play Source WEi WEi"},{"title":"Qualcomm, Inc. (QCOM) Stock: Is the Worst Over?","publication_date":"2017-02-13 19:18:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/demWEIHh2Wg/qualcomm-inc-qcom-stock-is-the-worst-over-cm747249","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips All s fair in love and war and apparently business at least until you get caught and sued that it That s the situation leading wireless communications chipmaker 160 Qualcomm Inc 160 NASDAQ"},{"title":"BlackBerry Ltd (BBRY) Stock Worth $8 a Share","publication_date":"2017-02-09 21:20:04 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C_1VqaCeK1E/blackberry-ltd-bbry-stock-worth-8-a-share-cm745865","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Saying it is better late than never is cliché so when BlackBerry Ltd NASDAQ BBRY announced it would license BBM the news was met with yawns The stock moved a bit over 4 on the week Still BBRY"},{"title":"BlackBerry unveils Cloud-based communications platform","publication_date":"2017-02-09 07:44:05 +0000","url":"http://in.finance.yahoo.com/news/blackberry-unveils-cloud-based-communications-074405486.html","summary":"BlackBerry unveils Cloud-based communications platform"},{"title":"BlackBerry Breaks Above 200-Day Moving Average - Bullish for BBRY","publication_date":"2017-02-08 18:18:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OUKeLxpRGYI/blackberry-breaks-above-200-day-moving-average-bullish-for-bbry-cm745007","summary":"In trading on Wednesday shares of BlackBerry Ltd Symbol BBRY crossed above their 200 day moving average of 7 30 changing hands as high as 7 31 per share BlackBerry Ltd shares are currently trading up about 2 4 on the day The chart below shows the one year performance of BBRY"},{"title":"BlackBerry to License Software to App Developers","publication_date":"2017-02-08 15:32:00 +0000","url":"http://www.investopedia.com/news/blackberry-license-software-app-developers/?partner=YahooSA","summary":"BlackBerry to License Software to App Developers"},{"title":"BlackBerry is trying a new way to make money from Messenger","publication_date":"2017-02-08 13:12:18 +0000","url":"http://www.cnbc.com/id/104268960?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104268960","summary":"BlackBerry is trying a new way to make money from Messenger"},{"title":"PRESS DIGEST- Canada-Feb 8","publication_date":"2017-02-08 10:48:56 +0000","url":"http://finance.yahoo.com/news/press-digest-canada-feb-8-104856935.html","summary":"[Reuters] - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL alerts-data.json alerts-fundamentals.json alerts.new.csv alerts.raw alerts.symbols alerts-symbols-list BBRY-1d-chart data.json headlines.json jq-linux64 symbol-1d.php symbol-1yr.php symbol-3mo.php symbol-6mo.php symbols.txt xml2json BlackBerry Ltd is preparing to turn ..."},{"title":"BlackBerry Launches New Communications Platform for Software Developers","publication_date":"2017-02-07 22:15:44 +0000","url":"http://blogs.wsj.com/cio/2017/02/07/blackberry-launches-new-communications-platform-for-software-developers/?mod=yahoo_hs","summary":"BlackBerry Launches New Communications Platform for Software Developers"},{"title":"BlackBerry Goes After Twilio With Messaging App Developer Kit","publication_date":"2017-02-07 20:00:00 +0000","url":"http://www.bloomberg.com/news/articles/2017-02-07/blackberry-goes-after-twilio-with-messaging-app-developer-kit?cmpid=yhoo.headline","summary":"BlackBerry Goes After Twilio With Messaging App Developer Kit"},{"title":"BlackBerry Introduces the Most Secure Cloud-Based Communications Platform for Developers","publication_date":"2017-02-07 20:00:00 +0000","url":"http://finance.yahoo.com/news/blackberry-introduces-most-secure-cloud-200000741.html","summary":"[Marketwired] - BlackBerry Limited entered the Communications Platform as a Service market today with the introduction of its BBM Enterprise SDK that will enable developers to integrate secure messaging, voice and video ..."},{"title":"With India Deal, BlackBerry Looks to Build Its Comeback Momentum","publication_date":"2017-02-07 12:18:00 +0000","url":"https://www.thestreet.com/story/13991510/1/with-india-deal-blackberry-looks-to-build-its-comeback-momentum.html?puc=yahoo&cm_ven=YAHOO","summary":"With India Deal, BlackBerry Looks to Build Its Comeback Momentum"},{"title":"BlackBerry Inks India Deal With Optiemus Infracom","publication_date":"2017-02-06 22:06:00 +0000","url":"http://www.investopedia.com/news/blackberry-inks-india-deal-optiemus-infracom/?partner=YahooSA","summary":"BlackBerry Inks India Deal With Optiemus Infracom"},{"title":"Is BlackBerry Mounting a Comeback? -- Tech Roundup","publication_date":"2017-02-06 21:43:00 +0000","url":"https://www.thestreet.com/story/13991744/1/is-blackberry-mounting-a-comeback-tech-roundup.html?puc=yahoo&cm_ven=YAHOO","summary":"[at TheStreet] - By licensing its brand and shifting away from hardware, BlackBerry's focus on India could yield big results."},{"title":"BlackBerry inks hardware licensing deal covering India","publication_date":"2017-02-06 16:57:10 +0000","url":"http://sg.finance.yahoo.com/news/blackberry-inks-hardware-licensing-deal-165710840.html","summary":"BlackBerry inks hardware licensing deal covering India"},{"title":"What Has Smartphone Makers Worried about Apple’s Ambitions?","publication_date":"2017-02-06 15:37:09 +0000","url":"http://marketrealist.com/2017/02/what-has-smartphone-makers-worried-about-apples-ambitions/?utm_source=yahoo&utm_medium=feed","summary":"What Has Smartphone Makers Worried about Apple’s Ambitions?"},{"title":"Jenny Holzer's Favorite Things","publication_date":"2017-02-06 15:08:36 +0000","url":"https://www.wsj.com/articles/jenny-holzers-favorite-things-1486393713?mod=yahoo_hs","summary":"Jenny Holzer's Favorite Things"},{"title":"BlackBerry partners with Optiemus to manufacture handsets in India","publication_date":"2017-02-06 06:08:04 +0000","url":"http://in.finance.yahoo.com/news/blackberry-partners-optiemus-manufacture-handsets-060804386.html","summary":"BlackBerry partners with Optiemus to manufacture handsets in India"},{"title":"BlackBerry Announces its Next Major Mobile Software Licensing Agreement with Optiemus in India","publication_date":"2017-02-06 04:58:32 +0000","url":"http://finance.yahoo.com/news/blackberry-announces-next-major-mobile-045832476.html","summary":"[Marketwired] - BlackBerry Limited , a global software leader in securing, connecting and mobilizing enterprises, is announcing its next major agreement to license BlackBerry software and services for the production of ..."},{"title":"Will MobileIron's (MOBL) Q4 Earnings Pull Off a Surprise?","publication_date":"2017-02-02 13:32:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GcW5UMpqd5Y/will-mobileirons-mobl-q4-earnings-pull-off-a-surprise-cm742008","summary":"MobileIron Inc MOBL is set to report fourth quarter 2016 results on Nov 7 Last quarter the company posted a positive earnings surprise of 27 27 Adjusted loss of 7 cents per share excluding stock based compensation was much narrower than the year ago loss figure of 17 cents Share"},{"title":"Is Apple A Double From Here?","publication_date":"2017-02-02 02:12:00 +0000","url":"http://www.forbes.com/sites/bryanrich/2017/02/01/is-apple-a-double-from-here/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix","summary":"Is Apple A Double From Here?"},{"title":"Nokia Corp (ADR) (NOK) Stock Is Still Hobbling","publication_date":"2017-02-01 18:30:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ojrfz1ehFJ4/nokia-corp-adr-nok-stock-is-still-hobbling-cm741722","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Nokia Corp ADR NYSE NOK is quintessentially Finnish beautiful rugged quirky and a bit tragic Once considered the preeminent mobile phone platform its reign was challenged briefly by"},{"title":"BlackBerry Advances Global Expansion of Its AtHoc Crisis Communication Software","publication_date":"2017-01-31 14:00:00 +0000","url":"http://finance.yahoo.com/news/blackberry-advances-global-expansion-athoc-140000700.html","summary":"[Marketwired] - BlackBerry Limited , today announced that BlackBerry Secure, the company's comprehensive approach to security addressing the entire enterprise from end point to end point, is now able to help organizations ..."},{"title":"Blackberry's Chen on U.S. Immigration Ban","publication_date":"2017-01-30 22:12:08 +0000","url":"http://finance.yahoo.com/video/blackberrys-chen-u-immigration-ban-221208857.html","summary":"Blackberry's Chen on U.S. Immigration Ban"},{"title":"3 Stocks to Watch on Monday: Apple Inc. (AAPL), BlackBerry Ltd (BBRY) and Delta Air Lines, Inc. (DAL)","publication_date":"2017-01-30 16:32:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oqU-Ez67c_I/3-stocks-to-watch-on-monday-apple-inc-aapl-blackberry-ltd-bbry-and-delta-air-lines-inc-dal-cm740239","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips There have been promises of Donald Trump s presidency improving the U S economy but a report from Source ETF one of the leading exchange traded fund product providers in Europe"},{"title":"BlackBerry Ltd (BBRY) DTEK70: Game-Changer or Non-Event?","publication_date":"2017-01-26 20:33:05 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0LBmqBdm5G0/blackberry-ltd-bbry-dtek70-game-changer-or-non-event-cm738967","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The rumor mill is spinning again with 160 BlackBerry Ltd 160 NASDAQ BBRY Code named Mercury the next BlackBerry device DTEK70 will reportedly get a Feb 25 160 launch date And BBRY"},{"title":"First Week of BBRY May 19th Options Trading","publication_date":"2017-01-24 17:34:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WCIgzdp6hQc/first-week-of-bbry-may-19th-options-trading-cm737446","summary":"Investors in BlackBerry Ltd Symbol BBRY saw new options begin trading this week for the May 19th expiration One of the key inputs that goes into the price an option buyer is willing to pay is the time value so with 115 days until expiration the newly trading contracts represent a"},{"title":"BlackBerry Enters Indian Market Via AtHoc","publication_date":"2017-01-23 16:46:00 +0000","url":"http://www.investopedia.com/news/blackberry-enters-indian-market-athoc/?partner=YahooSA","summary":"BlackBerry Enters Indian Market Via AtHoc"},{"title":"What Awaits Rogers Communications (RCI) in Q4 Earnings?","publication_date":"2017-01-20 14:41:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1T6XeQX-a9E/what-awaits-rogers-communications-rci-in-q4-earnings-cm735862","summary":"Rogers Communications Inc RCI the largest integrated telecom operator in Canada is slated to report fourth quarter 2016 results before the opening bell on Jan 26 Last quarter Rogers Communications posted a negative earnings surprise of 10 45 Moreover the company s earnings lagged"},{"title":"What's in Store for Comcast (CMCSA) this Earnings Season?","publication_date":"2017-01-20 13:39:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yl6YUOJ3CgE/whats-in-store-for-comcast-cmcsa-this-earnings-season-cm735815","summary":"Comcast Corp CMCSA the leading cable multi service operator MSO in the U S is slated to report fourth quarter 2016 results on Jan 26 before the opening bell Last quarter Comcast Corp s bottom line matched the Zacks Consensus Estimate However the company s earnings surpassed"},{"title":"What Awaits Rogers Communications (RCI) in Q4 Earnings?","publication_date":"2017-01-20 12:06:12 +0000","url":"http://finance.yahoo.com/news/awaits-rogers-communications-rci-q4-120612279.html","summary":"What Awaits Rogers Communications (RCI) in Q4 Earnings?"},{"title":"What's in Store for Comcast (CMCSA) this Earnings Season?","publication_date":"2017-01-20 11:58:11 +0000","url":"http://finance.yahoo.com/news/whats-store-comcast-cmcsa-earnings-115811828.html","summary":"What's in Store for Comcast (CMCSA) this Earnings Season?"},{"title":"Crown Castle (CCI) to Report Q4 Earnings: Will it Surprise?","publication_date":"2017-01-19 17:43:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DBDzzowSYkk/crown-castle-cci-to-report-q4-earnings-will-it-surprise-cm735507","summary":"Crown Castle International Corp CCI a leading wireless communication tower operator in the U S is scheduled to report fourth quarter 2016 financial numbers on Jan 25 after market close Last quarter the company posted a negative earnings surprise of 3 54 However the company s"},{"title":"Is a Beat in the Cards for Qualcomm (QCOM) Q1 Earnings?","publication_date":"2017-01-19 17:43:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gOHJOfBW8ag/is-a-beat-in-the-cards-for-qualcomm-qcom-q1-earnings-cm735493","summary":"Qualcomm Inc QCOM the largest manufacturer of wireless chipsets based on baseband technology in the U S is scheduled to report first quarter fiscal 2017 numbers on Jan 25 after market close Last quarter the company posted an impressive 19 39 positive earnings surprise Moreover"},{"title":"Is a Beat in the Cards for Qualcomm (QCOM) Q1 Earnings?","publication_date":"2017-01-19 15:28:03 +0000","url":"http://finance.yahoo.com/news/beat-cards-qualcomm-qcom-q1-152803469.html","summary":"Is a Beat in the Cards for Qualcomm (QCOM) Q1 Earnings?"},{"title":"Crown Castle (CCI) to Report Q4 Earnings: Will it Surprise?","publication_date":"2017-01-19 15:21:03 +0000","url":"http://finance.yahoo.com/news/crown-castle-cci-report-q4-152103491.html","summary":"Crown Castle (CCI) to Report Q4 Earnings: Will it Surprise?"},{"title":"Can Verizon (VZ) Pull Off a Surprise This Earnings Season?","publication_date":"2017-01-18 23:37:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-3np3QZJoJY/can-verizon-vz-pull-off-a-surprise-this-earnings-season-cm735127","summary":"U S telecom behemoth Verizon Communications Inc VZ is slated to report fourth quarter 2016 results before the opening bell on Jan 24 Last quarter Verizon posted an earnings surprise of 2 02 Moreover the company s earnings surpassed the Zacks Consensus Estimate in three of the"},{"title":"Will AT&T (T) Disappoint Investors This Earnings Season?","publication_date":"2017-01-18 22:38:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zDvFsarYCOs/will-att-t-disappoint-investors-this-earnings-season-cm735098","summary":"AT amp T Inc T is scheduled to report fourth quarter 2016 financial numbers on Jan 25 after markets close Last quarter AT amp T s bottom line matched the Zacks Consensus Estimate Moreover the company s earnings surpassed the Zacks Consensus Estimate in one of the previous four"},{"title":"Can Verizon (VZ) Pull Off a Surprise This Earnings Season?","publication_date":"2017-01-18 21:13:09 +0000","url":"http://finance.yahoo.com/news/verizon-vz-pull-off-surprise-211309560.html","summary":"Can Verizon (VZ) Pull Off a Surprise This Earnings Season?"},{"title":"Will AT&T (T) Disappoint Investors This Earnings Season?","publication_date":"2017-01-18 20:08:08 +0000","url":"http://finance.yahoo.com/news/t-t-disappoint-investors-earnings-200808062.html","summary":"Will AT&T (T) Disappoint Investors This Earnings Season?"},{"title":"Cincinnati Bell (CBB) to Hire 300, Expand Call Center Base","publication_date":"2017-01-16 16:39:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HIv63lj-e4U/cincinnati-bell-cbb-to-hire-300-expand-call-center-base-cm733925","summary":"Telecom service provider Cincinnati Bell Inc CBB is planning to hire 300 more employees at its universal call centers to enhance customer service The telco currently has more than 100 locally based universal call center agents assisting its customers This is a milestone for a company"},{"title":"Cincinnati Bell (CBB) to Hire 300, Expand Call Center Base","publication_date":"2017-01-16 14:17:02 +0000","url":"http://finance.yahoo.com/news/cincinnati-bell-cbb-hire-300-141702625.html","summary":"Cincinnati Bell (CBB) to Hire 300, Expand Call Center Base"},{"title":"How Symantec, FireEye, Cisco and Others Could Fit Into Trump's Cybersecurity Plan","publication_date":"2017-01-15 17:05:00 +0000","url":"https://www.thestreet.com/story/13954004/1/how-symantec-fireeye-cisco-and-others-could-fit-into-trump-s-cybersecurity-plan.html?puc=yahoo&cm_ven=YAHOO","summary":"[at TheStreet] - Security adviser Rudy Giuliani plans to reach out to the private sector for help defending the government from attacks."},{"title":"BBRY Crosses Above Key Moving Average Level","publication_date":"2017-01-13 17:38:12 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nIguO9uIffA/bbry-crosses-above-key-moving-average-level-cm733343","summary":"In trading on Friday shares of BlackBerry Ltd Symbol BBRY crossed above their 200 day moving average of 7 30 changing hands as high as 7 35 per share BlackBerry Ltd shares are currently trading up about 1 3 on the day The chart below shows the one year performance of BBRY shares"},{"title":"Here’s How iPhone 8 Could Drive Record Sales at Apple","publication_date":"2017-01-13 14:06:33 +0000","url":"http://marketrealist.com/2017/01/iphone-8-drive-record-sales-apple/?utm_source=yahoo&utm_medium=feed","summary":"Here’s How iPhone 8 Could Drive Record Sales at Apple"},{"title":"US Fear of China’s Semiconductor Ambitions: Qualcomm’s Gain?","publication_date":"2017-01-12 22:05:44 +0000","url":"http://marketrealist.com/2017/01/can-us-fear-chinas-semiconductor-ambitions-benefit-qualcomm/?utm_source=yahoo&utm_medium=feed","summary":"US Fear of China’s Semiconductor Ambitions: Qualcomm’s Gain?"},{"title":"iOS Products Will Lead to $1 Trillion for Apple -- Tech Roundup","publication_date":"2017-01-12 21:51:00 +0000","url":"https://www.thestreet.com/story/13953079/1/ios-products-will-lead-to-1-trillion-for-apple-tech-roundup.html?puc=yahoo&cm_ven=YAHOO","summary":"iOS Products Will Lead to $1 Trillion for Apple -- Tech Roundup"},{"title":"Apple Inc. (AAPL) Stock Cuts Production, But It May Not Be Time to Run","publication_date":"2017-01-11 17:56:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5M-wdCxOkII/apple-inc-aapl-stock-cuts-production-but-it-may-not-be-time-to-run-cm732269","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips While the world was singing Auld Lang Syne on New Year s Eve the Whiz Kids in Cupertino were singing a much different tune one that was a bit sadder It turns out that Apple Inc NASDAQ AAPL"},{"title":"Blackberry is quietly trying to make a comeback — but not with phones","publication_date":"2017-01-11 17:30:31 +0000","url":"http://finance.yahoo.com/news/blackberry-looking-comeback-not-phones-173031326.html","summary":"Blackberry is quietly trying to make a comeback — but not with phones"},{"title":"Liberty Interactive (QVCA) Raised to Buy on Solid Prospects","publication_date":"2017-01-11 17:01:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sgmBoNTBGSY/liberty-interactive-qvca-raised-to-buy-on-solid-prospects-cm732257","summary":"On Jan 10 Liberty Interactive Corp QVCA was upgraded by a notch to a Zacks Rank 2 Buy You can see the complete list of today s Zacks 1 Rank Strong Buy stocks here We believe the rollout and success in online sales international operations and foray into new markets and"},{"title":"[$$] Sonos turns to new chief to drive smart-homes push","publication_date":"2017-01-11 05:49:57 +0000","url":"http://www.ft.com/cms/s/2eccd906-d7ba-11e6-944b-e7eb37a6aa8e,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","summary":"[at Financial Times] - Sonos has promoted former BlackBerry manager Patrick Spence to take over as chief executive from founder John MacFarlane, after the rise of streaming music services propelled the wireless speaker maker ..."},{"title":"Has Blackberry Turned the Corner?","publication_date":"2017-01-10 20:52:10 +0000","url":"http://marketrealist.com/2017/01/blackberry-turned-corner/?utm_source=yahoo&utm_medium=feed","summary":"Has Blackberry Turned the Corner?"},{"title":"Apple Inc. (AAPL) iPhone 10th Birthday Also Marks the End of an Era","publication_date":"2017-01-09 20:49:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NGxoUQ-ied0/apple-inc-aapl-iphone-10th-birthday-also-marks-the-end-of-an-era-cm731277","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Happy birthday to the iPhone As difficult as it may be to recall a time when the popular defining smartphone from Apple Inc NASDAQ AAPL wasn t around it was ten years ago today the Steve"},{"title":"Will Apple Survive Nokia’s New Patent Lawsuit?","publication_date":"2017-01-09 20:43:02 +0000","url":"http://marketrealist.com/2017/01/will-apple-survive-nokias-new-patent-onslaught/?utm_source=yahoo&utm_medium=feed","summary":"Will Apple Survive Nokia’s New Patent Lawsuit?"},{"title":"A Timeline of Every New iPhone Feature Apple Has Introduced in the Last 10 Years","publication_date":"2017-01-09 19:45:00 +0000","url":"https://www.thestreet.com/slideshow/13947227/1/a-timeline-of-every-new-iphone-feature-apple-has-introduced-in-the-last-10-years.html?puc=yahoo&cm_ven=YAHOO","summary":"A Timeline of Every New iPhone Feature Apple Has Introduced in the Last 10 Years"},{"title":"Apple Inc. (AAPL): Why iPhone’s 10th Birthday Matters Right Now","publication_date":"2017-01-09 15:50:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qtFV3D3RWhI/apple-inc-aapl-why-iphones-10th-birthday-matters-right-now-cm730972","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips On the surface Jan 9 2017 might not seem like a particularly important date but if you follow the story of Apple Inc NASDAQ AAPL this day is huge Source Apple It was exactly a decade"},{"title":"Android Circuit: Galaxy S8 Launch Date Leaks, Galaxy Note Returns, Fixing Google Pixel Problems","publication_date":"2017-01-07 00:14:00 +0000","url":"http://www.forbes.com/sites/ewanspence/2017/01/06/android-news-digest-samsung-galaxy-s8-edge-pixel-blackberry-oneplus/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix","summary":"[at Forbes] - This week’s Android Circuit includes Samsung's new desktop mode for the Galaxy S8, two possible designs for the S8, the return of the Galaxy Note, how to fix the Google Pixel, BlackBerry's return at CES, OnePlus release Nougat based Oxygen OS, and a new guide to Material Design."},{"title":"BlackBerry: Keyboard Phone Not for Sale In India","publication_date":"2017-01-06 20:19:00 +0000","url":"http://www.investopedia.com/news/blackberry-keyboard-phone-not-sale-india/?partner=YahooSA","summary":"BlackBerry: Keyboard Phone Not for Sale In India"},{"title":"Rudy Giuliani: Hacking Is Becoming Ubiquitous","publication_date":"2017-01-05 20:29:54 +0000","url":"http://finance.yahoo.com/video/rudy-giuliani-hacking-becoming-ubiquitous-202954579.html","summary":"Rudy Giuliani: Hacking Is Becoming Ubiquitous"},{"title":"BlackBerry and Giuliani Partners Join Forces","publication_date":"2017-01-05 20:28:58 +0000","url":"http://finance.yahoo.com/video/blackberry-giuliani-partners-join-forces-202858671.html","summary":"BlackBerry and Giuliani Partners Join Forces"},{"title":"Cybercrime is Rampant. BlackBerry and Giuliani Partners Will Fight It Together.","publication_date":"2017-01-05 20:05:06 +0000","url":"http://www.publicnow.com/view/18AD01C776A2F375F1A6A58C263EBC4871C51836","summary":"[at noodls] - The annual bill from cybercrime is huge. How much? $400 billion a year, according to a 2015 estimate by British insurance company, Lloyd's. The cost of data breaches alone, according to Juniper ..."},{"title":"BlackBerry and Giuliani Partners Join Forces to Combat Cyber Threats","publication_date":"2017-01-05 18:00:50 +0000","url":"http://finance.yahoo.com/news/blackberry-giuliani-partners-join-forces-180050855.html","summary":"[Marketwired] - International CES 2017 - BlackBerry Limited today announced that BlackBerry Secure has been selected by Giuliani Partners as the underlying software platform to support the firm's cybersecurity consulting ..."},{"title":"China's TCL out to revive BlackBerry smartphones","publication_date":"2017-01-05 07:05:43 +0000","url":"http://uk.finance.yahoo.com/news/chinas-tcl-revive-blackberry-smartphones-070543540.html","summary":"China's TCL out to revive BlackBerry smartphones"},{"title":"BlackBerry QNX and Renesas Electronics America Collaborate to Develop an Automotive-Grade Technology Platform for Autonomous Driving","publication_date":"2017-01-04 19:30:00 +0000","url":"http://finance.yahoo.com/news/blackberry-qnx-renesas-electronics-america-193000236.html","summary":"[Marketwired] - Las Vegas, International CES 2017, LVCC North Hall, Booth 7029 - BlackBerry Limited and Renesas Electronics America Inc. put its joint autonomous driving technology platform in motion today on a test track ..."},{"title":"There’s a new BlackBerry phone, and it’s bringing the old-school keyboard back","publication_date":"2017-01-04 16:15:00 +0000","url":"http://finance.yahoo.com/news/blackberry-phone-bringing-old-school-161500639.html","summary":"There’s a new BlackBerry phone, and it’s bringing the old-school keyboard back"},{"title":"Trade sees halt to slide in BlackBerry","publication_date":"2017-01-04 12:47:26 +0000","url":"http://finance.yahoo.com/news/trade-sees-halt-slide-blackberry-124726174.html","summary":"Trade sees halt to slide in BlackBerry"},{"title":"The 5 tech trends that will dominate CES and 2017","publication_date":"2017-01-04 09:35:49 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=52D5C51A-C94B-11E6-8F68-B8977F716B7C&siteid=yhoof2","summary":"The 5 tech trends that will dominate CES and 2017"},{"title":"BlackBerry QNX Launches its Most Advanced and Secure Embedded Software Platform for Autonomous Drive and Connected Cars","publication_date":"2017-01-04 08:01:00 +0000","url":"http://finance.yahoo.com/news/blackberry-qnx-launches-most-advanced-080100292.html","summary":"[Marketwired] - International CES 2017, LVCC North Hall, Booth 7029 - BlackBerry Limited today announced its most advanced and secure embedded operating system for the automotive industry. QNX Software Development Platform ..."},{"title":"BlackBerry Announces QNX SDP 7.0 Platform For Autonomous Cars - Quick Facts","publication_date":"2017-01-04 03:16:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rzEJgVZwMkg/blackberry-announces-qnx-sdp-70-platform-for-autonomous-cars--quick-facts-20170104-00065","summary":"BlackBerry Announces QNX SDP 7.0 Platform For Autonomous Cars - Quick Facts"},{"title":"BlackBerry's Last Stand And Rebirth In Las Vegas","publication_date":"2017-01-03 23:36:00 +0000","url":"http://www.forbes.com/sites/ewanspence/2017/01/03/blackberry-keybaord-android-mercury-tcl/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix","summary":"[at Forbes] - CES, the time when the eyes and the keyboards of the world's tech press point towards the Las Vegas Convention Center, including the last BlackBerry handset from the Canadian company, and the first BlackBerry of the new breed from its manufacturing partner."},{"title":"Can BlackBerry Succeed in the Autonomous Vehicle Market?","publication_date":"2017-01-03 23:05:28 +0000","url":"http://marketrealist.com/2017/01/can-blackberry-succeed-autonomous-vehicle-market/?utm_source=yahoo&utm_medium=feed","summary":"Can BlackBerry Succeed in the Autonomous Vehicle Market?"},{"title":"Ignore All The Hype Around BlackBerry Ltd (BBRY) Stock","publication_date":"2017-01-03 16:22:32 +0000","url":"http://www.insidermonkey.com/blog/ignore-all-the-hype-around-blackberry-ltd-bbry-stock-514268/","summary":"Ignore All The Hype Around BlackBerry Ltd (BBRY) Stock"},{"title":"Do We Need to Be Concerned About BlackBerry?","publication_date":"2017-01-03 15:02:00 +0000","url":"http://www.investopedia.com/news/do-we-need-be-concerned-about-blackberry/?partner=YahooSA","summary":"Do We Need to Be Concerned About BlackBerry?"},{"title":"The 7 tech companies on death watch for 2017","publication_date":"2017-01-03 13:24:32 +0000","url":"http://finance.yahoo.com/video/7-tech-companies-death-watch-132432169.html","summary":"The 7 tech companies on death watch for 2017"},{"title":"Creators and Critics","publication_date":"2017-01-02 17:43:08 +0000","url":"http://www.publicnow.com/view/213A36EDB5E0E3C8A68152E726077C011D1F8480","summary":"[at noodls] - 'I've been all over the world and I've never seen a statue of a critic.' ― Composer Leonard Bernstein No one ever said turnarounds were easy. When you're a market leader and global icon reinventing itself ..."},{"title":"Inside Google’s Aim to Mirror Apple’s Smartphone Strategy","publication_date":"2017-01-02 12:36:25 +0000","url":"http://marketrealist.com/2016/12/inside-googles-aim-to-mirror-apples-smartphone-strategy/?utm_source=yahoo&utm_medium=feed","summary":"Inside Google’s Aim to Mirror Apple’s Smartphone Strategy"},{"title":"From Concept to Reality: BlackBerry-QNX’s Groundbreaking CES Tradition","publication_date":"2016-12-30 18:52:05 +0000","url":"http://www.publicnow.com/view/4FB6BCD5008B9C3F4D584E8E4725065E4B845EF3","summary":"[at noodls] - The annual Consumer Electronics Show in Las Vegas has been growing in importance for the automotive industry over the years. You can hardly fail to notice: this year, as in previous years, ..."},{"title":"BlackBerry Radar and Modagrafics Partnership – A New Dimension in Asset Management","publication_date":"2016-12-29 17:32:10 +0000","url":"http://www.publicnow.com/view/CC55277634D75CCA61CAEBA6506825543D1E7870","summary":"[at noodls] - The need for efficiency in the trucking and transport industry has never been more important. Improving trailer utilization, and reducing theft, delayed cargo, and spoiled cargo, are a few examples of ..."},{"title":"Interesting BBRY Put And Call Options For April 2017","publication_date":"2016-12-29 17:00:01 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fvwCiYZ0XZw/interesting-bbry-put-and-call-options-for-april-2017-cm727473","summary":"Investors in BlackBerry Ltd Symbol BBRY saw new options become available this week for the April 2017 expiration One of the key inputs that goes into the price an option buyer is willing to pay is the time value so with 113 days until expiration the newly available contracts represent"},{"title":"BlackBerry Ltd (BBRY) Stock: Don’t Gamble, Look At The Data Points","publication_date":"2016-12-29 15:57:27 +0000","url":"http://www.insidermonkey.com/blog/blackberry-ltd-bbry-stock-dont-gamble-look-at-the-data-points-513665/","summary":"BlackBerry Ltd (BBRY) Stock: Don’t Gamble, Look At The Data Points"},{"title":"New BlackBerry Smartphones Are Coming In January","publication_date":"2016-12-29 13:56:03 +0000","url":"http://www.investopedia.com/stock-analysis/122916/new-blackberry-smartphones-are-coming-january-bbry.aspx?partner=YahooSA","summary":"New BlackBerry Smartphones Are Coming In January"},{"title":"Post Earnings Coverage as Blackberry Reported Profit and Record Gross Margin","publication_date":"2016-12-29 13:15:00 +0000","url":"http://finance.yahoo.com/news/post-earnings-coverage-blackberry-reported-131500020.html","summary":"[Accesswire] - Upcoming AWS Coverage on B Communications Post-Earnings Results LONDON, UK / ACCESSWIRE / December 29, 2016 / Active Wall St. announces its post-earnings coverage on BlackBerry Ltd (NASDAQ: BBRY ). The ..."},{"title":"What To Expect From BlackBerry's Software Unit In 2017","publication_date":"2016-12-28 21:28:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HwWyle_5dEU/what-to-expect-from-blackberrys-software-unit-in-2017-cm727155","summary":"2017 will be all about software for BlackBerry BBRY as the firm shuts down its hardware operations to focus on brand licensing while its service access business becomes increasingly irrelevant amid user attrition from its legacy smartphone platforms Below we take a look at what to"},{"title":"BlackBerry QNX Partners with Obigo to Build a Better Browser for Your Car","publication_date":"2016-12-28 18:32:10 +0000","url":"http://www.publicnow.com/view/1678F45AF98C82D82B29887D9834CD9F3EDDF265","summary":"[at noodls] - Software plays a big role in current vehicles. The best example is your in-vehicle infotainment system. With just a few taps, you can play music from your mobile device, view and manage advanced ..."},{"title":"PRESS DIGEST- Canada - Dec 28","publication_date":"2016-12-28 10:50:03 +0000","url":"http://finance.yahoo.com/news/press-digest-canada-dec-28-105003818.html","summary":"[Reuters] - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL alerts-data.json alerts-fundamentals.json alerts.new.csv alerts.raw alerts.symbols alerts-symbols-list BBRY-1d-chart data.json headlines.json jq-linux64 symbol-1d.php symbol-1yr.php symbol-3mo.php symbol-6mo.php symbols.txt xml2json The federal government is looking ..."},{"title":"CES 2017: Holistic Security for the Software-Defined Car","publication_date":"2016-12-27 20:02:08 +0000","url":"http://www.publicnow.com/view/CDD34396C7977AEADB62D78897856E9B9FB70452","summary":"[at noodls] - Due to high-profile hacks on cars, it is hard to argue that safety can exist without security. Security is emerging as perhaps the most important factor in the evolution of the connected autonomous ..."},{"title":"ETFs with exposure to BlackBerry Ltd. : December 27, 2016","publication_date":"2016-12-27 17:28:26 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-blackberry-ltd-december-27-2016-2/","summary":"ETFs with exposure to BlackBerry Ltd. : December 27, 2016"},{"title":"Should You Invest in BlackBerry (BBRY) Stock Following Q3?","publication_date":"2016-12-27 15:01:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E1XbVKP0RcU/should-you-invest-in-blackberry-bbry-stock-following-q3-cm726160","summary":"Shares of BlackBerry Limited BBRY have been performing well of late despite the struggles in the broader market The stock comfortably outperformed the Zacks categorized Wireless Non US industry over the last six months The stock gained 8 33 as against the industry s decline of 7 50"},{"title":"Why the Earnings Streak Will Continue for BlackBerry (BBRY)","publication_date":"2016-12-27 15:00:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GslSDQO-u94/why-the-earnings-streak-will-continue-for-blackberry-bbry-cm726431","summary":"Looking for a stock that might be in a good position to beat earnings at its next report Consider BlackBerry Limited BBRY a firm in the Real Estate Operations industry which could be a great candidate for another beat This company has seen a nice streak of beating earnings"},{"title":"Here's Why BlackBerry's Stock Is Getting More Enticing by the Day","publication_date":"2016-12-27 13:38:00 +0000","url":"https://www.thestreet.com/story/13937050/1/here-s-why-blackberry-s-stock-is-getting-more-enticing-by-the-day.html?puc=yahoo&cm_ven=YAHOO","summary":"Here's Why BlackBerry's Stock Is Getting More Enticing by the Day"}],"result_count":839,"page_size":250,"current_page":1,"total_pages":4,"api_call_credits":1},"timeStamp": 1491053756,"trigger": "MARK AT OR ABOVE 7.90","triggerPrice":7.90,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"7.6199"},{"x":"1490967300","y":"7.82"},{"x":"1490967600","y":"7.83"},{"x":"1490967900","y":"7.9133"},{"x":"1490968200","y":"7.9901"},{"x":"1490968500","y":"8.01"},{"x":"1490968800","y":"8.0639"},{"x":"1490969100","y":"8"},{"x":"1490969400","y":"7.985"},{"x":"1490969700","y":"8.0103"},{"x":"1490970000","y":"7.985"},{"x":"1490970300","y":"7.9649"},{"x":"1490970600","y":"7.93"},{"x":"1490970900","y":"7.92"},{"x":"1490971200","y":"7.98"},{"x":"1490971500","y":"7.92"},{"x":"1490971800","y":"7.91"},{"x":"1490972100","y":"7.895"},{"x":"1490972400","y":"7.85"},{"x":"1490972700","y":"7.825"},{"x":"1490973000","y":"7.79"},{"x":"1490973300","y":"7.79"},{"x":"1490973600","y":"7.78"},{"x":"1490973900","y":"7.8299"},{"x":"1490974200","y":"7.885"},{"x":"1490974500","y":"7.87"},{"x":"1490974800","y":"7.84"},{"x":"1490975100","y":"7.871"},{"x":"1490975400","y":"7.865"},{"x":"1490975700","y":"7.85"},{"x":"1490976000","y":"7.841"},{"x":"1490976300","y":"7.85"},{"x":"1490976600","y":"7.86"},{"x":"1490976900","y":"7.85"},{"x":"1490977200","y":"7.855"},{"x":"1490977500","y":"7.85"},{"x":"1490977800","y":"7.85"},{"x":"1490978100","y":"7.835"},{"x":"1490978400","y":"7.8"},{"x":"1490978700","y":"7.8100000000000005"},{"x":"1490979000","y":"7.795"},{"x":"1490979300","y":"7.82"},{"x":"1490979600","y":"7.82"},{"x":"1490979900","y":"7.85"},{"x":"1490980200","y":"7.87"},{"x":"1490980500","y":"7.845"},{"x":"1490980800","y":"7.8100000000000005"},{"x":"1490981100","y":"7.82"},{"x":"1490981400","y":"7.825"},{"x":"1490981700","y":"7.82"},{"x":"1490982000","y":"7.8"},{"x":"1490982300","y":"7.8"},{"x":"1490982600","y":"7.77"},{"x":"1490982900","y":"7.735"},{"x":"1490983200","y":"7.71"},{"x":"1490983500","y":"7.745"},{"x":"1490983800","y":"7.7"},{"x":"1490984100","y":"7.745"},{"x":"1490984400","y":"7.745"},{"x":"1490984700","y":"7.705"},{"x":"1490985000","y":"7.715"},{"x":"1490985300","y":"7.7635"},{"x":"1490985600","y":"7.745"},{"x":"1490985900","y":"7.7664"},{"x":"1490986200","y":"7.8362"},{"x":"1490986500","y":"7.8100000000000005"},{"x":"1490986800","y":"7.845"},{"x":"1490987100","y":"7.84"},{"x":"1490987400","y":"7.8116"},{"x":"1490987700","y":"7.8149999999999995"},{"x":"1490988000","y":"7.82"},{"x":"1490988300","y":"7.8342"},{"x":"1490988600","y":"7.825"},{"x":"1490988900","y":"7.79"},{"x":"1490989200","y":"7.83"},{"x":"1490989500","y":"7.8218"},{"x":"1490989800","y":"7.78"},{"x":"1490990100","y":"7.75"},{"x":"1490990400","y":"7.79"},{"x":"1490990700","y":"7.7455"},{"x":"1490991000","y":"7.74"},{"x":"1490991300","y":"7.78"},{"x":"1490991600","y":"7.78"},{"x":"1490991900","y":"7.74"},{"x":"1490992200","y":"7.75"},{"x":"1490992800","y":"7.78"},{"x":"1490993400","y":"7.75"},{"x":"1490994000","y":"7.75"},{"x":"1490994600","y":"7.75"},{"x":"1490995500","y":"7.78"},{"x":"1490995800","y":"7.75"},{"x":"1490996100","y":"7.75"},{"x":"1490996400","y":"7.78"},{"x":"1490996700","y":"7.8"},{"x":"1490999700","y":"7.8100000000000005"},{"x":"1491000600","y":"7.8100000000000005"},{"x":"1491001200","y":"7.8100000000000005"},{"x":"1491001500","y":"7.8100000000000005"},{"x":"1491001800","y":"7.8100000000000005"},{"x":"1491002100","y":"7.77"},{"x":"1491003900","y":"7.79"},{"x":"1491004200","y":"7.77"},{"x":"1491004500","y":"7.8"} ], "color":"#03a9f4"}]},
{"id":"2","list":"Alerts","symbol": "CBAY","name": "CymaBay Therapeutics Inc","price": 4.3,"dollarChange": 0.01,"percentChange": 0.24,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/CBAY-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/CBAY-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/CBAY-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/CBAY-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/CBAY-1yr.php","open": 4.23,"high": 4.35,"low":4.18,"volume": 395770,"avgVol": 482936.483333,"sharesShort": 727758,"shortPercent": 2.531116,"marketCap": 83205993,"float": 28752451,"headlines":{"data":[{"title":"CymaBay Therapeutics to Present at Two Investor Conferences in April","publication_date":"2017-03-30 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-two-investor-120000586.html","summary":"[GlobeNewswire] - NEWARK, Calif., March 30, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced ..."},{"title":"CYMABAY THERAPEUTICS, INC. Financials","publication_date":"2017-03-29 17:04:06 +0000","url":"http://finance.yahoo.com/q/is?s=cbay","summary":"CYMABAY THERAPEUTICS, INC. Financials"},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-03-29 12:02:28 +0000","url":"http://biz.yahoo.com/e/170329/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"8:01 am CymaBay Therapeutics announces that Harold Van Wart will retire as CEO; Sujal Shah named as interim CEO","publication_date":"2017-03-29 12:01:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#cbay","summary":"8:01 am CymaBay Therapeutics announces that Harold Van Wart will retire as CEO; Sujal Shah named as interim CEO"},{"title":"CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.","publication_date":"2017-03-29 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announces-retirement-president-chief-120000184.html","summary":"[GlobeNewswire] - NEWARK, Calif., March 29, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced ..."},{"title":"CymaBay Reports Fourth Quarter and Year End 2016 Financial Results","publication_date":"2017-03-23 20:01:00 +0000","url":"http://finance.yahoo.com/news/cymabay-reports-fourth-quarter-end-200100143.html","summary":"[GlobeNewswire] - NEWARK, Calif., March 23, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ..."},{"title":"After-Hours Earnings Report for March 23, 2017 : MU, GME, KBH, ENV, OXM, SCVL, UPLD, SPWH, CBAY, NBY, VSTM, CYTX","publication_date":"2017-03-23 18:49:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sgu5UR9-wtk/after-hours-earnings-report-for-march-23-2017-mu-gme-kbh-env-oxm-scvl-upld-spwh-cbay-nby-vstm-cytx-cm764858","summary":"The following companies are expected to report earnings after hours on 03 23 2017 Visit our Earnings Calendar for a full list of expected earnings releases Micron Technology Inc MU is reporting for the quarter ending February 28 2017 The"},{"title":"Q4 2016 CymaBay Therapeutics Inc Earnings Release - Time Not Supplied","publication_date":"2017-03-23 11:07:06 +0000","url":"http://biz.yahoo.com/research/earncal/20170323.html?t=cbay","summary":"Q4 2016 CymaBay Therapeutics Inc Earnings Release - Time Not Supplied"},{"title":"CymaBay to Report Fourth Quarter And Year End 2016 Financial Results on Thursday, March 23","publication_date":"2017-03-16 20:48:08 +0000","url":"http://finance.yahoo.com/news/cymabay-report-fourth-quarter-end-204808686.html","summary":"[GlobeNewswire] - NEWARK, Calif., March 16, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ..."},{"title":"Will Cymabay Therapeutics (CBAY) Continue to Surge Higher?","publication_date":"2017-03-15 17:09:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y-sIcQDed6U/will-cymabay-therapeutics-cbay-continue-to-surge-higher-cm761220","summary":"As of late it has definitely been a great time to be an investor in 160 Cymabay Therapeutics Inc CBAY The stock has moved higher by 73 8 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest"},{"title":"Will Cymabay Therapeutics (CBAY) Continue to Surge Higher?","publication_date":"2017-03-15 14:37:02 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-cbay-continue-surge-143702459.html","summary":"Will Cymabay Therapeutics (CBAY) Continue to Surge Higher?"},{"title":"Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM...","publication_date":"2017-03-09 22:43:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MXg1EYtqzFA/gainers--losers-of-mar9-cbay-immu-tgtx-nspr-tndm-20170309-01447","summary":"Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM..."},{"title":"CymaBay Therapeutics to Present at Two Investor Conferences in March","publication_date":"2017-03-09 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-two-investor-130000997.html","summary":"[GlobeNewswire] - NEWARK, Calif., March 09, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ..."},{"title":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro","publication_date":"2017-03-08 16:17:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PaAfQgrJ-P8/zackscom-featured-highlights-apollo-investment-ballard-power-systems-cymabay-therapeutics-fate-therpautics-and-oclaro-cm757863","summary":"For Immediate Release Chicago IL March 08 2017 Stocks in this week s article include 160 Apollo Investment Corp NASDAQ AINV Free Report Ballard Power Systems NASDAQ BLDP Free Report Cymabay Therapeutics NASDAQ CBAY Free Report Fate"},{"title":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro","publication_date":"2017-03-08 14:30:02 +0000","url":"http://finance.yahoo.com/news/zacks-com-featured-highlights-apollo-143002874.html","summary":"Zacks.com featured highlights: Apollo Investment, Ballard Power Systems, Cymabay Therapeutics, Fate Therpautics and Oclaro"},{"title":"Explosive Stocks Under $10","publication_date":"2017-03-07 22:14:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kOBlTgGp2ss/explosive-stocks-under-10-cm757610","summary":"This screen is a bit of a departure from my normal stock screens Usually I require my screens to have a minimum price of 10 per share But I do at times scan for stocks under 10 And that s one of the screens I m running for myself right now Penny Stocks One dollar is a common"},{"title":"Explosive Stocks Under $10","publication_date":"2017-03-07 19:41:07 +0000","url":"http://finance.yahoo.com/news/explosive-stocks-under-10-194107205.html","summary":"Explosive Stocks Under $10"},{"title":"Progenics Pharmaceuticals (PGNX) in Focus: Stock Gains 8.3%","publication_date":"2017-02-28 14:52:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VewejAy4JS0/progenics-pharmaceuticals-pgnx-in-focus-stock-gains-83-cm754158","summary":"Progenics Pharmaceuticals PGNX was a big mover last session as the company saw its shares rise above 8 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above"},{"title":"Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS...","publication_date":"2017-02-27 22:33:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MYCJ86PzCsA/gainers--losers-of-feb27-ljpc-nvax-ktov-cycc-args-20170227-01773","summary":"Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS..."},{"title":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic","publication_date":"2017-02-22 15:53:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NN_Mur1Q4z0/the-zacks-analyst-blog-highlights-cymabay-therapeutics-attunity-lumentum-holdings-datawatch-and-arconic-cm751213","summary":"For Immediate Release Chicago IL February 22 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog"},{"title":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic","publication_date":"2017-02-22 14:30:02 +0000","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-cymabay-143002614.html","summary":"The Zacks Analyst Blog Highlights: Cymabay Therapeutics, Attunity, Lumentum Holdings, Datawatch and Arconic"},{"title":"5 Top Performers of Trump's First 30 Days in Office","publication_date":"2017-02-22 01:07:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CveD0TudIHs/5-top-performers-of-trumps-first-30-days-in-office-cm750976","summary":"After a brief lull markets have again hit fresh highs Investors reaffirmed their faith in the promises of the new administration and the Trump Rally looks set to continue over the current week Meanwhile Trump celebrated his first month in office by indicating that these gains were"},{"title":"5 Top Performers of Trump's First 30 Days in Office","publication_date":"2017-02-21 22:34:10 +0000","url":"http://finance.yahoo.com/news/5-top-performers-trumps-first-223410370.html","summary":"5 Top Performers of Trump's First 30 Days in Office"},{"title":"Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?","publication_date":"2017-02-14 17:19:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QMpFflj_9fQ/can-the-uptrend-continue-for-cymabay-therapeutics-cbay-cm747705","summary":"Investors certainly have to be happy with Cymabay Therapeutics Inc CBAY and its short term performance After all the stock has jumped by 19 1 in the past 4 weeks and it is also above its 20 Day Simple Moving Average as well This is certainly a good trend but investors are probably"},{"title":"Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?","publication_date":"2017-02-14 15:28:03 +0000","url":"http://finance.yahoo.com/news/uptrend-continue-cymabay-therapeutics-cbay-152803572.html","summary":"Can The Uptrend Continue for Cymabay Therapeutics (CBAY)?"},{"title":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","publication_date":"2017-02-13 17:21:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rvywCPYAflU/cerners-ehr-platform-to-enhance-health-care-at-san-juan-ngo-cm747142","summary":"Leading provider of health care technology Cerner Corporation CERN announced that it recently entered into an agreement to provide San Juan Regional Medical Center with a new electronic health record EHR platform San Juan Regional Medical Center is a non profit acute care hospital and"},{"title":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","publication_date":"2017-02-13 14:40:02 +0000","url":"http://finance.yahoo.com/news/cerners-ehr-platform-enhance-health-144002124.html","summary":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO"},{"title":"5 Breakout Stocks for Superior Returns","publication_date":"2017-02-10 16:22:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3W-SuQZz1IQ/5-breakout-stocks-for-superior-returns-cm746305","summary":"Utilizing a breakout investment strategy is a favored choice of active investors who are content only with returns superior to most other investments This approach involves homing in on stocks trading within a tight range and acquiring them when they move out of this band In keeping with"},{"title":"5 Breakout Stocks for Superior Returns","publication_date":"2017-02-10 13:49:01 +0000","url":"http://finance.yahoo.com/news/5-breakout-stocks-superior-returns-134901482.html","summary":"5 Breakout Stocks for Superior Returns"},{"title":"Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher","publication_date":"2017-02-09 15:21:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4mzl6Snn2gQ/cymabay-therapeutics-cbay-rises-stock-moves-92-higher-cm745390","summary":"Cymabay Therapeutics Inc CBAY was a big mover last session as the company saw its shares rise over 9 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above"},{"title":"Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher","publication_date":"2017-02-09 13:30:01 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-cbay-rises-stock-133001545.html","summary":"Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher"},{"title":"CymaBay Therapeutics to Present at the 2017 BIO CEO & Investor Conference","publication_date":"2017-02-07 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-2017-bio-130000903.html","summary":"[GlobeNewswire] - NEWARK, Calif., Feb. 07, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ..."},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-02-03 21:07:32 +0000","url":"http://biz.yahoo.com/e/170203/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Health Care Sector Update for 02/02/2017: CBAY,BNTC,STML","publication_date":"2017-02-02 20:11:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/thXN_sIiexE/health-care-sector-update-for-02022017-cbaybntcstml-cm742462","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 2 JNJ 0 2 PFE 0 09 PFE 0 09 MRK 3 2 MRK 3 2 ABT 0 7 ABT 0 7 AMGN 0 4 AMGN 0 4 Health care stocks were falling today with the NYSE Health Care Index NYP dropping about 0 3 while shares of health care companies in the S amp P"},{"title":"CymaBay Announces Pricing of Public Offering of Common Stock","publication_date":"2017-02-02 14:15:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announces-pricing-public-offering-141500057.html","summary":"[GlobeNewswire] - NEWARK, Calif., Feb. 02, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet need, today announced ..."},{"title":"CymaBay Announces Proposed Public Offering of Common Stock","publication_date":"2017-02-01 21:01:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announces-proposed-public-offering-210100357.html","summary":"[GlobeNewswire] - NEWARK, Calif., Feb. 01, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet need, today announced ..."},{"title":"Gainers & Losers Of The Day: CALA, EVOK, EYEG, OCRX, TENX...","publication_date":"2017-01-30 21:59:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HbRYS0jPzc8/gainers--losers-of-the-day-cala-evok-eyeg-ocrx-tenx-20170130-01445","summary":"Gainers & Losers Of The Day: CALA, EVOK, EYEG, OCRX, TENX..."},{"title":"CymaBay Therapeutics upgraded by H.C. Wainwright","publication_date":"2017-01-30 12:02:40 +0000","url":"http://finance.yahoo.com/q/ud?s=CBAY","summary":"CymaBay Therapeutics upgraded by H.C. Wainwright"},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-24 11:15:17 +0000","url":"http://biz.yahoo.com/e/170124/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"CymaBay Therapeutics Announces Successful Completion of Scientific Advice Discussions with the European Medicines Agency for Arhalofenate","publication_date":"2017-01-05 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-successful-completion-130000455.html","summary":"[GlobeNewswire] - NEWARK, Calif., Jan. 05, 2017-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced ..."},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement","publication_date":"2017-01-05 11:04:50 +0000","url":"http://biz.yahoo.com/e/170105/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement"},{"title":"Health Care Sector Update for 01/04/2017: SNY,AMGN,REGN,CBAY,AGRX","publication_date":"2017-01-04 21:16:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1c17MhPzHGg/health-care-sector-update-for-01042017-snyamgnregncbayagrx-cm729543","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 02 JNJ 0 02 PFE 1 05 PFE 1 05 MRK 1 31 MRK 1 31 ABT 0 08 ABT 0 08 AMGN 1 59 AMGN 1 59 Health care stocks still were mostly higher this afternoon with the NYSE Health Care Index climbing about 0 9 while shares of health"},{"title":"Surges & Plunges - EVOK, OREX, MRUS, IMGN, AGRX","publication_date":"2017-01-04 20:06:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MsnHxYXcbE4/surges--plunges--evok-orex-mrus-imgn-agrx-20170104-01221","summary":"Surges & Plunges - EVOK, OREX, MRUS, IMGN, AGRX"},{"title":"Health Care Sector Update for 01/04/2017: EVOK,CBAY,AGRX","publication_date":"2017-01-04 19:16:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GvPUjtHNMfI/health-care-sector-update-for-01042017-evokcbayagrx-cm729494","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 29 JNJ 0 29 PFE 0 45 PFE 0 45 MRK 1 04 MRK 1 04 ABT 0 03 ABT 0 03 AMGN 1 01 AMGN 1 01 Health care stocks were mostly higher today with the NYSE Health Care Index climbing about 0 4 while shares of health care companies in"},{"title":"Wednesday’s Top 5 Biopharma Movers","publication_date":"2017-01-04 17:15:23 +0000","url":"http://finance.yahoo.com/news/wednesday-top-5-biopharma-movers-171523550.html","summary":"Wednesday’s Top 5 Biopharma Movers"},{"title":"Taking A Look At CymaBay Therapeutics Inc (CBAY)’s Big Deal","publication_date":"2017-01-04 16:00:38 +0000","url":"http://www.insidermonkey.com/blog/taking-a-look-at-cymabay-therapeutics-inc-cbays-big-deal-514541/","summary":"Taking A Look At CymaBay Therapeutics Inc (CBAY)’s Big Deal"},{"title":"Here’s Why Apple, Tesla, and Three Other Stocks Are Trending","publication_date":"2017-01-04 13:10:26 +0000","url":"http://www.insidermonkey.com/blog/heres-why-apple-tesla-and-three-other-stocks-are-trending-514481/","summary":"Here’s Why Apple, Tesla, and Three Other Stocks Are Trending"},{"title":"AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal","publication_date":"2017-01-04 01:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EQUoX5n_LN8/agrx-fails-to-secure-investor-confidence-itek-hit-hard-cbay-rises-on-kowa-deal-20170104-00025","summary":"AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal"},{"title":"CymaBay Announces Exclusive Licensing Agreement with Kowa Pharmaceuticals America, Inc. for the Development and Commercialization of Arhalofenate in the United States","publication_date":"2017-01-03 21:01:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announces-exclusive-licensing-agreement-210100730.html","summary":"[GlobeNewswire] - —Kowa to fully fund development through NDA approval— CymaBay to receive up to $205 M in up-front and milestone payments— Conference call and webcast today at 4:30 pm ET. NEWARK, Calif., Jan. 03, 2017-- ..."},{"title":"Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers?","publication_date":"2016-12-17 00:54:58 +0000","url":"http://www.insidermonkey.com/blog/pain-therapeutics-inc-ptie-how-does-it-compare-against-its-peers-511434/","summary":"Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers?"},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-12-08 13:01:52 +0000","url":"http://biz.yahoo.com/e/161208/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"CymaBay Announces the Appointments of Robert Booth, Ph.D. and Caroline Loewy to Its Board of Directors","publication_date":"2016-12-08 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announces-appointments-robert-booth-130000087.html","summary":"[GlobeNewswire] - NEWARK, Calif., Dec. 08, 2016-- CymaBay Therapeutics, Inc., today announced the appointment of Robert Booth, Ph.D. and Caroline Loewy to the company’ s Board of Directors, effective December 6, 2016.. ..."},{"title":"CymaBay Therapeutics Announces the Initiation of its Next Phase 2 Study of Seladelpar (MBX-8025) in Patients with Primary Biliary Cholangitis","publication_date":"2016-12-07 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-initiation-next-130000320.html","summary":"[GlobeNewswire] - NEWARK, Calif., Dec. 07, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat indications with high unmet medical need, today announced the initiation ..."},{"title":"Anthera Announces Leadership Transition in Preparation of Commercialization of Sollpura and Future Development of blisibimod for IgA Nephropathy","publication_date":"2016-12-06 21:10:00 +0000","url":"http://finance.yahoo.com/news/anthera-announces-leadership-transition-preparation-211000003.html","summary":"[GlobeNewswire] - J. Craig Thompson promoted to Chief Executive Officer and appointed to the Board of Directors Paul F. Truex appointed as Executive Chairman of the Board Dr. Christopher Henney stepped down as Chairman ..."},{"title":"CymaBay Therapeutics Announces that the Recommended International Nonproprietary Name for MBX-8025 is Seladelpar","publication_date":"2016-12-06 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-recommended-international-130000523.html","summary":"[GlobeNewswire] - NEWARK, Calif., Dec. 06, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat indications with high unmet medical need, today announced that the World ..."},{"title":"CymaBay Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference","publication_date":"2016-11-28 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-28th-annual-130000116.html","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 28, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ..."},{"title":"CymaBay to Host Key Opinion Leader Meeting on Primary Biliary Cholangitis in New York City","publication_date":"2016-11-10 21:01:00 +0000","url":"http://finance.yahoo.com/news/cymabay-host-key-opinion-leader-210100319.html","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 10, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ..."},{"title":"CymaBay Therapeutics Announces U.S. Orphan Drug Designation for MBX-8025 for the Treatment of Primary Biliary Cholangitis","publication_date":"2016-11-10 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-u-orphan-130000336.html","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 10, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ..."},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-09 21:05:41 +0000","url":"http://biz.yahoo.com/e/161109/cbay10-q.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report"},{"title":"CymaBay Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-09 21:01:00 +0000","url":"http://finance.yahoo.com/news/cymabay-reports-third-quarter-2016-210100639.html","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 09, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and orphan ..."},{"title":"CymaBay Therapeutics Announces a Newly Issued U.S. Patent for the Use of MBX-8025 as a Treatment for Primary Biliary Cholangitis (PBC)","publication_date":"2016-11-09 13:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-newly-issued-130000566.html","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 09, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need including rare and orphan ..."},{"title":"CymaBay to Announce Third Quarter 2016 Financial Results on Wednesday, November 9","publication_date":"2016-11-02 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announce-third-quarter-2016-120000583.html","summary":"[GlobeNewswire] - NEWARK, Calif., Nov. 02, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ..."},{"title":"CymaBay Therapeutics Announces an Oral Late-Breaking Presentation of a Phase 2 Proof-of-Concept Study of MBX-8025 in Patients With Primary Biliary Cholangitis at the AASLD 2016 Liver Meeting","publication_date":"2016-10-20 18:41:42 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-oral-breaking-184142021.html","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 20, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ..."},{"title":"CymaBay Therapeutics Announces that MBX-8025 has Received European Medicines Agency PRIority MEdicines (PRIME) Designation for the Treatment of Primary Biliary Cholangitis","publication_date":"2016-10-20 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-mbx-8025-120000951.html","summary":"CymaBay Therapeutics Announces that MBX-8025 has Received European Medicines Agency PRIority MEdicines (PRIME) Designation for the Treatment of Primary Biliary Cholangitis"},{"title":"CymaBay Therapeutics Announces a Newly Issued U.S. Patent for MBX-8025 for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)","publication_date":"2016-10-11 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-newly-issued-120000908.html","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 11, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ..."},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-10-07 12:32:11 +0000","url":"http://biz.yahoo.com/e/161007/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"CymaBay Therapeutics Announces an Oral Presentation Describing the Efficacy of MBX-8025 in a Preclincal Model of NASH at the AASLD 2016 Liver Meeting","publication_date":"2016-10-06 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-oral-presentation-120000852.html","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 06, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ..."},{"title":"CymaBay Therapeutics Announces Plans to Initiate Its Next Phase 2 Study of MBX-8025 in Primary Biliary Cholangitis","publication_date":"2016-10-05 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-plans-initiate-120000536.html","summary":"[GlobeNewswire] - NEWARK, Calif., Oct. 05, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today announced ..."},{"title":"CymaBay Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference","publication_date":"2016-09-08 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-rodman-renshaw-120000125.html","summary":"[GlobeNewswire] - NEWARK, Calif., Sept. 08, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat diseases with high unmet medical need, today announced that ..."},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-09 20:06:07 +0000","url":"http://biz.yahoo.com/e/160809/cbay10-q.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report"},{"title":"CymaBay Reports Second Quarter 2016 Financial Results","publication_date":"2016-08-09 20:01:00 +0000","url":"http://finance.yahoo.com/news/cymabay-reports-second-quarter-2016-200100305.html","summary":"[GlobeNewswire] - NEWARK, Calif., Aug. 09, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies to treat diseases with high unmet medical need, today provided recent ..."},{"title":"CymaBay to Announce Second Quarter 2016 Financial Results on Tuesday, August 9","publication_date":"2016-08-02 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announce-second-quarter-2016-120000660.html","summary":"[GlobeNewswire] - NEWARK, Calif., Aug. 02, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that ..."},{"title":"CymaBay Announces Participation at Cantor Fitzgerald Healthcare Conference on July 12th in New York","publication_date":"2016-07-07 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-announces-participation-cantor-fitzgerald-120000248.html","summary":"[GlobeNewswire] - NEWARK, Calif., July 07, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that ..."},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-06 20:33:05 +0000","url":"http://biz.yahoo.com/e/160606/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"},{"title":"CymaBay Therapeutics Announces Top Line Efficacy and Safety Data From Its Phase 2 Study of Mbx-8025 in Patients With Primary Biliary Cholangitis (PBC)","publication_date":"2016-05-31 11:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-announces-top-line-110000344.html","summary":"[GlobeNewswire] - Study stopped early after review of safety and efficacy data demonstrated clear proof-of-concept and opportunity for further dose reduction to optimize clinical safety and efficacy Large statistically ..."},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure","publication_date":"2016-05-24 12:06:32 +0000","url":"http://biz.yahoo.com/e/160524/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure"},{"title":"CymaBay Therapeutics to Present at UBS Global Healthcare Conference","publication_date":"2016-05-19 12:00:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-present-ubs-global-120000798.html","summary":"[GlobeNewswire] - NEWARK, Calif., May 19, 2016-- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that ..."},{"title":"CymaBay Therapeutics Inc. (NASDAQ: CBAY) Analyst Coverage Initiated","publication_date":"2016-04-25 12:31:00 +0000","url":"http://finance.yahoo.com/news/cymabay-therapeutics-inc-nasdaq-cbay-123100492.html","summary":"[Accesswire] - NEWARK, CA / ACCESSWIRE / April 25, 2016 / CymaBay Therapeutics Inc. (NASDAQ: CBAY) a biopharmaceutical company focused on developing therapies to treat metabolic diseases, including serious rare and orphan ..."},{"title":"Health Care Sector Update for 04/21/2016: SRPT,CBAY,TRXC","publication_date":"2016-04-21 20:35:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EX9Dmx_Avc8/health-care-sector-update-for-04212016-srptcbaytrxc-cm609784","summary":"Top Health Care Stocks JNJ 0.45% PFE 0.09% MRK 0.65% ABT 0.14% AMGN +0.52% Health care stocks were mixed in afternoon trade, with the NYSE Health Care Index declining 0.2% while shares of health care companies in the S&P"},{"title":"Health Care Sector Update for 04/21/2016: BIIB,CBAY,TRXC","publication_date":"2016-04-21 18:19:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tK3s78J7-ts/health-care-sector-update-for-04212016-biibcbaytrxc-cm609705","summary":"Top Health Care Stocks JNJ 0.46% PFE 0.29% MRK 0.57% ABT 0.18% AMGN +0.42% Health care stocks were mixed in afternoon trade, with the NYSE Health Care Index declining less than 0.1% while shares of health care companies in"},{"title":"Corporate Insiders at Alcoa Inc. (AA) and Two Other Battered Companies Keep Buying Shares","publication_date":"2016-04-21 15:57:36 +0000","url":"http://www.insidermonkey.com/blog/corporate-insiders-at-alcoa-inc-aa-and-two-other-battered-companies-keep-buying-shares-444864/","summary":"Corporate Insiders at Alcoa Inc. (AA) and Two Other Battered Companies Keep Buying Shares"},{"title":"Penny Stocks To Watch: Thursday's List of Trending Small Cap Stocks April 7th","publication_date":"2016-04-07 18:13:00 +0000","url":"http://finance.yahoo.com/news/penny-stocks-watch-thursdays-list-181300982.html","summary":"[Accesswire] - MIAMI, FL / ACCESSWIRE / April 7, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. AMRN, CBAY, RXMD, and NWBO have been added to our watch list today. Continue reading to find out ..."},{"title":"Thursday 4/7 Insider Buying Report: ATU, CBAY","publication_date":"2016-04-07 16:01:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tnirOX1R_wk/thursday-47-insider-buying-report-atu-cbay-cm603062","summary":"As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, Actuant"},{"title":"Actuant Corporation (ATU) and 2 Other Battered Companies Receive a Vote of Confidence from Insiders","publication_date":"2016-04-07 11:27:26 +0000","url":"http://www.insidermonkey.com/blog/actuant-corporation-atu-and-2-other-battered-companies-receive-a-vote-of-confidence-from-insiders-441267/","summary":"Actuant Corporation (ATU) and 2 Other Battered Companies Receive a Vote of Confidence from Insiders"},{"title":"Edited Transcript of CBAY earnings conference call or presentation 29-Mar-16 8:30pm GMT","publication_date":"2016-03-30 20:26:06 +0000","url":"http://finance.yahoo.com/news/edited-transcript-cbay-earnings-conference-202606588.html","summary":"Edited Transcript of CBAY earnings conference call or presentation 29-Mar-16 8:30pm GMT"},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-K, Annual Report","publication_date":"2016-03-29 20:05:43 +0000","url":"http://biz.yahoo.com/e/160329/cbay10-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 10-K, Annual Report"},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-03-28 20:04:39 +0000","url":"http://biz.yahoo.com/e/160328/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"Biotech Stock Mailbag: How to Spot Red Flags in Clinical Trial Data","publication_date":"2016-03-24 13:58:00 +0000","url":"http://www.thestreet.com/story/13506801/1/biotech-stock-mailbag-how-to-spot-red-flags-in-clinical-trial-data.html?puc=yahoo&cm_ven=YAHOO","summary":"Biotech Stock Mailbag: How to Spot Red Flags in Clinical Trial Data"},{"title":"Health Care Sector Update for 03/18/2016: CBAY,TBIO,HTBX","publication_date":"2016-03-18 19:06:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gfFbmjMkqQA/health-care-sector-update-for-03182016-cbaytbiohtbx-cm595176","summary":"Top Health Care Stocks JNJ +0.96% PZE +0.90% MRK +1.27% ABT +1.20% AMGN +1.19% Health care stocks were enjoying their first positive day this week, with the NYSE Health Care Index climbing 0.6% higher while shares of health care"},{"title":"5 Stocks Under $10 Set to Soar Higher","publication_date":"2016-03-10 11:00:00 +0000","url":"http://www.thestreet.com/story/13489712/1/5-stocks-under-10-set-to-soar-higher.html?puc=yahoo&cm_ven=YAHOO","summary":"5 Stocks Under $10 Set to Soar Higher"},{"title":"Cymabay Gives Update on Phase III Program on Arhalofenate","publication_date":"2016-01-21 22:26:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Q17ipNmnQ0/cymabay-gives-update-on-phase-iii-program-on-arhalofenate-cm568780","summary":"Cymabay Therapeutics, Inc.CBAY announced that it has successfully completed the end of phase II meeting with the FDA for the phase III development program on arhalofenate. Arhalofenate is being developed in combination with Uloric (febuxostat) for the treatment of"},{"title":"Cymabay Gives Update on Phase III Program on Arhalofenate","publication_date":"2016-01-21 20:15:08 +0000","url":"http://finance.yahoo.com/news/cymabay-gives-phase-iii-program-201508507.html","summary":"Cymabay Gives Update on Phase III Program on Arhalofenate"},{"title":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-01-20 13:03:02 +0000","url":"http://biz.yahoo.com/e/160120/cbay8-k.html","summary":"CYMABAY THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Hedge Funds Aren’t Crazy About FXCM Inc (FXCM) Anymore","publication_date":"2015-12-10 09:06:50 +0000","url":"http://www.insidermonkey.com/blog/hedge-funds-arent-crazy-about-fxcm-inc-fxcm-anymore-401162/","summary":"Hedge Funds Aren’t Crazy About FXCM Inc (FXCM) Anymore"},{"title":"FDA reviewers question safety of AstraZeneca's gout drug","publication_date":"2015-10-21 14:51:08 +0000","url":"http://sg.finance.yahoo.com/news/fda-staff-reviewers-safety-astrazenecas-125806382.html","summary":"FDA reviewers question safety of AstraZeneca's gout drug"},{"title":"Cymabay Therapeutics (CBAY) Looks Good: Stock Up 7.2%","publication_date":"2015-09-21 15:42:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EUaWLvrx4is/cymabay-therapeutics-cbay-looks-good-stock-up-72-cm521908","summary":"Cymabay Therapeutics, Inc. ( CBAY ) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in"},{"title":"Health Care Sector Update for 05/08/2015: CBAY,ALDR,AMDA","publication_date":"2015-05-08 20:35:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bPsyDswNXdA/health-care-sector-update-for-05082015-cbayaldramda-cm474869","summary":"Top Health Care Stocks JNJ +1.86% PZE +1.46% MRK +2.30% ABT +1.01% AMGN +2.33% Health care stocks rallied Friday with the NYSE Health Care Sector Index surging over 1.5% while shares of health care companies in the S&P 500"},{"title":"CymaBay Therapeutics Slumps: CBAY Falls 18.5% in Session - Tale of the Tape","publication_date":"2015-02-25 15:49:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4LsydCJXXPk/cymabay-therapeutics-slumps-cbay-falls-185-in-session-tale-of-the-tape-cm448279","summary":"CymaBay Therapeutics Inc. ( CBAY ) saw a big move last session, as the company's shares fell by nearly 19% on the day. The move came on pretty good volume too with far more shares changing hands than in"}],"result_count":98,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1491054175,"trigger": "MARK AT OR ABOVE 4.35","triggerPrice":4.35,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"4.2427"},{"x":"1490967300","y":"4.22"},{"x":"1490967600","y":"4.18"},{"x":"1490967900","y":"4.19"},{"x":"1490968200","y":"4.2152"},{"x":"1490968500","y":"4.27"},{"x":"1490968800","y":"4.2865"},{"x":"1490969100","y":"4.306"},{"x":"1490969400","y":"4.35"},{"x":"1490969700","y":"4.33"},{"x":"1490970000","y":"4.285"},{"x":"1490970300","y":"4.3"},{"x":"1490970600","y":"4.2881"},{"x":"1490970900","y":"4.29"},{"x":"1490971200","y":"4.295"},{"x":"1490971500","y":"4.3"},{"x":"1490971800","y":"4.27"},{"x":"1490972100","y":"4.285"},{"x":"1490972400","y":"4.2999"},{"x":"1490972700","y":"4.29"},{"x":"1490973000","y":"4.28"},{"x":"1490973300","y":"4.2311"},{"x":"1490973600","y":"4.2362"},{"x":"1490973900","y":"4.23"},{"x":"1490974200","y":"4.19"},{"x":"1490974500","y":"4.22"},{"x":"1490974800","y":"4.18"},{"x":"1490975100","y":"4.21"},{"x":"1490975400","y":"4.2"},{"x":"1490975700","y":"4.2"},{"x":"1490976000","y":"4.2"},{"x":"1490976300","y":"4.2"},{"x":"1490976600","y":"4.24"},{"x":"1490976900","y":"4.24"},{"x":"1490977200","y":"4.2"},{"x":"1490977500","y":"4.2223"},{"x":"1490977800","y":"4.22"},{"x":"1490978100","y":"4.23"},{"x":"1490978400","y":"4.2"},{"x":"1490978700","y":"4.1928"},{"x":"1490979300","y":"4.2"},{"x":"1490979600","y":"4.2"},{"x":"1490979900","y":"4.2"},{"x":"1490980200","y":"4.19"},{"x":"1490980500","y":"4.2"},{"x":"1490980800","y":"4.2"},{"x":"1490981100","y":"4.21"},{"x":"1490981400","y":"4.2126"},{"x":"1490982000","y":"4.23"},{"x":"1490982300","y":"4.21"},{"x":"1490982900","y":"4.23"},{"x":"1490983200","y":"4.23"},{"x":"1490983500","y":"4.22"},{"x":"1490983800","y":"4.23"},{"x":"1490984100","y":"4.23"},{"x":"1490984400","y":"4.23"},{"x":"1490984700","y":"4.24"},{"x":"1490985000","y":"4.24"},{"x":"1490985300","y":"4.24"},{"x":"1490985600","y":"4.24"},{"x":"1490985900","y":"4.25"},{"x":"1490986200","y":"4.28"},{"x":"1490986500","y":"4.27"},{"x":"1490986800","y":"4.21"},{"x":"1490987100","y":"4.27"},{"x":"1490987400","y":"4.24"},{"x":"1490987700","y":"4.2699"},{"x":"1490988000","y":"4.29"},{"x":"1490988300","y":"4.28"},{"x":"1490988600","y":"4.29"},{"x":"1490988900","y":"4.28"},{"x":"1490989200","y":"4.2999"},{"x":"1490989500","y":"4.29"},{"x":"1490989800","y":"4.3"},{"x":"1490990100","y":"4.3"},{"x":"1490990400","y":"4.3"} ], "color":"#03a9f4"}]},
{"id":"3","list":"Alerts","symbol": "CNCE","name": "Concert Pharmaceuticals Inc","price": 17.06,"dollarChange": 0.69,"percentChange": 4.22,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/CNCE-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/CNCE-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/CNCE-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/CNCE-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/CNCE-1yr.php","open": 16.29,"high": 17.23,"low":16.15,"volume": 599501,"avgVol": 414031.466667,"sharesShort": 950400,"shortPercent": 4.256352,"marketCap": 207659532,"float": 22328982,"headlines":{"data":[{"title":"Why Concert Pharmaceuticals Is Music to Investors' Ears","publication_date":"2017-03-26 18:00:00 +0000","url":"https://www.thestreet.com/story/14037741/1/why-concert-pharmaceuticals-is-music-to-investors-ears.html?puc=yahoo&cm_ven=YAHOO","summary":"Why Concert Pharmaceuticals Is Music to Investors' Ears"},{"title":"Concert rebuffed $250M buyout offer from Vertex before CF drug deal","publication_date":"2017-03-24 14:50:08 +0000","url":"http://www.bizjournals.com/boston/news/2017/03/24/concert-rebuffed-250m-buyout-offer-from-vertex.html?ana=yahoo","summary":"Concert rebuffed $250M buyout offer from Vertex before CF drug deal"},{"title":"Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?","publication_date":"2017-03-24 12:01:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EkhtchfuyTA/will-concert-pharmaceuticals-cnce-continue-to-surge-higher-cm765055","summary":"As of late it has definitely been a great time to be an investor in Concert Pharmaceuticals Inc CNCE The stock has moved higher by 97 5 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that"},{"title":"Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?","publication_date":"2017-03-24 09:32:09 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-cnce-continue-surge-093209445.html","summary":"Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?"},{"title":"Moving Average Crossover Alert: Concert Pharmaceuticals (CNCE)","publication_date":"2017-03-17 16:07:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e_pPqsjoCDE/moving-average-crossover-alert-concert-pharmaceuticals-cnce-cm762225","summary":"Concert Pharmaceuticals Inc CNCE is looking like an interesting pick from a technical perspective as the company is seeing favorable trends on the moving average crossover front Recently the 50 Day Moving Average for CNCE broke out above the 200 Day Simple Moving Average suggesting"},{"title":"Moving Average Crossover Alert: Concert Pharmaceuticals (CNCE)","publication_date":"2017-03-17 14:15:02 +0000","url":"http://finance.yahoo.com/news/moving-average-crossover-alert-concert-141502032.html","summary":"Moving Average Crossover Alert: Concert Pharmaceuticals (CNCE)"},{"title":"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead","publication_date":"2017-03-15 15:10:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5aHbc55hL50/after-valeant-here-are-5-drug-stocks-bill-ackman-should-buy-instead-cm761004","summary":"Billionaire investor Bill Ackman has finally decided to pull out his investment in Canada based drugmaker Valeant Pharmaceuticals International Inc VRX Hedge fund Pershing Square made the announcement earlier this week and said that while Ackman and Steve Fraidin will remain on the"},{"title":"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead","publication_date":"2017-03-15 13:22:01 +0000","url":"http://finance.yahoo.com/news/valeant-5-drug-stocks-bill-132201437.html","summary":"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead"},{"title":"[$$] Charting the Market","publication_date":"2017-03-11 05:35:00 +0000","url":"http://www.barrons.com/articles/barrons-charting-the-market-1489210508?mod=yahoobarrons&ru=yahoo","summary":"[$$] Charting the Market"},{"title":"3 Biotech Stocks to Buy in March","publication_date":"2017-03-11 00:18:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KwMCTFA5GVg/3-biotech-stocks-to-buy-in-march-cm759560","summary":"Which biotech stocks look like smart picks right now 160 That s the question we posed to three of The Motley Fool s healthcare contributors All three answered with small cap biotech stocks Spark Therapeutics NASDAQ ONCE Albany Molecular Research NASDAQ AMRI"},{"title":"3 Biotech Stocks to Buy in March","publication_date":"2017-03-10 17:07:00 +0000","url":"http://www.fool.com/investing/2017/03/10/3-biotech-stocks-to-buy-in-march.aspx","summary":"3 Biotech Stocks to Buy in March"},{"title":"CONCERT PHARMACEUTICALS, INC. Financials","publication_date":"2017-03-09 18:04:09 +0000","url":"http://finance.yahoo.com/q/is?s=cnce","summary":"CONCERT PHARMACEUTICALS, INC. Financials"},{"title":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017","publication_date":"2017-03-09 16:18:40 +0000","url":"http://www.capitalcube.com/blog/index.php/concert-pharmaceuticals-inc-cnce-us-earnings-analysis-q4-2016-by-the-numbers-march-9-2017/","summary":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017"},{"title":"RDInvesting.com: Coverage Initiated on Concert Pharmaceuticals, Price Surges","publication_date":"2017-03-08 14:30:00 +0000","url":"http://finance.yahoo.com/news/rdinvesting-com-coverage-initiated-concert-143000354.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 8, 2017 / Concert Pharmaceuticals rose an astounding 62.07 percent on Monday to close at $15.64 as a result of its sale of its CTP-656 drug to fellow pharmaceutical company ..."},{"title":"Concert Pharmaceuticals, Inc.: Strong price momentum but will it sustain?","publication_date":"2017-03-07 22:04:50 +0000","url":"http://www.capitalcube.com/blog/index.php/concert-pharmaceuticals-inc-strong-price-momentum-but-will-it-sustain/","summary":"Concert Pharmaceuticals, Inc.: Strong price momentum but will it sustain?"},{"title":"Harry Boxer’s six biotechnology stocks to watch","publication_date":"2017-03-07 18:55:50 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2","summary":"Harry Boxer’s six biotechnology stocks to watch"},{"title":"Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M","publication_date":"2017-03-07 18:13:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1nMvaq1SZ6M/vertex-to-buy-concerts-cystic-fibrosis-candidate-for-160m-cm757339","summary":"Vertex Pharmaceuticals Incorporated VRTX announced a definitive deal to buy the worldwide development and commercialization rights of Concert Pharmaceuticals CNCE cystic fibrosis CF pipeline candidate CTP 656 for an upfront payment of 160 million in cash Shares of Concert Pharma"},{"title":"Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M","publication_date":"2017-03-07 15:53:03 +0000","url":"http://finance.yahoo.com/news/vertex-buy-concerts-cystic-fibrosis-155303084.html","summary":"Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M"},{"title":"Concert Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : CNCE-US : March 7, 2017","publication_date":"2017-03-07 12:16:54 +0000","url":"http://www.capitalcube.com/blog/index.php/concert-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-cnce-us-march-7-2017/","summary":"Concert Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : CNCE-US : March 7, 2017"},{"title":"Close Update: Wall Street Pares Losses But Weaker Finish Eyed as Politics, Rate Hike Weigh","publication_date":"2017-03-06 21:52:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4MThfm2IfxU/close-update-wall-street-pares-losses-but-weaker-finish-eyed-as-politics-rate-hike-weigh-cm756886","summary":"The main U S markets started the week lower paring losses in the latter part of the day but staying in the red with declines spread among almost all of the sectors on the S amp P 500 Risk aversion seemed to set in amid global and domestic political jitters as North Korea launched four"},{"title":"Health Care Sector Update for 03/06/2017: CNCE,VTRX,TGTX,IONS","publication_date":"2017-03-06 21:32:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aFkYFljUkq8/health-care-sector-update-for-03062017-cncevtrxtgtxions-cm756874","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 07 JNJ 0 07 PFE 0 25 PFE 0 25 MRK 0 06 MRK 0 06 ABT 0 05 ABT 0 05 AMGN 0 21 AMGN 0 21 Health care stocks were moderately lower late Monday with the NYSE Health Care Index posting a 0 3 retreat while shares of health care"},{"title":"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS...","publication_date":"2017-03-06 20:00:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-FtD2qL1YxA/gainers--losers-of-mar6-tgtx-cnce-dxtr-kura-args-20170306-01394","summary":"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS..."},{"title":"Monday’s Top Health Care Stocks Screaming Higher","publication_date":"2017-03-06 18:45:34 +0000","url":"http://finance.yahoo.com/news/monday-top-health-care-stocks-184534179.html","summary":"Monday’s Top Health Care Stocks Screaming Higher"},{"title":"Midday Update: Risk Aversion Prevails as N. Korea Fires Missiles, China Lowers Growth, Juppe Rules Out French Run","publication_date":"2017-03-06 18:32:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m16J9YYSoAM/midday-update-risk-aversion-prevails-as-n-korea-fires-missiles-china-lowers-growth-juppe-rules-out-french-run-cm756777","summary":"The Dow Jones Industrial Average was trading lower for a third consecutive day as caution overtook Wall Street Monday morning after North Korea launched four ballistic missiles towards the Sea of Japan and China lowered its growth forecasts for the year The Dow Jones Industrial Average was"},{"title":"Edited Transcript of CNCE earnings conference call or presentation 6-Mar-17 1:30pm GMT","publication_date":"2017-03-06 18:27:32 +0000","url":"http://finance.yahoo.com/news/edited-transcript-cnce-earnings-conference-182732180.html","summary":"Edited Transcript of CNCE earnings conference call or presentation 6-Mar-17 1:30pm GMT"},{"title":"Why Concert Pharmaceuticals Stock Is Soaring Today","publication_date":"2017-03-06 18:15:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rtYli1NqB5E/why-concert-pharmaceuticals-stock-is-soaring-today-cm756714","summary":"What happened Shares of Concert Pharmaceuticals NASDAQ CNCE 160 surged as much as 91 5 in morning trading on Monday as the result of a deal with Vertex Pharmaceuticals NASDAQ VRTX for the experimental cystic fibrosis CF drug 160 CTP 656 As of 11 45 a m EST the"},{"title":"$160M deal with Concert helps Vertex maintain dominance in cystic fibrosis","publication_date":"2017-03-06 17:45:08 +0000","url":"http://www.bizjournals.com/boston/news/2017/03/06/160m-deal-with-concert-helps-vertex-maintain.html?ana=yahoo","summary":"$160M deal with Concert helps Vertex maintain dominance in cystic fibrosis"},{"title":"Why Concert Pharmaceuticals Stock Is Soaring Today","publication_date":"2017-03-06 16:53:52 +0000","url":"http://www.fool.com/investing/2017/03/06/why-concert-pharmaceuticals-stock-is-soaring-today.aspx","summary":"Why Concert Pharmaceuticals Stock Is Soaring Today"},{"title":"Pre-Market Most Active for Mar 6, 2017 : SNAP, DB, BAC, TVIX, GM, CS, UN, MU, AUPH, GPRO, PTCT, CNCE","publication_date":"2017-03-06 13:52:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rnKICrFGIDk/pre-market-most-active-for-mar-6-2017-snap-db-bac-tvix-gm-cs-un-mu-auph-gpro-ptct-cnce-cm756479","summary":"The NASDAQ 100 Pre Market Indicator is down 6 38 to 5 367 1 The total Pre Market volume is currently 2 528 513 shares traded The following are the most active stocks for the pre market session Snap Inc SNAP is 1 26 at 28 35 with 1 772 973 shares traded following"},{"title":"What You Must Know About Cystic Fibrosis Drug CTP-656","publication_date":"2017-03-06 12:57:00 +0000","url":"http://www.thestreet.com/video/14027703/what-you-must-know-about-cystic-fibrosis-drug-ctp-656.html?puc=yahoov&cm_ven=YAHOOV","summary":"What You Must Know About Cystic Fibrosis Drug CTP-656"},{"title":"Concert Pharma shares rally 34% on news Vertex to pay up to $250 million for cystic fibrosis drug","publication_date":"2017-03-06 12:56:48 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=906BEC42-AED4-4608-8DB8-29715B0638F3&siteid=yhoof2","summary":"Concert Pharma shares rally 34% on news Vertex to pay up to $250 million for cystic fibrosis drug"},{"title":"Concert reports 4Q loss","publication_date":"2017-03-06 12:34:45 +0000","url":"http://sg.finance.yahoo.com/news/concert-reports-4q-loss-123445543.html","summary":"Concert reports 4Q loss"},{"title":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a","publication_date":"2017-03-06 12:23:27 +0000","url":"http://biz.yahoo.com/e/170306/cnce8-k.html","summary":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a"},{"title":"Concert Pharmaceuticals Reports Year Ended 2016 Financial Results","publication_date":"2017-03-06 12:15:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-reports-ended-2016-121500655.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today reported financial results for the year ended December 31, 2016, as well as provided an update on its product pipeline and corporate activities."},{"title":"Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma","publication_date":"2017-03-06 12:01:00 +0000","url":"https://www.thestreet.com/story/14027440/1/vertex-pharma-acquires-long-acting-version-of-cystic-fibrosis-drug-from-concert-pharma.html?puc=yahoo&cm_ven=YAHOO","summary":"Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma"},{"title":"Concert Pharmaceuticals (CNCE) Has Jumped To A 9-Month High","publication_date":"2017-03-06 09:39:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d5X7WZCwzvE/concert-pharmaceuticals-cnce-has-jumped-to-a-9month-high-20170306-00750","summary":"Concert Pharmaceuticals (CNCE) Has Jumped To A 9-Month High"},{"title":"3:09 am Concert Pharmaceuticals presents Phase 1 results CTP-543; on Track to begin Phase 2a Trial in Q1","publication_date":"2017-03-06 08:09:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#cnce","summary":"3:09 am Concert Pharmaceuticals presents Phase 1 results CTP-543; on Track to begin Phase 2a Trial in Q1"},{"title":"Vertex To Buy CTP-656 From Concert Pharma For Treatment Of Cystic Fibrosis","publication_date":"2017-03-06 07:04:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xNGuT3WQ_9Q/vertex-to-buy-ctp656-from-concert-pharma-for-treatment-of-cystic-fibrosis-20170306-00321","summary":"Vertex To Buy CTP-656 From Concert Pharma For Treatment Of Cystic Fibrosis"},{"title":"Concert Pharmaceuticals Presents CTP-543 Phase 1 Results at American Academy of Dermatology Annual Meeting","publication_date":"2017-03-04 15:00:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-presents-ctp-543-150000612.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today announced that the results from the Company’s Phase 1 single and multiple ascending dose trial evaluating CTP-543 in healthy volunteers were presented in a poster session at the American Academy of Dermatology’s Annual Meeting in Orlando, FL."},{"title":"Pre-Market Earnings Report for March 6, 2017 : FRP, MEET, CNCE, MVIS","publication_date":"2017-03-03 21:12:40 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SOn-IsJfkpo/pre-market-earnings-report-for-march-6-2017-frp-meet-cnce-mvis-cm756172","summary":"The following companies are expected to report earnings prior to market open on 03 06 2017 Visit our Earnings Calendar for a full list of expected earnings releases FairPoint Communications Inc FRP is reporting for the quarter ending December 31 2016"},{"title":"Concert Pharmaceuticals to Report Full Year 2016 Results on March 6, 2017, and Present at Upcoming Investor Conferences","publication_date":"2017-03-02 12:00:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-report-full-2016-120000700.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today announced that it will report its financial results for the year ended December 31, 2016, on Monday, March 6, 2017, before the U.S."},{"title":"Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S.","publication_date":"2017-01-24 00:31:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NVc_2RTfDn4/concerts-cnce-ctp-656-gets-orphan-drug-status-in-us-cm737056","summary":"Concert Pharmaceuticals Inc CNCE announced that the FDA has granted orphan drug designation to its candidate CTP 656 for the treatment of cystic fibrosis We note that orphan drug designation is granted to drugs capable of treating diseases affecting less than 200 000 people in the U"},{"title":"Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S.","publication_date":"2017-01-23 22:32:10 +0000","url":"http://finance.yahoo.com/news/concerts-cnce-ctp-656-gets-223210433.html","summary":"Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S."},{"title":"Here’s What A Concert Pharmaceuticals Inc (CNCE) Data Win Might Mean For The Company","publication_date":"2017-01-23 14:31:42 +0000","url":"http://www.insidermonkey.com/blog/heres-what-a-concert-pharmaceuticals-inc-cnce-data-win-might-mean-for-the-company-522046/","summary":"Here’s What A Concert Pharmaceuticals Inc (CNCE) Data Win Might Mean For The Company"},{"title":"Concert Pharmaceuticals Receives FDA Orphan Drug Designation for CTP-656 for the Treatment of Cystic Fibrosis","publication_date":"2017-01-20 13:30:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-receives-fda-orphan-133000325.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted orphan drug designation for CTP-656, Concert’s next generation CFTR potentiator being developed for the treatment of cystic fibrosis."},{"title":"Concert Offers Update on Cystic Fibrosis Drug, Stock Down","publication_date":"2017-01-18 19:37:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7VWpcltxQaQ/concert-offers-update-on-cystic-fibrosis-drug-stock-down-cm734972","summary":"Concert Pharmaceuticals Inc CNCE provided update on the development plan of its next generation CFTR potentiator CTP 656 for the treatment of cystic fibrosis in the U S and Europe Shares of the company were down approximately 14 on the news Moreover Concert s share price has"},{"title":"Concert Offers Update on Cystic Fibrosis Drug, Stock Down","publication_date":"2017-01-18 17:38:05 +0000","url":"http://finance.yahoo.com/news/concert-offers-cystic-fibrosis-drug-173805741.html","summary":"Concert Offers Update on Cystic Fibrosis Drug, Stock Down"},{"title":"Gainers & Losers Of The Day: PULM, FWP, TNDM, ADHD, CNCEâ€¦","publication_date":"2017-01-17 23:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qHhHgL84qyg/gainers--losers-of-the-day-pulm-fwp-tndm-adhd-cnce%C3%A2%C2%A6-20170117-01807","summary":"Gainers & Losers Of The Day: PULM, FWP, TNDM, ADHD, CNCEâ€¦"},{"title":"Tuesday Sector Laggards: Drugs, Biotechnology Stocks","publication_date":"2017-01-17 19:36:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S14gvhTV0Bk/tuesday-sector-laggards-drugs-biotechnology-stocks-cm734384","summary":"In trading on Tuesday drugs shares were relative laggards down on the day by about 2 4 Helping drag down the group were shares of Alcobra ADHD off about 49 9 and shares of Concert Pharmaceuticals CNCE off about 13 7 on the day Also lagging the market Tuesday"},{"title":"Concert Pharmaceuticals Provides Further Details on CTP-656 Development in U.S. and Europe","publication_date":"2017-01-17 12:00:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-provides-further-details-120000964.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today provided further details on the development plan in the U.S. and Europe for CTP-656, a next generation CFTR potentiator being developed for the treatment of cystic fibrosis."},{"title":"Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?","publication_date":"2016-12-29 11:59:12 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E3kYKmRXq0c/will-concert-pharmaceuticals-cnce-continue-to-surge-higher-cm727244","summary":"As of late it has definitely been a great time to be an investor in Concert Pharmaceuticals Inc CNCE The stock has moved higher by 8 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that the"},{"title":"Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?","publication_date":"2016-12-29 09:38:09 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-cnce-continue-surge-093809375.html","summary":"Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?"},{"title":"CALA Surges On BMY Deal, OVAS Hands Pink Slips, MACK Halts Breast Cancer Study","publication_date":"2016-12-21 23:00:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LivsjpkbrEE/cala-surges-on-bmy-deal-ovas-hands-pink-slips-mack-halts-breast-cancer-study-20161221-00953","summary":"CALA Surges On BMY Deal, OVAS Hands Pink Slips, MACK Halts Breast Cancer Study"},{"title":"Concert Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating CTP-656 for the Treatment of Cystic Fibrosis","publication_date":"2016-12-21 12:52:10 +0000","url":"http://www.publicnow.com/view/706ECED630EB561ABC072F644AC52D09EBCE15BF","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the initiation of a U.S.-based Phase 2 clinical trial evaluating CTP-656 (deuterated ivacaftor), a next ..."},{"title":"ETFs with exposure to Concert Pharmaceuticals, Inc. : December 19, 2016","publication_date":"2016-12-19 18:09:57 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-concert-pharmaceuticals-inc-december-19-2016/","summary":"ETFs with exposure to Concert Pharmaceuticals, Inc. : December 19, 2016"},{"title":"How Concert Pharmaceuticals Inc (CNCE) Stacks Up Against Its Peers","publication_date":"2016-12-18 16:39:07 +0000","url":"http://www.insidermonkey.com/blog/how-concert-pharmaceuticals-inc-cnce-stacks-up-against-its-peers-508496/","summary":"How Concert Pharmaceuticals Inc (CNCE) Stacks Up Against Its Peers"},{"title":"Concert Pharmaceuticals Announces CTP-543 Positive Top-Line Phase 1 Results","publication_date":"2016-12-14 12:30:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-announces-ctp-543-123000176.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today announced the Phase 1 single and multiple ascending dose trial evaluating CTP-543 in healthy volunteers has been completed. Concert is developing CTP-543 for the treatment of alopecia areata, an autoimmune disorder in which the immune system attacks hair follicles, resulting in patchy or complete hair loss."},{"title":"ETFs with exposure to Concert Pharmaceuticals, Inc. : December 8, 2016","publication_date":"2016-12-08 19:28:00 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-concert-pharmaceuticals-inc-december-8-2016/","summary":"ETFs with exposure to Concert Pharmaceuticals, Inc. : December 8, 2016"},{"title":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016","publication_date":"2016-11-23 15:44:08 +0000","url":"http://www.capitalcube.com/blog/index.php/concert-pharmaceuticals-inc-cnce-us-earnings-analysis-q3-2016-by-the-numbers-november-23-2016/","summary":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016"},{"title":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition","publication_date":"2016-11-08 12:34:22 +0000","url":"http://biz.yahoo.com/e/161108/cnce8-k.html","summary":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition"},{"title":"Concert Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Company Update","publication_date":"2016-11-08 12:07:18 +0000","url":"http://www.publicnow.com/view/B12C255ADD1469398D2F780FD4FEE15D4A5E61AC","summary":"[at noodls] - Conference Call Scheduled Today at 8:30 a.m. EST LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2016. ... This ..."},{"title":"Q3 2016 Concert Pharmaceuticals Inc Earnings Release - Before Market Open","publication_date":"2016-11-08 12:07:08 +0000","url":"http://biz.yahoo.com/research/earncal/20161108.html?t=cnce","summary":"Q3 2016 Concert Pharmaceuticals Inc Earnings Release - Before Market Open"},{"title":"Concert reports 3Q loss","publication_date":"2016-11-08 12:06:40 +0000","url":"http://sg.finance.yahoo.com/news/concert-reports-3q-loss-120640673.html","summary":"Concert reports 3Q loss"},{"title":"Concert Pharmaceuticals to Report Third Quarter 2016 Financial Results on November 8, 2016, and Present at Upcoming Investor Conferences","publication_date":"2016-11-01 11:13:13 +0000","url":"http://www.publicnow.com/view/7F7931D6D7B76472440BDD7A9C7EE112E4EE31FB","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2016 financial results on Tuesday, November 8, 2016, before the U.S. ..."},{"title":"Concert Pharmaceuticals Presents Poster at 2016 North American Cystic Fibrosis Conference","publication_date":"2016-10-27 15:15:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-presents-poster-2016-151500512.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today presented a poster describing Phase 1 food effect and multiple ascending dose results of CTP-656 at the North American Cystic Fibrosis Conference being held in Orlando, Florida."},{"title":"Concert Pharmaceuticals, Inc. (Nasdaq: CNCE) to Ring The Nasdaq Stock Market Closing Bell","publication_date":"2016-10-24 14:21:04 +0000","url":"http://www.publicnow.com/view/F82D2CCD9B9372409D6ECEF012ED0AE24F8CB4DF","summary":"[at noodls] - ADVISORY, Oct. 24, 2016 (GLOBE NEWSWIRE) -- What: Concert Pharmaceuticals, Inc. (Nasdaq:CNCE), a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity ..."},{"title":"Concert Pharmaceuticals Announces Upcoming Poster Presentation at North American Cystic Fibrosis Conference","publication_date":"2016-09-21 20:01:00 +0000","url":"http://finance.yahoo.com/news/concert-pharmaceuticals-announces-upcoming-poster-200100631.html","summary":"[Business Wire] - Concert Pharmaceuticals, Inc. today announced that the Company will present a poster at the 30th Annual North American Cystic Fibrosis Conference being held October 27-29, 2016, in Orlando, Florida."},{"title":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-09-16 20:07:04 +0000","url":"http://biz.yahoo.com/e/160916/cnce8-k.html","summary":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"A Decades-Old Drug Technology Finally Nears Its Big Breakthrough","publication_date":"2016-09-16 06:55:10 +0000","url":"http://www.bloomberg.com/news/articles/2016-09-16/a-decades-old-drug-technology-finally-nears-its-big-breakthrough?cmpid=yhoo.headline","summary":"A Decades-Old Drug Technology Finally Nears Its Big Breakthrough"},{"title":"Concert Pharmaceuticals Expands Management Team","publication_date":"2016-09-06 13:19:10 +0000","url":"http://www.publicnow.com/view/89E755DD087C93107FC9996DD5002E7E3C908849","summary":"[at noodls] - Appointment of Two Executives to Support Advancement of Product Pipeline: Christine Boisclair Named Vice President, Regulatory Affairs, and Scott Weintraub Named Vice President, Commercial and Product ..."},{"title":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-09-06 11:45:56 +0000","url":"http://biz.yahoo.com/e/160906/cnce8-k.html","summary":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"Concert Pharmaceuticals to Present at Upcoming Investor Conferences","publication_date":"2016-09-01 11:13:03 +0000","url":"http://www.publicnow.com/view/0A0F8181E895EC0D38F1AD9F8895F3B4FC260845","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences: The Wells Fargo ..."},{"title":"ETF’s with exposure to Concert Pharmaceuticals, Inc. : August 29, 2016","publication_date":"2016-08-29 15:14:10 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-concert-pharmaceuticals-inc-august-29-2016/","summary":"ETF’s with exposure to Concert Pharmaceuticals, Inc. : August 29, 2016"},{"title":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016","publication_date":"2016-08-11 16:16:55 +0000","url":"http://www.capitalcube.com/blog/index.php/concert-pharmaceuticals-inc-cnce-us-earnings-analysis-q2-2016-by-the-numbers-august-11-2016/","summary":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016"},{"title":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition","publication_date":"2016-08-09 12:08:10 +0000","url":"http://biz.yahoo.com/e/160809/cnce8-k.html","summary":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition"},{"title":"Concert reports 2Q loss","publication_date":"2016-08-09 11:11:23 +0000","url":"http://sg.finance.yahoo.com/news/concert-reports-2q-loss-111123729.html","summary":"Concert reports 2Q loss"},{"title":"Concert Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Company Update","publication_date":"2016-08-09 11:10:11 +0000","url":"http://www.publicnow.com/view/0FD8226D2463009586F01E3DCDC5D86D7AB91A9A","summary":"[at noodls] - Conference Call Scheduled Today at 8:30 a.m. EDT LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2016. ... This ..."},{"title":"Q2 2016 Concert Pharmaceuticals Inc Earnings Release - Before Market Open","publication_date":"2016-08-09 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20160809.html?t=cnce","summary":"Q2 2016 Concert Pharmaceuticals Inc Earnings Release - Before Market Open"},{"title":"Concert Pharmaceuticals to Report Second Quarter 2016 Financial Results on August 9, 2016","publication_date":"2016-08-02 11:21:07 +0000","url":"http://www.publicnow.com/view/9D1B5609631B9488F63515E0BA669FAFE40070EF","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2016 financial results on Tuesday, August 9, 2016, before the U.S. ..."},{"title":"Concert Pharmaceuticals Announces Webcast at Cantor Fitzgerald Healthcare Conference","publication_date":"2016-07-06 11:11:05 +0000","url":"http://www.publicnow.com/view/B30BA495938F4029F4F66FDA385D3E65DACA4C02","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the Cantor Fitzgerald Healthcare Conference on Wednesday, July ..."},{"title":"Coverage initiated on Concert Pharmaceuticals by Stifel","publication_date":"2016-07-01 11:00:30 +0000","url":"http://finance.yahoo.com/q/ud?s=CNCE","summary":"Coverage initiated on Concert Pharmaceuticals by Stifel"},{"title":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-10 20:13:21 +0000","url":"http://biz.yahoo.com/e/160610/cnce8-k.html","summary":"CONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"},{"title":"Concert Pharmaceuticals Presents CTP-656 Phase 1 Results at European Cystic Fibrosis Conference","publication_date":"2016-06-10 14:49:02 +0000","url":"http://www.publicnow.com/view/1EBD50ABCCDFDBAF5062811623536A8935B3EBCA","summary":"[at noodls] - Findings Confirmed Superior Pharmacokinetic Profile Relative to Kalydeco LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented results from a Phase 1 multiple ..."},{"title":"Concert Pharmaceuticals Initiates Phase 1 Trial of CTP-543 as a New Treatment for Alopecia Areata","publication_date":"2016-05-19 11:22:05 +0000","url":"http://www.publicnow.com/view/17586B7D326C3A24AD754EBAA97B9459BBC5B657","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated its Phase 1 clinical program for CTP-543, which is being developed for the treatment ..."},{"title":"Concert Pharmaceuticals to Present at Several Upcoming Investor Conferences","publication_date":"2016-05-17 12:42:12 +0000","url":"http://www.publicnow.com/view/51C57E3A7768CF16F7C667F072FCF01205D6B9F1","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences: The UBS 2016 Global ..."},{"title":"Noteworthy Insider Buying and Selling at MiMedx Group, Aetna & Others","publication_date":"2016-05-13 14:00:19 +0000","url":"http://www.insidermonkey.com/blog/noteworthy-insider-buying-and-selling-at-mimedx-group-aetna-others-449078/","summary":"Noteworthy Insider Buying and Selling at MiMedx Group, Aetna & Others"},{"title":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q1, 2016 By the Numbers","publication_date":"2016-05-11 15:28:40 +0000","url":"http://www.capitalcube.com/blog/index.php/concert-pharmaceuticals-inc-cnce-us-earnings-analysis-q1-2016-by-the-numbers/","summary":"Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q1, 2016 By the Numbers"},{"title":"Concert reports 1Q loss","publication_date":"2016-05-05 11:32:27 +0000","url":"http://sg.finance.yahoo.com/news/concert-reports-1q-loss-113227553.html","summary":"Concert reports 1Q loss"},{"title":"Concert Pharmaceuticals Reports First Quarter 2016 Financial Results","publication_date":"2016-05-05 11:11:06 +0000","url":"http://www.publicnow.com/view/EF84D8A56D8D636228FCAC99EF55CE799F897E20","summary":"[at noodls] - Conference Call Scheduled Today at 8:30 a.m. EDT LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2016. ... This ..."},{"title":"Concert Pharmaceuticals Unveils CTP-543 for Treatment of Alopecia Areata","publication_date":"2016-05-04 20:31:15 +0000","url":"http://www.publicnow.com/view/1DFC340000B3288779E261D8790AF1EF4F21C53A","summary":"[at noodls] - Phase 1 to Begin Second Quarter of 2016 Conference Call Scheduled Tomorrow at 8:30 a.m. EDT for Company Update and First Quarter 2016 Financial Results LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, ..."},{"title":"Concert Pharmaceuticals Announces Positive Data from Multiple Dose Phase 1 Clinical Trial of CTP-656, Lead Candidate for the Treatment of Cystic Fibrosis","publication_date":"2016-04-28 20:15:35 +0000","url":"http://www.publicnow.com/view/EE982C939F2EBB50D67CEDEEC98316EC38A6D7DD","summary":"[at noodls] - Multiple Dose Data Continues to Support Once-Daily Dosing and Differentiated Metabolite Profile Data to be Presented at the European Cystic Fibrosis Conference in June 2016 LEXINGTON, Mass.--(BUSINESS ..."},{"title":"Concert Pharmaceuticals to Report First Quarter 2016 Financial Results on May 5, 2016","publication_date":"2016-04-28 11:22:12 +0000","url":"http://www.publicnow.com/view/960FD31B42B6900287F4F0627F856FAD287629D9","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its first quarter 2016 financial results on Thursday, May 5, 2016, before the U.S. financial ..."},{"title":"7 Stocks Rising on Big Volume -- Here's How to Trade Them Now","publication_date":"2016-04-26 09:52:00 +0000","url":"http://www.thestreet.com/story/13543930/1/7-stocks-rising-on-big-volume-here-s-how-to-trade-them-now.html?puc=yahoo&cm_ven=YAHOO","summary":"7 Stocks Rising on Big Volume -- Here's How to Trade Them Now"},{"title":"Concert Pharmaceuticals (CNCE) in Focus: Stock Rises 5.6%","publication_date":"2016-04-25 14:59:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/foSfk0nhvNg/concert-pharmaceuticals-cnce-in-focus-stock-rises-56-cm610905","summary":"Concert Pharmaceuticals, Inc.CNCE was a big mover last session, as the company saw its shares rise almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session."},{"title":"Concert Pharmaceuticals Names Christine van Heek to Board of Directors","publication_date":"2016-04-14 11:17:08 +0000","url":"http://www.publicnow.com/view/A258C1D25D55E36E23A034EBE104D144785B4E65","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced today that Christine van Heek has been appointed to its Board of Directors and will serve as a member of its audit ..."},{"title":"Concert Pharmaceuticals Names Meghan FitzGerald to its Board of Directors","publication_date":"2016-03-23 11:09:10 +0000","url":"http://www.publicnow.com/view/C6B10236564C059096CAF5F4971ED46C912FEED2","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced today that Meghan FitzGerald has been appointed to its Board of Directors and will serve as a member of its compensation ..."},{"title":"Concert's Early-Stage Cystic Fibrosis Drug Shows Promise","publication_date":"2016-03-02 14:41:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3JUQeiaR8K8/concerts-early-stage-cystic-fibrosis-drug-shows-promise-cm587061","summary":"Concert Pharmaceuticals, Inc.CNCE announced new results from Part 1 of a multiple ascending dose phase I study on CTP 656 comparing the candidate to Vertex Pharmaceuticals Incorporated's VRTX Kalydeco (ivacaftor) for the treatment of patients with cystic fibrosis. The"},{"title":"Concert posts 4Q profit","publication_date":"2016-03-01 12:21:15 +0000","url":"http://sg.finance.yahoo.com/news/concert-posts-4q-profit-122115706.html","summary":"Concert posts 4Q profit"},{"title":"Increased Earnings Estimates Seen for Concert Pharmaceuticals (CNCE): Can It Move Higher?","publication_date":"2015-12-08 15:45:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/17bWiZmAgk4/increased-earnings-estimates-seen-for-concert-pharmaceuticals-cnce-can-it-move-higher-cm551628","summary":"Concert Pharmaceuticals, Inc. CNCE is a clinical stage biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short term momentum, but it is seeing solid activity on the"},{"title":"Concert Pharmaceuticals (CNCE): Strong Industry, Solid Earnings Estimate Revisions","publication_date":"2015-12-01 16:10:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3ZXtQIea9PU/concert-pharmaceuticals-cnce-strong-industry-solid-earnings-estimate-revisions-cm548770","summary":"One stock that might be an intriguing choice for investors right now is Concert Pharmaceuticals, Inc.CNCE . This is because this security in the Medical Drugs space is seeing solid earnings estimate revision activity, and is in great company"},{"title":"Instant Analysis: Vertex Pharmaceuticals Grabs an Important Regulatory Win","publication_date":"2015-11-20 17:51:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dVwdUb0RN2M/instant-analysis-vertex-pharmaceuticals-grabs-an-important-regulatory-win-cm545430","summary":"What happened? It's been a week to remember for shareholders of Vertex Pharmaceuticals (NASDAQ VRTX), as the cystic fibrosis leader once again received some great news from across the pond, which"},{"title":"Concert Pharmaceuticals Achieves $2 Million Milestone from Avanir Pharmaceuticals for Phase 3 Initiation of AVP-786 for Agitation in Patients with Alzheimer's Disease","publication_date":"2015-11-16 13:45:07 +0000","url":"http://www.noodls.com/view/1468310137588E5B5EB7E32BA2EBD9699CBC4303","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) today announced that it has achieved a $2 million milestone under its development and license agreement with Avanir Pharmaceuticals, ..."},{"title":"Jazz's Q3 Earnings & Revenues Grow Y/Y; Trims 2015 Outlook","publication_date":"2015-11-12 01:20:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MD50p2HSH5s/jazzs-q3-earnings-revenues-grow-yy-trims-2015-outlook-cm541904","summary":"Jazz Pharmaceuticals Public Limited CompanyJAZZ reported third quarter 2015 earnings of $2.16 per share (including share based compensation expense), increasing 7.5% year over year. Excluding the impact of share based compensation expense, third quarter 2015 earnings came in at"},{"title":"Concert Pharmaceuticals to Present at Upcoming Investor and Industry Conferences","publication_date":"2015-11-09 12:16:08 +0000","url":"http://www.noodls.com/view/4D2D092C2DD9731C360E69485F69303D08C41C1A","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences: Jefferies Autumn ..."},{"title":"Concert reports 3Q loss","publication_date":"2015-11-05 13:53:49 +0000","url":"http://sg.finance.yahoo.com/news/concert-reports-3q-loss-135349293.html","summary":"Concert reports 3Q loss"},{"title":"Concert Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Company Update","publication_date":"2015-11-05 12:20:19 +0000","url":"http://www.noodls.com/view/4643D8ABAB68427627837C15A6E34D251DD141FB","summary":"[at noodls] - Conference Call Scheduled Today at 8:30 a.m. EST LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2015. ... This ..."},{"title":"Concert Pharmaceuticals to Report Third Quarter 2015 Financial Results on November 5, 2015","publication_date":"2015-10-29 11:18:15 +0000","url":"http://www.noodls.com/view/068EC0AF23448FD7D7F967831B320BA4042EF77E","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2015 financial results on Thursday, November 5, 2015, before the U.S. ..."},{"title":"Vertex Turns Up the Heat on Cystic Fibrosis Challengers","publication_date":"2015-10-19 17:45:48 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HC_OUrgmOZY/vertex-turns-up-the-heat-on-cystic-fibrosis-challengers-cm531925","summary":"Source Vertex Pharmaceuticals. Back in 2012, Vertex Pharmaceuticals changed thousands of lives when it won approval to market Kalydeco to treat cystic fibrosis patients in the U.S. and EU. Cystic fibrosis,"},{"title":"A Double-Dose of Bad News Rocks Vertex Pharmaceuticals in September","publication_date":"2015-10-02 15:59:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IIM8qv6e1cQ/a-double-dose-of-bad-news-rocks-vertex-pharmaceuticals-in-september-cm526563","summary":"VRTX data by YCharts . As the saying goes, if you were a shareholder in Vertex Pharmaceuticals last month you \"probably shouldn't have gotten out of bed.\" Shares of the cystic fibrosis"},{"title":"Concert Pharmaceuticals (CNCE) Jumps: Stock Rises 23.1%","publication_date":"2015-09-24 14:43:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yS7iuQfT1w4/concert-pharmaceuticals-cnce-jumps-stock-rises-231-cm523264","summary":"Concert Pharmaceuticals, Inc. ( CNCE ) was a big mover last session, as its shares rose over 23% on the day. The upside was driven by encouraging phase 1 results for the company's experimental drug CTP 656. This also"},{"title":"Shareholders Breathe Easier As Concert Pharmaceuticals Rockets Higher by 23%","publication_date":"2015-09-24 02:35:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EGhRVSlz52M/shareholders-breathe-easier-as-concert-pharmaceuticals-rockets-higher-by-23-cm523176","summary":"What Shares of Concert Pharmaceuticals , a small cap biopharmaceutical company focused on developing novel small molecule drugs for the treatment of a variety of central nervous system and genetic disorders, finished"},{"title":"Concert Pharmaceuticals Announces Results of a Phase 1 Trial That Demonstrates CTP-656 Achieved a Superior Pharmacokinetic Profile to Kalydeco®","publication_date":"2015-09-22 15:15:06 +0000","url":"http://www.noodls.com/view/FCCD24BFB11060C013FD14770746B39339E9D582","summary":"[at noodls] - Results Presented at the Cystic Fibrosis Trusts UK Conference 2015 LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced positive data from a Phase 1 single ascending ..."},{"title":"Concert Pharmaceuticals to Present at Three Upcoming Investor Conferences","publication_date":"2015-09-02 11:04:06 +0000","url":"http://www.noodls.com/view/07BF59DAC7DEEEF28EB93CAEDF7DFEEC997FA5CA","summary":"[at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences: The Wells Fargo ..."},{"title":"Concert Pharmaceuticals (CNCE) Falls: Stock Goes Down 5.6%","publication_date":"2015-08-19 15:05:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kg3rrBynqTw/concert-pharmaceuticals-cnce-falls-stock-goes-down-56-cm510675","summary":"Concert Pharmaceuticals, Inc. ( CNCE ) saw a big move last session, as the company's shares fell nearly 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a"},{"title":"Health Care Sector Update for 08/12/2015: CNCE, PRTO RXII","publication_date":"2015-08-12 13:19:40 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1cPVlKhNmBI/health-care-sector-update-for-08122015-cnce-prto-rxii-cm508071","summary":"Top Health care stocks JNJ 0.1% PFE 0.3% ABT flat MRK 1.7% AMGN flat Health care shares were mainly lower in pre market trade Wednesday. In health care stocks news, Concert Pharmaceuticals ( CNCE ) shares were initiated by"},{"title":"Concert Pharmaceuticals (CNCE) in Focus: Stock Rises 5.2% - Tale of the Tape","publication_date":"2015-08-06 15:04:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6NBKgjpMbK8/concert-pharmaceuticals-cnce-in-focus-stock-rises-52-tale-of-the-tape-cm505837","summary":"Concert Pharmaceuticals, Inc. ( CNCE ) was a big mover last session, as its shares rose over 5% on the day. The upside was driven by the company's second quarter results wherein it posted profits of $41 million, after"},{"title":"Concert posts 2Q profit","publication_date":"2015-08-05 12:48:53 +0000","url":"http://sg.finance.yahoo.com/news/concert-posts-2q-profit-124853766.html","summary":"Concert posts 2Q profit"},{"title":"Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up","publication_date":"2015-07-29 12:26:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Su9_id5_7sI/wakefulness-drug-xyrem-keeps-jazz-pharmaceuticals-up-cm502145","summary":"C ataplexy sudden temporary muscle weakness is one of the most devastating symptoms of narcolepsy, a neurological disorder that disrupts sleep and wake cycles. Victims are prone to fall asleep"},{"title":"Concert Pharmaceuticals (CNCE) Crumbles: Stock Falls by 5.4% - Tale of the Tape","publication_date":"2015-06-29 14:34:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kF_RhFSBe2o/concert-pharmaceuticals-cnce-crumbles-stock-falls-by-54-tale-of-the-tape-cm491584","summary":"Concert Pharmaceuticals, Inc. ( CNCE ) saw a big move last session, as the company's shares fell by over 5% on the day. The move came on pretty good volume too with far more shares changing hands than in"},{"title":"Concert reports 4Q loss","publication_date":"2015-02-27 12:37:01 +0000","url":"http://sg.finance.yahoo.com/news/concert-reports-4q-loss-123701970.html","summary":"Concert reports 4Q loss"},{"title":"BUZZ-U.S. Stocks on the Move-Royale Energy, Methode, Concert Pharma","publication_date":"2014-06-26 18:06:38 +0000","url":"http://uk.finance.yahoo.com/news/buzz-u-stocks-move-royale-180638948.html","summary":"BUZZ-U.S. Stocks on the Move-Royale Energy, Methode, Concert Pharma"}],"result_count":121,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1490711383,"trigger": "MARK AT OR ABOVE 18.00","triggerPrice":18.00,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"16.9"},{"x":"1490967300","y":"16.3"},{"x":"1490967600","y":"16.46"},{"x":"1490967900","y":"16.33"},{"x":"1490968200","y":"16.22"},{"x":"1490968500","y":"16.23"},{"x":"1490968800","y":"16.35"},{"x":"1490969100","y":"16.3627"},{"x":"1490969400","y":"16.34"},{"x":"1490969700","y":"16.34"},{"x":"1490970000","y":"16.32"},{"x":"1490970300","y":"16.22"},{"x":"1490970600","y":"16.3"},{"x":"1490970900","y":"16.38"},{"x":"1490971200","y":"16.34"},{"x":"1490971500","y":"16.27"},{"x":"1490971800","y":"16.32"},{"x":"1490972100","y":"16.25"},{"x":"1490972400","y":"16.25"},{"x":"1490972700","y":"16.41"},{"x":"1490973000","y":"16.48"},{"x":"1490973300","y":"16.42"},{"x":"1490973600","y":"16.7"},{"x":"1490973900","y":"16.6"},{"x":"1490974200","y":"16.58"},{"x":"1490974500","y":"16.58"},{"x":"1490974800","y":"16.53"},{"x":"1490975100","y":"16.49"},{"x":"1490975400","y":"16.54"},{"x":"1490975700","y":"16.54"},{"x":"1490976000","y":"16.53"},{"x":"1490976300","y":"16.5248"},{"x":"1490976600","y":"16.52"},{"x":"1490977200","y":"16.56"},{"x":"1490977500","y":"16.58"},{"x":"1490978100","y":"16.53"},{"x":"1490978400","y":"16.55"},{"x":"1490978700","y":"16.44"},{"x":"1490979000","y":"16.42"},{"x":"1490979300","y":"16.42"},{"x":"1490979600","y":"16.42"},{"x":"1490979900","y":"16.43"},{"x":"1490980200","y":"16.41"},{"x":"1490980500","y":"16.41"},{"x":"1490981100","y":"16.27"},{"x":"1490981400","y":"16.31"},{"x":"1490981700","y":"16.38"},{"x":"1490982000","y":"16.34"},{"x":"1490982300","y":"16.34"},{"x":"1490982600","y":"16.42"},{"x":"1490982900","y":"16.43"},{"x":"1490983200","y":"16.41"},{"x":"1490983500","y":"16.43"},{"x":"1490983800","y":"16.39"},{"x":"1490984100","y":"16.5"},{"x":"1490984400","y":"16.57"},{"x":"1490984700","y":"16.52"},{"x":"1490985000","y":"16.5"},{"x":"1490985300","y":"16.57"},{"x":"1490985600","y":"16.61"},{"x":"1490985900","y":"16.75"},{"x":"1490986200","y":"16.8"},{"x":"1490986500","y":"16.91"},{"x":"1490986800","y":"17"},{"x":"1490987100","y":"16.99"},{"x":"1490987400","y":"17"},{"x":"1490987700","y":"17"},{"x":"1490988000","y":"16.97"},{"x":"1490988300","y":"16.97"},{"x":"1490988600","y":"16.98"},{"x":"1490988900","y":"17.005"},{"x":"1490989200","y":"17"},{"x":"1490989500","y":"17.06"},{"x":"1490989800","y":"17.17"},{"x":"1490990100","y":"17.06"},{"x":"1490990400","y":"17.06"} ], "color":"#03a9f4"}]},
{"id":"4","list":"Alerts","symbol": "DRNA","name": "Dicerna Pharmaceuticals Inc","price": 3.4,"dollarChange": 0.7,"percentChange": 25.93,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/DRNA-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/DRNA-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/DRNA-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/DRNA-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/DRNA-1yr.php","open": 2.75,"high": 3.4,"low":2.75,"volume": 2144300,"avgVol": 159866.933333,"sharesShort": 224494,"shortPercent": 1.081742,"marketCap": 59768642,"float": 20753001,"headlines":{"data":[{"title":"Edited Transcript of DRNA earnings conference call or presentation 30-Mar-17 8:30pm GMT","publication_date":"2017-03-31 04:19:05 +0000","url":"http://finance.yahoo.com/news/edited-transcript-drna-earnings-conference-041905918.html","summary":"Edited Transcript of DRNA earnings conference call or presentation 30-Mar-17 8:30pm GMT"},{"title":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a","publication_date":"2017-03-30 20:32:36 +0000","url":"http://biz.yahoo.com/e/170330/drna8-k.html","summary":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"},{"title":"Dicerna Pharmaceuticals posts 4Q loss","publication_date":"2017-03-30 20:24:43 +0000","url":"http://sg.finance.yahoo.com/news/dicerna-pharmaceuticals-posts-4q-loss-202443181.html","summary":"Dicerna Pharmaceuticals posts 4Q loss"},{"title":"Dicerna Reports Fourth Quarter and Full Year 2016 Financial and Operational Results","publication_date":"2017-03-30 20:07:00 +0000","url":"http://finance.yahoo.com/news/dicerna-reports-fourth-quarter-full-200700522.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational ribonucleic acid interference therapeutics, today reported financial and operational results for the fourth quarter and full year ended December 31, 2016."},{"title":"4:06 pm Dicerna Pharmaceuticals announces that a syndicate of current/new investors, led by Bain Capital Life Sciences, purchased $70 mln of redeemable convertible preferred stock in the co","publication_date":"2017-03-30 20:06:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#drna","summary":"4:06 pm Dicerna Pharmaceuticals announces that a syndicate of current/new investors, led by Bain Capital Life Sciences, purchased $70 mln of redeemable convertible preferred stock in the co"},{"title":"Dicerna Secures $70 Million in Convertible Preferred Stock Financing","publication_date":"2017-03-30 20:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-secures-70-million-convertible-200500764.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational ribonucleic acid interference therapeutics, today announced that it has signed a stock purchase agreement with a syndicate of current and new investors, led by Bain Capital Life Sciences, for the sale of redeemable convertible preferred stock for gross proceeds of $70.0 million."},{"title":"After-Hours Earnings Report for March 30, 2017 : FC, AEHR, MARK, DRNA, STKS, UNXL, UQM, MARA","publication_date":"2017-03-30 18:19:12 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kfobbf-Bgbk/after-hours-earnings-report-for-march-30-2017-fc-aehr-mark-drna-stks-unxl-uqm-mara-cm767935","summary":"The following companies are expected to report earnings after hours on 03 30 2017 Visit our Earnings Calendar for a full list of expected earnings releases Franklin Covey Company FC is reporting for the quarter ending February 28 2017 The"},{"title":"Q4 2016 Dicerna Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2017-03-30 11:07:04 +0000","url":"http://biz.yahoo.com/research/earncal/20170330.html?t=drna","summary":"Q4 2016 Dicerna Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"Dicerna Pharmaceuticals to Present at the BioCentury 24th Annual Future Leaders in the Biotech Industry Conference","publication_date":"2017-03-27 20:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-pharmaceuticals-present-biocentury-24th-200500202.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational ribonucleic acid interference therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present a corporate update at the BioCentury 24th Annual Future Leaders in the Biotech Industry Conference on Friday, April 7, 2017, at 3:00 p.m."},{"title":"Dicerna to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on March 30, 2017","publication_date":"2017-03-23 20:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-report-fourth-quarter-full-200500547.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational ribonucleic acid interference therapeutics, today announced that the Company will release its fourth quarter and full year 2016 financial results after market close on Thursday, March 30, 2017."},{"title":"Dicerna to Present at Cowen and Company 37th Annual Health Care Conference","publication_date":"2017-03-01 21:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-present-cowen-company-37th-210500707.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational ribonucleic acid interference therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017, at 8:00 a.m."},{"title":"Can The Uptrend Continue for Dicerna Pharmaceuticals (DRNA)?","publication_date":"2017-02-22 14:08:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rDhubTJ3xyE/can-the-uptrend-continue-for-dicerna-pharmaceuticals-drna-cm751123","summary":"Investors certainly have to be happy with Dicerna Pharmaceuticals Inc DRNA and its short term performance After all the stock has jumped by 9 8 in the past 4 weeks and it is also above its 20 Day Simple Moving Average as well This is certainly a good trend but investors are"},{"title":"Can The Uptrend Continue for Dicerna Pharmaceuticals (DRNA)?","publication_date":"2017-02-22 13:21:01 +0000","url":"http://finance.yahoo.com/news/uptrend-continue-dicerna-pharmaceuticals-drna-132101822.html","summary":"Can The Uptrend Continue for Dicerna Pharmaceuticals (DRNA)?"},{"title":"Dicerna Pharmaceuticals (DRNA) Rises: Stock Climbs 14%","publication_date":"2017-02-16 14:58:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t5GPsFA0T88/dicerna-pharmaceuticals-drna-rises-stock-climbs-14-cm748920","summary":"Dicerna Pharmaceuticals Inc DRNA was a big mover last session as the company saw its shares rise over 14 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above"},{"title":"Dicerna Pharmaceuticals (DRNA) Rises: Stock Climbs 14%","publication_date":"2017-02-16 13:30:01 +0000","url":"http://finance.yahoo.com/news/dicerna-pharmaceuticals-drna-rises-stock-133001202.html","summary":"Dicerna Pharmaceuticals (DRNA) Rises: Stock Climbs 14%"},{"title":"Stocks Most Likely to Beat Earnings for the week of February 13th","publication_date":"2017-02-13 18:17:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f2xQEc-dmD8/stocks-most-likely-to-beat-earnings-for-the-week-of-february-13th-cm747201","summary":"Here are four Zacks Rank 1 Strong Buy stocks that are likely to beat earnings for the week of February 13 th Ultra Clean Holdings Inc UCTT This manufacturer of production tools modules and subsystems has witnessed the Zacks Consensus Estimate for its current year earnings"},{"title":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","publication_date":"2017-02-13 17:21:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rvywCPYAflU/cerners-ehr-platform-to-enhance-health-care-at-san-juan-ngo-cm747142","summary":"Leading provider of health care technology Cerner Corporation CERN announced that it recently entered into an agreement to provide San Juan Regional Medical Center with a new electronic health record EHR platform San Juan Regional Medical Center is a non profit acute care hospital and"},{"title":"Stocks Most Likely to Beat Earnings for the week of February 13th","publication_date":"2017-02-13 15:55:03 +0000","url":"http://finance.yahoo.com/news/stocks-most-likely-beat-earnings-155503031.html","summary":"Stocks Most Likely to Beat Earnings for the week of February 13th"},{"title":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO","publication_date":"2017-02-13 14:40:02 +0000","url":"http://finance.yahoo.com/news/cerners-ehr-platform-enhance-health-144002124.html","summary":"Cerner's EHR Platform to Enhance Health Care at San Juan NGO"},{"title":"Micro-Cap Biotech Focus: Dicerna Pharmaceuticals Inc (DRNA) Presents Its Exciting New Drug Platform GalXC","publication_date":"2017-02-09 15:09:42 +0000","url":"http://www.insidermonkey.com/blog/micro-cap-biotech-focus-dicerna-pharmaceuticals-inc-drna-presents-its-exciting-new-drug-platform-galxc-536118/","summary":"Micro-Cap Biotech Focus: Dicerna Pharmaceuticals Inc (DRNA) Presents Its Exciting New Drug Platform GalXC"},{"title":"Dicerna to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference","publication_date":"2017-02-08 21:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-participate-fireside-chat-leerink-210500182.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational RNA interference therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will participate in an analyst-led fireside chat at the Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017, at 10:30 a.m."},{"title":"Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","publication_date":"2017-02-02 21:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-pharmaceuticals-inc-reports-inducement-210500602.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational RNA interference therapeutics, today announced that on January 31, 2017, the Compensation Committee of the Company's Board of Directors approved the grant of an inducement stock option to purchase a total of 75,000 shares of common stock to one new employee, with a grant date of January 31, 2017 ."},{"title":"Array BioPharma (ARRY) Jumps: Stock Adds 7.5% in Session","publication_date":"2017-01-16 15:39:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Q9-NwV45G4/array-biopharma-arry-jumps-stock-adds-75-in-session-cm733876","summary":"Array BioPharma Inc ARRY was a big mover last session as the company saw its shares rise over 7 on the day The move came on solid volume with far more shares changing hands than in a normal session This continues the recent uptrend of the company as the stock is now up 24 in the"},{"title":"Kindred Biosciences (KIN) Looks Good: Stock Jumps 9.5%","publication_date":"2017-01-16 15:39:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UWHG3Df39go/kindred-biosciences-kin-looks-good-stock-jumps-95-cm733860","summary":"Kindred Biosciences Inc KIN was a big mover last session as the company saw its shares rise over 9 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above"},{"title":"Kindred Biosciences (KIN) Looks Good: Stock Jumps 9.5%","publication_date":"2017-01-16 13:45:01 +0000","url":"http://finance.yahoo.com/news/kindred-biosciences-kin-looks-good-134501986.html","summary":"Kindred Biosciences (KIN) Looks Good: Stock Jumps 9.5%"},{"title":"Array BioPharma (ARRY) Jumps: Stock Adds 7.5% in Session","publication_date":"2017-01-16 13:30:01 +0000","url":"http://finance.yahoo.com/news/array-biopharma-arry-jumps-stock-133001445.html","summary":"Array BioPharma (ARRY) Jumps: Stock Adds 7.5% in Session"},{"title":"Coverage initiated on Dicerna Pharmaceuticals by H.C. Wainwright","publication_date":"2016-12-12 12:13:13 +0000","url":"http://finance.yahoo.com/q/ud?s=DRNA","summary":"Coverage initiated on Dicerna Pharmaceuticals by H.C. Wainwright"},{"title":"Do Hedge Funds Love Dicerna Pharmaceuticals Inc (DRNA)?","publication_date":"2016-12-11 12:09:43 +0000","url":"http://www.insidermonkey.com/blog/do-hedge-funds-love-dicerna-pharmaceuticals-inc-drna-505296/","summary":"Do Hedge Funds Love Dicerna Pharmaceuticals Inc (DRNA)?"},{"title":"DICERNA PHARMACEUTICALS INC Financials","publication_date":"2016-11-15 18:04:11 +0000","url":"http://finance.yahoo.com/q/is?s=drna","summary":"DICERNA PHARMACEUTICALS INC Financials"},{"title":"Dicerna to Present at the Stifel 2016 Healthcare Conference","publication_date":"2016-11-09 21:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-present-stifel-2016-healthcare-210500181.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational RNA interference therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present at the Stifel 2016 Healthcare Conference on Wednesday, November 16, 2016, from 3:45-4:25 p.m."},{"title":"Dicerna Pharmaceuticals posts 3Q loss","publication_date":"2016-11-07 22:52:49 +0000","url":"http://sg.finance.yahoo.com/news/dicerna-pharmaceuticals-posts-3q-loss-225249583.html","summary":"Dicerna Pharmaceuticals posts 3Q loss"},{"title":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a","publication_date":"2016-11-07 21:36:13 +0000","url":"http://biz.yahoo.com/e/161107/drna8-k.html","summary":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"},{"title":"Dicerna Reports Third Quarter 2016 Financial and Operational Results","publication_date":"2016-11-07 21:19:57 +0000","url":"http://www.publicnow.com/view/B5344A4AF4B3E79152479D174088ACFF4AD1F18E","summary":"[at noodls] - November 7, 2016 Management to Host Conference Call Today at 4:30 p.m. ET CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational RNA interference ..."},{"title":"Q3 2016 Dicerna Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2016-11-07 12:07:05 +0000","url":"http://biz.yahoo.com/research/earncal/20161107.html?t=drna","summary":"Q3 2016 Dicerna Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"Dicerna to Report Third Quarter 2016 Financial Results and Host Conference Call on November 7, 2016","publication_date":"2016-10-31 20:23:16 +0000","url":"http://www.publicnow.com/view/D64A507D506AFBD18BC2084BFC7F383040494823","summary":"[at noodls] - October 31, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the ..."},{"title":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-10-13 12:36:55 +0000","url":"http://biz.yahoo.com/e/161013/drna8-k.html","summary":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Dicerna Prioritizes Resources to Advance GalXC™ Product Candidates","publication_date":"2016-09-26 11:59:02 +0000","url":"http://www.publicnow.com/view/8F8445AD3827BC321EC2115CF29DC4EACA0179EE","summary":"[at noodls] - September 26, 2016 Primary Hyperoxaluria Development Program Transitioned From DCR-PH1 to Subcutaneously Delivered GalXC Candidate DCR-PHXC Clinical Development Discontinued for DCR-MYC in Oncology Indications ..."},{"title":"Dicerna Pharmaceuticals (DRNA) Worth a Look: Stock Up 6%","publication_date":"2016-09-22 14:24:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LIFoUmNmqs8/dicerna-pharmaceuticals-drna-worth-a-look-stock-up-6-cm683058","summary":"Dicerna Pharmaceuticals Inc DRNA was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading"},{"title":"Dicerna Pharmaceuticals (DRNA) Worth a Look: Stock Up 6%","publication_date":"2016-09-22 12:45:12 +0000","url":"http://finance.yahoo.com/news/dicerna-pharmaceuticals-drna-worth-look-124512361.html","summary":"Dicerna Pharmaceuticals (DRNA) Worth a Look: Stock Up 6%"},{"title":"Dicerna Pharmaceuticals, Inc. :DRNA-US: Earnings Analysis: Q2, 2016 By the Numbers : September 21, 2016","publication_date":"2016-09-21 17:23:41 +0000","url":"http://www.capitalcube.com/blog/index.php/dicerna-pharmaceuticals-inc-drna-us-earnings-analysis-q2-2016-by-the-numbers-september-21-2016/","summary":"Dicerna Pharmaceuticals, Inc. :DRNA-US: Earnings Analysis: Q2, 2016 By the Numbers : September 21, 2016"},{"title":"Dicerna to Present at September Investor Conferences","publication_date":"2016-09-06 20:19:01 +0000","url":"http://www.publicnow.com/view/56A5F2705581237BB6D0EE420ADB90844F0672DC","summary":"[at noodls] - September 6, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that Douglas ..."},{"title":"Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 7.5%","publication_date":"2016-08-16 14:38:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W-9rBdzGczc/dicerna-pharmaceuticals-drna-jumps-stock-rises-75-cm665864","summary":"Dicerna Pharmaceuticals, Inc.DRNA was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the"},{"title":"Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 7.5%","publication_date":"2016-08-16 12:25:12 +0000","url":"http://finance.yahoo.com/news/dicerna-pharmaceuticals-drna-jumps-stock-122512545.html","summary":"Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 7.5%"},{"title":"Edited Transcript of DRNA earnings conference call or presentation 4-Aug-16 8:30pm GMT","publication_date":"2016-08-05 14:10:54 +0000","url":"http://finance.yahoo.com/news/edited-transcript-drna-earnings-conference-141054435.html","summary":"Edited Transcript of DRNA earnings conference call or presentation 4-Aug-16 8:30pm GMT"},{"title":"Dicerna Pharmaceuticals posts 2Q loss","publication_date":"2016-08-04 22:13:41 +0000","url":"http://sg.finance.yahoo.com/news/dicerna-pharmaceuticals-posts-2q-loss-221341467.html","summary":"Dicerna Pharmaceuticals posts 2Q loss"},{"title":"Dicerna Reports Second Quarter 2016 Financial and Operational Results","publication_date":"2016-08-04 20:22:34 +0000","url":"http://www.publicnow.com/view/805FE02024346F46930406670C92235BFEDDB33B","summary":"[at noodls] - August 4, 2016 Management to Host Conference Call Today at 4:30 p.m. ET CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational RNA interference ..."},{"title":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a","publication_date":"2016-08-04 20:10:59 +0000","url":"http://biz.yahoo.com/e/160804/drna8-k.html","summary":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"},{"title":"Q2 2016 Dicerna Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2016-08-04 11:07:06 +0000","url":"http://biz.yahoo.com/research/earncal/20160804.html?t=drna","summary":"Q2 2016 Dicerna Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"Dicerna to Report Second Quarter 2016 Financial Results and Host Conference Call on August 4, 2016","publication_date":"2016-07-28 20:28:05 +0000","url":"http://www.publicnow.com/view/0A30A2B149B24D86AF5605631A6F9497436AD7B8","summary":"[at noodls] - July 28, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the Company ..."},{"title":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-07-11 20:02:55 +0000","url":"http://biz.yahoo.com/e/160711/drna8-k.html","summary":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"New Preclinical Data Show Potential of Dicerna GalXC™ Subcutaneous Delivery Platform as RNAi Drug Discovery Engine","publication_date":"2016-06-29 12:31:09 +0000","url":"http://www.publicnow.com/view/069C03DDD75C11E61A44A0DE5A6D7442E7ED6F72","summary":"[at noodls] - 2c58128d-4fad-4647-bac3-f0da91835bbb.pdf June 29, 2016 Consistent, Potent and Durable Silencing of Multiple Disease-Driving Genes in Non-Human Primates Reported at Investor Day Initial GalXC Program on ..."},{"title":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a","publication_date":"2016-06-15 12:23:22 +0000","url":"http://biz.yahoo.com/e/160615/drna8-k.html","summary":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a"},{"title":"Dicerna Appoints Martin Freed, M.D., to Board of Directors","publication_date":"2016-06-15 11:49:09 +0000","url":"http://www.publicnow.com/view/0B9A73819195A334673620B07F7D27F513EF7858","summary":"[at noodls] - 61dbff45-373f-4f48-b1df-a4a0c58e091d.pdf June 15, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, ..."},{"title":"Dicerna to Present at the Jefferies 2016 Healthcare Conference","publication_date":"2016-06-02 20:15:04 +0000","url":"http://www.publicnow.com/view/A982A8EEFBDE380AB3071FD001343F803D52BF2E","summary":"[at noodls] - ecdcad0e-052a-40bf-941f-da1756b1888d.pdf June 2, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, ..."},{"title":"Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 8.7%","publication_date":"2016-05-23 13:54:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkESqR0xvYw/dicerna-pharmaceuticals-drna-jumps-stock-rises-87-cm624823","summary":"Dicerna Pharmaceuticals, Inc.DRNA was a big mover last session, as its shares rose almost 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Friday's rally reverses"},{"title":"Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 8.7%","publication_date":"2016-05-23 12:15:12 +0000","url":"http://finance.yahoo.com/news/dicerna-pharmaceuticals-drna-jumps-stock-121512250.html","summary":"Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 8.7%"},{"title":"Dicerna Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-PH1 in Patients with Primary Hyperoxaluria Type 1 (PH1)","publication_date":"2016-05-13 13:58:20 +0000","url":"http://www.publicnow.com/view/4B3E588AAEE8FAF3E73BE0F906E9BEFEDEE706B9","summary":"[at noodls] - 7229bc1c-e61b-49e4-831b-66dbbfdb5134.pdf May 13, 2016 Milestone for DsiRNA Therapeutic Follows Receipt of Orphan Drug Designation in US and EU CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, ..."},{"title":"Dicerna Reports Potent Preclinical Activity with GalNAc-DsiRNA-EX Conjugates","publication_date":"2016-05-11 11:30:00 +0000","url":"http://finance.yahoo.com/news/dicerna-reports-potent-preclinical-activity-113000987.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational RNA interference therapeutics, today will present updated preclinical data demonstrating the potency of its proprietary GalNAc-DsiRNA-EX Conjugate technology in enabling direct delivery of RNAi-based therapy to the liver via subcutaneous injection, with potential utility against multiple therapeutic targets."},{"title":"Edited Transcript of DRNA earnings conference call or presentation 9-May-16 8:30pm GMT","publication_date":"2016-05-10 02:34:32 +0000","url":"http://finance.yahoo.com/news/edited-transcript-drna-earnings-conference-023432370.html","summary":"Edited Transcript of DRNA earnings conference call or presentation 9-May-16 8:30pm GMT"},{"title":"Dicerna Pharmaceuticals posts 1Q loss","publication_date":"2016-05-09 21:27:51 +0000","url":"http://sg.finance.yahoo.com/news/dicerna-pharmaceuticals-posts-1q-loss-212751326.html","summary":"Dicerna Pharmaceuticals posts 1Q loss"},{"title":"Dicerna Reports First Quarter 2016 Financial and Operational Results","publication_date":"2016-05-09 20:38:19 +0000","url":"http://www.publicnow.com/view/A72837F74DD34AFB52124FDE00020CE89FDA6C04","summary":"[at noodls] - 8e6467ae-7727-4782-885a-7908b90f4130.pdf May 9, 2016 Management to Host Conference Call Today at 4:30 p.m. ET CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading ..."},{"title":"Dicerna to Report First Quarter 2016 Financial Results and Host Conference Call on May 9, 2016","publication_date":"2016-05-02 20:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-report-first-quarter-2016-200500802.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational RNA interference therapeutics, today announced that the Company will release its first quarter 2016 financial results after market close on Monday, May 9, 2016."},{"title":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E","publication_date":"2016-04-18 20:35:59 +0000","url":"http://biz.yahoo.com/e/160418/drna8-k.html","summary":"DICERNA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E"},{"title":"Dicerna Announces Appointment of John \"Jack\" Green as Chief Financial Officer","publication_date":"2016-04-18 20:27:25 +0000","url":"http://www.publicnow.com/view/4A8F11FDE56FCA8843CB31AF27E37B1F8F8AB280","summary":"[at noodls] - 7c692447-f3b9-49cd-8157-ea67e99e187d.pdf April 18, 2016 Dicerna Announces Appointment of John \"Jack\" Green as Chief Financial Officer CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, ..."},{"title":"Dicerna Announces Appointment of John “Jack” Green as Chief Financial Officer","publication_date":"2016-04-18 20:05:00 +0000","url":"http://finance.yahoo.com/news/dicerna-announces-appointment-john-jack-200500995.html","summary":"[Business Wire] - Dicerna Pharmaceuticals, Inc. , a leading developer of investigational RNA interference therapeutics, today announced the appointment of John B. “Jack” Green as chief financial officer , effective immediately."},{"title":"Alnylam Begins Study for Primary Hyperoxaluria Type 1","publication_date":"2016-03-10 23:27:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rfwHTslTKTU/alnylam-begins-study-for-primary-hyperoxaluria-type-1-cm591672","summary":"Alnylam Pharmaceuticals, Inc.ALNY announced that it has started a phase I II study on ALN GO1 for the treatment of patients with primary hyperoxaluria type 1 (PH1). The randomized, single blind, placebo controlled phase I II study is being"},{"title":"Dicerna Pharmaceuticals posts 4Q loss","publication_date":"2016-03-10 21:21:33 +0000","url":"http://sg.finance.yahoo.com/news/dicerna-pharmaceuticals-posts-4q-loss-212133140.html","summary":"Dicerna Pharmaceuticals posts 4Q loss"},{"title":"Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","publication_date":"2015-12-31 21:49:11 +0000","url":"http://www.noodls.com/view/57E23BAFF0C6B488BBDFB98AE8E1393BE887F767","summary":"[at noodls] - 439ca636-19b7-416e-8622-c1a5c7b551bc.pdf December 31, 2015 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNA interference-based therapeutics ..."},{"title":"Alnylam Submits Clinical Trial Application for ALN-GO1 in UK","publication_date":"2015-12-22 23:19:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sFKGlHz3Vhc/alnylam-submits-clinical-trial-application-for-aln-go1-in-uk-cm557870","summary":"Alnylam Pharmaceuticals, Inc.ALNY announced that it has submitted a Clinical Trial Application (CTA) for ALN GO1 with the UK Medicines and Healthcare products Regulatory Agency for the treatment of patients with primary hyperoxaluria type 1 (PH1). The company plans"},{"title":"Dicerna Begins Dosing in First Clinical Trial of Therapy for Primary Hyperoxaluria Type 1 (PH1) in Healthy Volunteers","publication_date":"2015-12-21 21:46:18 +0000","url":"http://www.noodls.com/view/FDD0C983E7F008A99A095C87F2FA9D299FE4A05B","summary":"[at noodls] - e46a2477-48d7-436f-811a-60ab80d21835.pdf December 21, 2015 - Company Expects to Initiate Phase 1 Trial in Patients with PH1 in Early 2016 - - Ongoing Observational Study Measures Biomarkers Implicated ..."},{"title":"Dicerna Updates Progress on the Development of DCR-MYC for the Treatment of Solid Tumors","publication_date":"2015-12-21 21:26:16 +0000","url":"http://www.noodls.com/view/D57A5E6B1ED114CFBB4F82680A1BD728519990AB","summary":"[at noodls] - Dicerna Updates Progress on the Development of DCR-MYC for the Treatment of Solid Tumors"},{"title":"Dicerna Pharmaceuticals Appoints John \"Jack\" Green Interim Chief Financial Officer","publication_date":"2015-12-16 00:26:12 +0000","url":"http://www.noodls.com/view/D52C7F4560143DE2EE49D6409D05EDAB9A5B0CF3","summary":"[at noodls] - 80fde566-f1ba-400b-ba0e-21bdd8ed3491.pdf December 15, 2015 Dicerna Pharmaceuticals Appoints John 'Jack' Green Interim Chief Financial Officer CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, ..."},{"title":"Dicerna to Present at Two November Conferences","publication_date":"2015-11-13 16:26:10 +0000","url":"http://www.noodls.com/view/91440828BFE37CFF7573DD636CA778855D6E7C73","summary":"[at noodls] - 9deb8e7f-c96a-4c6a-ba5c-f9788107c9f2.pdf November 13, 2015 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leading developer of RNA interference (RNAi) therapeutics, ..."},{"title":"Dicerna Announces Third Quarter 2015 Financial and Operational Results","publication_date":"2015-11-10 21:36:14 +0000","url":"http://www.noodls.com/view/B68FE279369A74D16061D8EEB0046E1F08216503","summary":"[at noodls] - 425422cf-bd93-4e39-8914-9c5ba2fc2692.pdf November 10, 2015 -Management to Host Conference Call Today at 4:30 pm ET- CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader ..."},{"title":"Dicerna Pharmaceuticals posts 3Q loss","publication_date":"2015-11-10 21:21:40 +0000","url":"http://sg.finance.yahoo.com/news/dicerna-pharmaceuticals-posts-3q-loss-212140783.html","summary":"Dicerna Pharmaceuticals posts 3Q loss"},{"title":"Dicerna to Announce Third Quarter 2015 Financial Results and Host Conference Call on November 10, 2015","publication_date":"2015-11-03 21:57:01 +0000","url":"http://www.noodls.com/view/960B830EE91E4867A23725BF03E8E6CB78F8F480","summary":"[at noodls] - 7e96dba2-2035-45ed-82d8-faaeb5ca0ad6.pdf November 3, 2015 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNA interference-based therapeutics ..."},{"title":"Monday Sector Leaders: Biotechnology, Drugs","publication_date":"2015-11-02 20:12:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRjGmQXWszc/monday-sector-leaders-biotechnology-drugs-cm537761","summary":"In trading on Monday, biotechnology shares were relative leaders, up on the day by about 4.1%. Leading the group were shares of Dyax Corporation ( DYAX ), up about 28.7% and shares of Cytokinetics ( CYTK ) up about"},{"title":"Dicerna to Present at the Leerink Partners Rare Disease Roundtable","publication_date":"2015-09-24 21:34:13 +0000","url":"http://www.noodls.com/view/E39A3021F4641834EAFA6A7C068986582801F9A1","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leading developer of RNA interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president ..."},{"title":"Dicerna Pharmaceuticals (DRNA) Rises: Stock Gains 7.8%","publication_date":"2015-09-21 15:40:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVzx4gx4vQg/dicerna-pharmaceuticals-drna-rises-stock-gains-78-cm521886","summary":"Dicerna Pharmaceuticals, Inc. ( DRNA ) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in"},{"title":"Alnylam to Speed Up Development for Primary Hyperoxaluria","publication_date":"2015-09-09 21:22:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G00GQ_SC3nM/alnylam-to-speed-up-development-for-primary-hyperoxaluria-cm518184","summary":"Alnylam Pharmaceuticals, Inc. 's ALNY shares were up 7.1% on the company's announcement of selecting ALN GO1, for the treatment of primary hyperoxaluria type 1 (PH1). Based on encouraging pre clinical data, Alnylam has decided to speed up its"},{"title":"Dicerna Files IND Application for Primary Hyperoxaluria Drug","publication_date":"2015-09-04 19:15:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83fhjwnN4Fk/dicerna-files-ind-application-for-primary-hyperoxaluria-drug-cm516960","summary":"Dicerna Pharmaceuticals, Inc. 's DRNA shares were up almost 7.0% immediately after the company announced that it has submitted an Investigational New Drug (IND) application to the FDA for DCR PH1 for the treatment of primary hyperoxaluria type 1"},{"title":"Dicerna Pharmaceuticals Submits Investigational New Drug (IND) Application for DCR-PH1, an Investigational Therapy for Primary Hyperoxaluria Type 1 (PH1)","publication_date":"2015-09-02 11:44:15 +0000","url":"http://www.noodls.com/view/F92EBD662EC71E7EA545A24D358825120A7AC4EF","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of RNA interference (RNAi) therapeutics, today announced the submission of an investigational new drug ..."},{"title":"Dicerna Announces Second Quarter 2015 Financial and Operational Results","publication_date":"2015-09-02 11:44:15 +0000","url":"http://www.noodls.com/view/405FDF32375ACBC5BE2038258CEC731302B82146","summary":"[at noodls] - -Management to Host Conference Call Today at 4:30 pm ET- CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNA interference-based therapeutics ..."},{"title":"More capital for Canadian cancer cures: ProNAi Therapeutics increases proposed IPO deal size by 37%","publication_date":"2015-07-15 14:25:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jSr8RYPi78I/more-capital-for-canadian-cancer-cures-pronai-therapeutics-increases-proposed-ipo-deal-size-by-37-cm496545","summary":"ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, raised the proposed deal size for its upcoming IPO on Wednesday. The Vancouver, Canada based company now plans to raise $138 million by offering 8.1 million shares at"},{"title":"Canadian cancer biotech ProNAi Therapeutics sets terms for $101 million IPO","publication_date":"2015-07-06 14:24:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wf9EDrID-i8/canadian-cancer-biotech-pronai-therapeutics-sets-terms-for-101-million-ipo-cm493270","summary":"ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, announced terms for its IPO on Monday. The Vancouver, Canada based company plans to raise $101 million by offering 6.7 million shares at a price range of $14"},{"title":"Something good out of Canada: Cancer biotech ProNAi Therapeutics files for an $86 million IPO","publication_date":"2015-06-13 01:20:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cDttagY6HHU/something-good-out-of-canada-cancer-biotech-pronai-therapeutics-files-for-an-86-million-ipo-cm486706","summary":"ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The Vancouver, Canada based company, which was founded in 2003, plans"},{"title":"Health Care Sector Update for 06/11/2015: DRNA,ALNY,MRK,PTBI,PBMD","publication_date":"2015-06-11 17:21:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xbE5L6zO5ts/health-care-sector-update-for-06112015-drnaalnymrkptbipbmd-cm486182","summary":"Top Health Care Stocks JNJ +0.40% PZE +0.47% MRK +0.34% ABT 0.21% AMGN +1.44% Health care stocks were mostly higher, with the NYSE Health Care Sector Index rising 0.2% and shares of health care companies in the S&P 500"},{"title":"Why Shares Of Dicerna Pharmaceuticals Are Down Today","publication_date":"2015-05-21 19:58:15 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rzgAi-cFUhg/why-shares-of-dicerna-pharmaceuticals-are-down-today-cm479375","summary":"Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes just in case they're material to our investing thesis."},{"title":"Health Care Sector Update for 05/21/2015: CALA, DRNA, REGN","publication_date":"2015-05-21 12:56:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7-c3RxyUKX4/health-care-sector-update-for-05212015-cala-drna-regn-cm479108","summary":"Top Health care stocks JNJ 0.6% PFE 0.1% ABT flat MRK flat AMGN 0.1% Health care shares were mainly lower mixed in pre market trade Thursday. In health care stocks news, Calithera Biosciences ( CALA ), a clinical stage"},{"title":"Dicerna Pharmaceuticals (DRNA) Crumbles: Stock Falls by 6.4% - Tale of the Tape","publication_date":"2015-03-23 14:53:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RlVOTbhz06M/dicerna-pharmaceuticals-drna-crumbles-stock-falls-by-64-tale-of-the-tape-cm457558","summary":"Dicerna Pharmaceuticals, Inc. ( DRNA ) saw a big move last session, as the company's shares fell by 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a"},{"title":"After-Hours Earnings Report for March 12, 2015 : ULTA, ANAC, ZUMZ, FTD, IRET, OMED, INGN, IMOS, FF, FSM, CTIC, DRNA","publication_date":"2015-03-12 19:47:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/atoDzHnW1pE/after-hours-earnings-report-for-march-12-2015-ulta-anac-zumz-ftd-iret-omed-ingn-imos-ff-fsm-ctic-drna-cm454263","summary":"The following companies are expected to report earnings after hours on 03 12 2015. Visit our Earnings Calendar for a full list of expected earnings releases. Ulta Salon, Cosmetics & Fragrance, Inc. ( ULTA ) is"}],"result_count":91,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1491053842,"trigger": "MARK AT OR ABOVE 3.50","triggerPrice":3.50,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"2.9501"},{"x":"1490967300","y":"3"},{"x":"1490967600","y":"3.2800000000000002"},{"x":"1490967900","y":"3.254"},{"x":"1490968200","y":"3.18"},{"x":"1490968500","y":"3.0835"},{"x":"1490968800","y":"3.12"},{"x":"1490969100","y":"3.1516"},{"x":"1490969400","y":"3.13"},{"x":"1490969700","y":"3.1"},{"x":"1490970000","y":"3.15"},{"x":"1490970300","y":"3.11"},{"x":"1490970600","y":"3.08"},{"x":"1490970900","y":"3.1"},{"x":"1490971200","y":"3.05"},{"x":"1490971500","y":"3.1"},{"x":"1490971800","y":"3.1199"},{"x":"1490972100","y":"3.1"},{"x":"1490972400","y":"3.1"},{"x":"1490972700","y":"3.11"},{"x":"1490973000","y":"3.1"},{"x":"1490973300","y":"3.1"},{"x":"1490973600","y":"3.105"},{"x":"1490973900","y":"3.1244"},{"x":"1490974200","y":"3.15"},{"x":"1490974500","y":"3.1499"},{"x":"1490974800","y":"3.1484"},{"x":"1490975400","y":"3.12"},{"x":"1490975700","y":"3.12"},{"x":"1490976000","y":"3.13"},{"x":"1490976300","y":"3.1411"},{"x":"1490976600","y":"3.12"},{"x":"1490976900","y":"3.1101"},{"x":"1490977200","y":"3.12"},{"x":"1490977500","y":"3.12"},{"x":"1490978100","y":"3.135"},{"x":"1490978400","y":"3.14"},{"x":"1490978700","y":"3.14"},{"x":"1490979000","y":"3.13"},{"x":"1490979600","y":"3.15"},{"x":"1490979900","y":"3.135"},{"x":"1490980500","y":"3.1301"},{"x":"1490980800","y":"3.15"},{"x":"1490981100","y":"3.15"},{"x":"1490981400","y":"3.15"},{"x":"1490981700","y":"3.1401"},{"x":"1490982000","y":"3.15"},{"x":"1490982300","y":"3.1599"},{"x":"1490982600","y":"3.2"},{"x":"1490982900","y":"3.18"},{"x":"1490983200","y":"3.1575"},{"x":"1490983500","y":"3.1801"},{"x":"1490983800","y":"3.16"},{"x":"1490984100","y":"3.17"},{"x":"1490984400","y":"3.18"},{"x":"1490984700","y":"3.19"},{"x":"1490985000","y":"3.18"},{"x":"1490985300","y":"3.2"},{"x":"1490985600","y":"3.21"},{"x":"1490985900","y":"3.216"},{"x":"1490986200","y":"3.2099"},{"x":"1490986500","y":"3.2"},{"x":"1490986800","y":"3.204"},{"x":"1490987100","y":"3.23"},{"x":"1490987400","y":"3.2293"},{"x":"1490987700","y":"3.24"},{"x":"1490988000","y":"3.2584"},{"x":"1490988300","y":"3.25"},{"x":"1490988600","y":"3.25"},{"x":"1490988900","y":"3.31"},{"x":"1490989200","y":"3.27"},{"x":"1490989500","y":"3.3034"},{"x":"1490989800","y":"3.34"},{"x":"1490990100","y":"3.4"},{"x":"1490990400","y":"3.25"},{"x":"1490991600","y":"3.37"},{"x":"1490991900","y":"3.35"},{"x":"1490992200","y":"3.35"},{"x":"1490992500","y":"3.35"},{"x":"1490992800","y":"3.31"},{"x":"1490993100","y":"3.3"},{"x":"1490993400","y":"3.24"},{"x":"1490995500","y":"3.25"},{"x":"1490998500","y":"3.34"} ], "color":"#03a9f4"}]},
{"id":"5","list":"Alerts","symbol": "IDRA","name": "Idera Pharmaceuticals Inc","price": 2.4699999999999998,"dollarChange": -0.04,"percentChange": -1.6,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/IDRA-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/IDRA-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/IDRA-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/IDRA-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/IDRA-1yr.php","open": 2.5300000000000002,"high": 2.55,"low":2.42,"volume": 1391122,"avgVol": 1470660.200000,"sharesShort": 8503336,"shortPercent": 5.703350,"marketCap": 278805250,"float": 149093717,"headlines":{"data":[{"title":"ETFs with exposure to Idera Pharmaceuticals, Inc. : March 27, 2017","publication_date":"2017-03-27 19:59:39 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-march-27-2017/","summary":"ETFs with exposure to Idera Pharmaceuticals, Inc. : March 27, 2017"},{"title":"3 Stocks That Could Double Your Money","publication_date":"2017-03-25 17:58:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uAvQeR-W3fU/3-stocks-that-could-double-your-money-cm765613","summary":"Could you double your money in the next 12 months According to Wall Street you potentially can Analysts think the share prices could soar by at least 100 by a year from now for three biotech stocks Celldex Therapeutics NASDAQ CLDX Idera Pharmaceuticals NASDAQ"},{"title":"3 Stocks That Could Double Your Money","publication_date":"2017-03-25 16:03:00 +0000","url":"https://www.fool.com/investing/2017/03/25/3-stocks-that-could-double-your-money.aspx","summary":"3 Stocks That Could Double Your Money"},{"title":"Analyst Calls for Exponential Upside for Idera Pharmaceuticals","publication_date":"2017-03-25 14:10:26 +0000","url":"http://finance.yahoo.com/news/analyst-calls-exponential-upside-idera-141026771.html","summary":"Analyst Calls for Exponential Upside for Idera Pharmaceuticals"},{"title":"Idera Pharmaceuticals and XOMA Find Paths to Financial Growth","publication_date":"2017-03-23 13:30:00 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-xoma-paths-financial-133000589.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 23, 2017 / Two stocks that investors gained confidence in on Wednesday are both getting attention from stockholders on recent news announcements. Both the companies may ..."},{"title":"Mid-Afternoon Market Update: Sears Drops After Warning Of Ability To Continue As A Going Concern; Idera Pharma Shares Surge","publication_date":"2017-03-22 20:08:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H_Ja3BK7q70/mid-afternoon-market-update-sears-drops-after-warning-of-ability-to-continue-as-a-going-concern-idera-pharma-shares-surge-cm764372","summary":"Toward the end of trading Wednesday the Dow traded down 0 11 percent to 20 645 24 while the NASDAQ rose 0 29 percent to 5 810 89 The S amp P also rose gaining 0 11 percent to 2 346 66 Leading and Lagging Sectors Wednesday afternoon the technology sector proved to be a source"},{"title":"Mid-Day Market Update: Duluth Surges On Earnings Beat; Diana Containerships Shares Plummet","publication_date":"2017-03-22 17:36:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mhk0gJIcBcw/mid-day-market-update-duluth-surges-on-earnings-beat-diana-containerships-shares-plummet-cm764272","summary":"Midway through trading Wednesday the Dow traded down 0 03 percent to 20 661 19 while the NASDAQ rose 0 35 percent to 5 814 28 The S amp P also rose gaining 0 18 percent to 2 348 15 Leading and Lagging Sectors On Wednesday the technology sector proved to be a source of"},{"title":"Idera Pharma Shares Could Be A Four-Bagger, JMP Says","publication_date":"2017-03-22 13:08:55 +0000","url":"http://finance.yahoo.com/news/idera-pharma-shares-could-four-130855378.html","summary":"Idera Pharma Shares Could Be A Four-Bagger, JMP Says"},{"title":"Coverage initiated on Idera Pharma by JMP Securities","publication_date":"2017-03-22 10:55:06 +0000","url":"http://finance.yahoo.com/q/ud?s=IDRA","summary":"Coverage initiated on Idera Pharma by JMP Securities"},{"title":"IDERA PHARMACEUTICALS, INC. Financials","publication_date":"2017-03-21 17:04:10 +0000","url":"http://finance.yahoo.com/q/is?s=idra","summary":"IDERA PHARMACEUTICALS, INC. Financials"},{"title":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017","publication_date":"2017-03-17 15:38:53 +0000","url":"http://www.capitalcube.com/blog/index.php/idera-pharmaceuticals-inc-idra-us-earnings-analysis-q4-2016-by-the-numbers-march-17-2017/","summary":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017"},{"title":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017","publication_date":"2017-03-17 13:57:32 +0000","url":"http://www.capitalcube.com/blog/index.php/idera-pharmaceuticals-inc-idra-us-earnings-analysis-2016-by-the-numbers-march-17-2017/","summary":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017"},{"title":"Idera posts 4Q profit","publication_date":"2017-03-15 23:25:25 +0000","url":"http://sg.finance.yahoo.com/news/idera-posts-4q-profit-232525896.html","summary":"Idera posts 4Q profit"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-15 21:05:49 +0000","url":"http://biz.yahoo.com/e/170315/idra10-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report"},{"title":"Idera Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Provides Corporate Update","publication_date":"2017-03-15 20:30:00 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-reports-fourth-quarter-203000936.html","summary":"[GlobeNewswire] - -IM O-2125 Confirmed Responses in PD-1 Refractory Melanoma Appear Durable-. -First Third Generation Antisense Target Selected; Poised to Enter Clinical Development in 2018-. CAMBRIDGE, Mass. and EXTON, ..."},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr","publication_date":"2017-03-13 21:00:25 +0000","url":"http://biz.yahoo.com/e/170313/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr"},{"title":"Idera to Present at the 37th Annual Cowen and Company Health Care Conference","publication_date":"2017-03-02 12:30:00 +0000","url":"http://finance.yahoo.com/news/idera-present-37th-annual-cowen-123000959.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., March 02, 2017-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and ..."},{"title":"Idera Pharmaceuticals (IDRA) Looks Good: Stock Up 13.3%","publication_date":"2017-03-01 15:16:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SNlcodApPIw/idera-pharmaceuticals-idra-looks-good-stock-up-133-cm754733","summary":"Idera Pharmaceuticals Inc IDRA was a big mover last session as the company saw its shares rise over 13 on the day The move came on solid volume with far more shares changing hands than in a normal session This continues the recent uptrend of the company as the stock is now up 26 3 in"},{"title":"Idera Pharmaceuticals (IDRA) Looks Good: Stock Up 13.3%","publication_date":"2017-03-01 13:30:01 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-idra-looks-good-133001321.html","summary":"Idera Pharmaceuticals (IDRA) Looks Good: Stock Up 13.3%"},{"title":"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO...","publication_date":"2017-02-28 22:52:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jYIlQDqDXo4/gainers--losers-of-feb28-kite-pbmd-life-vrx-prgo-20170228-02153","summary":"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO..."},{"title":"Idera Drug Combo Study Posts Positive Results","publication_date":"2017-02-27 17:45:00 +0000","url":"http://www.investopedia.com/news/idera-drug-combo-does-well-early-study-idra/?partner=YahooSA","summary":"Idera Drug Combo Study Posts Positive Results"},{"title":"11:30 am Idera Pharma reports additional data from the dose-escalation phase of its ongoing Phase 1/2 clinical trial of intratumoral IMO-2125 at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium","publication_date":"2017-02-26 16:30:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#idra","summary":"11:30 am Idera Pharma reports additional data from the dose-escalation phase of its ongoing Phase 1/2 clinical trial of intratumoral IMO-2125 at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium"},{"title":"Idera Pharmaceuticals Presents Update from Ongoing Phase 1 Dose Escalation Clinical Trial of Intratumoral IMO-2125 in Combination with Ipilimumab in Metastatic Melanoma Patients Refractory to Anti-PD-1 Treatment at the 2017 ASCO-SITC Clinic","publication_date":"2017-02-24 16:30:00 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-presents-ongoing-phase-163000361.html","summary":"[GlobeNewswire] - ORLANDO, Fla., Feb. 24, 2017-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today ..."},{"title":"3 Biotech Stocks You May Be Overlooking","publication_date":"2017-02-22 21:51:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iIwcdIcBEH8/3-biotech-stocks-you-may-be-overlooking-cm751612","summary":"With hundreds of biotech stocks on the market who can keep up with them all Probably no one What happens as a result is that usually only the biggest biotechs or the small biotechs getting bought by the biggest biotechs get a lot of coverage 160 But sometimes those aren t the"},{"title":"3 Biotech Stocks You May Be Overlooking","publication_date":"2017-02-22 20:53:12 +0000","url":"http://www.fool.com/investing/2017/02/22/3-biotech-stocks-you-may-be-overlooking.aspx","summary":"3 Biotech Stocks You May Be Overlooking"},{"title":"Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development","publication_date":"2017-02-06 13:00:00 +0000","url":"http://finance.yahoo.com/news/idera-announces-appointment-jonathan-yingling-130000266.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., Feb. 06, 2017-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and ..."},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2017-01-09 13:01:45 +0000","url":"http://biz.yahoo.com/e/170109/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-06 21:03:16 +0000","url":"http://biz.yahoo.com/e/170106/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"Idera to Present at the 35th Annual J.P. Morgan Healthcare Conference","publication_date":"2017-01-04 17:00:00 +0000","url":"http://finance.yahoo.com/news/idera-present-35th-annual-j-170000951.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., Jan. 04, 2017-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and ..."},{"title":"ETFs with exposure to Idera Pharmaceuticals, Inc. : January 4, 2017","publication_date":"2017-01-04 16:07:13 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-january-4-2017/","summary":"ETFs with exposure to Idera Pharmaceuticals, Inc. : January 4, 2017"},{"title":"ETFs with exposure to Idera Pharmaceuticals, Inc. : December 21, 2016","publication_date":"2016-12-21 17:27:26 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-december-21-2016/","summary":"ETFs with exposure to Idera Pharmaceuticals, Inc. : December 21, 2016"},{"title":"Is the Options Market Predicting a Spike in Idera Pharmaceuticals (IDRA) Stock?","publication_date":"2016-12-15 16:56:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_bvgVIKBo04/is-the-options-market-predicting-a-spike-in-idera-pharmaceuticals-idra-stock-cm721939","summary":"Investors in shares of Idera Pharmaceuticals Inc IDRA need to pay close attention to the stock based on moves in the options market lately That is because the Put which expires on Dec 17 2016 for the 3 00 strike price had some of the highest implied volatility of all equity options"},{"title":"Is the Options Market Predicting a Spike in Idera Pharmaceuticals (IDRA) Stock?","publication_date":"2016-12-15 15:18:03 +0000","url":"http://finance.yahoo.com/news/options-market-predicting-spike-idera-151803478.html","summary":"Is the Options Market Predicting a Spike in Idera Pharmaceuticals (IDRA) Stock?"},{"title":"Why You Shouldn't Bet Against Idera (IDRA) Stock","publication_date":"2016-12-13 18:56:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V9SSdyTfKaQ/why-you-shouldnt-bet-against-idera-idra-stock-cm720874","summary":"One stock that might be an intriguing choice for investors right now is Idera Pharmaceuticals Inc IDRA This is because this security in the Medical Biomedical and Genetics space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry"},{"title":"Why You Shouldn't Bet Against Idera (IDRA) Stock","publication_date":"2016-12-13 16:44:04 +0000","url":"http://finance.yahoo.com/news/why-shouldnt-bet-against-idera-164404816.html","summary":"Why You Shouldn't Bet Against Idera (IDRA) Stock"},{"title":"How RAIT Financial Trust (RAS) Stacks Up Against Its Peers","publication_date":"2016-12-13 04:54:39 +0000","url":"http://www.insidermonkey.com/blog/how-rait-financial-trust-ras-stacks-up-against-its-peers-507302/","summary":"How RAIT Financial Trust (RAS) Stacks Up Against Its Peers"},{"title":"Is Idera Pharmaceuticals Inc (IDRA) a Good Stock to Buy?","publication_date":"2016-12-12 22:41:07 +0000","url":"http://www.insidermonkey.com/blog/is-idera-pharmaceuticals-inc-idra-a-good-stock-to-buy-506257/","summary":"Is Idera Pharmaceuticals Inc (IDRA) a Good Stock to Buy?"},{"title":"ETFs with exposure to Idera Pharmaceuticals, Inc. : December 9, 2016","publication_date":"2016-12-09 17:20:20 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-december-9-2016/","summary":"ETFs with exposure to Idera Pharmaceuticals, Inc. : December 9, 2016"},{"title":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q3, 2016 By the Numbers : December 8, 2016","publication_date":"2016-12-08 13:15:25 +0000","url":"http://www.capitalcube.com/blog/index.php/idera-pharmaceuticals-inc-idra-us-earnings-analysis-q3-2016-by-the-numbers-december-8-2016/","summary":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q3, 2016 By the Numbers : December 8, 2016"},{"title":"Why Idera Pharmaceuticals (IDRA) Could Be Positioned for a Surge","publication_date":"2016-12-02 16:03:04 +0000","url":"http://finance.yahoo.com/news/why-idera-pharmaceuticals-idra-could-160304050.html","summary":"Why Idera Pharmaceuticals (IDRA) Could Be Positioned for a Surge"},{"title":"Idera Gets $15 Million for Shelved GI Drug (IDRA)","publication_date":"2016-11-29 14:36:00 +0000","url":"http://www.investopedia.com/news/idera-signs-licensing-pact-nixed-gi-drug-idra/?partner=YahooSA","summary":"Idera Gets $15 Million for Shelved GI Drug (IDRA)"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure,","publication_date":"2016-11-28 13:29:23 +0000","url":"http://biz.yahoo.com/e/161128/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure,"},{"title":"Idera Pharmaceuticals and Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement for the Worldwide Rights to IMO-9200","publication_date":"2016-11-28 12:00:00 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-vivelix-pharmaceuticals-ltd-120000055.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass., EXTON, Pa. and HAMILTON, Bermuda, Nov. 28, 2016-- Idera Pharmaceuticals, Inc., and Vivelix Pharmaceuticals, Ltd. today announced that they have entered into an exclusive license and collaboration ..."},{"title":"Idera Pharmaceuticals Reports Translational Data Supporting the Mechanism of Action of Intratumoral IMO-2125 from Ongoing Phase 1 Dose Escalation in Clinical Trial in Combination with Ipilimumab in Metastatic Melanoma Patients Refractory to","publication_date":"2016-11-11 20:57:05 +0000","url":"http://www.publicnow.com/view/C53D0D913D931EC034A41332DEB7EBC254DDABEB","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ..."},{"title":"Idera to Present at the Stifel 2016 Healthcare Conference","publication_date":"2016-11-10 12:30:00 +0000","url":"http://finance.yahoo.com/news/idera-present-stifel-2016-healthcare-123000079.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., Nov. 10, 2016-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and ..."},{"title":"Idera Pharmaceuticals to Provide Multiple Presentations on Intratumoral IMO-2125 at the 2016 Society for Immunotherapy of Cancer (SITC) Annual Meeting","publication_date":"2016-11-09 12:30:00 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-multiple-presentations-intratumoral-123000882.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., Nov. 09, 2016-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and ..."},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-01 20:05:03 +0000","url":"http://biz.yahoo.com/e/161101/idra10-q.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report"},{"title":"Idera reports 3Q loss","publication_date":"2016-10-28 11:41:24 +0000","url":"http://sg.finance.yahoo.com/news/idera-reports-3q-loss-114124547.html","summary":"Idera reports 3Q loss"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a","publication_date":"2016-10-28 11:39:18 +0000","url":"http://biz.yahoo.com/e/161028/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"},{"title":"Idera Pharmaceuticals Reports Third Quarter 2016 Financial Results","publication_date":"2016-10-28 11:38:00 +0000","url":"http://www.publicnow.com/view/CAF27A756149A4365F7FC0A0D3C131EC0BDA4118","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ..."},{"title":"5 Stocks Insiders Love Right Now","publication_date":"2016-10-14 12:36:00 +0000","url":"https://www.thestreet.com/story/13853374/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO","summary":"5 Stocks Insiders Love Right Now"},{"title":"Wednesday 10/12 Insider Buying Report: IDRA, AZZ","publication_date":"2016-10-12 17:40:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QZ11d6ev1GE/wednesday-1012-insider-buying-report-idra-azz-cm692471","summary":"Bargain hunters are wise to pay careful attention to insider buying because although there are many various reasons for an insider to sell a stock presumably the only reason they would use their hard earned cash to make a purchase is that they expect to make money Today we look at"},{"title":"How Much Potential Does Idera Pharmaceuticals' Pipeline Really Have?","publication_date":"2016-10-09 15:44:05 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QLSLAetIYUc/how-much-potential-does-idera-pharmaceuticals-pipeline-really-have-cm690771","summary":"Image source Getty Images Shares of Idera Pharmaceuticals NASDAQ IDRA are down around 15 year to date And that s a good thing relatively speaking The clinical stage biotech s stock was down by more than 55 just a few months ago Idera s current market cap of over"},{"title":"How Much Potential Does Idera Pharmaceuticals' Pipeline Really Have?","publication_date":"2016-10-09 13:43:31 +0000","url":"http://www.fool.com/investing/2016/10/09/how-much-potential-does-idera-pharmaceuticals-pipe.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2","summary":"How Much Potential Does Idera Pharmaceuticals' Pipeline Really Have?"},{"title":"5 Companies That Destroyed Shareholders This Past Week","publication_date":"2016-10-08 13:55:53 +0000","url":"http://247wallst.com/investing/2016/10/08/5-companies-that-destroyed-shareholders-this-past-week-2/","summary":"5 Companies That Destroyed Shareholders This Past Week"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S","publication_date":"2016-10-07 20:56:18 +0000","url":"http://biz.yahoo.com/e/161007/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S"},{"title":"Why Idera Pharmaceuticals Inc Stock Is Falling Again","publication_date":"2016-10-07 16:12:56 +0000","url":"http://www.fool.com/investing/2016/10/07/why-idera-pharmaceuticals-inc-is-falling-again.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2","summary":"Why Idera Pharmaceuticals Inc Stock Is Falling Again"},{"title":"Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock","publication_date":"2016-10-07 13:29:02 +0000","url":"http://www.publicnow.com/view/A6A029CBD2179BFD0F9520605EEC85FCEEC40031","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., Oct. 07, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) ('Idera' or the 'Company') today announced the pricing of an underwritten public offering of ..."},{"title":"Why Idera Pharmaceuticals Inc. Is Down Big Today","publication_date":"2016-10-06 20:42:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wqN38NN3yyg/why-idera-pharmaceuticals-inc-is-down-big-today-cm690037","summary":"Image source Getty Images What After the company announced that it plans to raise capital through a common stock offering shares of Idera Pharmaceuticals NASDAQ IDRA fell by 16 as of 3 30 p m EDT on Thursday So what The clinical"},{"title":"Why Idera Pharmaceuticals Inc. Is Down Big Today","publication_date":"2016-10-06 20:15:15 +0000","url":"http://www.fool.com/investing/2016/10/06/why-idera-pharmaceuticals-inc-is-down-big-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2","summary":"Why Idera Pharmaceuticals Inc. Is Down Big Today"},{"title":"Mid-Afternoon Market Update: Crude Oil Up 1.5%; Alnylam Pharma Shares Tumble On Revusiran Termination","publication_date":"2016-10-06 20:03:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1vdXtjBkWTE/mid-afternoon-market-update-crude-oil-up-15-alnylam-pharma-shares-tumble-on-revusiran-termination-cm690024","summary":"Toward the end of trading Thursday the Dow traded down 0 05 percent to 18 271 28 while the NASDAQ declined 0 11 percent to 5 310 15 However the S amp P 500 gained 0 10 percent to 2 161 89 Leading and Lagging Sectors Thursday afternoon energy shares gained by 0 67"},{"title":"Idera Announces $50M Public Offering (IDRA)","publication_date":"2016-10-06 18:34:00 +0000","url":"http://www.investopedia.com/news/idera-announces-50m-public-offering-idra/?partner=YahooSA","summary":"Idera Announces $50M Public Offering (IDRA)"},{"title":"Three Biotech Companies With Large Upside Potential","publication_date":"2016-10-06 17:25:48 +0000","url":"http://finance.yahoo.com/news/three-biotech-companies-large-upside-172548901.html","summary":"Three Biotech Companies With Large Upside Potential"},{"title":"Idera Pharmaceuticals Sinks on Secondary Offering","publication_date":"2016-10-06 16:45:43 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-sinks-secondary-offering-164543171.html","summary":"Idera Pharmaceuticals Sinks on Secondary Offering"},{"title":"Why Traders Are Keenly Watching Twitter, Zumiez, Idera, and More","publication_date":"2016-10-06 07:00:46 +0000","url":"http://www.insidermonkey.com/blog/why-traders-are-keenly-watching-twitter-zumiez-idera-and-more-478932/","summary":"Why Traders Are Keenly Watching Twitter, Zumiez, Idera, and More"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-10-05 21:21:30 +0000","url":"http://biz.yahoo.com/e/161005/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Idera Pharmaceuticals Announces Proposed Public Offering of Common Stock","publication_date":"2016-10-05 20:18:03 +0000","url":"http://www.publicnow.com/view/AF003E456E6A3A00C8A22D71C9B88AAA79232849","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) ('Idera' or the 'Company') today announced that it intends to offer and sell up to $50,000,000 ..."},{"title":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : October 3, 2016","publication_date":"2016-10-03 14:55:54 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-october-3-2016/","summary":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : October 3, 2016"},{"title":"Idera Pharmaceuticals Presents New Third Generation Antisense (3GA) Data at the 12th Annual Meeting of the Oligonucleotide Therapeutics Society","publication_date":"2016-09-27 11:30:00 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-presents-third-generation-113000405.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., Sept. 27, 2016-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic acid-based ..."},{"title":"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial","publication_date":"2016-09-27 02:18:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KUQnhvR44UY/arry-hits-columbus-goals-kite-flies-afterhrs-fda-places-hold-on-cvm-trial-20160927-00041","summary":"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial"},{"title":"Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metasta...","publication_date":"2016-09-26 11:29:06 +0000","url":"http://www.publicnow.com/view/5D7FA5EC09B2A0E9E6719DA00EA075F7FF33653C","summary":"[at noodls] - (GLOBE NEWSWIRE via COMTEX) --3 Patients with PD-1 Refractory Cutaneous Melanoma are Responders Including One Complete Response (CR) Driven by Increased Prioritization of IMO-2125 Clinical Development, ..."},{"title":"Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metastatic Melanoma","publication_date":"2016-09-26 11:29:06 +0000","url":"http://www.publicnow.com/view/6836704A87F81B496C8AE972A9522CC9B3B79B97","summary":"[at noodls] - - 3 Patients with PD-1 Refractory Cutaneous Melanoma are Responders Including One Complete Response (CR) - - Driven by Increased Prioritization of IMO-2125 Clinical Development, Company Suspends Development ..."},{"title":"Mid-Day Market Update: Crude Oil Up 2.75%; Mast Therapeutics Shares Drop After Sickle Cell Drug Phase 3 Trial Fail","publication_date":"2016-09-21 17:50:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/513lkjhSW-Y/mid-day-market-update-crude-oil-up-275-mast-therapeutics-shares-drop-after-sickle-cell-drug-phase-3-trial-fail-cm682799","summary":"Midway through trading Wednesday the Dow traded up 0 32 percent to 18 187 31 while the NASDAQ climbed 0 15 percent to 5 249 03 The S amp P also rose gaining 0 32 percent to 2 146 52 Leading and Lagging Sectors On Wednesday basic materials shares gained 1 25 percent"},{"title":"Mid-Day Market Update: Tobira Therapeutics Jumps Following Allergan Buyout; HNI Shares Slide","publication_date":"2016-09-20 17:35:32 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9sr-89rNsNI/mid-day-market-update-tobira-therapeutics-jumps-following-allergan-buyout-hni-shares-slide-cm682188","summary":"Midway through trading Tuesday the Dow traded up 0 26 percent to 18 167 66 while the NASDAQ climbed 0 17 percent to 5 243 88 The S amp P also rose gaining 0 17 percent to 2 142 85 Leading and Lagging Sectors On Tuesday healthcare shares gained 0 70 percent Meanwhile top"},{"title":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : September 20, 2016","publication_date":"2016-09-20 14:30:48 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-september-20-2016/","summary":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : September 20, 2016"},{"title":"Idera Pharmaceuticals in Focus: Stock Adds 8.8% in Session","publication_date":"2016-09-20 14:25:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5D5gF3v1X0c/idera-pharmaceuticals-in-focus-stock-adds-88-in-session-cm681870","summary":"Idera Pharmaceuticals Inc IDRA was a big mover last session as the company saw its shares rise nearly 9 on the day The move came on solid volume leading to far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up"},{"title":"Idera Pharmaceuticals in Focus: Stock Adds 8.8% in Session","publication_date":"2016-09-20 12:15:12 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-focus-stock-adds-121512802.html","summary":"Idera Pharmaceuticals in Focus: Stock Adds 8.8% in Session"},{"title":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : September 8, 2016","publication_date":"2016-09-08 14:20:39 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-september-8-2016/","summary":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : September 8, 2016"},{"title":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : August 26, 2016","publication_date":"2016-08-26 14:30:44 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-august-26-2016/","summary":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : August 26, 2016"},{"title":"Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology","publication_date":"2016-08-24 11:18:04 +0000","url":"http://www.publicnow.com/view/5B67A3132EB9795A74C5174556BA59D231B9FDAB","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ..."},{"title":"Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology","publication_date":"2016-08-24 11:00:00 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-presents-novel-mechanism-110000559.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., Aug. 24, 2016-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic acid-based ..."},{"title":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : August 12, 2016","publication_date":"2016-08-12 18:27:26 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-august-12-2016/","summary":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : August 12, 2016"},{"title":"Idera to Present at the 2016 Wedbush PacGrow Healthcare Conference","publication_date":"2016-08-12 13:30:00 +0000","url":"http://finance.yahoo.com/news/idera-present-2016-wedbush-pacgrow-133000809.html","summary":"[GlobeNewswire] - CAMBRIDGE, Mass. and EXTON, Pa., Aug. 12, 2016-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and ..."},{"title":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016","publication_date":"2016-08-11 16:19:45 +0000","url":"http://www.capitalcube.com/blog/index.php/idera-pharmaceuticals-inc-idra-us-earnings-analysis-q2-2016-by-the-numbers-august-11-2016/","summary":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016"},{"title":"Idera reports 2Q loss","publication_date":"2016-08-02 11:31:26 +0000","url":"http://sg.finance.yahoo.com/news/idera-reports-2q-loss-113126005.html","summary":"Idera reports 2Q loss"},{"title":"Idera Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update","publication_date":"2016-08-02 11:11:08 +0000","url":"http://www.publicnow.com/view/59E7533ACEE43ADBC397DD10B0312AFFC576D7FA","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ..."},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-02 10:33:48 +0000","url":"http://biz.yahoo.com/e/160802/idra10-q.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report"},{"title":"Buy 5 Attractive Biotechs at Bargain Prices","publication_date":"2016-07-05 17:46:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1tGdcvewv0A/buy-5-attractive-biotechs-at-bargain-prices-cm644780","summary":"In retrospect, we had a roller coaster ride in the first half of this year. 2016 started off on a negative note for the U.S. markets.  The markets rallied back only to be thrown in the storm of uncertainty"},{"title":"Buy 5 Attractive Biotechs at Bargain Prices","publication_date":"2016-07-05 16:07:04 +0000","url":"http://finance.yahoo.com/news/buy-5-attractive-biotechs-bargain-160704884.html","summary":"Buy 5 Attractive Biotechs at Bargain Prices"},{"title":"Technology Sector Update for 07/05/2016: VUZI","publication_date":"2016-07-05 14:23:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rWXeTnt1-2A/technology-sector-update-for-07052016-vuzi-cm644641","summary":"Top Technology Stocks MSFT 0.3% AAPL 1.0% IBM 0.3% CSCO 1.4% GOOG 0.6% Technology shares were lower in early trade on Tuesday. In technology stocks news, Vuzix ( VUZI ), a provider of video eyewear and smart glasses products,"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-17 13:07:15 +0000","url":"http://biz.yahoo.com/e/160617/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"},{"title":"Idera Pharmaceuticals (IDRA) Catches Eye: Stock Rises 8.3%","publication_date":"2016-06-17 11:02:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yzYAgkAnbwE/idera-pharmaceuticals-idra-catches-eye-stock-rises-83-cm636821","summary":"Idera Pharmaceuticals, Inc.IDRA was a big mover last session, as its shares rose over 8% on the day. The upside was driven by a rating upgrade of the company. This also led to far more shares changing hands than"},{"title":"Idera Pharmaceuticals (IDRA) Catches Eye: Stock Rises 8.3%","publication_date":"2016-06-17 08:41:08 +0000","url":"http://finance.yahoo.com/news/idera-pharmaceuticals-idra-catches-eye-084108764.html","summary":"Idera Pharmaceuticals (IDRA) Catches Eye: Stock Rises 8.3%"},{"title":"The Zacks Analyst Blog Highlights: Biogen, Merrimack Pharmaceuticals, Retrophin, Idera Pharmaceuticals and Acorda Therapeutics","publication_date":"2016-06-09 16:20:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uEUS0PIyaa8/the-zacks-analyst-blog-highlights-biogen-merrimack-pharmaceuticals-retrophin-idera-pharmaceuticals-and-acorda-therapeutics-cm632970","summary":"For Immediate Release Chicago, IL June 9, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"},{"title":"The Zacks Analyst Blog Highlights: Biogen, Merrimack Pharmaceuticals, Retrophin, Idera Pharmaceuticals and Acorda Therapeutics","publication_date":"2016-06-09 13:30:01 +0000","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-biogen-133001712.html","summary":"The Zacks Analyst Blog Highlights: Biogen, Merrimack Pharmaceuticals, Retrophin, Idera Pharmaceuticals and Acorda Therapeutics"},{"title":"Forget Biogen (BIIB), Buy These 5 Biotech Stocks Instead","publication_date":"2016-06-08 18:14:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Amood9ocQoY/forget-biogen-biib-buy-these-5-biotech-stocks-instead-cm632439","summary":"Biogen Inc.'sBIIB shares declined 12.8% yesterday with the company announcing disappointing top line results on one of its most watched experimental multiple sclerosis (MS) treatments, opicinumab (anti LINGO 1). The company said that opicinumab missed the primary as well"},{"title":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : June 7, 2016","publication_date":"2016-06-07 21:39:08 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-june-7-2016/","summary":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : June 7, 2016"},{"title":"Idera to Present at Two June Investor Healthcare Conferences","publication_date":"2016-06-07 13:08:06 +0000","url":"http://www.publicnow.com/view/C1BDE70F14887BEF78DA6C7A3F7DC6F2713C940E","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., June 07, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ..."},{"title":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : May 19, 2016","publication_date":"2016-05-19 23:34:04 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-idera-pharmaceuticals-inc-may-19-2016/","summary":"ETF’s with exposure to Idera Pharmaceuticals, Inc. : May 19, 2016"},{"title":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q1, 2016 By the Numbers","publication_date":"2016-05-18 15:57:24 +0000","url":"http://www.capitalcube.com/blog/index.php/idera-pharmaceuticals-inc-idra-us-earnings-analysis-q1-2016-by-the-numbers/","summary":"Idera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q1, 2016 By the Numbers"},{"title":"Idera Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update","publication_date":"2016-05-13 07:58:03 +0000","url":"http://www.publicnow.com/view/9214C74ED498E7A972C9BC37F813EFB595A1E3C8","summary":"[at noodls] - 9 of 10 Waldenstrom's Macroglobulinemia Patients Treated at the Highest Dosehave Demonstrated Reductions in IgM or M-Protein Levels in Ongoing Trial Company is on Track to Deliver Data from 4 Clinical ..."},{"title":"Idera to Release 2016 First Quarter Results on May 9, 2016","publication_date":"2016-05-13 07:58:03 +0000","url":"http://www.publicnow.com/view/557AB9FEDA17603463AED89AE1F27D678DA764EB","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., May 05, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ..."},{"title":"Idera Presents Preclinical Data Demonstrating Enhanced Systemic Anti-Tumor Activity from Combination Treatment with Intra-tumoral IMO-2125 and IDO-1 Inhibitor at AACR Annual Meeting 2016","publication_date":"2016-05-13 07:58:03 +0000","url":"http://www.publicnow.com/view/04E8039952BFDB038258AD1A0D0F61A45F457CD0","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., April 19, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ..."},{"title":"Idera Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today","publication_date":"2016-05-09 21:00:00 +0000","url":"http://biz.yahoo.com/cc/6/152006.html","summary":"Idera Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today"},{"title":"Idera reports 1Q loss","publication_date":"2016-05-09 20:45:45 +0000","url":"http://sg.finance.yahoo.com/news/idera-reports-1q-loss-204545297.html","summary":"Idera reports 1Q loss"},{"title":"Sum Up The Pieces: IWV Could Be Worth $133","publication_date":"2016-04-05 12:59:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yVY4ljBvMzc/sum-up-the-pieces-iwv-could-be-worth-133-cm601697","summary":"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"},{"title":"8 Biotech Stocks Under $10 Making Big Moves Higher","publication_date":"2016-03-20 13:50:00 +0000","url":"http://www.thestreet.com/story/13500950/1/8-biotech-stocks-under-10-making-big-moves-higher.html?puc=yahoo&cm_ven=YAHOO","summary":"8 Biotech Stocks Under $10 Making Big Moves Higher"},{"title":"Idera reports 4Q loss","publication_date":"2016-03-10 12:57:45 +0000","url":"http://sg.finance.yahoo.com/news/idera-reports-4q-loss-125344897.html","summary":"Idera reports 4Q loss"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","publication_date":"2016-03-10 11:36:30 +0000","url":"http://biz.yahoo.com/e/160310/idra10-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report"},{"title":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-03-07 14:03:22 +0000","url":"http://biz.yahoo.com/e/160307/idra8-k.html","summary":"IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"Forget Inovio Pharmaceuticals, Inc.: These 2 Stocks Are Better Buys","publication_date":"2016-01-26 23:21:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LHF30-Z9YS4/forget-inovio-pharmaceuticals-inc-these-2-stocks-are-better-buys-cm570677","summary":"Image Source Inovio Pharmaceuticals. Sure, the future for the DNA immunotherapies under development by Inovio Pharmaceuticals (NASDAQ INO) seems very promising. But after a year when Inovio's shares dropped nearly"},{"title":"Why Shares in Idera Pharmaceuticals, Inc. Dropped 10% Today","publication_date":"2016-01-15 22:17:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5tuUyGaQePc/why-shares-in-idera-pharmaceuticals-inc-dropped-10-today-cm566501","summary":"Image source Idera Pharmaceuticals. What After presenting at the J.P. Morgan healthcare conference on Wednesday and hitting a new 52 week low yesterday, shares in Idera Pharmaceuticals   slumped by"},{"title":"Why Idera Pharmaceuticals Inc. Shares Dropped 36% in 2015","publication_date":"2016-01-13 14:16:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yhq46_9Qr0A/why-idera-pharmaceuticals-inc-shares-dropped-36-in-2015-cm565093","summary":"What Shareholders of Idera Pharmaceuticals , a clinical stage biopharmaceutical company focused on cancer and other rare diseases, had a rough 2015. The company's shares lost more than 36% of their value in during the"},{"title":"3 Biotech Stocks to Buy in January","publication_date":"2016-01-12 13:15:04 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cYxuoiVMTkA/3-biotech-stocks-to-buy-in-january-cm564355","summary":"Image source TBIT via Pixabay. Biotech stocks are off to a rough start in 2016. Several of the most popular exchange traded funds that focus on the industry have been sold"},{"title":"Idera Pharmaceuticals (IDRA) Jumps: Stock Rises 13.7%","publication_date":"2015-12-08 15:46:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/voz007nLyWw/idera-pharmaceuticals-idra-jumps-stock-rises-137-cm551649","summary":"Idera Pharmaceuticals, Inc.IDRA was a big mover last session, as the company saw its shares rise nearly 14% on the day. The upside came after the company presented positive data from Phase 1 2 clinical trial for IMO 8400."},{"title":"Why Idera Pharmaceuticals Shares Soared Today","publication_date":"2015-12-07 22:40:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tHGjAhTi9rY/why-idera-pharmaceuticals-shares-soared-today-cm551288","summary":"Image source Idera Pharmaceuticals. What After presenting early stage data in support of its drug for Waldenstrom's macroglobulinemia, Idera Pharmaceuticals shares cimbed 14.7 earlier today. So what Idera"},{"title":"Health Care Sector Update for 12/07/2015: IDRA,XBIT,THLD","publication_date":"2015-12-07 21:55:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0q40UECARo4/health-care-sector-update-for-12072015-idraxbitthld-cm551276","summary":"Top Health Care Stocks JNJ +0.36% PZE 0.37% MRK +0.56% ABT +0.08% AMGN 2.01% Health care stocks finished well above their session lows Monday, with the NYSE Health Care Index falling about 0.4% while shares of health care companies"},{"title":"Monday Sector Leaders: Biotechnology, Hospital & Medical Practitioners","publication_date":"2015-11-23 20:05:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YK5CIzUoYEg/monday-sector-leaders-biotechnology-hospital-medical-practitioners-cm546257","summary":"In trading on Monday, biotechnology shares were relative leaders, up on the day by about 2%. Leading the group were shares of Aptose Biosciences ( APTO ), up about 19.1% and shares of Idera Pharmaceuticals ( IDRA ) up"},{"title":"Idera to Collaborate With GSK to Identify 3rd Generation Antisense Molecules for Treatment of Renal Disease","publication_date":"2015-11-23 13:15:36 +0000","url":"http://www.noodls.com/view/052D88164730346A5890D5D5F76E1FBD3456E7AE","summary":"[at noodls] - Idera to Collaborate With GSK to Identify 3rd Generation Antisense Molecules for Treatment of Renal Disease"},{"title":"Idera Announces Appointment of Joanna Horobin as Chief Medical Officer","publication_date":"2015-11-18 13:45:19 +0000","url":"http://www.noodls.com/view/4B9C98172020E4D0E742564ABA57C466214C13F6","summary":"[at noodls] - Idera Announces Appointment of Joanna Horobin as Chief Medical Officer"},{"title":"Health Care Sector Update for 11/06/2015: IDRA, LXRX, SNY","publication_date":"2015-11-06 14:17:20 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yafJLGKxq24/health-care-sector-update-for-11062015-idra-lxrx-sny-cm539808","summary":"Top Health care stocks JNJ flat PFE 0.3% ABT flat MRK flat AMGN flat Health care shares were manly unchanged in pre market trade Friday. In health care stocks news, Apricus Biosciences, Inc ( APRI ) saw its price"},{"title":"Idera Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update","publication_date":"2015-11-06 12:54:20 +0000","url":"http://www.noodls.com/view/1E152499C68E5736A0D8ED1E35E3BFDAF13734FE","summary":"[at noodls] - Idera Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update"},{"title":"Idera reports 3Q loss","publication_date":"2015-11-06 12:46:03 +0000","url":"http://sg.finance.yahoo.com/news/idera-reports-3q-loss-124603376.html","summary":"Idera reports 3Q loss"},{"title":"Idera Pharmaceuticals to Present Phase 1/2 IMO-8400 Clinical Data in Waldenstrom’s Macroglobulinemia at the 2015 American Society of Hematology Annual Meeting","publication_date":"2015-11-05 14:20:07 +0000","url":"http://www.noodls.com/view/3BFE129EB6782FBAA2B6FB5D5A51B4181ECD7656","summary":"[at noodls] - Idera Pharmaceuticals to Present Phase 1/2 IMO-8400 Clinical Data in Waldenstrom’s Macroglobulinemia at the 2015 American Society of Hematology Annual Meeting"},{"title":"Idera Pharmaceuticals Presents New Intratumoral IMO-2125 Preclinical Data at CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference","publication_date":"2015-09-16 13:19:02 +0000","url":"http://www.noodls.com/view/1C598DE37F55BAE0C52EDCD19018875B5D57DA06","summary":"[at noodls] - - First presentations of intratumoral IMO-2125 pre-clinical activity show induction of systemic antitumor immune responses resulting in tumor growth inhibition and changes in checkpoint gene expression ..."},{"title":"Idera to Present at the 22nd Annual NewsMakers in the Biotech Industry Conference","publication_date":"2015-09-04 16:36:10 +0000","url":"http://www.noodls.com/view/78A1E36122C06B10B1B21A64E37333A576EBB1E5","summary":"[at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., Sept. 4, 2015 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ..."},{"title":"Idera posts 3Q loss","publication_date":"2014-11-07 12:12:47 +0000","url":"http://sg.finance.yahoo.com/news/idera-posts-3q-loss-121247308--finance.html","summary":"Idera posts 3Q loss"}],"result_count":127,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1491054351,"trigger": "MARK AT OR ABOVE 2.60","triggerPrice":2.60,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"2.485"},{"x":"1490967300","y":"2.49"},{"x":"1490967600","y":"2.4861"},{"x":"1490967900","y":"2.48"},{"x":"1490968200","y":"2.48"},{"x":"1490968500","y":"2.48"},{"x":"1490968800","y":"2.499"},{"x":"1490969100","y":"2.49"},{"x":"1490969400","y":"2.4699999999999998"},{"x":"1490969700","y":"2.48"},{"x":"1490970000","y":"2.4885"},{"x":"1490970300","y":"2.5"},{"x":"1490970600","y":"2.4892"},{"x":"1490970900","y":"2.51"},{"x":"1490971200","y":"2.505"},{"x":"1490971500","y":"2.51"},{"x":"1490971800","y":"2.5"},{"x":"1490972100","y":"2.495"},{"x":"1490972400","y":"2.49"},{"x":"1490972700","y":"2.5"},{"x":"1490973000","y":"2.5"},{"x":"1490973300","y":"2.5"},{"x":"1490973600","y":"2.5"},{"x":"1490973900","y":"2.5"},{"x":"1490974200","y":"2.48"},{"x":"1490974500","y":"2.4742"},{"x":"1490974800","y":"2.4762"},{"x":"1490975100","y":"2.48"},{"x":"1490975400","y":"2.49"},{"x":"1490975700","y":"2.49"},{"x":"1490976000","y":"2.5"},{"x":"1490976300","y":"2.49"},{"x":"1490976600","y":"2.4801"},{"x":"1490976900","y":"2.49"},{"x":"1490977200","y":"2.495"},{"x":"1490977500","y":"2.49"},{"x":"1490977800","y":"2.49"},{"x":"1490978100","y":"2.49"},{"x":"1490978400","y":"2.49"},{"x":"1490978700","y":"2.49"},{"x":"1490979000","y":"2.49"},{"x":"1490979300","y":"2.49"},{"x":"1490979600","y":"2.49"},{"x":"1490979900","y":"2.49"},{"x":"1490980200","y":"2.49"},{"x":"1490980500","y":"2.48"},{"x":"1490980800","y":"2.49"},{"x":"1490981100","y":"2.49"},{"x":"1490981400","y":"2.485"},{"x":"1490981700","y":"2.5"},{"x":"1490982000","y":"2.5"},{"x":"1490982300","y":"2.49"},{"x":"1490982600","y":"2.5"},{"x":"1490982900","y":"2.5"},{"x":"1490983200","y":"2.48"},{"x":"1490983500","y":"2.48"},{"x":"1490983800","y":"2.4501"},{"x":"1490984100","y":"2.46"},{"x":"1490984400","y":"2.465"},{"x":"1490984700","y":"2.465"},{"x":"1490985000","y":"2.465"},{"x":"1490985300","y":"2.46"},{"x":"1490985600","y":"2.455"},{"x":"1490985900","y":"2.4596"},{"x":"1490986200","y":"2.4692"},{"x":"1490986500","y":"2.46"},{"x":"1490986800","y":"2.4599"},{"x":"1490987100","y":"2.43"},{"x":"1490987400","y":"2.43"},{"x":"1490987700","y":"2.445"},{"x":"1490988000","y":"2.455"},{"x":"1490988300","y":"2.432"},{"x":"1490988600","y":"2.4299"},{"x":"1490988900","y":"2.45"},{"x":"1490989200","y":"2.46"},{"x":"1490989500","y":"2.45"},{"x":"1490989800","y":"2.4699999999999998"},{"x":"1490990100","y":"2.46"},{"x":"1490990400","y":"2.4699999999999998"},{"x":"1490991000","y":"2.4699999999999998"},{"x":"1491004500","y":"2.49"} ], "color":"#03a9f4"}]},
{"id":"6","list":"Alerts","symbol": "INFI","name": "Infinity Pharmaceuticals Inc","price": 3.23,"dollarChange": -0.11,"percentChange": -3.3,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/INFI-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/INFI-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/INFI-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/INFI-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/INFI-1yr.php","open": 3.29,"high": 3.3,"low":3.1,"volume": 783048,"avgVol": 1212339.250000,"sharesShort": 3542844,"shortPercent": 7.025799,"marketCap": 140042141,"float": 50426205,"headlines":{"data":[{"title":"What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?","publication_date":"2017-03-30 12:51:00 +0000","url":"http://www.investopedia.com/partner/zacks/what-makes-valeant-pharmaceuticals-vrx-strong-sell/?partner=YahooSA","summary":"What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?"},{"title":"Should You Get Rid of Patheon (PTHN) Now?","publication_date":"2017-03-29 15:04:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hx3C2NzfRNU/should-you-get-rid-of-patheon-pthn-now-cm767168","summary":"Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your"},{"title":"What Makes Tesaro (TSRO) a Strong Sell?","publication_date":"2017-03-29 14:01:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WIE_m9OUJ5c/what-makes-tesaro-tsro-a-strong-sell-cm767175","summary":"Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your"},{"title":"Should You Get Rid of Patheon (PTHN) Now?","publication_date":"2017-03-29 12:47:12 +0000","url":"http://finance.yahoo.com/news/rid-patheon-pthn-now-124712860.html","summary":"Should You Get Rid of Patheon (PTHN) Now?"},{"title":"What Makes Tesaro (TSRO) a Strong Sell?","publication_date":"2017-03-29 12:42:12 +0000","url":"http://finance.yahoo.com/news/makes-tesaro-tsro-strong-sell-124212587.html","summary":"What Makes Tesaro (TSRO) a Strong Sell?"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a","publication_date":"2017-03-29 12:01:58 +0000","url":"http://biz.yahoo.com/e/170329/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a"},{"title":"Are Options Traders Betting on a Big Move in Infinity Pharmaceuticals (INFI) Stock?","publication_date":"2017-03-28 12:48:12 +0000","url":"http://finance.yahoo.com/news/options-traders-betting-big-move-124812817.html","summary":"Are Options Traders Betting on a Big Move in Infinity Pharmaceuticals (INFI) Stock?"},{"title":"ETFs with exposure to Infinity Pharmaceuticals, Inc. : March 27, 2017","publication_date":"2017-03-27 19:59:53 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-infinity-pharmaceuticals-inc-march-27-2017/","summary":"ETFs with exposure to Infinity Pharmaceuticals, Inc. : March 27, 2017"},{"title":"3 Reasons Why Infinity Pharmaceuticals (INFI) is a Great Momentum Stock","publication_date":"2017-03-23 12:31:12 +0000","url":"http://finance.yahoo.com/news/3-reasons-why-infinity-pharmaceuticals-123112561.html","summary":"3 Reasons Why Infinity Pharmaceuticals (INFI) is a Great Momentum Stock"},{"title":"Infinity Pharma Focuses on Cancer Drug: Competition Looms","publication_date":"2017-03-21 21:07:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7FVmtEhtjk/infinity-pharma-focuses-on-cancer-drug-competition-looms-cm763747","summary":"We issued an updated research report on Infinity Pharmaceuticals Inc INFI on Mar 20 2017 Infinity s share price has increased considerably by 148 9 year to date while the Zacks classified Medical Drugs industry gained 4 7 The company is currently focused on the development of"},{"title":"Infinity Pharma Focuses on Cancer Drug: Competition Looms","publication_date":"2017-03-21 19:19:07 +0000","url":"http://finance.yahoo.com/news/infinity-pharma-focuses-cancer-drug-191907991.html","summary":"Infinity Pharma Focuses on Cancer Drug: Competition Looms"},{"title":"Infinity Pharmaceuticals, Inc. :INFI-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017","publication_date":"2017-03-20 14:23:48 +0000","url":"http://www.capitalcube.com/blog/index.php/infinity-pharmaceuticals-inc-infi-us-earnings-analysis-2016-by-the-numbers-march-20-2017/","summary":"Infinity Pharmaceuticals, Inc. :INFI-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017"},{"title":"INFINITY PHARMACEUTICALS, INC. Financials","publication_date":"2017-03-18 17:04:09 +0000","url":"http://finance.yahoo.com/q/is?s=infi","summary":"INFINITY PHARMACEUTICALS, INC. Financials"},{"title":"Infinity (INFI) Reports Narrower-than-Expected Loss in Q4","publication_date":"2017-03-15 18:07:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dkH2ic5WnTk/infinity-infi-reports-narrower-than-expected-loss-in-q4-cm761255","summary":"Infinity Pharmaceuticals Inc INFI reported a loss of 46 cents per share in fourth quarter 2016 much narrower than the Zacks Consensus Estimate loss of 63 cents Also in the year ago quarter the company had reported loss of 80 cents Since Infinity does not have any approved product in"},{"title":"Infinity (INFI) Reports Narrower-than-Expected Loss in Q4","publication_date":"2017-03-15 15:36:03 +0000","url":"http://finance.yahoo.com/news/infinity-infi-reports-narrower-expected-153603287.html","summary":"Infinity (INFI) Reports Narrower-than-Expected Loss in Q4"},{"title":"Infinity reports 4Q loss","publication_date":"2017-03-14 20:34:28 +0000","url":"http://sg.finance.yahoo.com/news/infinity-reports-4q-loss-203428402.html","summary":"Infinity reports 4Q loss"},{"title":"Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today","publication_date":"2017-03-14 20:30:00 +0000","url":"http://biz.yahoo.com/cc/9/155939.html","summary":"Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement","publication_date":"2017-03-14 20:20:40 +0000","url":"http://biz.yahoo.com/e/170314/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement"},{"title":"4:17 pm Infinity Pharmaceutical beats by $0.03, misses on revs","publication_date":"2017-03-14 20:17:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#infi","summary":"4:17 pm Infinity Pharmaceutical beats by $0.03, misses on revs"},{"title":"Infinity Provides Company Update and Reports Fourth Quarter 2016 Financial Results","publication_date":"2017-03-14 20:05:00 +0000","url":"http://finance.yahoo.com/news/infinity-provides-company-reports-fourth-200500236.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., March 14, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its full-year 2016 financial results and provided an update on the company, including its ..."},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-03-14 19:49:40 +0000","url":"http://biz.yahoo.com/e/170314/infi10-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report"},{"title":"Q4 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2017-03-14 11:07:03 +0000","url":"http://biz.yahoo.com/research/earncal/20170314.html?t=infi","summary":"Q4 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"Gainers & Losers Of Mar.13: ALIM, AEMD, VSTM, ARLZ, OSIR...","publication_date":"2017-03-13 22:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PeYsLLm3RJw/gainers--losers-of-mar13-alim-aemd-vstm-arlz-osir-20170313-01297","summary":"Gainers & Losers Of Mar.13: ALIM, AEMD, VSTM, ARLZ, OSIR..."},{"title":"IPI-549 Featured at 15th International Congress on Targeted Anticancer Therapies","publication_date":"2017-03-06 13:01:00 +0000","url":"http://finance.yahoo.com/news/ipi-549-featured-15th-international-130100794.html","summary":"[PR Newswire] - PARIS, March 6, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Phase 1 clinical data for IPI-549, an orally administered immuno-oncology development candidate that ..."},{"title":"Mid-Morning Market Update: Markets Edge Lower; Abercrombie & Fitch Earnings Miss Views","publication_date":"2017-03-02 16:17:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_EThMuVzuhU/mid-morning-market-update-markets-edge-lower-abercrombie-fitch-earnings-miss-views-cm755462","summary":"Following the market opening Thursday the Dow traded down 0 01 percent to 21 115 01 while the NASDAQ declined 0 20 percent to 5 892 09 The S amp P also fell dropping 0 19 percent to 2 391 30 Leading and Lagging Sectors Utilities shares climbed by 0 02 percent in trading"},{"title":"Infinity Announces Presentation on IPI-549 at AACR Annual Meeting","publication_date":"2017-03-02 13:32:00 +0000","url":"http://finance.yahoo.com/news/infinity-announces-presentation-ipi-549-133200778.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., March 2, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new Phase 1 data for IPI-549, an orally administered immuno-oncology development candidate ..."},{"title":"Infinity Pharmaceuticals (INFI) Catches Eye: Stock Up 13.5%","publication_date":"2017-03-01 15:15:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CyeiTy1qv4Q/infinity-pharmaceuticals-infi-catches-eye-stock-up-135-cm754833","summary":"Infinity Pharmaceuticals Inc INFI was a big mover last session as the company saw its shares rise almost 7 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above"},{"title":"Infinity Pharmaceuticals (INFI) Catches Eye: Stock Up 13.5%","publication_date":"2017-03-01 13:40:01 +0000","url":"http://finance.yahoo.com/news/infinity-pharmaceuticals-infi-catches-eye-134001493.html","summary":"Infinity Pharmaceuticals (INFI) Catches Eye: Stock Up 13.5%"},{"title":"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO...","publication_date":"2017-02-28 22:52:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jYIlQDqDXo4/gainers--losers-of-feb28-kite-pbmd-life-vrx-prgo-20170228-02153","summary":"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO..."},{"title":"Infinity Announces the Date of Its Full-Year 2016 Financial Results Conference Call and Webcast","publication_date":"2017-02-28 13:02:00 +0000","url":"http://finance.yahoo.com/news/infinity-announces-date-full-2016-130200568.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Feb. 28, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, March 14, 2017, at 4:30 p.m. ET to review its full-year 2016 financial ..."},{"title":"Infinity to Present at 37th Annual Cowen and Company Healthcare Conference","publication_date":"2017-02-27 13:02:00 +0000","url":"http://finance.yahoo.com/news/infinity-present-37th-annual-cowen-130200484.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Cowen and Company 37 th Annual Healthcare Conference on Monday, March 6, 2017, at ..."},{"title":"Infinity Announces Promotion of Jeffery Kutok, M.D., Ph.D. to Chief Scientific Officer","publication_date":"2017-02-13 13:32:00 +0000","url":"http://finance.yahoo.com/news/infinity-announces-promotion-jeffery-kutok-133200434.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Feb. 13, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) today announced that Jeffery Kutok, M.D., Ph.D. has been promoted to the role of chief scientific officer, effective immediately. In this role, Dr. Kutok will be responsible for overseeing biology and translational science efforts, including preclinical collaborations, to support the ongoing clinical development of IPI-549, Infinity's oral immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma)."},{"title":"Infinity to Present at the 2017 BIO CEO & Investor Conference","publication_date":"2017-02-06 13:32:00 +0000","url":"http://finance.yahoo.com/news/infinity-present-2017-bio-ceo-133200963.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Feb. 6, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the 2017 BIO CEO & Investor Conference in New York City on Monday, February 13, 2017. ..."},{"title":"Faster FDA Approval Process Could Ignite These Biotech Stocks in 2017","publication_date":"2017-02-02 14:45:00 +0000","url":"http://finance.yahoo.com/news/faster-fda-approval-process-could-144500131.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 2, 2017 / The Biotech Industry has performed admirably in 2017, despite the negative attention drug makers have been receiving. The iShares NASDAQ Biotechnology Index ..."},{"title":"Gainers & Losers Of The Day: PULM, ETRM, SMMT, BVX, ARQL...","publication_date":"2017-02-01 22:29:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZB_dn9p9tLw/gainers--losers-of-the-day-pulm-etrm-smmt-bvx-arql-20170201-01814","summary":"Gainers & Losers Of The Day: PULM, ETRM, SMMT, BVX, ARQL..."},{"title":"Health Care Sector Update for 01/20/2017: INFI,IDXG,PSTI","publication_date":"2017-01-20 21:37:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wP9HNt1otow/health-care-sector-update-for-01202017-infiidxgpsti-cm736230","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 03 JNJ 0 03 PFE 0 09 PFE 0 09 MRK 0 22 MRK 0 22 ABT 3 92 ABT 3 92 AMGN 0 35 AMGN 0 35 Health care stocks have turned somewhat lower in late trade with the NYSE Health Care Index dropping about 0 3 while shares of health"},{"title":"Infinity Presents Preclinical Data and Phase 1 Clinical Data on IPI-549 at PI3K Keystone Symposia Conference","publication_date":"2017-01-20 18:00:00 +0000","url":"http://finance.yahoo.com/news/infinity-presents-preclinical-data-phase-180000869.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Jan. 20, 2017 /PRNewswire/ -- Today, during a plenary session at the Keystone Symposia Conference, \"PI3K Pathways in Immunology, Growth Disorders and Cancer,\" Infinity Pharmaceuticals, ..."},{"title":"Gainers & Losers Of The Day: CATB, MCUR, BIOC, SSH, ZYNEâ€¦","publication_date":"2017-01-19 20:17:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dyddD7IfBA0/gainers--losers-of-the-day-catb-mcur-bioc-ssh-zyne%C3%A2%C2%A6-20170119-01587","summary":"Gainers & Losers Of The Day: CATB, MCUR, BIOC, SSH, ZYNEâ€¦"},{"title":"Gainers & Losers Of The Day: PULM, FWP, TNDM, ADHD, CNCEâ€¦","publication_date":"2017-01-17 23:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qHhHgL84qyg/gainers--losers-of-the-day-pulm-fwp-tndm-adhd-cnce%C3%A2%C2%A6-20170117-01807","summary":"Gainers & Losers Of The Day: PULM, FWP, TNDM, ADHD, CNCEâ€¦"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan","publication_date":"2017-01-09 13:32:54 +0000","url":"http://biz.yahoo.com/e/170109/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan"},{"title":"Infinity Provides 2017 Goals and Financial Guidance","publication_date":"2017-01-09 13:03:00 +0000","url":"http://finance.yahoo.com/news/infinity-provides-2017-goals-financial-130300737.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Jan. 9, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today outlined anticipated milestones for IPI-549, a potentially first-in-class immuno-oncology product candidate ..."},{"title":"Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy","publication_date":"2017-01-08 16:20:00 +0000","url":"https://www.thestreet.com/story/13942111/1/5-stocks-insiders-are-loading-up-on.html?puc=yahoo&cm_ven=YAHOO","summary":"Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy"},{"title":"Infinity To Present At 35th Annual J.P. Morgan Annual Healthcare Conference","publication_date":"2017-01-05 13:30:00 +0000","url":"http://finance.yahoo.com/news/infinity-present-35th-annual-j-133000310.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Jan. 5, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 35 th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2017, at 10:30 ..."},{"title":"Infinity Announces Organizational Changes","publication_date":"2017-01-04 13:33:18 +0000","url":"http://www.publicnow.com/view/FD6FBAFFEE54812F8225BCA679A123F409854217","summary":"[at noodls] - CAMBRIDGE, Mass., Jan. 4, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Lawrence Bloch, M.D., J.D., has been promoted to president. In his new role, Dr. Bloch ..."},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-01-04 13:32:17 +0000","url":"http://biz.yahoo.com/e/170104/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"Infinity Announces Organizational Changes","publication_date":"2017-01-04 13:00:00 +0000","url":"http://finance.yahoo.com/news/infinity-announces-organizational-changes-130000294.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Jan. 4, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) today announced that Lawrence Bloch, M.D., J.D., has been promoted to president. In his new role, Dr. Bloch will retain responsibility for the finance, business development, corporate communications and investor relations functions at Infinity and will assume responsibility for pharmaceutical development as well as facilities operations. Dr. Bloch will continue to report to Adelene Perkins, Infinity's chief executive officer."},{"title":"5 Stocks Insiders Love Right Now","publication_date":"2016-12-21 19:06:00 +0000","url":"https://www.thestreet.com/story/13934409/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO","summary":"5 Stocks Insiders Love Right Now"},{"title":"How Health Insurance Innovations Inc (HIIQ) Stacks Up Against Its Peers","publication_date":"2016-12-19 14:37:06 +0000","url":"http://www.insidermonkey.com/blog/how-health-insurance-innovations-inc-hiiq-stacks-up-against-its-peers-511221/","summary":"How Health Insurance Innovations Inc (HIIQ) Stacks Up Against Its Peers"},{"title":"Is Infinity Pharmaceuticals Inc. (INFI) a Good Stock to Buy?","publication_date":"2016-12-10 21:38:13 +0000","url":"http://www.insidermonkey.com/blog/is-infinity-pharmaceuticals-inc-infi-a-good-stock-to-buy-502242/","summary":"Is Infinity Pharmaceuticals Inc. (INFI) a Good Stock to Buy?"},{"title":"Infinis plc announces second quarter results for year ending 31.03.17 £350m 7% Senior Notes due 2019","publication_date":"2016-11-16 10:18:15 +0000","url":"http://www.publicnow.com/view/3C89B60ECB611C21C8EEBB56DE2CEFD72C0A1352","summary":"[at noodls] - £350 million 7% Senior Notes due 2019 Quarterly Results Announcement Infinis plc, an indirectly wholly owned subsidiary of Infinis Energy Limited, announces its results for the quarter ended 30 September ..."},{"title":"VIVUS (VVUS) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-12 10:27:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mvryVSScHUU/vivus-vvus-reports-narrower-than-expected-loss-in-q3-cm708232","summary":"VIVUS Inc VVUS reported a loss of 9 cents per share in the third quarter of 2016 narrower than both the year ago loss of 15 cents and the Zacks Consensus Estimate of a loss of 25 cents FindTheCompany Graphiq However the company reported total revenue of 13 4 million in"},{"title":"VIVUS (VVUS) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-11 22:28:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T32UUUgGNw8/vivus-vvus-reports-narrower-than-expected-loss-in-q3-cm708145","summary":"VIVUS Inc VVUS reported a loss of 9 cents per share in the third quarter of 2016 narrower than both the year ago loss of 15 cents and the Zacks Consensus Estimate of a loss of 25 cents FindTheCompany Graphiq However the company reported total revenue of 13 4 million"},{"title":"Infinity (INFI) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-11 22:28:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PNIRu5mrDDs/infinity-infi-reports-narrower-than-expected-loss-in-q3-cm708138","summary":"Infinity Pharmaceuticals Inc INFI reported a loss of 39 cents per share in third quarter 2016 much narrower than the Zacks Consensus Estimate of a loss of 84 cents In the year ago quarter the company had reported earnings of 84 cents Since Infinity does not have any approved product"},{"title":"Infinity (INFI) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-11 20:06:08 +0000","url":"http://finance.yahoo.com/news/infinity-infi-reports-narrower-expected-200608241.html","summary":"Infinity (INFI) Reports Narrower-than-Expected Loss in Q3"},{"title":"Endocyte (ECYT) Stock Up on Lower-than-Expected Q3 Loss","publication_date":"2016-11-11 15:16:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Hgh0rSSP94/endocyte-ecyt-stock-up-on-lower-than-expected-q3-loss-cm707715","summary":"Endocyte Inc ECYT reported a third quarter 2016 loss of 21 cents per share narrower than both the Zacks Consensus Estimate of a loss of 27 cents and the year ago loss of 24 cents The company s shares gained 3 following the release of its quarterly results"},{"title":"Mannkind (MNKD) Q3 Earnings Beat, Inks Deal with Sanofi","publication_date":"2016-11-10 22:13:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BhcBsvctcnU/mannkind-mnkd-q3-earnings-beat-inks-deal-with-sanofi-cm707466","summary":"MannKind Corp MNKD reported earnings of 26 cents per share in the third quarter of 2016 as against a loss of 8 cents in the prior year quarter The Zacks Consensus Estimate was a loss of 6 cents In April MannKind regained the rights to develop and commercialize Afrezza the company s"},{"title":"Mannkind (MNKD) Q3 Earnings Beat, Inks Deal with Sanofi","publication_date":"2016-11-10 20:32:08 +0000","url":"http://finance.yahoo.com/news/mannkind-mnkd-q3-earnings-beat-203208987.html","summary":"Mannkind (MNKD) Q3 Earnings Beat, Inks Deal with Sanofi"},{"title":"Catalyst (CPRX) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-10 15:57:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wp3e2AsM8C0/catalyst-cprx-reports-narrower-than-expected-loss-in-q3-cm706981","summary":"Catalyst Pharmaceuticals Inc CPRX reported a loss of 5 cents per share in the third quarter of 2016 a penny narrower than the Zacks Consensus Estimate and in line with the year ago figure FindTheCompany Graphiq Being a development stage company Catalyst Pharma does"},{"title":"Keryx (KERX) Q3 Loss Wider than Expected, Restores Supply","publication_date":"2016-11-10 15:57:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YjVel8_pf8Q/keryx-kerx-q3-loss-wider-than-expected-restores-supply-cm707095","summary":"Keryx Biopharmaceuticals Inc KERX reported third quarter 2016 loss of 39 cents per share which was significantly wider than both the Zacks Consensus Estimate of 22 cents and the year ago loss of 29 cents FindTheCompany Graphiq On the other hand revenues came in"},{"title":"Mylan (MYL) Q3 Earnings & Revenues Miss on EpiPen Woes","publication_date":"2016-11-10 14:56:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vpiLMYsvuXs/mylan-myl-q3-earnings-revenues-miss-on-epipen-woes-cm706987","summary":"Mylan N V s MYL third quarter 2016 earnings of 1 38 per share missed the Zacks Consensus Estimate of 1 50 and declined 3 from the year ago quarter reflecting significant contribution from new products in the prior year period FindTheCompany Graphiq In the"},{"title":"Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up On Opdivo Combination Therapy","publication_date":"2016-11-10 14:50:30 +0000","url":"http://www.insidermonkey.com/blog/bristol-myers-squibb-company-bmy-infinity-pharmaceuticals-inc-infi-team-up-on-opdivo-combination-therapy-486714/","summary":"Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up On Opdivo Combination Therapy"},{"title":"Blog Coverage Bristol-Myers Squibb and Infinity Pharma Collaborate for Clinical Trials to Test Combination Drugs","publication_date":"2016-11-10 13:15:00 +0000","url":"http://finance.yahoo.com/news/blog-coverage-bristol-myers-squibb-131500299.html","summary":"[Accesswire] - LONDON, UK / ACCESSWIRE / November 10, 2016 / Active Wall St. blog coverage looks at the headline from Bristol-Myers Squibb Co. (NASDAQ: BMY ) and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) (\"Infinity\")as ..."},{"title":"Edited Transcript of INFI earnings conference call or presentation 9-Nov-16 9:30pm GMT","publication_date":"2016-11-10 02:27:07 +0000","url":"http://finance.yahoo.com/news/edited-transcript-infi-earnings-conference-022707634.html","summary":"Edited Transcript of INFI earnings conference call or presentation 9-Nov-16 9:30pm GMT"},{"title":"Repros (RPRX) Loss Narrower Y/Y in Q3, Pipeline in Focus","publication_date":"2016-11-09 22:54:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TDxUcInJ4dI/repros-rprx-loss-narrower-yy-in-q3-pipeline-in-focus-cm706824","summary":"Repros Therapeutics Inc RPRX reported a loss of 17 cents per share in the third quarter of 2016 significantly narrower than the year ago loss of 27 cents primarily due to lower expenses related to the development of the company s pipeline candidates enclomiphene and Proellex as well as"},{"title":"Celldex (CLDX) Q3 Loss Narrower than Expected, Sales Beat","publication_date":"2016-11-09 22:53:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AYRnb_MXI2k/celldex-cldx-q3-loss-narrower-than-expected-sales-beat-cm706815","summary":"Celldex Therapeutics Inc CLDX reported third quarter 2016 loss of 29 cents per share narrower than both the Zacks Consensus Estimate and the year ago loss of 32 cents FindTheCompany Graphiq Total revenue in the third quarter of 2016 surged 120 year over year to 2 2"},{"title":"Infinity reports 3Q loss","publication_date":"2016-11-09 22:12:32 +0000","url":"http://sg.finance.yahoo.com/news/infinity-reports-3q-loss-221232676.html","summary":"Infinity reports 3Q loss"},{"title":"Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today","publication_date":"2016-11-09 21:30:00 +0000","url":"http://biz.yahoo.com/cc/5/154865.html","summary":"Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today"},{"title":"Infinity Provides Company Update and Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-09 21:21:19 +0000","url":"http://www.publicnow.com/view/1BCCD1815678D07015B1B21776A02D57D365065F","summary":"[at noodls] - CAMBRIDGE, Mass., Nov. 9, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its third quarter 2016 financial results and its transition of the company to focus on IPI-549, ..."},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement","publication_date":"2016-11-09 21:14:43 +0000","url":"http://biz.yahoo.com/e/161109/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-09 20:54:37 +0000","url":"http://biz.yahoo.com/e/161109/infi10-q.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report"},{"title":"Infinity Announces Second Publication on PI3K-Gamma in Nature","publication_date":"2016-11-09 18:19:12 +0000","url":"http://www.publicnow.com/view/B3C8315903C5B04150F2F0198A720F3B5B9EBA60","summary":"[at noodls] - CAMBRIDGE, Mass., Nov. 9, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the publication of new findings by research collaborators at Memorial Sloan Kettering Cancer ..."},{"title":"Theravance (TBPH) Posts Narrower-than-Expected Q3 Loss","publication_date":"2016-11-09 16:56:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tiJvTRW7Fdo/theravance-tbph-posts-narrower-than-expected-q3-loss-cm706514","summary":"Theravance Biopharma Inc TBPH reported third quarter 2016 loss of 73 cents per share much narrower than both the Zacks Consensus Estimate of a loss of 95 cents and the year ago loss of 1 40 Total revenue in the quarter surged 78 3 year over year to 19 1 million on the back"},{"title":"Jazz Pharma (JAZZ) Q3 Earnings Top, Sales Lag Estimates","publication_date":"2016-11-09 15:56:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CUw38JfH-PE/jazz-pharma-jazz-q3-earnings-top-sales-lag-estimates-cm706427","summary":"Jazz Pharmaceuticals Public Limited Company JAZZ reported third quarter 2016 earnings of 2 16 per share including stock based compensation expense which surpassed the Zacks Consensus Estimate of 1 57 Earnings were however almost unchanged from the year ago tally Excluding stock"},{"title":"Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance","publication_date":"2016-11-09 14:57:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_rpXNVRjHm8/valeant-pharma-vrx-q3-earnings-miss-slashes-guidance-cm706290","summary":"Shares of pharmaceutical company Valeant Pharmaceuticals Inc VRX fell over 21 after the company reported disappointing third quarter 2016 results and slashed its sales and earnings outlook for the year The company s adjusted earnings per share of 1 55 missed the Zacks Consensus Estimate"},{"title":"Ophthotech (OPHT) Q3 Loss Wider than Expected, Sales Fall","publication_date":"2016-11-09 14:57:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cHryhnPh_kQ/ophthotech-opht-q3-loss-wider-than-expected-sales-fall-cm706275","summary":"Ophthotech Corporation OPHT reported third quarter 2016 loss of 1 71 per share wider than both the Zacks Consensus Estimate of a loss of 1 60 and the year ago loss of 1 14 Since Ophthotech does not have any approved product in its portfolio yet the company s top line solely"},{"title":"Conatus (CNAT) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-09 14:56:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DgPLQ_a7sH8/conatus-cnat-reports-narrower-than-expected-loss-in-q3-cm706267","summary":"Conatus Pharmaceuticals Inc CNAT reported third quarter 2016 loss of 31 cents per share narrower than the Zacks Consensus Estimate of a loss of 33 cents The reported loss was however in line with the year ago figure FindTheCompany Graphiq With no approved product"},{"title":"Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with IPI-549 in Advanced Solid Tumors","publication_date":"2016-11-09 12:09:14 +0000","url":"http://www.publicnow.com/view/7727F54392662264D05B0FE92D843782F67569D9","summary":"[at noodls] - CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced a clinical trial collaboration to evaluate Bristol-Myers ..."},{"title":"Q3 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2016-11-09 12:07:06 +0000","url":"http://biz.yahoo.com/research/earncal/20161109.html?t=infi","summary":"Q3 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Advanced Solid Tumors","publication_date":"2016-11-09 11:59:00 +0000","url":"http://finance.yahoo.com/news/bristol-myers-squibb-infinity-pharmaceuticals-115900337.html","summary":"[PR Newswire] - CAMBRIDGE, Mass. and NEW YORK, Nov. 9, 2016 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced a clinical trial collaboration to ..."},{"title":"Endo (ENDP) Q3 Earnings & Revenues Beat; View Intact","publication_date":"2016-11-08 21:39:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ojz-pV_uZGc/endo-endp-q3-earnings-revenues-beat-view-intact-cm705869","summary":"Endo International plc s ENDP third quarter 2016 earnings of 1 01 per share were significantly above the Zacks Consensus Estimate of 81 cents However reported earnings slipped 1 from the year ago figure The company s shares were up around 7 in the pre market trading Revenues came"},{"title":"Horizon (HZNP) Stock Up Despite Q3 Earnings, Revenue Miss","publication_date":"2016-11-08 18:42:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CU8A4o_MwKI/horizon-hznp-stock-up-despite-q3-earnings-revenue-miss-cm705472","summary":"Horizon Pharma plc HZNP reported third quarter 2016 earnings of 56 cents per share including the impact of share based compensation expense and tax adjustments which surged approximately 85 from the year ago period Reported earnings however missed the Zacks Consensus Estimate of 63"},{"title":"Humana (HUM) Partners with MDLIVE, Improves MA Plans","publication_date":"2016-11-08 18:35:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5kC-OCqzQ7Q/humana-hum-partners-with-mdlive-improves-ma-plans-cm705448","summary":"Humana Inc HUM recently joined forces with MDLIVE a renowned telemedicine services and software provider to improve its Medicare Advantage MA plans in Georgia The alliance mainly aims to provide virtual access to doctors in selected counties across Georgia and South Carolina to the"},{"title":"Arena (ARNA) Q3 Loss Lower than Expected, Revenues Rise","publication_date":"2016-11-08 18:24:05 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PwEXdjZ4fGs/arena-arna-q3-loss-lower-than-expected-revenues-rise-cm705442","summary":"Arena Pharmaceuticals Inc ARNA reported a loss of 5 cents per share in the third quarter of 2016 narrower than both the year ago loss of 11 cents and the Zacks Consensus Estimate of a loss of 7 cents Total revenue surged 110 year over year to 19 2 million which includes 11 million"},{"title":"ARIAD (ARIA) Stock Up on Narrower-than-Expected Q3 Loss","publication_date":"2016-11-08 17:03:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pR3RQEyMSuk/ariad-aria-stock-up-on-narrower-than-expected-q3-loss-cm705654","summary":"ARIAD Pharmaceutical Inc ARIA reported third quarter 2016 loss of 14 cents per share narrower than the Zacks Consensus Estimate of a loss of 19 cents and the year ago loss of 29 cents Higher U S Iclusig sales and lower costs led to narrower loss in the quarter Third quarter revenues"},{"title":"Endo (ENDP) Q3 Earnings & Revenues Beat; View Intact","publication_date":"2016-11-08 14:58:02 +0000","url":"http://finance.yahoo.com/news/endo-endp-q3-earnings-revenues-145802168.html","summary":"Endo (ENDP) Q3 Earnings & Revenues Beat; View Intact"},{"title":"AVEO Pharmaceuticals' (AVEO) Q3 Loss Lower than Expected","publication_date":"2016-11-07 22:53:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cx8FZ9ZaKK0/aveo-pharmaceuticals-aveo-q3-loss-lower-than-expected-cm705275","summary":"AVEO Pharmaceuticals Inc AVEO reported a third quarter 2016 loss of 7 cents per share narrower than the Zacks Consensus Estimate of a loss of 12 cents The company had reported earnings of 14 cents per share in the year ago period FindTheCompany Graphiq AVEO does"},{"title":"AVEO Pharmaceuticals' (AVEO) Q3 Loss Lower than Expected","publication_date":"2016-11-07 20:59:08 +0000","url":"http://finance.yahoo.com/news/aveo-pharmaceuticals-aveo-q3-loss-205908357.html","summary":"AVEO Pharmaceuticals' (AVEO) Q3 Loss Lower than Expected"},{"title":"Immune Design (IMDZ) Worth a Look: Stock Up 5% in Session","publication_date":"2016-11-07 13:35:01 +0000","url":"http://finance.yahoo.com/news/immune-design-imdz-worth-look-133501934.html","summary":"Immune Design (IMDZ) Worth a Look: Stock Up 5% in Session"},{"title":"Aegerion (AEGR) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-04 18:20:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-GhSTNSGq44/aegerion-aegr-reports-narrower-than-expected-loss-in-q3-cm703951","summary":"Aegerion Pharmaceuticals Inc AEGR reported a loss of 46 cents per share in the second quarter of 2016 narrower than the Zacks Consensus Estimate of a loss of 67 cents The company had reported earnings of 7 cents in the year ago period Quarterly revenues came in at 35 4 million"},{"title":"Geron (GERN) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-04 15:13:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VR70PPAnRbc/geron-gern-reports-narrower-than-expected-loss-in-q3-cm704008","summary":"Geron Corporation GERN reported a loss of 2 cents per share in the third quarter of 2016 narrower than the Zacks Consensus Estimate of a loss of 6 cents The company had reported earnings of 17 cents in the year ago quarter FindTheCompany Graphiq Quarterly revenues came"},{"title":"Aduro (ADRO) Stock Down on Wider-than-Expected Q3 Loss","publication_date":"2016-11-04 15:12:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DGWtx11pTkU/aduro-adro-stock-down-on-wider-than-expected-q3-loss-cm703964","summary":"Aduro BioTech Inc ADRO reported third quarter 2016 loss of 54 cents per share wider than the Zacks Consensus Estimate of a loss of 49 cents The company had reported earnings of a penny in the year ago quarter Aduro s shares were down almost 8 since the release of its third quarter"},{"title":"Intercept (ICPT) Q3 Loss Narrower than Expected, Sales Miss","publication_date":"2016-11-04 15:12:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gPVDWikpyXQ/intercept-icpt-q3-loss-narrower-than-expected-sales-miss-cm703939","summary":"Intercept Pharmaceuticals Inc ICPT posted a loss of 3 59 per share in the third quarter of 2016 narrower than the Zacks Consensus Estimate of a loss of 3 72 but wider than the year ago loss of 2 10 FindTheCompany Graphiq Quarterly revenues came in at 5 2 million"},{"title":"Epizyme (EPZM) Reports Narrower-than-Expected Loss in Q3","publication_date":"2016-11-04 14:15:04 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qkk5q6vE7Bo/epizyme-epzm-reports-narrower-than-expected-loss-in-q3-cm704067","summary":"Epizyme Inc EPZM reported a loss of 42 cents per share in the third quarter of 2016 narrower than both the Zacks Consensus Estimate and the year ago loss of 56 cents FindTheCompany Graphiq Quarter in Detail The company earned collaboration revenues of 6 6 million"},{"title":"Radius Health (RDUS) Q3 Loss Match Estimates, Wider Y/Y","publication_date":"2016-11-04 14:14:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uzCuo9Bh2ps/radius-health-rdus-q3-loss-match-estimates-wider-yy-cm704058","summary":"Radius Health Inc RDUS posted a loss of 1 07 per share in the third quarter of 2016 in line with the Zacks Consensus Estimate but wider than the year ago loss of 68 cents With no approved product in its portfolio the company has not generated any revenue yet In this scenario"},{"title":"Infinity Moves the Date of its Third Quarter 2016 Financial Results Conference Call and Webcast","publication_date":"2016-11-04 10:56:08 +0000","url":"http://www.publicnow.com/view/E2B0EBFFD901637C431C919DE11A9BA4C466093F","summary":"[at noodls] - CAMBRIDGE, Mass., Nov. 4, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has moved the date of its third quarter 2016 financial results conference call and webcast ..."},{"title":"Pacira (PCRX) Misses Q3 Earnings Estimates, Beats on Sales","publication_date":"2016-11-03 22:08:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e6QS_nieB_g/pacira-pcrx-misses-q3-earnings-estimates-beats-on-sales-cm703694","summary":"Pacira Pharmaceuticals Inc PCRX reported third quarter 2016 earnings of 2 cents including the impact of stock based compensation missing the Zacks Consensus Estimate of 3 cents and declining from the year ago quarter figure of 10 cents Revenues on the other hand surged 10 year"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Stat","publication_date":"2016-11-03 21:15:30 +0000","url":"http://biz.yahoo.com/e/161103/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Stat"},{"title":"Aerie (AERI) Q3 Loss Wider than Expected, Pipeline in Focus","publication_date":"2016-11-03 17:09:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4ndHu1giosA/aerie-aeri-q3-loss-wider-than-expected-pipeline-in-focus-cm703371","summary":"Aerie Pharmaceuticals Inc AERI posted third quarter 2016 loss of 81 cents per share including stock based compensation wider than both the Zacks Consensus Estimate of a loss of 70 cents and the year ago loss of 69 cents FindTheCompany Graphiq Being a development"},{"title":"Alkermes (ALKS) Q3 Loss in Line, Sales Miss; '16 View Intact","publication_date":"2016-11-03 15:10:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w0nv3FditPg/alkermes-alks-q3-loss-in-line-sales-miss-16-view-intact-cm703228","summary":"Alkermes plc ALKS reported a loss of 25 cents per share including the impact of share based compensation expense in the third quarter of 2016 in line with the Zacks Consensus Estimate The reported loss was however narrower than the year ago tally of 43 cents Alkermes reported revenues"},{"title":"Momenta (MNTA) Q3 Loss Narrower than Expected, Sales Up","publication_date":"2016-11-03 15:10:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CeNe-bZBRfI/momenta-mnta-q3-loss-narrower-than-expected-sales-up-cm703215","summary":"Momenta Pharmaceuticals Inc MNTA reported a loss of 26 cents per share in the third quarter of 2016 narrower than both the Zacks Consensus Estimate of a loss of 29 cents and the year ago loss of 44 cents FindTheCompany Graphiq Moreover revenues in the quarter"},{"title":"Alnylam (ALNY) Q3 Loss Wider than Expected, Revenues Up","publication_date":"2016-11-03 14:10:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0VuEQ4cZeFQ/alnylam-alny-q3-loss-wider-than-expected-revenues-up-cm703253","summary":"Alnylam Pharmaceuticals Inc ALNY reported a loss of 1 21 per share in the third quarter of 2016 wider than both the Zacks Consensus Estimate of a loss of 1 19 and the year ago figure of 91 cents FindTheCompany Graphiq Quarterly revenues on the other hand"},{"title":"Momenta (MNTA) Q3 Loss Narrower than Expected, Sales Up","publication_date":"2016-11-03 13:16:01 +0000","url":"http://finance.yahoo.com/news/momenta-mnta-q3-loss-narrower-131601282.html","summary":"Momenta (MNTA) Q3 Loss Narrower than Expected, Sales Up"},{"title":"QLT's (QLTI) Reports In-Line Q3 Loss, Merger in Focus","publication_date":"2016-11-02 17:10:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D_Z3M4yWkTE/qlts-qlti-reports-in-line-q3-loss-merger-in-focus-cm702646","summary":"QLT Inc QLTI reported a loss of 11 cents per share in the third quarter of 2016 in line with the Zacks Consensus Estimate but wider than the year ago loss of 5 cents The company did not report any revenues during the quarter as was the case a year ago The company s research"},{"title":"Shire (SHPG) Misses Q3 Earnings & Revenue Estimates","publication_date":"2016-11-02 13:16:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pAd0YjyyWWY/shire-shpg-misses-q3-earnings-revenue-estimates-cm702303","summary":"Shire plc SHPG reported third quarter 2016 earnings of 3 17 per American Depositary Share ADS missing the Zacks Consensus Estimate of 3 18 and down from the year ago tally of 3 24 Revenues on the other hand surged 109 to 3 45 billion but lagged the Zacks Consensus Estimate"},{"title":"Prothena (PRTA) Reports Wider-than-Expected Loss in Q3","publication_date":"2016-11-02 13:16:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LfteEggr9c/prothena-prta-reports-wider-than-expected-loss-in-q3-cm702300","summary":"Prothena Corporation plc PRTA reported a loss of 1 26 per share in the third quarter of 2016 wider than both the Zacks Consensus Estimate of a loss of 1 23 and the year ago loss of 73 cents Moreover quarterly revenues came in at 0 3 million down 25 primarily due to"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Costs Associated with","publication_date":"2016-11-02 11:36:12 +0000","url":"http://biz.yahoo.com/e/161102/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Costs Associated with"},{"title":"Verastem Licenses Duvelisib from Infinity Pharmaceuticals","publication_date":"2016-11-02 11:00:12 +0000","url":"http://www.publicnow.com/view/EBB91932CA16A9AA4B9A75EC40813319FB901A32","summary":"[at noodls] - Transaction Adds Complementary Late-Stage Product Candidate from a Clinically Validated Drug Class to Verastem's Pipeline Duvelisib Has Demonstrated Clinical Activity in Lymphoid Malignancies License of ..."},{"title":"AVEO Pharmaceuticals (AVEO) Q3 Earnings: What's in Store?","publication_date":"2016-11-01 18:17:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nSig-uYNmV0/aveo-pharmaceuticals-aveo-q3-earnings-whats-in-store-cm701830","summary":"AVEO Pharmaceuticals Inc AVEO is expected to report third quarter 2016 results this month The company has an impressive track record for the last four reported quarters While it has beaten estimates on three occasions it met expectations in one with an average positive surprise of 57"},{"title":"Jazz Pharma (JAZZ) Q3 Earnings: A Disappointment in Store?","publication_date":"2016-11-01 14:19:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8yJ_3K-hM3s/jazz-pharma-jazz-q3-earnings-a-disappointment-in-store-cm701576","summary":"Jazz Pharmaceuticals plc JAZZ is scheduled to report third quarter 2016 results on Nov 8 after the market closes Last quarter the company had comfortably surpassed expectations with a positive earnings surprise of 5 26 Jazz s track record is quite encouraging with the company"},{"title":"Epizyme (EPZM) Q3 Earnings: What's in Store for the Stock?","publication_date":"2016-11-01 14:17:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KCtlOsKB214/epizyme-epzm-q3-earnings-whats-in-store-for-the-stock-cm701682","summary":"Epizyme Inc EPZM is scheduled to report third quarter 2016 results on Nov 3 before the opening bell Last quarter the company recorded a positive earnings surprise of 2 00 Let s see how things are shaping up for this quarter Factors Influencing This Quarter Epizyme is"},{"title":"Horizon (HZNP) Q3 Earnings Preview: Stock to Disappoint?","publication_date":"2016-11-01 14:16:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kE4V6w775a8/horizon-hznp-q3-earnings-preview-stock-to-disappoint-cm701664","summary":"Horizon Pharma plc HZNP is scheduled to report third quarter 2016 results on Nov 7 before the opening bell Horizon s performance has been far from encouraging with the company missing earnings estimates thrice and surpassing the same in one out of the four trailing quarters Overall"},{"title":"Radius Health (RDUS): Will It Disappoint in Q3 Earnings?","publication_date":"2016-11-01 14:16:15 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RhqXirjbnr8/radius-health-rdus-will-it-disappoint-in-q3-earnings-cm701660","summary":"Radius Health Inc RDUS is scheduled to report third quarter 2016 financial results on Nov 3 before the market closes Last quarter the company recorded a negative earnings surprise of 3 06 Radius Health has a disappointing track record so far The company has missed estimates in all of"},{"title":"Geron (GERN) Q3 Earnings: Will the Store Pull a Surprise?","publication_date":"2016-11-01 13:17:15 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UGW7ffCtRho/geron-gern-q3-earnings-will-the-store-pull-a-surprise-cm701536","summary":"Geron Corporation GERN is scheduled to report third quarter 2016 results on Nov 3 after the market closes In the last reported quarter the company recorded a positive surprise of 28 57 Let s see how things are shaping up for the upcoming announcement Imetelstat Remains in"},{"title":"Keryx (KERX) Q3 Earnings Preview: Stock to Beat Estimates?","publication_date":"2016-11-01 13:16:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NBIUMKsM0QM/keryx-kerx-q3-earnings-preview-stock-to-beat-estimates-cm701617","summary":"Keryx Biopharmaceuticals Inc KERX is expected to report third quarter 2016 results on Nov 3 Let s see how things are shaping up for this announcement Factors Influencing This Quarter Apart from license fees Keryx s top line comprises revenues generated by its only marketed"},{"title":"Intercept (ICPT) Q3 Earnings Preview: What's in the Cards?","publication_date":"2016-11-01 13:16:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sNBFeM5NHTE/intercept-icpt-q3-earnings-preview-whats-in-the-cards-cm701605","summary":"Intercept Pharmaceuticals Inc ICPT is scheduled to report third quarter 2016 results on Nov 3 before market opens In the last reported quarter the company recorded a positive surprise of 16 49 Let s see how things are shaping up for this announcement Factors at"},{"title":"Radius Health (RDUS): Will It Disappoint in Q3 Earnings?","publication_date":"2016-11-01 13:13:01 +0000","url":"http://finance.yahoo.com/news/radius-health-rdus-disappoint-q3-131301441.html","summary":"Radius Health (RDUS): Will It Disappoint in Q3 Earnings?"},{"title":"Horizon (HZNP) Q3 Earnings Preview: Stock to Disappoint?","publication_date":"2016-11-01 13:09:01 +0000","url":"http://finance.yahoo.com/news/horizon-hznp-q3-earnings-preview-130901606.html","summary":"Horizon (HZNP) Q3 Earnings Preview: Stock to Disappoint?"},{"title":"Novo Nordisk (NVO) Tops Q3 Earnings, Revenues Up Y/Y","publication_date":"2016-10-31 18:15:20 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IeBZPeLf2wc/novo-nordisk-nvo-tops-q3-earnings-revenues-up-yy-cm701243","summary":"Novo Nordisk A S NVO reported third quarter 2016 earnings of 58 cents per American Depository Receipt ADR above the Zacks Consensus Estimate of 56 cents and up from the year ago figure of 49 cents Quarterly revenues were also up 3 4 year over year to 4 1 billion Reported"},{"title":"ImmunoGen (IMGN) Reports Wider-than-Expected Loss","publication_date":"2016-10-31 16:19:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WcFiUFlb2F8/immunogen-imgn-reports-wider-than-expected-loss-cm701083","summary":"ImmunoGen Inc IMGN reported a loss of 46 cents per share excluding restructuring charge in the three months ended Sep 30 wider than both the Zacks Consensus Estimate of a loss of 38 cents and the year ago loss of 39 cents We note that ImmunoGen is transitioning to a fiscal year ending"},{"title":"Novo Nordisk (NVO) Tops Q3 Earnings, Revenues Up Y/Y","publication_date":"2016-10-31 15:38:03 +0000","url":"http://finance.yahoo.com/news/novo-nordisk-nvo-tops-q3-153803073.html","summary":"Novo Nordisk (NVO) Tops Q3 Earnings, Revenues Up Y/Y"},{"title":"Conatus (CNAT) Q3 Earnings: What's in Store for the Stock?","publication_date":"2016-10-31 14:17:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xyvVgaSUhp8/conatus-cnat-q3-earnings-whats-in-store-for-the-stock-cm700972","summary":"Conatus Pharmaceuticals Inc CNAT is expected to report third quarter 2016 results on Nov 2 Conatus performance so far has been impressive with the company surpassing expectations on three occasions while posting in line results in one Overall the company has posted an average beat"},{"title":"Exelixis (EXEL) Q3 Earnings: What's in Store for the Stock?","publication_date":"2016-10-31 14:16:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ny3mYZ728cM/exelixis-exel-q3-earnings-whats-in-store-for-the-stock-cm700963","summary":"Exelixis Inc EXEL is scheduled to report third quarter 2016 results on Nov 3 after the market closes Exelixis had a mixed track record over the last four quarters The company surpassed expectations twice in the four trailing quarters and missed the same in the remaining two with"},{"title":"ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?","publication_date":"2016-10-31 14:16:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QrdDpzGVf7Y/acadia-pharma-acad-will-it-disappoint-in-q3-earnings-cm700962","summary":"ACADIA Pharmaceuticals Inc ACAD is expected to report third quarter 2016 results on Nov 3 In the four trailing quarters the company has missed estimates thrice bringing the average negative earnings surprise to 15 72 ACADIA PHARMA Price and EPS"},{"title":"Infinity Announces The Date Of Its Third Quarter 2016 Financial Results Conference Call And Webcast","publication_date":"2016-10-31 12:23:08 +0000","url":"http://www.publicnow.com/view/1262AD75855C20F33AA58FA9DA588D5EE7FBA2DC","summary":"[at noodls] - CAMBRIDGE, Mass., Oct. 31, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Monday, November 7, 2016, at 4:30 p.m. ET. During the call, management will ..."},{"title":"Infinis plc to be sold to 3i Infrastructure plc","publication_date":"2016-10-31 10:03:11 +0000","url":"http://www.publicnow.com/view/9E086F5801A9C7F2939D43F4A7C76A44E3C4107F","summary":"[at noodls] - Infinis plc to be sold to 3i Infrastructure plc 31 October 2016 Our ultimate shareholders, Terra Firma, announced today that the Infinis Group has entered into an agreement to sell Infinis plc and its ..."},{"title":"ARIAD (ARIA): Is a Beat in the Cards this Earnings Season?","publication_date":"2016-10-28 19:34:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L4xyDL6EDxo/ariad-aria-is-a-beat-in-the-cards-this-earnings-season-cm700305","summary":"ARIAD Pharmaceuticals Inc ARIA is expected to report third quarter 2016 results on Nov 1 In the last reported quarter the company recorded a positive earnings surprise of 670 Overall ARIAD has posted an average positive earnings surprise of 153 54 in the four trailing quarters Let"},{"title":"Seattle Genetics (SGEN) Loss Narrower than Expected in Q3","publication_date":"2016-10-28 19:32:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r2WQSJA7A8E/seattle-genetics-sgen-loss-narrower-than-expected-in-q3-cm700470","summary":"Seattle Genetics Inc SGEN reported a loss of 23 cents per share narrower than the Zacks Consensus Estimate of a loss of 29 cents but wider than the year ago loss of 21 cents Revenues came in at 106 3 million up 26 5 year over year primarily on the back of strong sales of"},{"title":"Seattle Genetics (SGEN) Loss Narrower than Expected in Q3","publication_date":"2016-10-28 17:55:05 +0000","url":"http://finance.yahoo.com/news/seattle-genetics-sgen-loss-narrower-175505171.html","summary":"Seattle Genetics (SGEN) Loss Narrower than Expected in Q3"},{"title":"AbbVie (ABBV) Q3 Earnings in Line, Revenues Lag Estimates","publication_date":"2016-10-28 17:33:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0rQZXDRYDiE/abbvie-abbv-q3-earnings-in-line-revenues-lag-estimates-cm700410","summary":"AbbVie Inc ABBV reported third quarter 2016 earnings of 1 21 per share in line with the Zacks Consensus Estimate but up 7 1 from the year ago quarter FindTheCompany Graphiq Revenues increased 8 2 to 6 43 billion in the third quarter but missed the Zacks"},{"title":"Agenus (AGEN) Reports Wider-than-Expected Loss in Q3","publication_date":"2016-10-28 15:35:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J2YfD1aMdOk/agenus-agen-reports-wider-than-expected-loss-in-q3-cm700168","summary":"Agenus Inc AGEN reported third quarter 2016 loss of 47 cents per share including non cash expenses wider than the Zacks Consensus Estimate of a loss of 32 cents as well as the loss of 16 cents in the prior year quarter Lower revenues and higher costs hurt earnings in the"},{"title":"United Therapeutics (UTHR) Beats Q3 Earnings, Sales Miss","publication_date":"2016-10-28 13:58:01 +0000","url":"http://finance.yahoo.com/news/united-therapeutics-uthr-beats-q3-135801925.html","summary":"United Therapeutics (UTHR) Beats Q3 Earnings, Sales Miss"},{"title":"McKesson (MCK) Misses on Q2 Earnings & Sales, Cuts View","publication_date":"2016-10-28 13:44:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2SMUsErOyl8/mckesson-mck-misses-on-q2-earnings-sales-cuts-view-cm700128","summary":"McKesson Corporation MCK reported second quarter fiscal 2017 ended Sep 30 2016 earnings of 2 94 per share missing the Zacks Consensus Estimate of 3 05 and declining from the year ago figure of 3 17 FindTheCompany Graphiq Revenues on the other hand improved 2 5 to"},{"title":"Aerie Pharmaceuticals (AERI) Q3 Earnings: Will It Beat?","publication_date":"2016-10-28 00:41:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XuyYRKP2Mog/aerie-pharmaceuticals-aeri-q3-earnings-will-it-beat-cm699913","summary":"We expect Aerie Pharmaceuticals Inc AERI to beat expectations when it reports third quarter earnings results on Nov 2 after market close However Aerie s performance over the last four quarters has been disappointing The company reported a wider than expected loss thrice in the four"},{"title":"AmerisourceBergen (ABC) Q3 Earnings: Will It Disappoint?","publication_date":"2016-10-27 16:46:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7R_ZQGx1XWs/amerisourcebergen-abc-q3-earnings-will-it-disappoint-cm699487","summary":"AmerisourceBergen Corporation ABC is set to report fourth quarter and fiscal 2016 results on Nov 2 before the opening bell AmerisourceBergen s track record has been quite impressive with the company comfortably beating estimates in three of the four trailing quarters In the last"},{"title":"Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2","publication_date":"2016-10-26 15:53:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GHhuVeh21MY/dr-reddys-rdy-earnings-revenues-decline-yy-in-q2-cm698533","summary":"Dr Reddy s Laboratories Ltd RDY reported second quarter fiscal 2017 earnings per American Depositary Share ADS of 27 cents down 57 1 year over year Moreover quarterly revenues declined 10 year over year to 539 million primarily due to lower contribution from all its"},{"title":"Inovio Stock Down on FDA Hold on VGX-3100 Phase III Study","publication_date":"2016-10-25 13:01:01 +0000","url":"http://finance.yahoo.com/news/inovio-stock-down-fda-hold-130101516.html","summary":"Inovio Stock Down on FDA Hold on VGX-3100 Phase III Study"},{"title":"What's Ahead for ImmunoGen (IMGN) This Earnings Season?","publication_date":"2016-10-24 23:24:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mrY-XIYS410/whats-ahead-for-immunogen-imgn-this-earnings-season-cm697521","summary":"ImmunoGen Inc IMGN is scheduled to report its results for the three months ended Sep 30 2016 on Oct 28 before the opening bell Note that ImmunoGen is transitioning to a fiscal year ending Dec 31 effective Jan 1 2017 ImmunoGen s track record has been disappointing so far with the"},{"title":"Alkermes Depression Candidate Positive in Phase III Study","publication_date":"2016-10-21 15:27:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bj_k-93xFEs/alkermes-depression-candidate-positive-in-phase-iii-study-cm696597","summary":"Alkermes plc ALKS announced positive top line data from the third phase III efficacy study FORWARD 5 Focused On Results With A Rethinking of Depression on its pipeline candidate ALKS 5461 The company is evaluating ALKS 5461 for the adjunctive treatment of major depressive disorder MDD"},{"title":"McKesson (MCK) Q2 Earnings: Stock Likely to Disappoint?","publication_date":"2016-10-21 14:04:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FfdIFEQGJvo/mckesson-mck-q2-earnings-stock-likely-to-disappoint-cm696488","summary":"McKesson Corporation MCK is scheduled to report second quarter fiscal 2017 results on Oct 27 after the market closes Last quarter the company delivered a positive earnings surprise of 4 48 Although the company has beaten estimates thrice in the last four quarters it has an"},{"title":"Alexion Graft-Versus-Host Disease Drug Wins Orphan Status","publication_date":"2016-10-20 17:27:20 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b4VrFi1OLFQ/alexion-graft-versus-host-disease-drug-wins-orphan-status-cm696084","summary":"Alexion Pharmaceuticals Inc ALXN announced that the FDA has granted orphan drug designation ODD to its pipeline candidate ALXN1007 for the treatment of acute graft versus host disease GVHD The FDA through its Office of Orphan Products Development grants this status to candidates"},{"title":"Novartis (NVS) Q3 Earnings: Stock to Beat Estimates Again?","publication_date":"2016-10-20 15:29:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GqlEdEiHZy8/novartis-nvs-q3-earnings-stock-to-beat-estimates-again-cm695944","summary":"Novartis AG NVS is scheduled to report third quarter 2016 results on Oct 25 In the last reported quarter it recorded a positive earnings surprise of 3 39 Overall Novartis has posted an average negative earnings surprise of 2 38 in the four trailing quarters Let s see how things"},{"title":"Vertex (VRTX) Q3 Earnings: What's in Store for the Stock?","publication_date":"2016-10-20 14:52:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JQ7hEh4CwZE/vertex-vrtx-q3-earnings-whats-in-store-for-the-stock-cm695825","summary":"Biotech company Vertex Pharmaceuticals VRTX will be reporting third quarter 2016 results on Oct 25 after the market closes Vertex s track record is mixed with the company delivering positive surprises in three of the last four quarters and missing expectations in one The average"},{"title":"ETF’s with exposure to Infinity Pharmaceuticals, Inc. : October 4, 2016","publication_date":"2016-10-04 14:00:14 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-infinity-pharmaceuticals-inc-october-4-2016/","summary":"ETF’s with exposure to Infinity Pharmaceuticals, Inc. : October 4, 2016"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement","publication_date":"2016-10-03 12:02:22 +0000","url":"http://biz.yahoo.com/e/161003/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement"},{"title":"Infinity Pharmaceuticals (INFI) Stock Rises on 'Favorable' Cancer Drug Trial Results","publication_date":"2016-09-27 17:26:00 +0000","url":"https://www.thestreet.com/story/13753759/1/infinity-pharmaceuticals-infi-stock-rises-on-favorable-cancer-drug-trial-results.html?puc=yahoo&cm_ven=YAHOO","summary":"Infinity Pharmaceuticals (INFI) Stock Rises on 'Favorable' Cancer Drug Trial Results"},{"title":"Infinity Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference","publication_date":"2016-09-26 21:15:00 +0000","url":"http://finance.yahoo.com/news/infinity-presents-initial-clinical-preclinical-211500093.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Sept. 26, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced initial clinical and new preclinical data for IPI-549, an orally administered immuno-oncology ..."},{"title":"Infinity Announces Publication On PI3K-Gamma In Nature","publication_date":"2016-09-19 15:48:03 +0000","url":"http://www.publicnow.com/view/0D240C2515E9C183997001D9A259DBB5E28C15C6","summary":"[at noodls] - CAMBRIDGE, Mass., Sept. 19, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the publication of new findings by research collaborators at University of California San ..."},{"title":"Infinity Announces Presentations On IPI-549 At Upcoming Immuno-Oncology Meeting","publication_date":"2016-09-06 12:45:00 +0000","url":"http://finance.yahoo.com/news/infinity-announces-presentations-ipi-549-124500402.html","summary":"[PR Newswire] - CAMBRIDGE, Mass., Sept. 6, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new preclinical data as well as early clinical data from an ongoing Phase 1 study will ..."},{"title":"Infinis plc announces first quarter results for year ending 31.03.17 £350m 7% Senior Notes due 2019","publication_date":"2016-08-25 09:18:07 +0000","url":"http://www.publicnow.com/view/9BEBF4E46176DC9D6DACD9B859AE0F5EC469E6E5","summary":"[at noodls] - £350 million 7% Senior Notes due 2019 Quarterly Results Announcement Infinis plc (the \"issuer\"), an indirectly wholly owned subsidiary of Infinis Energy Limited, announces its results for the ..."},{"title":"Call announcement Infinis plc 1st quarter results for the year ending 31 March 2017 £350m 7% Senior Notes due 2019","publication_date":"2016-08-24 09:48:07 +0000","url":"http://www.publicnow.com/view/0C8A114C623F1F9A2A49D32B29ECE73B25F07A57","summary":"[at noodls] - 18 August 2016 Quarterly Results Announcement £350m 7% Senior Notes due 2019 Infinis plc (the \"Issuer\"), an indirect wholly owned subsidiary of Infinis Energy Limited, will be announcing its ..."},{"title":"Edited Transcript of INFI earnings conference call or presentation 9-Aug-16 8:30pm GMT","publication_date":"2016-08-09 21:36:36 +0000","url":"http://finance.yahoo.com/news/edited-transcript-infi-earnings-conference-213636434.html","summary":"Edited Transcript of INFI earnings conference call or presentation 9-Aug-16 8:30pm GMT"},{"title":"Infinity beats 2Q profit forecasts","publication_date":"2016-08-09 21:13:36 +0000","url":"http://sg.finance.yahoo.com/news/infinity-beats-2q-profit-forecasts-211336894.html","summary":"Infinity beats 2Q profit forecasts"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement","publication_date":"2016-08-09 20:11:25 +0000","url":"http://biz.yahoo.com/e/160809/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement"},{"title":"Infinity Provides Company Update And Reports Second Quarter 2016 Financial Results","publication_date":"2016-08-09 20:10:03 +0000","url":"http://www.publicnow.com/view/D0E9C42A376741CA1AF86281802AB351DC2A55EB","summary":"[at noodls] - CAMBRIDGE, Mass., Aug. 9, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its second quarter 2016 financial results. Additionally, the company provided an update on its ..."},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-09 19:57:13 +0000","url":"http://biz.yahoo.com/e/160809/infi10-q.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report"},{"title":"Q2 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2016-08-09 11:07:01 +0000","url":"http://biz.yahoo.com/research/earncal/20160809.html?t=infi","summary":"Q2 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"3 Troubled Pharma Stocks That Could Rally Soon","publication_date":"2016-08-09 03:19:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ski-z_CXIQc/3-troubled-pharma-stocks-that-could-rally-soon-cm662194","summary":"Rocked by scandals and facing greater political scrutiny, the pharmaceutical industry faces one of its steepest challenges in recent memory. With a critical earnings test looming over the horizon, the"},{"title":"Infinity Announces The Date Of Its Second Quarter 2016 Financial Results Conference Call And Webcast","publication_date":"2016-08-02 13:01:03 +0000","url":"http://www.publicnow.com/view/75A178875F9818D484C95E2BCEDD501EFFF9DAB1","summary":"[at noodls] - CAMBRIDGE, Mass., Aug. 2, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 9, 2016, at 4:30 p.m. ET. During the call, management will review ..."},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-07-26 21:19:25 +0000","url":"http://biz.yahoo.com/e/160726/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"ETF’s with exposure to Infinity Pharmaceuticals, Inc. : July 18, 2016","publication_date":"2016-07-18 17:54:39 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-infinity-pharmaceuticals-inc-july-18-2016/","summary":"ETF’s with exposure to Infinity Pharmaceuticals, Inc. : July 18, 2016"},{"title":"Infinis plc £350m 7% Senior Notes due 2019 Announcement of annual results for the year ended 31 March 2016","publication_date":"2016-07-06 08:31:03 +0000","url":"http://www.publicnow.com/view/715CF0DBFAD20BB55F9BA3CD9A264145DE49F247","summary":"[at noodls] - 25e53bbd-1453-432f-8a3a-028769918e21.pdf £350 million 7% Senior Notes due 2019 Annual Results Announcement Infinis plc (the \"Issuer\"), an indirectly wholly owned subsidiary of Infinis Energy ..."},{"title":"Infinity Regains Duvelisib Rights, Announces Restructuring","publication_date":"2016-06-29 17:51:32 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Msk7z9oZdh0/infinity-regains-duvelisib-rights-announces-restructuring-cm642796","summary":"Infinity Pharmaceuticals, Inc.INFI announced that AbbVie Inc. ABBV has exercised its right to terminate the collaboration with the company for the development and commercialization of duvelisib. Both companies had entered into discussions related to the restructuring of the partnership,"},{"title":"Infinity Regains Duvelisib Rights, Announces Restructuring","publication_date":"2016-06-29 15:08:03 +0000","url":"http://finance.yahoo.com/news/infinity-regains-duvelisib-rights-announces-150803459.html","summary":"Infinity Regains Duvelisib Rights, Announces Restructuring"},{"title":"Call announcement Infinis plc annual results for the year ending 31 March 2016 £350m 7% Senior Notes due 2019","publication_date":"2016-06-29 12:21:12 +0000","url":"http://www.publicnow.com/view/9EC565B62A56C72E5228E2CFC1797848067E5CE6","summary":"[at noodls] - Fax transmission 29 June 2016 Annual Results Announcement £350 million 7% Senior Notes due 2019 Infinis plc (the \"Issuer\"), an indirectly wholly-owned subsidiary of Infinis Energy Limited (formerly ..."},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Costs Associated w","publication_date":"2016-06-28 12:22:41 +0000","url":"http://biz.yahoo.com/e/160628/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Costs Associated w"},{"title":"Infinity Regains Worldwide Rights To Duvelisib Following Mutual Agreement With AbbVie To End Collaboration","publication_date":"2016-06-28 11:11:05 +0000","url":"http://www.publicnow.com/view/3DD8FC0656FFC914B404E94F7329628B1DF3A0A9","summary":"[at noodls] - CAMBRIDGE, Mass., June 28, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that AbbVie Inc. has exercised its right to end its collaboration with Infinity to develop ..."},{"title":"7 Stocks Under $10 to Trade for Big Post-Brexit Gains","publication_date":"2016-06-26 13:31:00 +0000","url":"https://www.thestreet.com/story/13619971/1/7-stocks-under-10-to-trade-for-big-post-brexit-gains.html?puc=yahoo&cm_ven=YAHOO","summary":"7 Stocks Under $10 to Trade for Big Post-Brexit Gains"},{"title":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-22 20:44:17 +0000","url":"http://biz.yahoo.com/e/160622/infi8-k.html","summary":"INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"},{"title":"ETF’s with exposure to Infinity Pharmaceuticals, Inc. : June 20, 2016","publication_date":"2016-06-20 18:37:22 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-infinity-pharmaceuticals-inc-june-20-2016/","summary":"ETF’s with exposure to Infinity Pharmaceuticals, Inc. : June 20, 2016"},{"title":"6 Companies That Destroyed Shareholders Last Week","publication_date":"2016-06-19 14:15:41 +0000","url":"http://247wallst.com/investing/2016/06/19/6-companies-that-destroyed-shareholders-last-week-3/","summary":"6 Companies That Destroyed Shareholders Last Week"},{"title":"Lifshitz & Miller Law Firm Announces Investigation of CBL & Associates Properties, Inc., Eagle Pharmaceuticals, Inc., HCP, Inc., Immunomedics, Inc., Infinity Pharmaceuticals Inc., Neovasc, Inc., and Unilife Corporation","publication_date":"2016-06-17 23:09:00 +0000","url":"http://finance.yahoo.com/news/lifshitz-miller-law-firm-announces-230900210.html","summary":"[PR Newswire] - NEW YORK, June 17, 2016 /PRNewswire/ -- CBL & Associates Properties, Inc. (CBL) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the CBL board. Specifically, on ..."},{"title":"[$$] Infinity Pharmaceuticals' Disappointing Data","publication_date":"2016-06-16 10:01:00 +0000","url":"http://www.barrons.com/articles/infinity-pharmaceuticals-disappointing-data-1466071269?mod=yahoobarrons&ru=yahoo","summary":"[$$] Infinity Pharmaceuticals' Disappointing Data"},{"title":"Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Bob Evans Farms Shares Drop Following Weak Forecast","publication_date":"2016-06-15 19:48:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uAVOtV3Sy-0/mid-afternoon-market-update-fed-leaves-rates-unchanged-bob-evans-farms-shares-drop-following-weak-forecast-cm635992","summary":"Toward the end of trading Wednesday, the Dow traded up 0.37 percent to 17,740.63 while the NASDAQ climbed 0.35 percent to 4,860.48. The S&P also rose, gaining 0.41 percent to 2,083.90. Leading and Lagging Sectors"},{"title":"Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint","publication_date":"2016-06-15 19:30:00 +0000","url":"https://www.thestreet.com/story/13609117/1/infinity-pharmaceuticals-faces-downgrades-as-drug-results-disappoint.html?puc=yahoo&cm_ven=YAHOO","summary":"Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint"},{"title":"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Infinity Pharmaceuticals Inc. (INFI)","publication_date":"2016-06-15 18:32:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-183200277.html","summary":"[PR Newswire] - NEW YORK, June 15, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Infinity Pharmaceuticals ..."},{"title":"Infinity Pharmaceuticals Cannot Cure Downgrades After Drug Study","publication_date":"2016-06-15 17:30:00 +0000","url":"http://realmoney.thestreet.com/articles/06/15/2016/infinity-pharmaceuticals-cannot-cure-downgrades-after-drug-study?puc=yahoo&cm_ven=YAHOO","summary":"Infinity Pharmaceuticals Cannot Cure Downgrades After Drug Study"},{"title":"Infinity (INFI) at 52-Week Low on Disappointing Duvelisib Data","publication_date":"2016-06-15 16:09:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SptHCi-S5B4/infinity-infi-at-52-week-low-on-disappointing-duvelisib-data-cm635857","summary":"Infinity Pharmaceuticals, Inc. 's INFI shares plunged 69.2% to hit a new 52 week low, after the company announced unfavorable data from the phase II DYNAMO study on its lead candidate, duvelisib, for the treatment of refractory indolent non"},{"title":"6 Biopharma Movers Making a Run on Wednesday","publication_date":"2016-06-15 15:05:12 +0000","url":"http://247wallst.com/healthcare-business/2016/06/15/6-biopharma-movers-making-a-run-on-wednesday/","summary":"6 Biopharma Movers Making a Run on Wednesday"},{"title":"Infinity Pharmaceuticals (INFI) Stock Tanks on Lymphoma Drug Letdown","publication_date":"2016-06-15 03:08:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7cyJqkeN8tI/infinity-pharmaceuticals-infi-stock-tanks-on-lymphoma-drug-letdown-cm635577","summary":"Infinity Pharmaceuticals Inc.  (NASDAQ INFI ) shares took a nosedive as the company revealed new results of a drug trial. Source FlickrA Phase 2 trial of a non Hodgkin's lymphoma"},{"title":"CHMA Trims Workforce, INFI''s DYNAMO Disappoints, Marathon Joins DMD Race","publication_date":"2016-06-14 22:46:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/miHHQW-M88g/chma-trims-workforce-infis-dynamo-disappoints-marathon-joins-dmd-race-20160614-01112","summary":"CHMA Trims Workforce, INFI''s DYNAMO Disappoints, Marathon Joins DMD Race"},{"title":"CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race","publication_date":"2016-06-14 22:46:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fJX5lmZQdB0/chma-trims-workforce-infis-dynamo-disappoints-marathon-joins-dmd-race-20160614-01108","summary":"CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race"},{"title":"Mid-Afternoon Market Update: Crude Oil Down Over 1%; Motorcar Parts of America Shares Spike Higher","publication_date":"2016-06-14 20:18:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/64iqNyb_GYc/mid-afternoon-market-update-crude-oil-down-over-1-motorcar-parts-of-america-shares-spike-higher-cm635460","summary":"Toward the end of trading Tuesday, the Dow traded down 0.50 percent to 17,644.22 while the NASDAQ declined 0.40 percent to 4,829.18. The S&P also fell, dropping 0.42 percent to 2,070.42. Leading and Lagging Sectors On Tuesday, non cyclical"},{"title":"Why Infinity Pharmaceuticals Inc. Is Being Obliterated Today","publication_date":"2016-06-14 18:04:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kO-xgRGThmQ/why-infinity-pharmaceuticals-inc-is-being-obliterated-today-cm635323","summary":"Image source Getty Images. What Shareholders of the clinical stage biotech InfinityPharmaceuticals (NASDAQ INFI) are having a very rough day. The stock has collapsed, shedding more than 70% of its value"},{"title":"Mid-Day Market Update: Yingli Green Energy Surges Following Q1 Earnings; Infinity Pharmaceuticals Shares Tumble","publication_date":"2016-06-14 17:43:19 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mfYcmM8jUQ0/mid-day-market-update-yingli-green-energy-surges-following-q1-earnings-infinity-pharmaceuticals-shares-tumble-cm635355","summary":"Midway through trading Tuesday, the Dow traded down 0.52 percent to 17,640.81 while the NASDAQ declined 0.48 percent to 4,825.04. The S&P also fell, dropping 0.45 percent to 2,069.67. Leading and Lagging Sectors <b>On Tuesday, non cyclical consumer goods"},{"title":"Mid-Morning Market Update: Markets Mostly Lower; Isle of Capri Casinos Profit Beats Views","publication_date":"2016-06-14 15:28:19 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/79Db2BEFcZ0/mid-morning-market-update-markets-mostly-lower-isle-of-capri-casinos-profit-beats-views-cm635248","summary":"Following the market opening Tuesday, the Dow traded down 0.25 percent to 17,688.07 while the NASDAQ climbed 0.07 percent to 4,852.02. The S&P also fell, dropping 0.12 percent to 2,076.48. Leading and Lagging Sectors On"},{"title":"Infinity Reports Topline Results From DYNAMO™, A Phase 2 Monotherapy Study Of Investigational Molecule Duvelisib In Refractory Indolent Non-Hodgkin Lymphoma","publication_date":"2016-06-14 10:09:05 +0000","url":"http://www.publicnow.com/view/1F5DFEB5C11EA48CD88B972D56CFD224423DCC1F","summary":"[at noodls] - CAMBRIDGE, Mass., June 14, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that DYNAMO™, a registration-focused Phase 2 monotherapy study evaluating the efficacy and ..."},{"title":"Infinity Pharma To Close Down Discovery Research Organization - Quick Facts","publication_date":"2016-06-14 06:06:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DroofxSRSgE/infinity-pharma-to-close-down-discovery-research-organization--quick-facts-20160614-00134","summary":"Infinity Pharma To Close Down Discovery Research Organization - Quick Facts"},{"title":"Infinity Pharma To Close Down Discovery Research Organization - Quick Facts","publication_date":"2016-06-14 06:06:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dHrLefPXt0o/infinity-pharma-to-close-down-discovery-research-organization--quick-facts-20160614-00133","summary":"Infinity Pharma To Close Down Discovery Research Organization - Quick Facts"},{"title":"Infinity Announces Launch Of Disease Awareness Campaign For Hematologic Malignancies","publication_date":"2016-06-01 12:33:06 +0000","url":"http://www.publicnow.com/view/2EC18C962645089F364BAC95D4AD86DEDA0122DB","summary":"[at noodls] - CAMBRIDGE, Mass., June 1, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the launch of a mechanism of disease (MOD) awareness initiative designed to educate community ..."},{"title":"Infinity To Participate In Three June Investor Conferences","publication_date":"2016-05-31 20:23:07 +0000","url":"http://www.publicnow.com/view/C1FB4342F10E78A38D0E3AE24EC6E62E56502BA2","summary":"[at noodls] - CAMBRIDGE, Mass., May 31, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that management will present at the following investor conferences: Jefferies Healthcare Conference, ..."},{"title":"Infinis announces commercial operation of A'Chruach wind farm","publication_date":"2016-05-27 15:47:06 +0000","url":"http://www.publicnow.com/view/F8696E7CD0E78302E2630146335E81744393E1F0","summary":"[at noodls] - 9e92a847-1136-4311-857d-ad286901122e.pdf 27 May 2016 Infinis announces commercial operation of A'Chruach Wind Farm Infinis Energy (\"Infinis\"), the UK's leading independent generator of renewable ..."},{"title":"Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549, At Upcoming EHA And ASCO Meetings","publication_date":"2016-05-19 12:32:02 +0000","url":"http://www.publicnow.com/view/C0A5076D46EC22926596FCFD6B54BCCA577380E2","summary":"[at noodls] - CAMBRIDGE, Mass., May 19, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new data will be presented for duvelisib, an investigational, oral, dual inhibitor of phosphoinositide-3-kinase ..."},{"title":"Mid-Day Market Update: TETRA Technologies Drops Following Weak Results; Krispy Kreme Shares Spike Higher","publication_date":"2016-05-15 05:34:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TimV4oxrUVA/mid-day-market-update-tetra-technologies-drops-following-weak-results-krispy-kreme-shares-spike-higher-cm618396","summary":"Midway through trading Monday, the Dow traded down 0.23 percent to 17,699.06 while the NASDAQ climbed 0.36 percent to 4,753.37. The S&P also rose, gaining 0.07 percent to 2,058.52. Leading and Lagging Sectors On Monday,"},{"title":"Infinity reports 1Q loss","publication_date":"2016-05-04 21:51:44 +0000","url":"http://sg.finance.yahoo.com/news/infinity-reports-1q-loss-215144437.html","summary":"Infinity reports 1Q loss"},{"title":"Infinity Provides Company Update And Reports First Quarter 2016 Financial Results","publication_date":"2016-05-04 20:31:12 +0000","url":"http://www.publicnow.com/view/0739EAAB4A38EBBFE1D4588B53B62D24B17DE0A0","summary":"[at noodls] - CAMBRIDGE, Mass., May 4, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2016 financial results and ongoing progress with its pipeline, including duvelisib, ..."},{"title":"Infinity to Participate in Three May Investor Conferences","publication_date":"2016-04-27 12:11:49 +0000","url":"http://www.publicnow.com/view/D47CDE09BFF3BBE8D10EB635D6311392F6FD639F","summary":"[at noodls] - CAMBRIDGE, Mass., April 27, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that management will be participating at the following investor conferences: Deutsche Bank ..."},{"title":"Infinity Announces the Date of its First Quarter 2016 Financial Results Conference Call and Webcast","publication_date":"2016-04-20 12:21:06 +0000","url":"http://www.publicnow.com/view/5ED13EA56AA13FDDAA15E8FE9550D1E0E94B8AFA","summary":"[at noodls] - CAMBRIDGE, Mass., April 20, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Wednesday, May 4, 2016, at 4:30 p.m. ET. During the call, management will review ..."},{"title":"IPI-549 Alters the Immune-Suppressive Microenvironment and Enhances the Activity of Checkpoint Inhibitors in Preclinical Models","publication_date":"2016-04-18 12:32:02 +0000","url":"http://www.publicnow.com/view/9BF16E5A1F68323A75B865B6764E073B160F7EDD","summary":"[at noodls] - CAMBRIDGE, Mass., April 18, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced new preclinical data for IPI-549, an orally administered immuno-oncology development candidate ..."},{"title":"Mid-Morning Market Update: Markets Mixed; Monsanto Posts Lower Q2 Profit","publication_date":"2016-04-06 15:20:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yRZaV2NjGcI/mid-morning-market-update-markets-mixed-monsanto-posts-lower-q2-profit-cm602482","summary":"Following the market opening Wednesday, the Dow traded down 0.21 percent to 17,566.62 while the NASDAQ gained 0.19 percent to 4,853.17. The S&P also fell, dropping 0.08 percent to 2,043.64. Leading and Lagging Sectors On"},{"title":"Look Under The Hood: IBB Has 56% Upside","publication_date":"2016-03-24 13:13:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-JdeSiRzMtQ/look-under-the-hood-ibb-has-56-upside-cm597260","summary":"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"},{"title":"Mid-Day Market Update: Mattress Firm Drops Following Weak Results; NQ Mobile Shares Surge","publication_date":"2016-03-22 17:31:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NJgTKOyXibU/mid-day-market-update-mattress-firm-drops-following-weak-results-nq-mobile-shares-surge-cm596495","summary":"Midway through trading Tuesday, the Dow traded down 0.18 percent to 17,591.44 while the NASDAQ gained 0.04 percent to 4,810.66. The S&P also fell, dropping 0.16 percent to 2,048.42. Leading and Lagging Sectors Tuesday morning,"},{"title":"Health Care Sector Update for 03/02/2016: EYEG, INFI","publication_date":"2016-03-02 14:51:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MefU6x9JwqQ/health-care-sector-update-for-03022016-eyeg-infi-cm587202","summary":"Top Health care stocks JNJ 0.5% PFE +0.2% ABT flat MRK flat AMGN flat Health care shares were mainly unchanged in pre market trade on Wednesday. In health care stocks news, Eyegate Pharmaceuticals ( EYEG ) has received an"},{"title":"Infinity (INFI) Q4 Loss Narrower than Expected, Revenues Lag","publication_date":"2016-02-24 18:26:17 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m7MrH0afOCQ/infinity-infi-q4-loss-narrower-than-expected-revenues-lag-cm584200","summary":"Infinity Pharmaceuticals, Inc.INFI reported a loss of 80 cents per share in the fourth quarter of 20Array5, narrower than both the Zacks Consensus Estimate and the year ago loss of 83 cents. Infinity Pharmaceuticals Inc. (INFI) Street EPS &"},{"title":"Infinity reports 4Q loss","publication_date":"2016-02-23 22:05:34 +0000","url":"http://sg.finance.yahoo.com/news/infinity-reports-4q-loss-220534504.html","summary":"Infinity reports 4Q loss"},{"title":"Infinity Provides Key 2016 Goals and Financial Guidance","publication_date":"2016-01-11 13:18:05 +0000","url":"http://www.noodls.com/view/17688A85D27E26472A8ABA442B310BDDC3F0567F","summary":"[at noodls] - , /PRNewswire/ -- (NASDAQ: INFI) today outlined 2016 anticipated milestones for duvelisib, an oral, dual inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, and provided financial guidance ..."},{"title":"Infinity to Present at J.P. Morgan Annual Healthcare Conference","publication_date":"2016-01-06 13:22:11 +0000","url":"http://www.noodls.com/view/4A6EA3EF0B54D22C79441E566E0D58213A3F4AA7","summary":"[at noodls] - , /PRNewswire/ -- (NASDAQ: INFI) will be presenting at the J.P. Morgan 34 Annual Healthcare Conference on , at () in A live webcast of this Infinity presentation will be accessible on the Investors/Media ..."},{"title":"Medidata's Risk-Based Monitoring Solution Selected by Infinity Pharmaceuticals to Advance Oncology Research","publication_date":"2015-11-23 22:33:17 +0000","url":"http://www.noodls.com/view/38AD170A02A7408AE146C3388F670BE0E669ABCF","summary":"[at noodls] - Increased Adoption of the Medidata Clinical Cloud ® Enables Safer, Faster and More Insightful Clinical Trials NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based ..."},{"title":"Infinis Energy plc Half Year Financial Results for 6 months ended 30 September 2015","publication_date":"2015-11-12 08:56:06 +0000","url":"http://www.noodls.com/view/5B1327265D14A794CA845ABC1B880AC4A7851BE9","summary":"[at noodls] - 057f047a-cfe5-42a1-9094-540d4b0e6e12.pdf Infinis Energy plc (Symbol: INFI) Half Year Financial Results For the six months ended 30 September 2015 Constructing capacity, delivering clean and affordable ..."},{"title":"Infinity beats Street 3Q forecasts","publication_date":"2015-11-05 22:51:31 +0000","url":"http://sg.finance.yahoo.com/news/infinity-beats-street-3q-forecasts-225131571.html","summary":"Infinity beats Street 3Q forecasts"},{"title":"Infinity Provides Company Update And Reports Third Quarter 2015 Financial Results","publication_date":"2015-11-05 21:22:19 +0000","url":"http://www.noodls.com/view/345B7D96A11A5654DC590BAAE8A2044303E9ADC5","summary":"[at noodls] - Infinity Provides Company Update And Reports Third Quarter 2015 Financial Results"},{"title":"Infinity Announces The Date Of Its Third Quarter 2015 Financial Results Conference Call And Webcast","publication_date":"2015-10-28 12:07:06 +0000","url":"http://www.noodls.com/view/C8735910D5A89D36D1F1BD5ED0C8E0351090A927","summary":"[at noodls] - Infinity Announces The Date Of Its Third Quarter 2015 Financial Results Conference Call And Webcast"},{"title":"Infinity reports 2Q loss","publication_date":"2015-08-06 12:57:44 +0000","url":"http://sg.finance.yahoo.com/news/infinity-reports-2q-loss-125744924.html","summary":"Infinity reports 2Q loss"},{"title":"Ahead of the Bell: Infinity Pharmaceuticals shares slide","publication_date":"2015-01-08 13:22:21 +0000","url":"http://sg.finance.yahoo.com/news/ahead-bell-infinity-pharmaceuticals-shares-132221551.html","summary":"Ahead of the Bell: Infinity Pharmaceuticals shares slide"},{"title":"Infinity beats 3Q profit forecasts","publication_date":"2014-11-06 22:54:34 +0000","url":"http://sg.finance.yahoo.com/news/infinity-beats-3q-profit-forecasts-225434673--finance.html","summary":"Infinity beats 3Q profit forecasts"}],"result_count":214,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1490816603,"trigger": "MARK AT OR ABOVE 3.60","triggerPrice":3.60,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"3.24"},{"x":"1490967300","y":"3.22"},{"x":"1490967600","y":"3.19"},{"x":"1490967900","y":"3.204"},{"x":"1490968200","y":"3.19"},{"x":"1490968500","y":"3.1968"},{"x":"1490968800","y":"3.2003"},{"x":"1490969100","y":"3.19"},{"x":"1490969400","y":"3.1677"},{"x":"1490969700","y":"3.14"},{"x":"1490970000","y":"3.1399"},{"x":"1490970300","y":"3.18"},{"x":"1490970600","y":"3.18"},{"x":"1490970900","y":"3.17"},{"x":"1490971200","y":"3.16"},{"x":"1490971500","y":"3.17"},{"x":"1490971800","y":"3.2"},{"x":"1490972100","y":"3.185"},{"x":"1490972400","y":"3.17"},{"x":"1490972700","y":"3.1699"},{"x":"1490973000","y":"3.16"},{"x":"1490973300","y":"3.17"},{"x":"1490973600","y":"3.17"},{"x":"1490973900","y":"3.17"},{"x":"1490974200","y":"3.17"},{"x":"1490974500","y":"3.1792"},{"x":"1490974800","y":"3.19"},{"x":"1490975100","y":"3.195"},{"x":"1490975400","y":"3.194"},{"x":"1490975700","y":"3.195"},{"x":"1490976000","y":"3.2"},{"x":"1490976300","y":"3.19"},{"x":"1490976600","y":"3.195"},{"x":"1490976900","y":"3.2099"},{"x":"1490977200","y":"3.22"},{"x":"1490977500","y":"3.2153"},{"x":"1490977800","y":"3.24"},{"x":"1490978100","y":"3.25"},{"x":"1490978400","y":"3.245"},{"x":"1490978700","y":"3.245"},{"x":"1490979000","y":"3.235"},{"x":"1490979300","y":"3.22"},{"x":"1490979600","y":"3.225"},{"x":"1490979900","y":"3.23"},{"x":"1490980200","y":"3.225"},{"x":"1490980500","y":"3.23"},{"x":"1490980800","y":"3.225"},{"x":"1490981100","y":"3.225"},{"x":"1490981400","y":"3.23"},{"x":"1490981700","y":"3.231"},{"x":"1490982000","y":"3.24"},{"x":"1490982300","y":"3.24"},{"x":"1490982600","y":"3.23"},{"x":"1490982900","y":"3.25"},{"x":"1490983200","y":"3.245"},{"x":"1490983500","y":"3.2409"},{"x":"1490983800","y":"3.195"},{"x":"1490984100","y":"3.215"},{"x":"1490984400","y":"3.215"},{"x":"1490984700","y":"3.21"},{"x":"1490985000","y":"3.215"},{"x":"1490985300","y":"3.215"},{"x":"1490985600","y":"3.19"},{"x":"1490985900","y":"3.19"},{"x":"1490986200","y":"3.2"},{"x":"1490986500","y":"3.2"},{"x":"1490986800","y":"3.23"},{"x":"1490987100","y":"3.224"},{"x":"1490987400","y":"3.24"},{"x":"1490987700","y":"3.22"},{"x":"1490988000","y":"3.23"},{"x":"1490988300","y":"3.23"},{"x":"1490988600","y":"3.225"},{"x":"1490988900","y":"3.225"},{"x":"1490989200","y":"3.22"},{"x":"1490989500","y":"3.22"},{"x":"1490989800","y":"3.235"},{"x":"1490990100","y":"3.23"},{"x":"1490990400","y":"3.23"},{"x":"1490991000","y":"3.23"},{"x":"1490991600","y":"3.15"} ], "color":"#03a9f4"}]},
{"id":"7","list":"Alerts","symbol": "MAGS","name": "Magal Security Systems Ltd","price": 7.52,"dollarChange": -0.05,"percentChange": -0.53,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/MAGS-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/MAGS-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/MAGS-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/MAGS-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/MAGS-1yr.php","open": 7.57,"high": 7.71,"low":7.33,"volume": 149700,"avgVol": 228769.700000,"sharesShort": 431580,"shortPercent": 1.882832,"marketCap": 104978829,"float": 22921848,"headlines":{"data":[{"title":"Carpe Diem for Dip Buying","publication_date":"2017-03-29 20:12:00 +0000","url":"http://realmoney.thestreet.com/articles/03/29/2017/carpe-diem-dip-buying?puc=yahoo&cm_ven=YAHOO","summary":"Carpe Diem for Dip Buying"},{"title":"Magal Security Systems Announces Filing of 2016 Annual Report","publication_date":"2017-03-29 19:30:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-announces-filing-193000925.html","summary":"[PR Newswire] - YEHUD, Israel, March 29, 2017 /PRNewswire/ -- Magal Security Systems Ltd. (Magal (NASDAQ: MAGS)) today announced that earlier today it filed its annual report containing audited consolidated financial ..."},{"title":"Magal posts 4Q profit","publication_date":"2017-03-29 11:44:27 +0000","url":"http://sg.finance.yahoo.com/news/magal-posts-4q-profit-114427250.html","summary":"Magal posts 4Q profit"},{"title":"7:31 am Magal Security reports Q4 EPS of $0.13 vs. $0.15 in prior year period; revs rose 5% YoY to $20.3 mln - no estimates","publication_date":"2017-03-29 11:31:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#mags","summary":"7:31 am Magal Security reports Q4 EPS of $0.13 vs. $0.15 in prior year period; revs rose 5% YoY to $20.3 mln - no estimates"},{"title":"Magal Security Systems Ltd. Reports Fourth Quarter & Full Year 2016 Financial Results","publication_date":"2017-03-29 11:30:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-ltd-reports-113000398.html","summary":"[PR Newswire] - YEHUD, Israel, March 29, 2017 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results for the three month and full year period ended December 31, 2016. Management ..."},{"title":"Q4 2016 Magal Security Systems Ltd Earnings Release - Time Not Supplied","publication_date":"2017-03-29 11:07:03 +0000","url":"http://biz.yahoo.com/research/earncal/20170329.html?t=mags","summary":"Q4 2016 Magal Security Systems Ltd Earnings Release - Time Not Supplied"},{"title":"Magal-S3 RoboGuard® System Receives First Serial Order from Israeli Governmental Customer","publication_date":"2017-03-21 12:53:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-roboguard-system-receives-125300841.html","summary":"[PR Newswire] - Magal Security Systems Ltd. (MAGS) today announced that it received its first serial order for its revolutionary RoboGuard® system. The customer, which is an Israeli governmental customer, recently announced the RoboGuard® system to be operational. The announcement followed a series of rigorous in-the-field tests and ongoing inspections, conducted by the customer."},{"title":"Magal Security Systems Ltd. to Release Fourth Quarter and Full Year 2016 Results on Wednesday, March 29, 2017","publication_date":"2017-03-13 13:00:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-ltd-release-130000706.html","summary":"[PR Newswire] - YEHUD, Israel, March 13, 2017 /PRNewswire/ -- Magal Security Systems Ltd. (NASDAQ: MAGS) today announced that it intends to publish its fourth quarter and full year 2016 results on Wednesday, March 29, ..."},{"title":"Mid-Afternoon Market Update: Dow Surges Over 100 Points; Eyegate Pharmaceuticals Shares Spike Higher","publication_date":"2017-02-21 20:56:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ue0tQUpCVm4/mid-afternoon-market-update-dow-surges-over-100-points-eyegate-pharmaceuticals-shares-spike-higher-cm750890","summary":"Toward the end of trading Tuesday the Dow traded up 0 50 percent to 20 727 45 while the NASDAQ gained 0 30 percent to 5 856 03 The S amp P also rose gaining 0 50 percent to 2 362 95 Leading and Lagging Sectors Energy shares climbed by 1 10 percent in trading on Tuesday"},{"title":"Magal Wins $8.5 Million in New Orders for Innovative Border Protection Solutions in Israel","publication_date":"2017-02-06 16:11:00 +0000","url":"http://finance.yahoo.com/news/magal-wins-8-5-million-161100398.html","summary":"[PR Newswire] - Magal Security Systems Ltd. (MAGS) today announced it has recently won a series of purchase orders amounting to over $8.5 million. The orders include the supply, integration and support of new innovative border and perimeter protection solutions to the Israeli Ministry of Defence (IMOD). Commented Saar Koursh, CEO of Magal, \"We are happy to have been selected by the Israeli Ministry of Defence, for the supply and integration of border and perimeter security technology."},{"title":"Israel’s Magal Seeks Mexico Wall Deal as Trump Buoys Shares","publication_date":"2017-01-29 14:21:10 +0000","url":"http://www.bloomberg.com/news/articles/2017-01-29/israel-s-magal-pushes-for-mexico-wall-deal-as-trump-buoys-shares?cmpid=yhoo.headline","summary":"Israel’s Magal Seeks Mexico Wall Deal as Trump Buoys Shares"},{"title":"Israel’s Magal Pushes for Mexico Wall Deal as Trump Buoys Shares","publication_date":"2017-01-29 14:21:10 +0000","url":"http://finance.yahoo.com/news/israel-magal-pushes-mexico-wall-142110774.html","summary":"Israel’s Magal Pushes for Mexico Wall Deal as Trump Buoys Shares"},{"title":"Magal Wins $5.5 Million in New Projects for Integrated Security Systems","publication_date":"2017-01-12 13:00:00 +0000","url":"http://finance.yahoo.com/news/magal-wins-5-5-million-130000318.html","summary":"[PR Newswire] - Magal Security Systems Ltd. (MAGS) today announced it has recently won a series of projects, amounting to over $5.5 million. The projects include the upgrade and support of the integrated security systems for the 2017 African Cup of Nations Games. Magal originally provided the current systems to the games committee for the 2012 games."},{"title":"Is Galena Biopharma Inc (GALE) a Good Stock to Buy?","publication_date":"2016-12-14 18:18:44 +0000","url":"http://www.insidermonkey.com/blog/is-galena-biopharma-inc-gale-a-good-stock-to-buy-2-508846/","summary":"Is Galena Biopharma Inc (GALE) a Good Stock to Buy?"},{"title":"Magal Security Systems Ltd. :MAGS-US: Earnings Analysis: Q3, 2016 By the Numbers : December 2, 2016","publication_date":"2016-12-02 14:45:17 +0000","url":"http://www.capitalcube.com/blog/index.php/magal-security-systems-ltd-mags-us-earnings-analysis-q3-2016-by-the-numbers-december-2-2016/","summary":"Magal Security Systems Ltd. :MAGS-US: Earnings Analysis: Q3, 2016 By the Numbers : December 2, 2016"},{"title":"Magal posts 3Q profit","publication_date":"2016-11-29 14:31:36 +0000","url":"http://sg.finance.yahoo.com/news/magal-posts-3q-profit-143136956.html","summary":"Magal posts 3Q profit"},{"title":"Magal Security Systems Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-29 14:24:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-reports-third-142400784.html","summary":"[PR Newswire] - YEHUD, Israel, Nov. 29, 2016 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results for the three and nine months periods ended September 30, 2016. Management ..."},{"title":"Magal's North American Subsidiary Delivers Security Systems to Secure NATO's Rapidly Deployable Military Camps","publication_date":"2016-11-28 13:00:00 +0000","url":"http://finance.yahoo.com/news/magals-north-american-subsidiary-delivers-130000169.html","summary":"[PR Newswire] - Magal Security Systems Ltd. (MAGS) announced today that Senstar its North American subsidiary, successfully delivered to the North Atlantic Treaty Organization (NATO) , a perimeter electronic security systems (ESS) for its rapidly deployable military camps used throughout the world. NATO has complete military camps that can be rapidly deployed when and where they are needed. Commented Saar Koursh, CEO of Magal, \"We are very pleased with our successful delivery of these important systems to NATO and we look forward to working closely with NATO personnel in the coming weeks as we train them on our systems."},{"title":"Trump's Mexican wall a boon for Israeli security company","publication_date":"2016-11-24 06:17:50 +0000","url":"http://finance.yahoo.com/news/trumps-mexican-wall-boon-israeli-061743532.html","summary":"Trump's Mexican wall a boon for Israeli security company"},{"title":"[$$] Israel's Magal sees Mexican wall as no barrier to business","publication_date":"2016-11-17 14:40:13 +0000","url":"http://www.ft.com/cms/s/12b46246-abf2-11e6-9cb3-bb8207902122,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","summary":"[$$] Israel's Magal sees Mexican wall as no barrier to business"},{"title":"Magal S3 to Release Third Quarter 2016 Results on Tuesday, November 29, 2016","publication_date":"2016-11-15 13:00:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-release-third-quarter-130000089.html","summary":"[PR Newswire] - YAHUD, Israel, November 15, 2016 /PRNewswire/ -- Magal S 3 (NASDAQ G MS: MAGS, TASE: MAGS) today announced that it intends to publish its third quarter 2016 results on Tuesday, November 29, 2016. The Company ..."},{"title":"Magal S3 to Release Third Quarter 2016 Results More >>","publication_date":"2016-11-15 09:48:08 +0000","url":"http://www.publicnow.com/view/9A887D877E2F79577B4D260B4AE92D3A7C2C91E5","summary":"[at noodls] - FOR IMMEDIATE RELEASE Magal S to Release Third Quarter 2016 Results on Tuesday, November 29, 2016 YAHUD, ISRAEL, November 15, 2016 -- Magal S (NASDAQ GMS: MAGS, TASE: MAGS) today announced that it intends ..."},{"title":"Magal Announces Release of its new Video Management Software More >>","publication_date":"2016-10-31 14:53:08 +0000","url":"http://www.publicnow.com/view/E18772D71C4CF46530C71B77A0AD0A2795866A92","summary":"[at noodls] - 17 Altalef St. PO Box 70, Yehud Industrial Zone 56100, Israel Magal Announces Release of its new Video Management Software & Expansion of its Sales Team into the United States Yehud, Israel - October 11, ..."},{"title":"Magal Announces Release of its New Video Management Software & Expansion of its Sales Team into the United States","publication_date":"2016-10-18 12:00:00 +0000","url":"http://finance.yahoo.com/news/magal-announces-release-video-management-120000108.html","summary":"[PR Newswire] - Magal Security Systems Ltd. (MAGS) announced the release the latest version of its VMS (video management software) known as Aimetis Symphony 7. The Aimetis Symphony 7 is an all-in-one solution for video management, analytics and alarm management, offering seamless integration for video surveillance deployments of all sizes. Commented Saar Koursh, CEO of Magal, \"With the release of Aimetis Symphony 7, it is clear there is no better, well rounded VMS on the market today."},{"title":"Magal Announces Successful Conclusion of Oversubscribed Rights Offering More >>","publication_date":"2016-10-06 07:19:05 +0000","url":"http://www.publicnow.com/view/6961225B846AB57AB28A624AEB035356129B92F7","summary":"[at noodls] - YEHUD, Israel, October 5, 2016 /PRNewswire/ -- Magal Security Systems Ltd. (MAGS) announced the successful completion of its oversubscribed rights offering to shareholders. Magal will receive gross proceeds ..."},{"title":"Magal Announces Successful Conclusion of Oversubscribed Rights Offering","publication_date":"2016-10-05 20:01:00 +0000","url":"http://finance.yahoo.com/news/magal-announces-successful-conclusion-oversubscribed-200100614.html","summary":"[PR Newswire] - Commented Saar Koursh, CEO of Magal, \"We are pleased with the results of the offering which, due to strong investor demand, was oversubscribed. Magal has filed a Registration Statement on Form F-1, which has been declared effective by the Securities and Exchange Commission, and the rights offering is being effected by means of a prospectus forming part of such registration statement."},{"title":"Magal Announces Appointment of Kobi Vinokur as Chief Financial Officer More >>","publication_date":"2016-09-14 14:08:08 +0000","url":"http://www.publicnow.com/view/A8AAC5709F3B681AAA4606621A053C7D9BCE2539","summary":"[at noodls] - YEHUD, Israel, September 6, 2016 /PRNewswire/ -- Magal Security Systems Ltd. (MAGS) announced today that Mr. Kobi Vinokur has been appointed as CFO of the Company. Mr. Vinokur will replace Mr. Ilan Ovadia, ..."},{"title":"Magal Announces Commencement of Rights Offering More >>","publication_date":"2016-09-12 13:58:03 +0000","url":"http://www.publicnow.com/view/A3C6A7326E50C66FD3A7BDA77C833EC98DB25D0E","summary":"[at noodls] - Magal Announces Commencement of Rights Offering Yehud, Israel - September 7, 2016 - Magal Security Systems Ltd. (NASDAQ: MAGS) announced today that it has commenced a rights offering for approximate gross ..."},{"title":"Magal Announces Commencement of Rights Offering","publication_date":"2016-09-07 20:26:00 +0000","url":"http://finance.yahoo.com/news/magal-announces-commencement-rights-offering-202600428.html","summary":"[PR Newswire] - Magal Security Systems Ltd. (MAGS) announced today that it has commenced a rights offering for approximate gross proceeds of $24 million. Magal has granted, at no charge to the holders of record of its Ordinary Shares, par value NIS 1.00 per share, as of 5:00 p.m., New York City time, on September 9, 2016, the record date for the rights offering, one non-transferable subscription right for each eight (8) Ordinary Shares owned. Each subscription right entitles the holder to purchase three (3) Ordinary Shares at a subscription price of $11.58 (reflecting a price of $3.86 per Ordinary Share)."},{"title":"Magal Security Systems Names Kobi Vinokur CFO","publication_date":"2016-09-06 23:26:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jAi3UDfhN8I/magal-security-systems-names-kobi-vinokur-cfo-20160906-01410","summary":"Magal Security Systems Names Kobi Vinokur CFO"},{"title":"Magal Announces Appointment of Kobi Vinokur as Chief Financial Officer","publication_date":"2016-09-06 20:27:00 +0000","url":"http://finance.yahoo.com/news/magal-announces-appointment-kobi-vinokur-202700844.html","summary":"[PR Newswire] - YEHUD, Israel, September 6, 2016 /PRNewswire/ -- Magal Security Systems Ltd. (NASDAQ: MAGS) announced today that Mr. Kobi Vinokur has been appointed as CFO of the Company. Mr. Vinokur will replace Mr. ..."},{"title":"Magal Security Systems Reports Second Quarter 2016 Financial Results More >>","publication_date":"2016-08-31 11:53:06 +0000","url":"http://www.publicnow.com/view/1CD16B803F38BFEDA11CEC3016681BEE3C1A3A33","summary":"[at noodls] - FOR IMMEDIATE RELEASE Magal Security Systems Reports Second Quarter 2016 Financial Results YEHUD, ISRAEL, August 31, 2016 -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results ..."},{"title":"Q2 2016 Magal Security Systems Ltd Earnings Release - Time Not Supplied","publication_date":"2016-08-31 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20160831.html?t=mags","summary":"Q2 2016 Magal Security Systems Ltd Earnings Release - Time Not Supplied"},{"title":"Magal reports 2Q loss","publication_date":"2016-08-31 10:58:47 +0000","url":"http://sg.finance.yahoo.com/news/magal-reports-2q-loss-105847128.html","summary":"Magal reports 2Q loss"},{"title":"Magal Security Systems Reports Second Quarter 2016 Financial Results","publication_date":"2016-08-31 10:48:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-reports-second-104800957.html","summary":"[PR Newswire] - YEHUD, Israel, Aug. 31, 2016 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results for the three and six month period ended June 30, 2016. Management will hold ..."},{"title":"Magal Security Systems Reports Second Quarter 2016 Financial Results More >>","publication_date":"2016-08-08 10:08:05 +0000","url":"http://www.publicnow.com/view/7C79DA4CEA7F68E7EC41C631DF9BEBD2EC8F3CD0","summary":"[at noodls] - FOR IMMEDIATE RELEASE Magal S to Release Second Quarter 2016 Results on Wednesday, August 31, 2016 YAHUD, ISRAEL, August 8, 2016 -- Magal S (NASDAQ GMS: MAGS, TASE: MAGS) today announced that it intends ..."},{"title":"Magal S3 to Release Second Quarter 2016 Results on Wednesday, August 31, 2016","publication_date":"2016-08-08 10:00:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-release-second-quarter-100000625.html","summary":"[PR Newswire] - YAHUD, Israel, August 8, 2016 /PRNewswire/ -- Magal S 3 (NASDAQ G MS: MAGS, TASE: MAGS) today announced that it intends to publish its second quarter 2016 results on Wednesday, August 31, 2016. The Company ..."},{"title":"The Israeli Company That Fenced in Gaza Eyes Trump's Mexico Wall","publication_date":"2016-08-01 21:00:01 +0000","url":"http://www.bloomberg.com/news/articles/2016-08-01/israel-s-magal-eyes-trump-wall-boasting-gaza-tested-smart-fence?cmpid=yhoo.headline","summary":"The Israeli Company That Fenced in Gaza Eyes Trump's Mexico Wall"},{"title":"Magal Awarded Large Framework Contract to Secure the City of Holon","publication_date":"2016-08-01 10:00:00 +0000","url":"http://finance.yahoo.com/news/magal-awarded-large-framework-contract-100000748.html","summary":"Magal Awarded Large Framework Contract to Secure the City of Holon"},{"title":"Magal Awarded Large Framework Contract More >>","publication_date":"2016-08-01 09:11:03 +0000","url":"http://www.publicnow.com/view/B9403D6BCE9F96237A313C89FD41F2DEFA36D983","summary":"[at noodls] - Magal S is a leading international provider of cyber and physical security, safety & site management solutions and products (NASDAQ: MAGS ). ... This is an abstract of the original noodl. To continue reading ..."},{"title":"Magal Security Systems Reports First Quarter 2016 Financial Results More >>","publication_date":"2016-06-06 11:48:10 +0000","url":"http://www.publicnow.com/view/90134B09B50E5B901302DC6473E82FD6FFED0950","summary":"[at noodls] - FOR IMMEDIATE RELEASE MAGAL SECURITY SYSTEMS REPORTS FIRST QUARTER 2016 FINANCIAL RESULTS YEHUD, ISRAEL, May 31, 2016 -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results ..."},{"title":"Magal Security Systems Ltd. :MAGS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016","publication_date":"2016-06-03 14:56:53 +0000","url":"http://www.capitalcube.com/blog/index.php/magal-security-systems-ltd-mags-us-earnings-analysis-q1-2016-by-the-numbers-june-3-2016/","summary":"Magal Security Systems Ltd. :MAGS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016"},{"title":"Magal reports 1Q loss","publication_date":"2016-05-31 11:36:29 +0000","url":"http://sg.finance.yahoo.com/news/magal-reports-1q-loss-113629784.html","summary":"Magal reports 1Q loss"},{"title":"Magal Security Systems Reports First Quarter 2016 Financial Results","publication_date":"2016-05-31 11:28:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-reports-first-112800043.html","summary":"[PR Newswire] - YEHUD, Israel, May 31, 2016 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results for the three month period ended March 31, 2016. Management will hold an investors' ..."},{"title":"Q1 2016 Magal Security Systems Ltd Earnings Release - Time Not Supplied","publication_date":"2016-05-31 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20160531.html?t=mags","summary":"Q1 2016 Magal Security Systems Ltd Earnings Release - Time Not Supplied"},{"title":"Magal Wins a $9 Million Oorder To Secure Two Prisons In West Africa More >>","publication_date":"2016-05-24 11:36:06 +0000","url":"http://www.publicnow.com/view/EFD27DEF7C57C98FF48232DC162C78A15F9A6349","summary":"[at noodls] - FOR IMMEDIATE RELEASE PRESS RELEASE MAGAL WINS A $9 MILLION ORDER TO SECURE TWO PRISONS IN WEST AFRICA YAHUD, Israel - May 24, 2016 - Magal Security Systems, Ltd. (NASDAQ: MAGS) announced today it has ..."},{"title":"Magal Wins a $9 Million Order to Secure Two Prisons in West Africa","publication_date":"2016-05-24 10:00:00 +0000","url":"http://finance.yahoo.com/news/magal-wins-9-million-order-100000659.html","summary":"[PR Newswire] - YAHUD, Israel, May 24, 2016 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ: MAGS) announced today it has received an order of $9 million for complete turnkey security solutions, protecting two newly ..."},{"title":"Magal S3 to Release First Quarter 2016 Results on Tuesday, May 31, 2016","publication_date":"2016-05-23 10:56:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-release-first-quarter-105600260.html","summary":"[PR Newswire] - YAHUD, Israel, May 23, 2016 /PRNewswire/ -- Magal S 3 (NASDAQ G MS: MAGS, TASE: MAGS) today announced that it intends to publish its first quarter 2016 results on Tuesday, May 31, 2016. The Company will ..."},{"title":"Magal Wins $10 Million in Orders to Secure and Maintain Critical Power Utility Sites in LatAm","publication_date":"2016-05-10 10:53:00 +0000","url":"http://finance.yahoo.com/news/magal-wins-10-million-orders-105300154.html","summary":"Magal Wins $10 Million in Orders to Secure and Maintain Critical Power Utility Sites in LatAm"},{"title":"Magal Wins $10 Million in Orders to Secure and Maintain Critical Power Utility Sites in LATAM More >>","publication_date":"2016-05-10 09:58:02 +0000","url":"http://www.publicnow.com/view/CB322A048596A4CAF5C3018C4BAE82B0E86B8B8A","summary":"[at noodls] - FOR IMMEDIATE RELEASE PRESS RELEASE MAGAL WINS $10 MILLION IN ORDERS TO SECURE AND MAINTAIN CRITICAL POWER UTILITY SITES IN LATAM YAHUD, Israel - May 10, 2016 - Magal Security Systems, Ltd. (NASDAQ: MAGS) ..."},{"title":"MAGAL SECURITY SYSTEMS LTD Financials","publication_date":"2016-04-01 17:04:27 +0000","url":"http://finance.yahoo.com/q/is?s=mags&annual","summary":"MAGAL SECURITY SYSTEMS LTD Financials"},{"title":"Magal S3 Acquires Aimetis Corp – Global Leaders In VMS Software More >>","publication_date":"2016-04-01 16:55:04 +0000","url":"http://www.publicnow.com/view/FACAAA3656E5F0F7C3A95BB8951DEA812C02098A","summary":"[at noodls] - PRESS RELEASE MAGAL S3 ACQUIRES AIMETIS CORP - A GLOBAL LEADER IN VMS SOFTWARE - DIVERSIFYING AND EXPANDING ITS PRODUCT PORTFOLIO YEHUD, Israel - April 1st, 2016 -- Magal Security Systems, Ltd. (NASDAQ ..."},{"title":"Magal S3 Acquires Aimetis Corp - a Global Leader in VMS Software: Diversifying and Expanding Its Product Portfolio","publication_date":"2016-04-01 16:45:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-acquires-aimetis-corp-164500636.html","summary":"Magal S3 Acquires Aimetis Corp - a Global Leader in VMS Software: Diversifying and Expanding Its Product Portfolio"},{"title":"Magal Security Systems Ltd. :MAGS-US: Earnings Analysis: Q4, 2015 By the Numbers","publication_date":"2016-04-01 15:21:27 +0000","url":"http://www.capitalcube.com/blog/index.php/magal-security-systems-ltd-mags-us-earnings-analysis-q4-2015-by-the-numbers/","summary":"Magal Security Systems Ltd. :MAGS-US: Earnings Analysis: Q4, 2015 By the Numbers"},{"title":"Magal Security Systems Announces Filing Of 2015 Annual Report","publication_date":"2016-03-29 18:54:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-announces-filing-185400854.html","summary":"Magal Security Systems Announces Filing Of 2015 Annual Report"},{"title":"Magal Security systems reports Fourth Quarter and Full Year 2015 Financial Reports More >>","publication_date":"2016-03-29 10:22:03 +0000","url":"http://www.publicnow.com/view/6179867035895AA0E1F9C7600BD62F83FAA88135","summary":"[at noodls] - MAGAL SECURITY SYSTEMS REPORTS FOURTH QUARTER AND FULL YEAR 2015 FINANCIAL RESULTS YEHUD, ISRAEL, March 29, 2015 -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results for ..."},{"title":"Magal Security Systems Reports Fourth Quarter and Full Year 2015 Financial Results","publication_date":"2016-03-29 10:16:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-reports-fourth-101600481.html","summary":"[PR Newswire] - YEHUD, Israel, March 29, 2016 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results for the three month and full year periods ended December 31, 2015. Management ..."},{"title":"Defexpo India 2016: MAGAL to Highlight Fiber-Optic Sensors for Fence‚ Pipeline‚ and Dataline Protection More >>","publication_date":"2016-03-21 14:22:44 +0000","url":"http://www.publicnow.com/view/511DEEF7BE6C7FE7F30B71720B9A88E1B920107D","summary":"[at noodls] - Defexpo India 2016: MAGAL to Highlight Fiber-Optic Sensors for Fence, Pipeline, and Dataline Protection The Company has completed development of the new generation of FiberPatrol-PR, enabling coverage ..."},{"title":"Magal S3 to Present at the 28th Annual Roth Conference on Tuesday, March 15, 2016","publication_date":"2016-03-08 11:00:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-present-28th-annual-110000232.html","summary":"[PR Newswire] - YAHUD, Israel, March 8, 2016 /PRNewswire/ -- Magal S 3 (NASDAQ G MS: MAGS, TASE: MAGS) today announced that it will participate at the 28th Annual Roth Conference to be held between March 13 - 16, 2016 ..."},{"title":"Magal Receives Homeland Security Orders Totaling $8.4 Million More >>","publication_date":"2016-01-05 12:18:08 +0000","url":"http://www.noodls.com/view/C7BBD2367FE9818F4B9D67D6F7DC31BABA4AC6C2","summary":"[at noodls] - FOR IMMEDIATE RELEASE PRESS RELEASE MAGAL RECEIVES HOMELAND SECURITY ORDERS TOTALING $8.4 MILLION YAHUD, Israel - January 5, 2016 -- Magal Security Systems, Ltd. (NASDAQ GM: MAGS) today announced that ..."},{"title":"Magal Receives Homeland Security Orders Totaling $8.4 Million","publication_date":"2016-01-05 11:00:00 +0000","url":"http://finance.yahoo.com/news/magal-receives-homeland-security-orders-110000078.html","summary":"[PR Newswire] - YAHUD, Israel, January 5, 2016 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ GM: MAGS) today announced that it has received several orders in Israel for homeland security (HLS) infrastructure. The ..."},{"title":"Magal Security Systems Reports Third Quarter 2015 Financial Results More >>","publication_date":"2015-11-24 12:53:36 +0000","url":"http://www.noodls.com/view/621BC27671268854ED9DE0E61C8652F09CD1107C","summary":"[at noodls] - MAGAL SECURITY SYSTEMS REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS YEHUD, ISRAEL, November 24, 2015 -- Magal Security Systems, Ltd. (NASDAQ: MAGS) today announced its financial results for the three and ..."},{"title":"Magal Security Systems Reports Third Quarter 2015 Financial Results","publication_date":"2015-11-24 11:02:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-reports-third-110200777.html","summary":"Magal Security Systems Reports Third Quarter 2015 Financial Results"},{"title":"Magal S3 to Release Third Quarter 2015 Results on Tuesday, November 24, 2015","publication_date":"2015-11-12 14:30:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-release-third-quarter-143000754.html","summary":"[PR Newswire] - YAHUD, Israel, November 12, 2015 /PRNewswire/ -- Magal S 3 (NASDAQ GMS: MAGS, TASE: MAGS) today announced that it intends to publish its third quarter 2015 results on Tuesday November 24, 2015. The Company ..."},{"title":"Consumer Sector Update for 08/31/2015: MAGS, JCP, IGLD","publication_date":"2015-08-31 13:29:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1CpTLfaEqks/consumer-sector-update-for-08312015-mags-jcp-igld-cm514934","summary":"Top Consumer Shares Â WMT flat MCD flat DIS flat CVS flat KO flat GE 0.79% Consumer shares were generally flat in pre market trade Monday. In consumer stocks news, Magal Security Systems ( MAGS ) reported slim Q2"},{"title":"Magal Security Systems Reports Second Quarter 2015 Financial Results","publication_date":"2015-08-31 11:34:00 +0000","url":"http://finance.yahoo.com/news/magal-security-systems-reports-second-113400612.html","summary":"[PR Newswire] - YAHUD, Israel, Aug. 31, 2015 /PRNewswire/ -- Magal Security Systems, Ltd. (NASDAQ NMS: MAGS) today announced its financial results for the three and six month periods ended June 30, 2015. Management will ..."},{"title":"Magal Security Systems Reports Second Quarter 2015 Financial Results More >>","publication_date":"2015-08-31 11:13:05 +0000","url":"http://www.noodls.com/view/E50A9E0AB8924EB8EE47F25A092DC7C7BC6FA087","summary":"[at noodls] - FOR IMMEDIATE RELEASE MAGAL SECURITY SYSTEMS REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS YAHUD, ISRAEL, August 31, 2015 -- Magal Security Systems, Ltd. (NASDAQ NMS: MAGS) today announced its financial ..."},{"title":"Magal S3 to Release Second Quarter 2015 Results on Monday, August 31, 2015","publication_date":"2015-08-19 09:00:00 +0000","url":"http://finance.yahoo.com/news/magal-s3-release-second-quarter-090000437.html","summary":"[PR Newswire] - YAHUD, Israel, August 19, 2015 /PRNewswire/ -- Magal S 3 (NASDAQ G MS: MAGS, TASE: MAGS) today announced that it intends to publish its second quarter 2015 results on August 31, 2015. The Company will ..."},{"title":"Magal wins contract to secure 200+ KM of pipeline with long range fiber optic sensor More >>","publication_date":"2015-08-17 14:33:18 +0000","url":"http://www.noodls.com/view/FCC62DF2A310DC7C0D9B9716A353202B1253D401","summary":"[at noodls] - FOR IMMEDIATE RELEASE PRESS RELEASE MAGAL WINS CONTRACT TO SECURE 200+ Km OF PIPELINE WITH LONG RANGE FIBER OPTIC SENSOR YAHUD, Israel - August 17, 2015 -- Magal Security Systems, Ltd. (NASDAQ: MAGS) announced ..."},{"title":"Magal Wins Contract to Secure 200+ KM Of Pipeline With Long Range Fiber Optic Sensor","publication_date":"2015-08-17 09:00:00 +0000","url":"http://finance.yahoo.com/news/magal-wins-contract-secure-200-090000189.html","summary":"Magal Wins Contract to Secure 200+ KM Of Pipeline With Long Range Fiber Optic Sensor"},{"title":"Consumer Sector Update for 05/13/2015: MAGS,RENT,POST","publication_date":"2015-05-13 16:57:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zk_AXluteWc/consumer-sector-update-for-05132015-magsrentpost-cm476544","summary":"Top Consumer Stocks WMT 0.64% MCD 0.29% DIS 0.12% CVS 0.43% KO +1.14% Consumer stocks were mixed Wednesday with shares of consumer staples companies in the S&P 500 holding on to a 0.1% gain while shares of consumer discretionary"},{"title":"Magal posts 4Q profit","publication_date":"2015-03-26 12:24:49 +0000","url":"http://sg.finance.yahoo.com/news/magal-posts-4q-profit-122449036.html","summary":"Magal posts 4Q profit"},{"title":"Sector Update: Tech Stocks Trimming Earlier Losses; Magal Security Systems Near 6-Year High Ahead of RoboGuard Launch","publication_date":"2014-09-03 20:36:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2fveBitYZYU/sector-update-tech-stocks-trimming-earlier-losses-magal-security-systems-near-6-year-high-ahead-of-roboguard-launch-cm386686","summary":"Top Tech Stocks MSFT 0.18% AAPL 4.17% IBM +0.19% CSCO +0.64% GOOG 0.04% Technology stocks were mostly lower today with shares of technology companies in the S&P 500 losing almost 0.6%. In company news, Magal Security Systems Ltd. ("},{"title":"Sector Update: Tech","publication_date":"2014-09-03 20:16:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-MwVnkJFFA/sector-update-tech-cm386657","summary":"Technology stocks were mostly lower today with shares of technology companies in the S&P 500 losing almost 0.6%. In company news, Magal Security Systems Ltd. ( MAGS ) rallied to a nearly six year high Wednesday after the security"},{"title":"Earnings Reaction History: Magal Security Systems Ltd, 60.0% Follow-Through Indicator, 8.1% Sensitive","publication_date":"2014-03-27 11:03:15 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/boqVILGzxws/earnings-reaction-history-magal-security-systems-ltd-600-follow-through-indicator-81-sensitive-cm339190","summary":"Expected Earnings Release 03 27 2014, Premarket Avg. Extended Hours Dollar Volume $112,859 Magal Security Systems Ltd ( MAGS ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can"}],"result_count":75,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1490816648,"trigger": "MARK AT OR ABOVE 8.00","triggerPrice":8.00,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"7.7"},{"x":"1490967300","y":"7.6"},{"x":"1490967600","y":"7.5600000000000005"},{"x":"1490967900","y":"7.49"},{"x":"1490968200","y":"7.482"},{"x":"1490968500","y":"7.466"},{"x":"1490968800","y":"7.4794"},{"x":"1490969100","y":"7.49"},{"x":"1490969400","y":"7.5375"},{"x":"1490969700","y":"7.498"},{"x":"1490970000","y":"7.47"},{"x":"1490970300","y":"7.47"},{"x":"1490970600","y":"7.3856"},{"x":"1490970900","y":"7.39"},{"x":"1490971200","y":"7.3708"},{"x":"1490971500","y":"7.44"},{"x":"1490971800","y":"7.4232"},{"x":"1490972100","y":"7.4127"},{"x":"1490972400","y":"7.4"},{"x":"1490972700","y":"7.4199"},{"x":"1490973000","y":"7.42"},{"x":"1490973300","y":"7.4212"},{"x":"1490973900","y":"7.45"},{"x":"1490974500","y":"7.547"},{"x":"1490974800","y":"7.55"},{"x":"1490975400","y":"7.54"},{"x":"1490975700","y":"7.5"},{"x":"1490976000","y":"7.52"},{"x":"1490976300","y":"7.5600000000000005"},{"x":"1490976900","y":"7.58"},{"x":"1490977200","y":"7.579"},{"x":"1490977500","y":"7.5600000000000005"},{"x":"1490977800","y":"7.5600000000000005"},{"x":"1490978100","y":"7.5600000000000005"},{"x":"1490978400","y":"7.55"},{"x":"1490978700","y":"7.5624"},{"x":"1490979000","y":"7.5716"},{"x":"1490979300","y":"7.5635"},{"x":"1490979600","y":"7.5601"},{"x":"1490979900","y":"7.575"},{"x":"1490980500","y":"7.5762"},{"x":"1490980800","y":"7.579"},{"x":"1490981100","y":"7.6"},{"x":"1490981400","y":"7.6"},{"x":"1490982000","y":"7.58"},{"x":"1490982300","y":"7.61"},{"x":"1490982600","y":"7.6"},{"x":"1490982900","y":"7.5801"},{"x":"1490983200","y":"7.5821"},{"x":"1490983500","y":"7.58"},{"x":"1490983800","y":"7.58"},{"x":"1490984100","y":"7.57"},{"x":"1490984400","y":"7.57"},{"x":"1490984700","y":"7.57"},{"x":"1490985300","y":"7.5600000000000005"},{"x":"1490985600","y":"7.55"},{"x":"1490985900","y":"7.5411"},{"x":"1490986200","y":"7.54"},{"x":"1490986500","y":"7.51"},{"x":"1490986800","y":"7.53"},{"x":"1490987700","y":"7.531"},{"x":"1490988300","y":"7.55"},{"x":"1490988900","y":"7.555"},{"x":"1490989200","y":"7.54"},{"x":"1490989500","y":"7.545"},{"x":"1490989800","y":"7.54"},{"x":"1490990100","y":"7.54"},{"x":"1490990400","y":"7.52"} ], "color":"#03a9f4"}]},
{"id":"8","list":"Alerts","symbol": "RSO","name": "Resource Capital Corp","price": 9.77,"dollarChange": -0.01,"percentChange": -0.11,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/RSO-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/RSO-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/RSO-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/RSO-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/RSO-1yr.php","open": 9.76,"high": 9.84,"low":9.71,"volume": 411100,"avgVol": 464375.950000,"sharesShort": 1564575,"shortPercent": 4.983011,"marketCap": 260820168,"float": 31398186,"headlines":{"data":[{"title":"Ex-Div Reminder for Resource Capital Series A Cumulative Redeemable Preferred Stock","publication_date":"2017-03-28 18:59:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/conIruuHld8/ex-div-reminder-for-resource-capital-series-a-cumulative-redeemable-preferred-stock-cm766824","summary":"On 3 30 17 Resource Capital Corp s 8 50 Series A Cumulative Redeemable Preferred Stock Symbol RSO PRA will trade ex dividend for its quarterly dividend of 0 5312 payable on 5 1 17 As a percentage of RSO PRA s recent share price of 24 70 this dividend works out to approximately 2 15"},{"title":"Ex-Div Reminder for Resource Capital Corp's Series B Cumulative Redeemable Preferred Stock","publication_date":"2017-03-28 18:58:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yIEwvfZkzBQ/ex-div-reminder-for-resource-capital-corps-series-b-cumulative-redeemable-preferred-stock-cm766810","summary":"On 3 30 17 Resource Capital Corp s 8 25 Series B Cumulative Redeemable Preferred Stock Symbol RSO PRB will trade ex dividend for its quarterly dividend of 0 5156 payable on 5 1 17 As a percentage of RSO PRB s recent share price of 23 80 this dividend works out to approximately 2 17"},{"title":"Resource Capital Corp. (RSO) Ex-Dividend Date Scheduled for March 29, 2017","publication_date":"2017-03-28 13:26:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yJnHg96BUdA/resource-capital-corp-rso-ex-dividend-date-scheduled-for-march-29-2017-cm766505","summary":"Resource Capital Corp RSO will begin trading ex dividend on March 29 2017 A cash dividend payment of 0 05 per share is scheduled to be paid on April 27 2017 Shareholders who purchased RSO prior to the ex dividend date are eligible for the cash dividend payment This represents an 88"},{"title":"RESOURCE CAPITAL CORP. Financials","publication_date":"2017-03-22 17:04:10 +0000","url":"http://finance.yahoo.com/q/is?s=rso","summary":"RESOURCE CAPITAL CORP. Financials"},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividends for Preferred Stock","publication_date":"2017-03-21 12:30:00 +0000","url":"http://finance.yahoo.com/news/capital-corp-declares-quarterly-cash-123000603.html","summary":"[Marketwired] - Resource Capital Corp. announced today that it will pay a cash dividend on its 8.50% Series A Cumulative Redeemable Preferred Stock for the period from January 31, 2017 through and including April 30, ..."},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividend","publication_date":"2017-03-20 20:01:00 +0000","url":"http://finance.yahoo.com/news/capital-corp-declares-quarterly-cash-200100549.html","summary":"[Marketwired] - Resource Capital Corp. announced today that its Board of Directors has declared a cash dividend of $0.05 per common share for the quarter ending March 31, 2017. The dividend will be paid on April 27, 2017 ..."},{"title":"Resource Capital Corp. 2014-CRE2, Ltd. -- Moody's upgrades ratings of two classes of notes issued by Resource Capital Corp. 2014-CRE2, Ltd.","publication_date":"2017-03-16 21:24:07 +0000","url":"http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_363545&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170316_PR_363545","summary":"Resource Capital Corp. 2014-CRE2, Ltd. -- Moody's upgrades ratings of two classes of notes issued by Resource Capital Corp. 2014-CRE2, Ltd."},{"title":"RESOURCE CAPITAL CORP. Files SEC form 10-K, Annual Report","publication_date":"2017-03-16 10:09:17 +0000","url":"http://biz.yahoo.com/e/170316/rso10-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 10-K, Annual Report"},{"title":"Edited Transcript of RSO earnings conference call or presentation 14-Mar-17 12:30pm GMT","publication_date":"2017-03-14 23:35:40 +0000","url":"http://finance.yahoo.com/news/edited-transcript-rso-earnings-conference-233540641.html","summary":"Edited Transcript of RSO earnings conference call or presentation 14-Mar-17 12:30pm GMT"},{"title":"Resource Capital Corp Earnings Call scheduled for 8:30 am ET today","publication_date":"2017-03-14 12:30:00 +0000","url":"http://biz.yahoo.com/cc/7/155957.html","summary":"Resource Capital Corp Earnings Call scheduled for 8:30 am ET today"},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex","publication_date":"2017-03-14 10:04:26 +0000","url":"http://biz.yahoo.com/e/170314/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex"},{"title":"Resource Capital reports 4Q loss","publication_date":"2017-03-14 09:44:06 +0000","url":"http://sg.finance.yahoo.com/news/capital-reports-4q-loss-094406047.html","summary":"Resource Capital reports 4Q loss"},{"title":"3:49 am Resource Capital beats on top and bottom lines","publication_date":"2017-03-14 07:49:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#rso","summary":"3:49 am Resource Capital beats on top and bottom lines"},{"title":"Resource Capital Corp. Reports Results for Three Months and Year Ended December 31, 2016","publication_date":"2017-03-13 23:37:33 +0000","url":"http://finance.yahoo.com/news/capital-corp-reports-results-three-233733310.html","summary":"[Marketwired] - Resource Capital Corp."},{"title":"After-Hours Earnings Report for March 13, 2017 : CHRS, IPAR, IRET, KMG, BLCM, RYI, ENZ, GDEN, BREW, LMNR, PETX, RSO","publication_date":"2017-03-13 19:01:19 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CzJHDB8tESo/after-hours-earnings-report-for-march-13-2017-chrs-ipar-iret-kmg-blcm-ryi-enz-gden-brew-lmnr-petx-rso-cm760138","summary":"The following companies are expected to report earnings after hours on 03 13 2017 Visit our Earnings Calendar for a full list of expected earnings releases Coherus BioSciences Inc CHRS is reporting for the quarter ending December 31 2016 The"},{"title":"Q4 2016 Resource Capital Corp Earnings Release - After Market Close","publication_date":"2017-03-13 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20170313.html?t=rso","summary":"Q4 2016 Resource Capital Corp Earnings Release - After Market Close"},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2017-03-08 21:08:45 +0000","url":"http://biz.yahoo.com/e/170308/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"Resource Capital Corp. to Report 2016 Fourth Quarter and Fiscal Year Operating Results","publication_date":"2017-03-01 13:30:00 +0000","url":"http://finance.yahoo.com/news/capital-corp-report-2016-fourth-133000291.html","summary":"[GlobeNewswire] - NEW YORK, March 01, 2017-- Resource Capital Corp. announced today that it will release its 2016 fourth quarter and fiscal year operating results on Monday, March 13, 2017, after market hours, and it invites ..."},{"title":"Moody's affirms rating of one class of notes issued by Resource 2015-CRE3","publication_date":"2017-02-01 21:25:03 +0000","url":"http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_361548&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170201_PR_361548","summary":"Moody's affirms rating of one class of notes issued by Resource 2015-CRE3"},{"title":"Harwood Feffer LLP Announces Investigation of Resource Capital Corp.","publication_date":"2017-01-25 21:09:00 +0000","url":"http://finance.yahoo.com/news/harwood-feffer-llp-announces-investigation-210900277.html","summary":"[PR Newswire] - NEW YORK, Jan. 25, 2017 /PRNewswire/ -- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential claims against the board of directors of Resource Capital Corp. (\"Resource Capital\" or ..."},{"title":"Update in Lawsuit for Investors in Resource Capital Corp. (NYSE: RSO) Announced by Shareholders Foundation","publication_date":"2017-01-23 15:00:00 +0000","url":"http://finance.yahoo.com/news/lawsuit-investors-capital-corp-nyse-150000575.html","summary":"[Accesswire] - SAN DIEGO, CA / ACCESSWIRE / January 23, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Resource Capital Corp. (NYSE: RSO) in New York over ..."},{"title":"Bragar Eagel & Squire, P.C. Is Investigating Resource Capital Corp (RSO) on Behalf of Stockholders and Encourages Investors to Contact the Firm","publication_date":"2017-01-13 22:30:00 +0000","url":"http://finance.yahoo.com/news/bragar-eagel-squire-p-c-223000762.html","summary":"[Business Wire] - Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Resource Capital Corp concerning whether the board has breached its fiduciary duties to stockholders."},{"title":"Resource Capital Corp's 8.50% Series A Cumulative Redeemable Preferred Stock Ex-Dividend Reminder","publication_date":"2016-12-27 20:58:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_SSSGbZWnN8/resource-capital-corps-850-series-a-cumulative-redeemable-preferred-stock-ex-dividend-reminder-cm726648","summary":"On 12 28 16 Resource Capital Corp s 8 50 Series A Cumulative Redeemable Preferred Stock Symbol RSO PRA will trade ex dividend for its quarterly dividend of 0 5312 payable on 1 30 17 As a percentage of RSO PRA s recent share price of 24 49 this dividend works out to approximately 2"},{"title":"Resource Capital Corp. (RSO) Ex-Dividend Date Scheduled for December 28, 2016","publication_date":"2016-12-27 14:25:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GFzPIvB7eFo/resource-capital-corp-rso-ex-dividend-date-scheduled-for-december-28-2016-cm726357","summary":"Resource Capital Corp RSO will begin trading ex dividend on December 28 2016 A cash dividend payment of 0 05 per share is scheduled to be paid on January 27 2017 Shareholders who purchased RSO prior to the ex dividend date are eligible for the cash dividend payment This represents"},{"title":"IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Resource Capital Corp. and Advises Investors with Losses to Contact the Firm","publication_date":"2016-12-22 23:10:00 +0000","url":"http://finance.yahoo.com/news/important-investor-alert-goldberg-law-231000293.html","summary":"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Resource Capital Corp. concerning possible violations of federal securities laws."},{"title":"Glancy Prongay & Murray LLP Commences Investigation on Behalf of Resource Capital Corp. Investors","publication_date":"2016-12-22 21:16:00 +0000","url":"http://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-211600326.html","summary":"[Business Wire] - Glancy Prongay & Murray LLP announces an investigation on behalf of Resource Capital Corp. investors concerning the Company and its officers’ possible violations of federal securities laws."},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividends for Preferred Stock","publication_date":"2016-12-16 14:08:12 +0000","url":"http://www.publicnow.com/view/98082C894948A043B3EE83DA545F62B1C9CE2F07","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 12/16/16 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today that it will pay a cash dividend on its 8.50% Series A Cumulative Redeemable Preferred Stock ..."},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividend","publication_date":"2016-12-15 14:00:00 +0000","url":"http://finance.yahoo.com/news/capital-corp-declares-quarterly-cash-140000898.html","summary":"[Marketwired] - Resource Capital Corp. announced today that its Board of Directors has declared a cash dividend of $0.05 per common share for the quarter ending December 31, 2016. The dividend will be paid on January ..."},{"title":"How Navigator Holdings Ltd (NVGS) Stacks Up Against Its Peers","publication_date":"2016-12-13 06:47:27 +0000","url":"http://www.insidermonkey.com/blog/how-navigator-holdings-ltd-nvgs-stacks-up-against-its-peers-507208/","summary":"How Navigator Holdings Ltd (NVGS) Stacks Up Against Its Peers"},{"title":"Lifshitz & Miller Law Firm Announces Investigation of Georgetown Bancorp, Inc., Lattice Semiconductor Corporation, Mallinckrodt Public Limited Company, Mentor Graphics Corporation, PAREXEL International Corporation, Resource Capital Corp., ","publication_date":"2016-12-01 16:45:00 +0000","url":"http://finance.yahoo.com/news/lifshitz-miller-law-firm-announces-164500194.html","summary":"[PR Newswire] - NEW YORK, Dec.1, 2016 /PRNewswire/ -- Georgetown Bancorp, Inc. (GTWN) Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the GTWN board in connection with the sale ..."},{"title":"Resource Capital downgraded by JMP Securities","publication_date":"2016-11-18 12:55:46 +0000","url":"http://finance.yahoo.com/q/ud?s=RSO","summary":"Resource Capital downgraded by JMP Securities"},{"title":"SHAREHOLDER ALERT: Holzer & Holzer Announces Investigations Into Resource Capital and Mallinckrodt Public","publication_date":"2016-11-17 16:48:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-holzer-holzer-announces-164800023.html","summary":"[Business Wire] - Holzer & Holzer, LLC is investigating whether certain statements made by Resource Capital Corp. and Mallinckrodt Public Ltd. Co. regarding their business and operations complied with federal securities laws."},{"title":"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Resource Capital Corp. (RSO)","publication_date":"2016-11-17 15:15:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151500915.html","summary":"[PR Newswire] - NEW YORK, Nov. 17, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Resource Capital Corp. (\"RSO\" or ..."},{"title":"INVESTOR ALERT: Investigation of Resource Capital Corp. Announced by Law Offices of Howard G. Smith","publication_date":"2016-11-16 23:41:00 +0000","url":"http://finance.yahoo.com/news/investor-alert-investigation-capital-corp-234100341.html","summary":"[Business Wire] - Law Offices of Howard G. Smith announces an investigation on behalf of investors of Resource Capital Corp. concerning the Company and its officers’ possible violations of federal securities laws."},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-11-14 22:40:16 +0000","url":"http://biz.yahoo.com/e/161114/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"Financial Sector Update for 11/14/2016: O,RF,RSO","publication_date":"2016-11-14 21:28:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8L9fWmSZ3os/financial-sector-update-for-11142016-orfrso-cm708983","summary":"Top Financial StocksTop Financial Stocks JPM 3 3 JPM 3 3 BAC 5 4 BAC 5 4 WFC 2 4 WFC 2 4 C 3 4 C 3 4 USB 1 4 USB 1 4 Financial stocks continued to advance Monday with the NYSE Financial Sector Index climbing nearly 2 1 while financial companies in the S amp P 500 Index were"},{"title":"Financial Sector Update for 11/14/2016: PN,RF,RSO","publication_date":"2016-11-14 19:07:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PqCcyDZQzs0/financial-sector-update-for-11142016-pnrfrso-cm708898","summary":"Top Financial StocksTop Financial Stocks JPM 3 51 JPM 3 51 BAC 5 00 BAC 5 00 WFC 2 71 WFC 2 71 C 2 65 C 2 65 USB 0 79 USB 0 79 Financial stocks were advancing today with the NYSE Financial Sector Index climbing nearly 1 0 while financial companies in the S amp P 500 Index"},{"title":"Edited Transcript of RSO earnings conference call or presentation 14-Nov-16 1:30pm GMT","publication_date":"2016-11-14 16:13:39 +0000","url":"http://finance.yahoo.com/news/edited-transcript-rso-earnings-conference-161339218.html","summary":"Edited Transcript of RSO earnings conference call or presentation 14-Nov-16 1:30pm GMT"},{"title":"Resource Capital Corp Earnings Call scheduled for 8:30 am ET today","publication_date":"2016-11-14 13:30:00 +0000","url":"http://biz.yahoo.com/cc/6/154916.html","summary":"Resource Capital Corp Earnings Call scheduled for 8:30 am ET today"},{"title":"Resource Capital reports 3Q results","publication_date":"2016-11-14 10:09:09 +0000","url":"http://sg.finance.yahoo.com/news/capital-reports-3q-results-100909512.html","summary":"Resource Capital reports 3Q results"},{"title":"Resource Capital Corp. (RSO) Has Tumbled To A New Low After Q3 Report","publication_date":"2016-11-14 09:58:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0NStery5mjM/resource-capital-corp-rso-has-tumbled-to-a-new-low-after-q3-report-20161114-00765","summary":"Resource Capital Corp. (RSO) Has Tumbled To A New Low After Q3 Report"},{"title":"Resource Capital Corp. (RSO) Has Tumbled To A New Low After Q3 Report","publication_date":"2016-11-14 09:58:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mYttgYZOXW0/resource-capital-corp-rso-has-tumbled-to-a-new-low-after-q3-report-20161114-00764","summary":"Resource Capital Corp. (RSO) Has Tumbled To A New Low After Q3 Report"},{"title":"Resource Capital Corp. Reports Results for Three and Nine Months Ended September 30, 2016","publication_date":"2016-11-13 23:37:10 +0000","url":"http://www.publicnow.com/view/98147970496C551CC364F1E8155D06FFE8136D30","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 11/13/16 -- Resource Capital Corp. (NYSE: RSO) Significant Items and Highlights GAAP net loss allocable to common shares was $(1.69) and $(1.42) per share-diluted and Adjusted ..."},{"title":"Q3 2016 Resource Capital Corp Earnings Release - After Market Close","publication_date":"2016-11-13 12:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20161113.html?t=rso","summary":"Q3 2016 Resource Capital Corp Earnings Release - After Market Close"},{"title":"Resource Capital Corp. to Report Third Quarter 2016 Operating Results","publication_date":"2016-11-09 22:11:09 +0000","url":"http://www.publicnow.com/view/66F8A2A674CC2536AFDF5A1417CF10FE8F623A97","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 11/09/16 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today that it will release its third quarter 2016 operating results on Sunday evening, November ..."},{"title":"Resource Capital Corp. to Report Third Quarter 2016 Operating Results","publication_date":"2016-11-09 22:00:00 +0000","url":"http://finance.yahoo.com/news/capital-corp-report-third-quarter-220000590.html","summary":"[Marketwired] - Resource Capital Corp. announced today that it will release its third quarter 2016 operating results on Sunday evening, November 13, 2016, and it invites investors and other interested parties to listen ..."},{"title":"Robbins Arroyo LLP: Resource Capital Corp. (RSO) Investors Survive Defendants' Motion to Dismiss in Securities Class Action","publication_date":"2016-10-28 23:57:00 +0000","url":"http://finance.yahoo.com/news/robbins-arroyo-llp-capital-corp-235700736.html","summary":"[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP announces that a lawsuit was filed against Resource Capital Corp. in the U.S. District Court for the Southern District of New York, alleging violations of the Securities Exchange Act of 1934 by Resource Capital's officers and directors."},{"title":"Johnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics, Inc., KemPharm, Inc., Neos Therapeutics, Inc., CommVault Systems, Inc. and Resource Capital Corp.","publication_date":"2016-10-26 13:02:00 +0000","url":"http://finance.yahoo.com/news/johnson-weaver-llp-initiates-investigations-130200962.html","summary":"[PR Newswire] - Johnson & Weaver, LLP, is investigating potential violations of federal and state laws by certain officers and directors of Bellerophon Therapeutics, Inc. (BLPH). On February 13, 2015, Bellerophon's sold 13 million shares of stock in its initial public stock offering (the \"IPO\"), raising $60.0 million in new capital. However, since the IPO, Bellerophon's stock has imploded, on October 25, 2016, the stock closed at $1.40."},{"title":"Resource Capital Research Report","publication_date":"2016-10-04 03:48:06 +0000","url":"http://www.publicnow.com/view/A66D2B98E72DB3C652DA38D8612EEA27ADD9E31E","summary":"[at noodls] - ASX RELEASE 4 October 2016 ASX: ARU RESOURCE CAPITAL RESEARCH REPORT Arafura Resources Limited (ASX: ARU, \"Arafura\" or the \"Company\") is pleased to advise that Resource Capital Research ..."},{"title":"Ex-Div Reminder for Resource Capital Series A Cumulative Redeemable Preferred Stock","publication_date":"2016-09-27 19:20:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u7Upg7NuZe8/ex-div-reminder-for-resource-capital-series-a-cumulative-redeemable-preferred-stock-cm685522","summary":"On 9 29 16 Resource Capital Corp s 8 50 Series A Cumulative Redeemable Preferred Stock Symbol RSO PRA will trade ex dividend for its quarterly dividend of 0 5312 payable on 10 31 16 As a percentage of RSO PRA s recent share price of 23 92 this dividend works out to approximately 2"},{"title":"Resource Capital Corp. (RSO) Ex-Dividend Date Scheduled for September 28, 2016","publication_date":"2016-09-27 13:18:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ri7X77I0zLk/resource-capital-corp-rso-ex-dividend-date-scheduled-for-september-28-2016-cm685194","summary":"Resource Capital Corp RSO will begin trading ex dividend on September 28 2016 A cash dividend payment of 0 42 per share is scheduled to be paid on October 28 2016 Shareholders who purchased RSO prior to the ex dividend date are eligible for the cash dividend payment This marks the"},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividends for Preferred Stock","publication_date":"2016-09-20 12:58:04 +0000","url":"http://www.publicnow.com/view/6D04D41D599099749D1097675519CB56DFDC1192","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 09/20/16 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today that it will pay a cash dividend on its 8.50% Series A Cumulative Redeemable Preferred Stock ..."},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividend","publication_date":"2016-09-19 15:28:01 +0000","url":"http://www.publicnow.com/view/86A9A3D6D3BFDFA0CED3CA594B04E3659218C005","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 09/19/16 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today that its Board of Directors has declared a cash dividend of $0.42 per common share for the ..."},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events","publication_date":"2016-09-14 21:16:07 +0000","url":"http://biz.yahoo.com/e/160914/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events"},{"title":"Resource Capital Corp.'s External Manager Successfully Acquired by C-III Capital Partners LLC","publication_date":"2016-09-08 20:39:02 +0000","url":"http://www.publicnow.com/view/0CA2C6A241CE5C33B64B1BC8C415E066D8FD8B1B","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 09/08/16 -- Resource Capital Corp. (NYSE: RSO) ('RSO'), announced today that C-III Capital Partners LLC ('C-III'), a leading commercial real estate investment management ..."},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Termination of a Material Definitive Agreement","publication_date":"2016-08-10 19:07:46 +0000","url":"http://biz.yahoo.com/e/160810/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Termination of a Material Definitive Agreement"},{"title":"RESOURCE CAPITAL CORP. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-09 18:54:49 +0000","url":"http://biz.yahoo.com/e/160809/rso10-q.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 10-Q, Quarterly Report"},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib","publication_date":"2016-08-05 17:36:22 +0000","url":"http://biz.yahoo.com/e/160805/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib"},{"title":"[$$] CVC Credit Partners Buys Northport Capital From Resource Capital","publication_date":"2016-08-05 16:45:46 +0000","url":"http://www.wsj.com/articles/cvc-credit-partners-buys-northport-capital-from-resource-capital-1470415544?mod=yahoo_hs","summary":"[$$] CVC Credit Partners Buys Northport Capital From Resource Capital"},{"title":"CVC Credit, Coller Capital acquire Northport Capital from Resource Capital","publication_date":"2016-08-05 01:15:24 +0000","url":"http://uk.finance.yahoo.com/news/cvc-credit-coller-capital-acquire-011524400.html","summary":"CVC Credit, Coller Capital acquire Northport Capital from Resource Capital"},{"title":"Noteworthy Tuesday Option Activity: GNRC, BBY, RSO","publication_date":"2016-08-02 20:52:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kVHPZ63qhNQ/noteworthy-tuesday-option-activity-gnrc-bby-rso-cm659124","summary":"Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Generac Holdings Inc (Symbol GNRC), where a total of 1,364 contracts have traded so far, representing approximately 136,400 underlying shares. That amounts"},{"title":"Financial Sector Update for 08/02/2016: AJG,OZM,RSO","publication_date":"2016-08-02 20:28:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nm018Gu61yI/financial-sector-update-for-08022016-ajgozmrso-cm659154","summary":"Top Financial Stocks JPM 0.30% BAC 1.22% WFC 0.23% C 1.22% USB 0.43% Financial stocks were ending sharply lower today, with the NYSE Financial Sector Index sinking about 1.0% while financial companies in the S&P 500 Index were falling"},{"title":"Financial Sector Update for 08/02/2016: NYRT,OZM,RSO","publication_date":"2016-08-02 17:52:17 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_iu6xTU-sMo/financial-sector-update-for-08022016-nyrtozmrso-cm659024","summary":"Top Financial Stocks JPM 0.42% BAC 1.29% WFC 0.48% C 1.93% USB 1.20% Financial stocks were sharply lower today, with the NYSE Financial Sector Index sinking about 1.1% while financial companies in the S&P 500 Index were falling over"},{"title":"Edited Transcript of RSO earnings conference call or presentation 2-Aug-16 12:30pm GMT","publication_date":"2016-08-02 16:11:03 +0000","url":"http://finance.yahoo.com/news/edited-transcript-rso-earnings-conference-161103091.html","summary":"Edited Transcript of RSO earnings conference call or presentation 2-Aug-16 12:30pm GMT"},{"title":"Resource Capital reports 2Q results","publication_date":"2016-08-02 10:20:52 +0000","url":"http://sg.finance.yahoo.com/news/capital-reports-2q-results-102052608.html","summary":"Resource Capital reports 2Q results"},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex","publication_date":"2016-08-02 10:07:36 +0000","url":"http://biz.yahoo.com/e/160802/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex"},{"title":"Resource Capital Corp. Reports Results for Three and Six Months Ended June 30, 2016","publication_date":"2016-08-02 01:21:06 +0000","url":"http://www.publicnow.com/view/0E43263E91C1FB267BB00E3D8135AB720A40098C","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 08/01/16 -- Resource Capital Corp. (NYSE: RSO) Highlights and Significant Items On August 1, 2016, RSO entered into an agreement to sell Northport TRS, LLC ('Northport'), ..."},{"title":"Q2 2016 Resource Capital Corp Earnings Release - After Market Close","publication_date":"2016-08-01 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20160801.html?t=rso","summary":"Q2 2016 Resource Capital Corp Earnings Release - After Market Close"},{"title":"Placement to Raise $2.25 million","publication_date":"2016-08-01 02:28:01 +0000","url":"http://www.publicnow.com/view/441724FB5F9FE3BF61CC7BA16715860CFF7C2A6F","summary":"[at noodls] - ASX Announcement (ASX: HMX) 1 August 2016 Share Placement Raises approximately $2.25 million Resource Capital Funds takes Strategic Stake‌ Hammer Metals Limited (\"Hammer\" or \"the Company\") ..."},{"title":"mREITs' Q2 Earnings to Watch on Aug 1: MTGE, ANH, AJX, RSO","publication_date":"2016-07-29 13:26:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uAla7XQC2Xw/mreits-q2-earnings-to-watch-on-aug-1-mtge-anh-ajx-rso-cm657148","summary":"The second quarter earnings is now in full swing with several companies from the broader finance sector having reported their results already. Real estate investment trusts (\"REIT\") space, which is an important part of the finance sector, is no"},{"title":"mREITs' Q2 Earnings to Watch on Aug 1: MTGE, ANH, AJX, RSO","publication_date":"2016-07-29 12:37:12 +0000","url":"http://finance.yahoo.com/news/mreits-q2-earnings-watch-aug-123712486.html","summary":"mREITs' Q2 Earnings to Watch on Aug 1: MTGE, ANH, AJX, RSO"},{"title":"Resource Capital Corp. to Report Operating Results for Second Quarter 2016","publication_date":"2016-07-19 13:00:00 +0000","url":"http://finance.yahoo.com/news/capital-corp-report-operating-results-130000243.html","summary":"[GlobeNewswire] - NEW YORK, July 19, 2016-- Resource Capital Corp. announced today that it will release its second quarter 2016 operating results on Monday, August 1, 2016, after market hours, and invites investors and ..."},{"title":"Resource Capital Corp. (RSO) Ex-Dividend Date Scheduled for June 28, 2016","publication_date":"2016-06-27 13:35:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hwyffrL9uvI/resource-capital-corp-rso-ex-dividend-date-scheduled-for-june-28-2016-cm641056","summary":"Resource Capital Corp. ( RSO ) will begin trading ex dividend on June 28, 2016. A cash dividend payment of $0.42 per share is scheduled to be paid on July 28, 2016. Shareholders who purchased RSO prior to the"},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividends for Preferred Stock","publication_date":"2016-06-17 14:19:46 +0000","url":"http://www.publicnow.com/view/EC64A1E416ADC26E232786311CBD1AEAF556381A","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 06/17/16 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today that it will pay a cash dividend on its 8.50% Series A Cumulative Redeemable Preferred Stock ..."},{"title":"Resource Capital Corp. Declares Quarterly Cash Dividend","publication_date":"2016-06-16 20:49:04 +0000","url":"http://www.publicnow.com/view/502291FEB32CF7F2B043B22410283D9253384A09","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 06/16/16 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today that its Board of Directors has declared a cash dividend of $0.42 per common share for the ..."},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-06 20:25:38 +0000","url":"http://biz.yahoo.com/e/160606/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"},{"title":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princip","publication_date":"2016-05-26 10:04:44 +0000","url":"http://biz.yahoo.com/e/160526/rso8-k.html","summary":"RESOURCE CAPITAL CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princip"},{"title":"Financial Sector Update for 05/23/2016: REXI,RSO,GARS,ARES,ACAS,AGNC","publication_date":"2016-05-23 17:24:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f8kskg9tcD0/financial-sector-update-for-05232016-rexirsogarsaresacasagnc-cm625054","summary":"Top Financial Stocks JPM 0.02% BAC 0.07% WFC 0.29% C +0.27% USB 0.07% Financial stocks were narrowly lower Monday, with the NYSE Financial Sector Index slipping about 0.2% while financial companies in the S&P 500 Index were declining just"},{"title":"Local asset manager agrees to be sold to Texas company for $270M","publication_date":"2016-05-23 15:15:30 +0000","url":"http://www.bizjournals.com/philadelphia/morning_roundup/2016/05/local-asset-manager-agrees-to-be-sold-to-texas.html?ana=yahoo","summary":"Local asset manager agrees to be sold to Texas company for $270M"},{"title":"Resource Capital Corp.'s External Manager to Be Acquired by C-III Capital Partners LLC","publication_date":"2016-05-23 11:56:02 +0000","url":"http://www.publicnow.com/view/AC559DF46C0779295A26C4E5F09EA9ECE8133D57","summary":"[at noodls] - PHILADELPHIA, PA -- (Marketwired) -- 05/23/16 -- Resource Capital Corp. (NYSE: RSO) ('RSO'), announced today that Resource America, Inc. (NASDAQ: REXI) ('Resource America'), the parent company of RSO's ..."},{"title":"Resource America To Be Acquired By C-III Capital - Quick Facts","publication_date":"2016-05-23 07:53:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4GlqCJFbkeY/resource-america-to-be-acquired-by-ciii-capital--quick-facts-20160523-00268","summary":"Resource America To Be Acquired By C-III Capital - Quick Facts"},{"title":"Resource Capital Corp's Series A Cumulative Redeemable Preferred Stock Shares Cross 10.5% Yield Mark","publication_date":"2016-05-18 21:55:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Tpr6vXvhAU/resource-capital-corps-series-a-cumulative-redeemable-preferred-stock-shares-cross-105-yield-mark-cm623105","summary":"In trading on Wednesday, shares of Resource Capital Corp's 8.50% Series A Cumulative Redeemable Preferred Stock (Symbol RSO.PRA) were yielding above the 10.5% mark based on its quarterly dividend (annualized to $2.125), with shares changing hands as low as"},{"title":"Edited Transcript of RSO earnings conference call or presentation 3-May-16 12:30pm GMT","publication_date":"2016-05-03 18:07:54 +0000","url":"http://finance.yahoo.com/news/edited-transcript-rso-earnings-conference-180754955.html","summary":"Edited Transcript of RSO earnings conference call or presentation 3-May-16 12:30pm GMT"},{"title":"Resource Capital Corp Earnings Call scheduled for 8:30 am ET today","publication_date":"2016-05-03 12:30:00 +0000","url":"http://biz.yahoo.com/cc/0/151500.html","summary":"Resource Capital Corp Earnings Call scheduled for 8:30 am ET today"},{"title":"Resource Capital Corp. Reports Results for Three Months Ended March 31, 2016","publication_date":"2016-05-03 01:30:10 +0000","url":"http://www.publicnow.com/view/6CE60729ABBEB6A2E1BD79751EFBAEA98E7F7D8C","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 05/02/16 -- Resource Capital Corp. (NYSE: RSO) Highlights and Significant Items Adjusted Funds from Operations ('AFFO') of $0.47 per share-diluted (see Schedule I). GAAP ..."},{"title":"Resource Capital Corp. to Report Operating Results for First Quarter 2016","publication_date":"2016-04-21 13:27:13 +0000","url":"http://www.publicnow.com/view/1A2C72F580714468EC0F3539793B9B467542146A","summary":"[at noodls] - NEW YORK, April 21, 2016 (GLOBE NEWSWIRE) -- Resource Capital Corp. (NYSE:RSO) (the 'Company') announced today that it will release its first quarter 2016 operating results on Monday May 2, 2016, after ..."},{"title":"Ex-Div Reminder for Resource Capital Corp's 8.50% Series A Cumulative Redeemable Preferred Stock","publication_date":"2016-03-28 18:19:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0jcq4PWkk2E/ex-div-reminder-for-resource-capital-corps-850-series-a-cumulative-redeemable-preferred-stock-cm598459","summary":"On 3 30 16, Resource Capital Corp's 8.50% Series A Cumulative Redeemable Preferred Stock (Symbol RSO.PRA) will trade ex dividend, for its quarterly dividend of $0.5312, payable on 5 2 16. As a percentage of RSO.PRA's recent share price"},{"title":"Resource Capital Corp. (RSO) Ex-Dividend Date Scheduled for March 29, 2016","publication_date":"2016-03-28 13:35:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_YhRi81YnHY/resource-capital-corp-rso-ex-dividend-date-scheduled-for-march-29-2016-cm598072","summary":"Resource Capital Corp. ( RSO ) will begin trading ex dividend on March 29, 2016. A cash dividend payment of $0.42 per share is scheduled to be paid on April 28, 2016. Shareholders who purchased RSO prior to the"},{"title":"Resource Capital Approves $50M Securities Buyback Program","publication_date":"2016-03-16 17:53:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jj2Jqt8IeKQ/resource-capital-approves-50m-securities-buyback-program-cm593998","summary":"In a notable development, the board of directors of Resource Capital Corp.RSO has authorized a new securities repurchase program for a maximum amount of $50 million. Of this, $16.5 million capacity remains available under the New York based mortgage"},{"title":"Noront Announces Ammended Debt Arrangements With Resource Capital Fund V HTML","publication_date":"2016-01-04 14:08:30 +0000","url":"http://www.noodls.com/view/4F546071B7BF2651A84E4A458E40BA7081EB37E0","summary":"[at noodls] - TORONTO, ON--(Marketwired - January 04, 2016) - Noront Resources Ltd. ('Noront' or the 'Company') (: ) has entered into an amending agreement dated December 31, 2015 (the 'Amending Agreement') with its ..."},{"title":"Ex-Div Reminder for Resource Capital Corp's 8.50% Series A Cumulative Redeemable Preferred Stock","publication_date":"2015-12-28 21:18:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HS54E7DYhuo/ex-div-reminder-for-resource-capital-corps-850-series-a-cumulative-redeemable-preferred-stock-cm559276","summary":"On 12 30 15, Resource Capital Corp's 8.50% Series A Cumulative Redeemable Preferred Stock (Symbol RSO.PRA) will trade ex dividend, for its quarterly dividend of $0.5312, payable on 2 1 16. As a percentage of RSO.PRA's recent share price"},{"title":"The Zacks Analyst Blog Highlights: Townsquare Media, Resource Capital, NRG Yield, Pattern Energy Group and Swift Transportation","publication_date":"2015-12-18 16:18:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ih6YLas2pI/the-zacks-analyst-blog-highlights-townsquare-media-resource-capital-nrg-yield-pattern-energy-group-and-swift-transportation-cm556392","summary":"For Immediate Release Chicago, IL December 18, 2015 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"},{"title":"Financial Sector Update for 12/17/2015: RSO,MNRK,KCAP","publication_date":"2015-12-17 18:51:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J7i6YxtLo4s/financial-sector-update-for-12172015-rsomnrkkcap-cm556060","summary":"Top Financial Stocks PM 1.57% BAC 1.86% WFC 0.14% C 1.61% USB 0.83% Financial stocks were giving back a portion of yesterday's late day spike, with the NYSE Financial Sector Index falling about 1.2% this afternoon and the S&P"},{"title":"Fed Finally Hikes Rate: Top 5 Winners","publication_date":"2015-12-17 16:21:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AcBXtsAuLp0/fed-finally-hikes-rate-top-5-winners-cm555936","summary":"The Federal Reserve raised its key interest rate for the first time in nearly a decade. This assured investors that the U.S. economy is resilient enough to bear the future increase in borrowing costs. However, the hike in the"},{"title":"The Zacks Analyst Blog Highlights: Ashford Hospitality Prime, Resource Capital, FelCor Lodging Trust, Starwood Waypoint Residential Trust and LaSalle Hotel Properties","publication_date":"2015-12-16 16:19:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vzXJ903crWI/the-zacks-analyst-blog-highlights-ashford-hospitality-prime-resource-capital-felcor-lodging-trust-starwood-waypoint-residential-trust-and-lasalle-hotel-properties-cm555466","summary":"For Immediate Release Chicago, IL December 16, 2015 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"},{"title":"Wellgreen Platinum Signs C$11.4 Million Financing Package led by Resource Capital Fund VI L.P.","publication_date":"2015-11-04 23:28:03 +0000","url":"http://www.noodls.com/view/0470029E197AC2639E9E9A48C7196BA78B1F862D","summary":"[at noodls] - November 4, 2015 - Vancouver, BC - Wellgreen Platinum Ltd. ('Wellgreen Platinum' or the 'Company') (TSX: WG; OTC-QX: WGPLF) is pleased to announce that it has entered into definitive agreements with investors ..."},{"title":"Resource Capital Corp. to Report Operating Results for Third Quarter 2015","publication_date":"2015-10-15 21:02:14 +0000","url":"http://www.noodls.com/view/35463EA02AFBBA1CF12DACC9D3E73B7E31C45202","summary":"[at noodls] - NEW YORK, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Resource Capital Corp. (NYSE:RSO) (the 'Company') announced today that it will release its third quarter 2015 operating results on Tuesday, November 3, 2015, ..."},{"title":"Resource Capital Corp. Announces New $250 Million Facility With Morgan Stanley Bank, N.A.","publication_date":"2015-09-15 20:09:09 +0000","url":"http://www.noodls.com/view/4C549BFC81820286024EC5F36FCEEE156694A711","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 09/15/15 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today that it has entered into a new $250 million commercial real estate term financing facility ..."},{"title":"Resource Capital Corp. Announces Effectiveness of Reverse Stock Split","publication_date":"2015-08-31 21:53:13 +0000","url":"http://www.noodls.com/view/004E18C50EB750764445BDE5B2422723B251C6D3","summary":"[at noodls] - NEW YORK, NY -- (Marketwired) -- 08/31/15 -- Resource Capital Corp. (NYSE: RSO) (the 'Company') announced today the effectiveness of its previously disclosed one-for-four reverse stock split of the Company's ..."},{"title":"Resource Capital Fund Confirms Voting Support for Merger of Uranium Resources and Anatolia","publication_date":"2015-08-26 12:51:08 +0000","url":"http://www.noodls.com/view/299DF4CA04AA95D81361B776149126FD78C64CFE","summary":"[at noodls] - CENTENNIAL, Colo. & PERTH, Australia--(BUSINESS WIRE)-- Uranium Resources, Inc. (Nasdaq: URRE; URI) and Anatolia EnergyLimited (ASX: AEK) jointly announce that URI's 24% shareholder Resource Capital Fund ..."},{"title":"Resource Capital posts 4Q profit","publication_date":"2015-02-26 14:24:54 +0000","url":"http://sg.finance.yahoo.com/news/capital-posts-4q-profit-114306668.html","summary":"Resource Capital posts 4Q profit"},{"title":"Resource Capital posts 3Q profit","publication_date":"2014-11-04 10:03:45 +0000","url":"http://sg.finance.yahoo.com/news/capital-posts-3q-profit-100345903--finance.html","summary":"Resource Capital posts 3Q profit"}],"result_count":102,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1491054259,"trigger": "MARK AT OR ABOVE 9.95","triggerPrice":9.95,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"9.8"},{"x":"1490967300","y":"9.8"},{"x":"1490967600","y":"9.73"},{"x":"1490967900","y":"9.78"},{"x":"1490968200","y":"9.75"},{"x":"1490968500","y":"9.73"},{"x":"1490969100","y":"9.73"},{"x":"1490969400","y":"9.74"},{"x":"1490969700","y":"9.74"},{"x":"1490970000","y":"9.725"},{"x":"1490970300","y":"9.73"},{"x":"1490970600","y":"9.73"},{"x":"1490970900","y":"9.75"},{"x":"1490971200","y":"9.75"},{"x":"1490971500","y":"9.74"},{"x":"1490971800","y":"9.74"},{"x":"1490972100","y":"9.73"},{"x":"1490972400","y":"9.73"},{"x":"1490972700","y":"9.73"},{"x":"1490973000","y":"9.76"},{"x":"1490973300","y":"9.7501"},{"x":"1490973600","y":"9.75"},{"x":"1490973900","y":"9.75"},{"x":"1490974200","y":"9.755"},{"x":"1490974500","y":"9.76"},{"x":"1490974800","y":"9.73"},{"x":"1490975100","y":"9.735"},{"x":"1490975400","y":"9.74"},{"x":"1490975700","y":"9.745"},{"x":"1490976000","y":"9.79"},{"x":"1490976300","y":"9.79"},{"x":"1490976600","y":"9.8"},{"x":"1490976900","y":"9.79"},{"x":"1490977200","y":"9.83"},{"x":"1490977500","y":"9.821"},{"x":"1490977800","y":"9.81"},{"x":"1490978100","y":"9.8"},{"x":"1490978400","y":"9.81"},{"x":"1490979000","y":"9.82"},{"x":"1490979300","y":"9.8"},{"x":"1490979600","y":"9.78"},{"x":"1490979900","y":"9.78"},{"x":"1490980200","y":"9.79"},{"x":"1490980500","y":"9.82"},{"x":"1490980800","y":"9.81"},{"x":"1490981100","y":"9.815"},{"x":"1490981400","y":"9.81"},{"x":"1490981700","y":"9.83"},{"x":"1490982000","y":"9.825"},{"x":"1490982300","y":"9.825"},{"x":"1490982600","y":"9.825"},{"x":"1490982900","y":"9.81"},{"x":"1490983200","y":"9.8"},{"x":"1490983500","y":"9.8"},{"x":"1490983800","y":"9.8"},{"x":"1490984100","y":"9.8"},{"x":"1490984400","y":"9.81"},{"x":"1490984700","y":"9.82"},{"x":"1490985000","y":"9.815"},{"x":"1490985300","y":"9.81"},{"x":"1490985600","y":"9.81"},{"x":"1490985900","y":"9.82"},{"x":"1490986200","y":"9.815"},{"x":"1490986500","y":"9.81"},{"x":"1490986800","y":"9.8"},{"x":"1490987100","y":"9.8"},{"x":"1490987400","y":"9.8"},{"x":"1490987700","y":"9.805"},{"x":"1490988000","y":"9.8"},{"x":"1490988300","y":"9.815"},{"x":"1490988600","y":"9.82"},{"x":"1490988900","y":"9.805"},{"x":"1490989200","y":"9.8"},{"x":"1490989500","y":"9.8"},{"x":"1490989800","y":"9.81"},{"x":"1490990100","y":"9.78"},{"x":"1490990400","y":"9.77"} ], "color":"#03a9f4"}]},
{"id":"9","list":"Alerts","symbol": "SFUN","name": "Fang Holdings Limited American Depositary Shares (Each representing Four Class A Ordinary Shares HK$1.00 par value)","price": 3.26,"dollarChange": 0.6,"percentChange": 22.56,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/SFUN-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/SFUN-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/SFUN-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/SFUN-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/SFUN-1yr.php","open": 2.56,"high": 3.3,"low":2.56,"volume": 16950684,"avgVol": 2910362.483333,"sharesShort": 22952672,"shortPercent": 4.894037,"marketCap": 1397597962,"float": 468992605,"headlines":{"data":[{"title":"Edited Transcript of SFUN earnings conference call or presentation 31-Mar-17 12:00pm GMT","publication_date":"2017-03-31 23:56:01 +0000","url":"http://finance.yahoo.com/news/edited-transcript-sfun-earnings-conference-235601297.html","summary":"Edited Transcript of SFUN earnings conference call or presentation 31-Mar-17 12:00pm GMT"},{"title":"Pawar Law Group Announces Investigation of Securities Claims Against Fang Holdings Ltd. - SFUN","publication_date":"2017-03-31 20:49:00 +0000","url":"http://finance.yahoo.com/news/pawar-law-group-announces-investigation-204900872.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 31, 2017 / The Pawar Law Group announces it is investigating potential securities claims on behalf of shareholders of Fang Holdings Ltd. (NYSE: SFUN) resulting from allegations ..."},{"title":"Why Fang Holdings Ltd. Stock Skyrocketed Today","publication_date":"2017-03-31 17:26:13 +0000","url":"https://www.fool.com/investing/2017/03/31/why-fang-holdings-ltd-stock-skyrocketed-today.aspx","summary":"Why Fang Holdings Ltd. Stock Skyrocketed Today"},{"title":"SouFun reports 4Q loss","publication_date":"2017-03-31 11:58:41 +0000","url":"http://sg.finance.yahoo.com/news/soufun-reports-4q-loss-115841681.html","summary":"[AP] - On a per-share basis, the Beijing-based company said it had a loss of 2 cents. The real estate internet company posted revenue of $174.7 million in the period. For the year, the company reported that its ..."},{"title":"7:47 am Fang reports EPS in-line, misses on revs; sees profitable FY17 on lower revenue (consensus +11%)","publication_date":"2017-03-31 11:47:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#sfun","summary":"7:47 am Fang reports EPS in-line, misses on revs; sees profitable FY17 on lower revenue (consensus +11%)"},{"title":"Q4 2016 Fang Holdings Ltd Earnings Release - Before Market Open","publication_date":"2017-03-31 11:07:04 +0000","url":"http://biz.yahoo.com/research/earncal/20170331.html?t=sfun","summary":"Q4 2016 Fang Holdings Ltd Earnings Release - Before Market Open"},{"title":"Fang Announces Fourth Quarter and Fiscal Year 2016 Results","publication_date":"2017-03-31 11:00:00 +0000","url":"http://finance.yahoo.com/news/fang-announces-fourth-quarter-fiscal-110000926.html","summary":"[PR Newswire] - BEIJING, March 31, 2017 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) (\"Fang\" or \"we\"), the leading real estate Internet portal in China, today announced its unaudited financial ..."},{"title":"Fang Expects Decrease In Revenue But Profitable For Whole Year 2017","publication_date":"2017-03-31 07:59:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HOnfN5a0Qh4/fang-expects-decrease-in-revenue-but-profitable-for-whole-year-2017-20170331-00333","summary":"Fang Expects Decrease In Revenue But Profitable For Whole Year 2017"},{"title":"SouFun Holdings Q4 16 Earnings Conference Call At 8:00 AM ET","publication_date":"2017-03-31 07:00:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/td13y47n8DU/soufun-holdings-q4-16-earnings-conference-call-at-800-am-et-20170331-00216","summary":"SouFun Holdings Q4 16 Earnings Conference Call At 8:00 AM ET"},{"title":"Pre-Market Earnings Report for March 31, 2017 : BBRY, SFUN, SORL, QRHC","publication_date":"2017-03-30 20:19:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R7EG1nyiZTw/pre-market-earnings-report-for-march-31-2017-bbry-sfun-sorl-qrhc-cm768004","summary":"The following companies are expected to report earnings prior to market open on 03 31 2017 Visit our Earnings Calendar for a full list of expected earnings releases BlackBerry Limited BBRY is reporting for the quarter ending February 28 2017 The"},{"title":"The SFUN Paradox: Analysts Bearish But Forecast 85.31% Gains","publication_date":"2017-03-30 14:09:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jENF9Cgd83U/the-sfun-paradox-analysts-bearish-but-forecast-8531-gains-cm767605","summary":"Analyst ratings can sometimes be complicated and we here at ETF Channel have noticed a bit of a paradox with Fang Holdings Ltd Symbol SFUN The average 12 month price target for SFUN averaging the work of 4 analysts reveals an average price target of 5 02 share That s a whopping 85"},{"title":"Alliqua BioMedical, SCANA Drop into Wednesday’s 52-Week Low Club","publication_date":"2017-03-29 20:04:19 +0000","url":"http://finance.yahoo.com/news/alliqua-biomedical-scana-drop-wednesday-200419739.html","summary":"Alliqua BioMedical, SCANA Drop into Wednesday’s 52-Week Low Club"},{"title":"FANG NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Fang Holdings Limited To Contact The Firm","publication_date":"2017-03-29 19:08:00 +0000","url":"http://finance.yahoo.com/news/fang-notification-faruqi-faruqi-llp-190800119.html","summary":"[PR Newswire] - NEW YORK, March 29, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Fang Holdings Limited (\"Fang\" or the \"Company\") ..."},{"title":"EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Fang Holdings Limited - SFUN","publication_date":"2017-03-29 18:28:00 +0000","url":"http://finance.yahoo.com/news/equity-alert-rosen-law-firm-182800178.html","summary":"[Business Wire] - Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Fang Holdings Limited resulting from allegations that Fang Holdings may have issued materially misleading business information to the investing public."},{"title":"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Fang Holdings Limited (SFUN)","publication_date":"2017-03-29 17:44:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-174400953.html","summary":"[PR Newswire] - NEW YORK, March 29, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fang Holdings Limited (\"Fang Holdings\" ..."},{"title":"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fang Holdings Limited - SFUN","publication_date":"2017-03-29 16:42:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-164200373.html","summary":"[PR Newswire] - NEW YORK, March 29, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fang Holdings Limited (\"Fang\" or the \"Company\") (NYSE: SFUN). Such investors ..."},{"title":"Fang Holdings Limited to Report Fourth Quarter and Full Year 2016 Financial Results on March 31, 2017","publication_date":"2017-03-24 10:00:00 +0000","url":"http://finance.yahoo.com/news/fang-holdings-limited-report-fourth-100000536.html","summary":"[PR Newswire] - BEIJING, March 24, 2017 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN ) ( \"Fang\" or \"we\"), the leading real estate Internet portal in China, today announced that it will report ..."},{"title":"Market Recon: Watch the Euro and Big Banks Like Deutsche and Credit Suisse","publication_date":"2017-03-09 11:44:00 +0000","url":"https://www.thestreet.com/story/14034236/1/market-recon-watch-the-euro-and-big-banks-like-deutsche-and-credit-suisse.html?puc=yahoo&cm_ven=YAHOO","summary":"Market Recon: Watch the Euro and Big Banks Like Deutsche and Credit Suisse"},{"title":"Asian ADRs Move Lower in Tuesday Trading","publication_date":"2017-02-28 15:50:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kQJCqW9mhc8/asian-adrs-move-lower-in-tuesday-trading-cm754189","summary":"American depository receipts of Asian stocks were trading 0 18 lower at 151 67 on the Bank of New York Mellon Asia ADR Index on Tuesday American depository receipts of Asian stocks were trading 0 18 lower at 151 67 on the Bank of New York Mellon Asia ADR Index on Tuesday In North Asia"},{"title":"Fang downgraded by Morgan Stanley","publication_date":"2017-02-24 11:16:13 +0000","url":"http://finance.yahoo.com/q/ud?s=SFUN","summary":"Fang downgraded by Morgan Stanley"},{"title":"Fang Enters into Agreement to Terminate the Restructuring","publication_date":"2017-02-21 12:17:00 +0000","url":"http://finance.yahoo.com/news/fang-enters-agreement-terminate-restructuring-121700212.html","summary":"[PR Newswire] - BEIJING, Feb. 21, 2017 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) (\"we,\" \"our,\" or \"Fang\"), the leading real estate Internet portal in China, today announced that ..."},{"title":"Fang To End Proposed Acquisition Of Wanli Controlling Stake - Quick Facts","publication_date":"2017-02-21 07:29:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L9ixrg3vh7E/fang-to-end-proposed-acquisition-of-wanli-controlling-stake--quick-facts-20170221-00459","summary":"Fang To End Proposed Acquisition Of Wanli Controlling Stake - Quick Facts"},{"title":"[$$] China's Property Market Has a New Blind Spot","publication_date":"2017-02-14 09:49:09 +0000","url":"https://www.wsj.com/articles/chinas-property-market-has-a-new-blind-spot-1487065745?mod=yahoo_hs","summary":"[at The Wall Street Journal] - A private-sector data provider has quietly stopped publishing a widely watched barometer of China’s property market that was one of the few alternatives to an official gauge, leaving a hole in a government-dominated ..."},{"title":"Amkor buying Portuguese semiconductor packaging solutions company","publication_date":"2017-02-02 18:25:07 +0000","url":"http://www.bizjournals.com/phoenix/news/2017/02/02/amkor-buying-portuguese-semiconductor-packaging.html?ana=yahoo","summary":"[at American City Business Journals] - Tempe-based Amkor Technology Inc. is acquiring a Portuguese semiconductor packaging solutions company. Amkor (AMKR), one of the world’s largest providers of outsourced semiconductor packaging and test services, said it is acquiring Porto, Portugal-based Nanium S.A. to strengthen the company’s position in the fast-growing market of wafer-level packaging for smartphones, tablets and other applications. “This strategic acquisition will enhance Amkor’s position as one of the leading providers of WLP (wafer-level packaging) and WLFO (wafer-level fan-out) packaging solutions,” said Steve Kelley, Amkor’s president and chief executive officer."},{"title":"Will Fang Holdings (SFUN) Continue to Surge Higher?","publication_date":"2017-01-05 15:42:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6hnYUOtihNw/will-fang-holdings-sfun-continue-to-surge-higher-cm729777","summary":"As of late it has definitely been a great time to be an investor in Fang Holdings Limited SFUN The stock has moved higher by 10 3 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that the"},{"title":"Will Fang Holdings (SFUN) Continue to Surge Higher?","publication_date":"2017-01-05 13:19:01 +0000","url":"http://finance.yahoo.com/news/fang-holdings-sfun-continue-surge-131901961.html","summary":"Will Fang Holdings (SFUN) Continue to Surge Higher?"},{"title":"ETFs with exposure to Fang Holdings Ltd. : January 4, 2017","publication_date":"2017-01-04 16:30:25 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-fang-holdings-ltd-january-4-2017/","summary":"ETFs with exposure to Fang Holdings Ltd. : January 4, 2017"},{"title":"China's Property Market Is Freezing Up: Sell This Stock Now","publication_date":"2016-12-15 02:13:00 +0000","url":"http://blogs.barrons.com/asiastocks/2016/12/14/chinas-property-market-is-freezing-up-sell-this-stock-now/?mod=yahoobarrons&ru=yahoo","summary":"[at Barrons.com] - China's property market will go through a long winter as the government launches restrictive policies to avoid another home price bubble. Deutsche Bank's Alvin Jiang and Alan Hellawell downgraded online real estate portals Soufun (SFUN) to Sell and 58.com (WUBA) to Neutral today. The analysts wrote: Both the online property transaction business and the related listing business are suffering from the cold property market."},{"title":"Fang Provides Update on Restructuring","publication_date":"2016-12-13 12:13:00 +0000","url":"http://finance.yahoo.com/news/fang-provides-restructuring-121300818.html","summary":"[PR Newswire] - BEIJING, Dec. 13, 2016 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) (\"we,\" \"our,\" or \"Fang\"), the leading real estate Internet portal in China, today provided a further ..."},{"title":"Fang Updates On Chongqing Wanli New Energy Restructuring","publication_date":"2016-12-13 07:22:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2vbnUcbcs6E/fang-updates-on-chongqing-wanli-new-energy-restructuring-20161213-00219","summary":"Fang Updates On Chongqing Wanli New Energy Restructuring"},{"title":"Near a 3-Year Low, Is 58.com Inc. (ADR) a Buy?","publication_date":"2016-12-09 16:59:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aUT8JfvQ7Fo/near-a-3-year-low-is-58com-inc-adr-a-buy-cm719333","summary":"With the market near all time highs it can be tough for contrarian investors to find decent stocks that have fallen to multi year lows But as I perused that list of hated stocks one Chinese stock 58 com NYSE WUBA stood out 58 com posted double or triple digit sales"},{"title":"Near a 3-Year Low, Is 58.com Inc. (ADR) a Buy?","publication_date":"2016-12-09 15:19:06 +0000","url":"http://www.fool.com/investing/2016/12/09/near-a-3-year-low-is-58com-inc-adr-a-buy.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2","summary":"Near a 3-Year Low, Is 58.com Inc. (ADR) a Buy?"},{"title":"Is Convergys Corporation (CVG) a Good Stock to Invest in?","publication_date":"2016-12-05 17:04:56 +0000","url":"http://www.insidermonkey.com/blog/is-convergys-corporation-cvg-a-good-stock-to-invest-in-497689/","summary":"Is Convergys Corporation (CVG) a Good Stock to Invest in?"},{"title":"Post Earnings Coverage as Fang Q3 Topline Rise on Ecommerce Revenues","publication_date":"2016-12-05 13:15:00 +0000","url":"http://finance.yahoo.com/news/post-earnings-coverage-fang-q3-131500687.html","summary":"[Accesswire] - Upcoming AWS Coverage on 58.com Post-Earnings Results LONDON, UK / ACCESSWIRE / December 5, 2016 / Active Wall St. announces its post-earnings coverage on Fang Holdings Ltd (NYSE: SFUN ). The Company reported ..."},{"title":"ETFs with exposure to Fang Holdings Ltd. : December 1, 2016","publication_date":"2016-12-01 16:48:06 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-fang-holdings-ltd-december-1-2016/","summary":"ETFs with exposure to Fang Holdings Ltd. : December 1, 2016"},{"title":"After Hours Most Active for Nov 30, 2016 : FDC, INFO, MSFT, BAC, SFUN, BMY, AAPL, SIRI, INTC, NRG, EPD, SGEN","publication_date":"2016-11-30 22:05:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wDDkHgW8sU0/after-hours-most-active-for-nov-30-2016-fdc-info-msft-bac-sfun-bmy-aapl-siri-intc-nrg-epd-sgen-cm716039","summary":"The NASDAQ 100 After Hours Indicator is up 1 54 to 4 812 35 The total After hours volume is currently 93 435 420 shares traded The following are the most active stocks for the after hours session First Data Corporation FDC is unchanged at 14 57 with 11 101 653"},{"title":"Fang Holdings Ltd. :SFUN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016","publication_date":"2016-11-30 14:38:08 +0000","url":"http://www.capitalcube.com/blog/index.php/fang-holdings-ltd-sfun-us-earnings-analysis-q3-2016-by-the-numbers-november-30-2016/","summary":"Fang Holdings Ltd. :SFUN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016"},{"title":"Company News for November 29, 2016","publication_date":"2016-11-29 16:57:07 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oH5F3yYiunY/company-news-for-november-29-2016-cm715144","summary":"160 160 160 Shares of Cognizant Technology Solutions Corp CTSH surged 7 after activist investor Elliot Management said he wants the company to boost profitability and return more of its cash to shareholders 160 160 160 Shares of PhaseRx Inc PZRX climbed almost"},{"title":"Why Fang Holdings Ltd. Stock Plunged Today","publication_date":"2016-11-28 22:54:25 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7mXNXYlLra0/why-fang-holdings-ltd-stock-plunged-today-cm714772","summary":"Shanghai skyscrapers Image source Getty Images What happened Shares of Fang Holdings Ltd NYSE SFUN were down 12 2 as of 2 47 p m EST after the Chinese online real estate portal released weaker than expected third quarter 2016 results So what Quarterly revenue rose"},{"title":"Why Fang Holdings Ltd. Stock Plunged Today","publication_date":"2016-11-28 21:18:00 +0000","url":"http://www.fool.com/investing/2016/11/28/why-fang-holdings-ltd-stock-plunged-today.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news","summary":"Why Fang Holdings Ltd. Stock Plunged Today"},{"title":"Mid-Day Market Update: Crude Oil Up Over 2%; PhaseRx Shares Spike Higher","publication_date":"2016-11-28 18:58:17 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F9OxA0UjwO4/mid-day-market-update-crude-oil-up-over-2-phaserx-shares-spike-higher-cm714624","summary":"Midway through trading Monday the Dow traded down 0 24 percent to 19 106 29 while the NASDAQ declined 0 24 percent to 5 386 02 The S amp P also fell dropping 0 30 percent to 2 206 79 Leading and Lagging Sectors On Monday utilities shares gained by 1 06 percent Meanwhile"},{"title":"Mid-Morning Market Update: Markets Open Lower; Edwards Lifesciences To Buy Valtech Cardio","publication_date":"2016-11-28 16:15:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NNBF4gFRiLU/mid-morning-market-update-markets-open-lower-edwards-lifesciences-to-buy-valtech-cardio-cm714527","summary":"Following the market opening Monday the Dow traded down 0 28 percent to 19 098 52 while the NASDAQ declined 0 20 percent to 5 387 90 The S amp P also fell dropping 0 23 percent to 2 208 35 Leading and Lagging Sectors Monday morning utilities shares gained by 0 68"},{"title":"Edited Transcript of SFUN earnings conference call or presentation 28-Nov-16 1:00pm GMT","publication_date":"2016-11-28 15:16:03 +0000","url":"http://finance.yahoo.com/news/edited-transcript-sfun-earnings-conference-151603181.html","summary":"Edited Transcript of SFUN earnings conference call or presentation 28-Nov-16 1:00pm GMT"},{"title":"Wall Street Falters But Oil Rebounds after Report Says Iraq will Cooperate with OPEC Members","publication_date":"2016-11-28 14:50:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f41XwJXe4xI/wall-street-falters-but-oil-rebounds-after-report-says-iraq-will-cooperate-with-opec-members-cm714417","summary":"U S stocks were pointing to a lower open on Monday potentially halting a four day winning streak for the Dow Jones Industrial Average and the S amp P 500 U S stocks were pointing to a lower open on Monday potentially halting a four day winning streak for the Dow Jones Industrial Average and"},{"title":"U.S. Futures Tumble Along with Oil as OPEC Deal Looks Elusive","publication_date":"2016-11-28 13:50:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/35JvBpJRJ68/us-futures-tumble-along-with-oil-as-opec-deal-looks-elusive-cm714354","summary":"U S stock futures pointed to modest losses on Monday potentially halting a four day winning streak for the Dow Jones Industrial Average and the S amp P 500 U S stock futures pointed to modest losses on Monday potentially halting a four day winning streak for the Dow Jones Industrial Average"},{"title":"Fang Holdings Ltd Earnings Call scheduled for 8:00 am ET today","publication_date":"2016-11-28 13:00:00 +0000","url":"http://biz.yahoo.com/cc/9/154979.html","summary":"Fang Holdings Ltd Earnings Call scheduled for 8:00 am ET today"},{"title":"Q3 2016 Fang Holdings Ltd Earnings Release - Before Market Open","publication_date":"2016-11-28 12:07:03 +0000","url":"http://biz.yahoo.com/research/earncal/20161128.html?t=sfun","summary":"Q3 2016 Fang Holdings Ltd Earnings Release - Before Market Open"},{"title":"SouFun reports 3Q loss","publication_date":"2016-11-28 11:46:34 +0000","url":"http://sg.finance.yahoo.com/news/soufun-reports-3q-loss-114634764.html","summary":"[AP] - On a per-share basis, the Beijing-based company said it had a loss of 1 cent. Losses, adjusted for investment gains, came to 3 cents per share. The real estate Internet company posted revenue of $250.1 ..."},{"title":"Fang Announces Third Quarter 2016 Results","publication_date":"2016-11-28 11:30:00 +0000","url":"http://finance.yahoo.com/news/fang-announces-third-quarter-2016-113000498.html","summary":"[PR Newswire] - BEIJING, Nov. 28, 2016 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) (\"we,\" \"our,\" or \"Fang\"), the leading real estate Internet portal in China, announced today its unaudited ..."},{"title":"Pre-Market Earnings Report for November 28, 2016 : SFUN, LEJU","publication_date":"2016-11-27 21:20:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ih4WRW7kCvI/pre-market-earnings-report-for-november-28-2016-sfun-leju-cm714273","summary":"The following companies are expected to report earnings prior to market open on 11 28 2016 Visit our Earnings Calendar for a full list of expected earnings releases Fanf Holdings Limited SFUN is reporting for the quarter ending September 30 2016"},{"title":"Pre-Market Earnings Report for November 28, 2016 : SFUN, LEJU","publication_date":"2016-11-25 21:14:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FEM6lOaM4m8/pre-market-earnings-report-for-november-28-2016-sfun-leju-cm714123","summary":"The following companies are expected to report earnings prior to market open on 11 28 2016 Visit our Earnings Calendar for a full list of expected earnings releases Fanf Holdings Limited SFUN is reporting for the quarter ending September 30 2016"},{"title":"Fang Holdings Limited to Report Third Quarter 2016 Financial Results on November 28, 2016","publication_date":"2016-11-18 11:10:18 +0000","url":"http://www.publicnow.com/view/173D65A1480B28CF68D1D6B275D067302D50255B","summary":"[at noodls] - BEIJING, Nov. 18, 2016 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN, 'Fang' or 'we'), the leading real estate Internet portal in China, today announced that it will report its unaudited third quarter ..."},{"title":"Fang Holdings Limited to Report Third Quarter 2016 Financial Results on November 28, 2016","publication_date":"2016-11-18 10:30:00 +0000","url":"http://finance.yahoo.com/news/fang-holdings-limited-report-third-103000893.html","summary":"[PR Newswire] - BEIJING, Nov. 18, 2016 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN, \"Fang\" or \"we\"), the leading real estate Internet portal in China, today announced that it will report its ..."},{"title":"NOTICE OF REPURCHASE RIGHT AT THE OPTION OF THE HOLDER TO HOLDERS OF 2.00% CONVERTIBLE SENIOR NOTES DUE 2018 OF FANG HOLDINGS LIMITED","publication_date":"2016-11-16 09:28:05 +0000","url":"http://www.publicnow.com/view/83EA571C6A3028F69112AA1BE6D80283F2E30037","summary":"[at noodls] - NOTICE OF REPURCHASE RIGHT AT THE OPTION OF THE HOLDER TO HOLDERS OF 2.00% CONVERTIBLE SENIOR NOTES DUE 2018 OF FANG HOLDINGS LIMITED 1 CUSIP Number 836034AB4 This purchase right expires at 5:00 p.m., ..."},{"title":"Financial Sector Update for 11/11/2016: AKR,KNSL,SFUN","publication_date":"2016-11-11 18:47:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WtCkcnjaDmA/financial-sector-update-for-11112016-akrknslsfun-cm708022","summary":"Top Financial StocksTop Financial Stocks JPM 0 46 JPM 0 46 BAC 1 09 BAC 1 09 WFC 0 29 WFC 0 29 C 2 13 C 2 13 USB 0 33 USB 0 33 Financial stocks were little changed this afternoon erasing small declines earlier in today s session The NYSE Financial Sector Index recently was"},{"title":"Fang Announces Dismissal of Securities Class Action Claims","publication_date":"2016-11-11 09:10:10 +0000","url":"http://www.publicnow.com/view/4DDA81DAD4518D46F2D17341CB7F21B546762587","summary":"[at noodls] - BEIJING, Nov. 11, 2016 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) ('Fang,'the 'Company,' 'we' or 'our'), the leading real estate Internet portal in China, today announced that the United States ..."},{"title":"Fang Announces Appointment of Dr. Hua Lei as CFO","publication_date":"2016-11-01 11:13:07 +0000","url":"http://www.publicnow.com/view/5986B894ECA7DFB782B107AF68728E532DFDD08F","summary":"[at noodls] - BEIJING, Nov. 1, 2016 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) ('Fang,' the 'Company,' 'we' or 'our'), the leading real estate Internet portal in China, announced the appointment of Dr. Hua Lei ..."},{"title":"How The Parts Add Up: PGJ Headed For $38","publication_date":"2016-10-25 14:24:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CBtPfnmF_0A/how-the-parts-add-up-pgj-headed-for-38-cm697672","summary":"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For"},{"title":"Business Services Stock Outlook - October 2016","publication_date":"2016-10-21 21:23:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BSYg51h48b0/business-services-stock-outlook-october-2016-cm696742","summary":"The business services sector provides ancillary services to the other players in the market Hence the core business of one company in this sector can be a business service for another Importantly this dynamism opens the door to many business services companies Notably business"},{"title":"Bristol-Myers, Staples Fall into Monday’s 52-Week Low Club","publication_date":"2016-10-10 20:04:53 +0000","url":"http://247wallst.com/investing/2016/10/10/bristol-myers-staples-fall-into-mondays-52-week-low-club/","summary":"Bristol-Myers, Staples Fall into Monday’s 52-Week Low Club"},{"title":"FANG HOLDINGS LTD Financials","publication_date":"2016-09-27 17:04:07 +0000","url":"http://finance.yahoo.com/q/is?s=sfun&annual","summary":"FANG HOLDINGS LTD Financials"},{"title":"China's Property Markets Continue To Bloom Even As More Cities Curb Buying","publication_date":"2016-09-27 05:17:00 +0000","url":"http://blogs.barrons.com/asiastocks/2016/09/27/chinas-property-markets-continue-to-bloom-even-as-more-cities-curb-buying/?mod=yahoobarrons&ru=yahoo","summary":"China's Property Markets Continue To Bloom Even As More Cities Curb Buying"},{"title":"Fang Announces Appointment of New Acting CFO","publication_date":"2016-09-22 10:41:09 +0000","url":"http://www.publicnow.com/view/D964EBC1D262F24595F843A1AA47844224A5B080","summary":"[at noodls] - BEIJING, Sept. 22, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) ('Fang,' the 'Company,' 'we' or 'our'), the leading real estate Internet portal in China, today announced the appointment of ..."},{"title":"Analysts Forecast 10% Upside For FNI","publication_date":"2016-09-20 14:21:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OLbFPXOH1BU/analysts-forecast-10-upside-for-fni-cm681914","summary":"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the"},{"title":"Fang Announces Results of 2016 Annual General Meeting","publication_date":"2016-09-17 09:58:07 +0000","url":"http://www.publicnow.com/view/AAFF57927DC5C10F0C8719F5F76EC70E27E2CAD1","summary":"[at noodls] - BEIJING, Sept. 9, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) ('Fang,' 'we' or 'our'), the leading real estate Internet portal in China, today announced that it held its 2016 annual general ..."},{"title":"Less loved but good value; investors in Asia look to buy on the cheap","publication_date":"2016-09-16 02:04:16 +0000","url":"http://sg.finance.yahoo.com/news/less-loved-good-value-investors-014859990.html","summary":"Less loved but good value; investors in Asia look to buy on the cheap"},{"title":"Fang Announces Results of 2016 Annual General Meeting","publication_date":"2016-09-09 08:20:03 +0000","url":"http://www.publicnow.com/view/A248684A9EA17DE66128988A90E830C29E6EBFBF","summary":"[at noodls] - BEIJING, Sept. 9, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) ('Fang,' 'we' or 'our'), the leading real estate Internet portal in China, today announced that it held its 2016 annual general ..."},{"title":"Liberty Tax (TAX) Incurs Q1 Loss as Expected; Revenues Fall","publication_date":"2016-09-05 15:17:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SILj6kfFQLw/liberty-tax-tax-incurs-q1-loss-as-expected-revenues-fall-cm674651","summary":"Liberty Tax Service s parent company Liberty Tax Inc TAX reported first quarter fiscal 2017 ending Jul 31 net loss of 68 cents per share in line with the Zacks Consensus Estimate Quarterly loss was a cent wider than the year ago loss Lower revenues were held responsible for"},{"title":"Liberty Tax (TAX) Incurs Q1 Loss as Expected; Revenues Fall","publication_date":"2016-09-05 13:05:01 +0000","url":"http://finance.yahoo.com/news/liberty-tax-tax-incurs-q1-130501446.html","summary":"Liberty Tax (TAX) Incurs Q1 Loss as Expected; Revenues Fall"},{"title":"JPMorgan Releases A Barrage Of Coverage On Chinese Internet Stocks","publication_date":"2016-08-31 19:48:20 +0000","url":"http://finance.yahoo.com/news/jpmorgan-releases-barrage-coverage-chinese-194820572.html","summary":"JPMorgan Releases A Barrage Of Coverage On Chinese Internet Stocks"},{"title":"SouFun (SFUN) Stock Gains Despite CLSA Downgrade","publication_date":"2016-08-26 18:32:00 +0000","url":"https://www.thestreet.com/story/13686954/1/soufun-sfun-stock-gains-despite-clsa-downgrade.html?puc=yahoo&cm_ven=YAHOO","summary":"SouFun (SFUN) Stock Gains Despite CLSA Downgrade"},{"title":"1 Wall Street Pro Is Souring on SouFun","publication_date":"2016-08-26 16:30:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a7z8r0Tpl30/1-wall-street-pro-is-souring-on-soufun-cm670804","summary":"Image source The Motley Fool. Life's not getting any easier for SouFun (NYSE SFUN)  investors. CLSA analyst Man Ho Lam is downgrading shares of the online housing portal this morning, slashing his"},{"title":"1 Wall Street Pro Is Souring on SouFun","publication_date":"2016-08-26 15:08:00 +0000","url":"http://www.fool.com/investing/2016/08/26/1-wall-street-pro-is-souring-on-soufun.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2","summary":"1 Wall Street Pro Is Souring on SouFun"},{"title":"SouFun (SFUN) Q2 Loss Narrower Than Expected, View Intact","publication_date":"2016-08-26 14:48:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S3b-7ioowDM/soufun-sfun-q2-loss-narrower-than-expected-view-intact-cm670605","summary":"SouFun Holdings Ltd.SFUN reported operating net loss of 9 cents per share in the second quarter of 2016, narrower than the Zacks Consensus Estimate of a loss of 10 cents. The company had earned 4 cents per"},{"title":"SouFun (SFUN) Q2 Loss Narrower Than Expected, View Intact","publication_date":"2016-08-26 12:59:12 +0000","url":"http://finance.yahoo.com/news/soufun-sfun-q2-loss-narrower-125912587.html","summary":"SouFun (SFUN) Q2 Loss Narrower Than Expected, View Intact"},{"title":"Why SouFun (SFUN) Stock Is Slumping Today","publication_date":"2016-08-25 15:51:00 +0000","url":"https://www.thestreet.com/story/13685589/1/why-soufun-sfun-stock-is-slumping-today.html?puc=yahoo&cm_ven=YAHOO","summary":"Why SouFun (SFUN) Stock Is Slumping Today"},{"title":"SouFun reports 2Q loss","publication_date":"2016-08-25 12:07:39 +0000","url":"http://sg.finance.yahoo.com/news/soufun-reports-2q-loss-120739045.html","summary":"SouFun reports 2Q loss"},{"title":"SouFun Holdings Ltd Earnings Call scheduled for 8:00 am ET today","publication_date":"2016-08-25 12:00:00 +0000","url":"http://biz.yahoo.com/cc/4/153724.html","summary":"SouFun Holdings Ltd Earnings Call scheduled for 8:00 am ET today"},{"title":"Fang Announces Second Quarter 2016 Results","publication_date":"2016-08-25 11:58:00 +0000","url":"http://finance.yahoo.com/news/fang-announces-second-quarter-2016-115800759.html","summary":"[PR Newswire] - BEIJING, Aug. 25, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) (\"we,\" \"our,\" or \"Fang\"), the leading real estate Internet portal in China, announced today its ..."},{"title":"Q2 2016 SouFun Holdings Ltd Earnings Release - Before Market Open","publication_date":"2016-08-25 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20160825.html?t=sfun","summary":"Q2 2016 SouFun Holdings Ltd Earnings Release - Before Market Open"},{"title":"Soufun Holdings Limited to Report Second Quarter 2016 Financial Results on August 25, 2016","publication_date":"2016-08-17 11:41:06 +0000","url":"http://www.publicnow.com/view/383F2B096278C201BFAFC97E6769D044A36F47BF","summary":"[at noodls] - BEIJING, August 17, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN, 'Fang' or 'we'), the leading real estate internet portal in China, will report its unaudited second quarter 2016 financial ..."},{"title":"Monday's Market Wrap: U.S. Stock Market Hits New Reocord Highs Again","publication_date":"2016-08-15 20:28:47 +0000","url":"http://finance.yahoo.com/news/mondays-market-wrap-u-stock-202847222.html","summary":"Monday's Market Wrap: U.S. Stock Market Hits New Reocord Highs Again"},{"title":"ETF’s with exposure to SouFun Holdings Ltd. : August 12, 2016","publication_date":"2016-08-12 18:43:55 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-soufun-holdings-ltd-august-12-2016/","summary":"ETF’s with exposure to SouFun Holdings Ltd. : August 12, 2016"},{"title":"Fang to Hold 2016 Annual General Meeting on September 8, 2016","publication_date":"2016-08-09 11:20:11 +0000","url":"http://www.publicnow.com/view/579F27589B19B960104BB2B6F3490FE47E0AEBA3","summary":"[at noodls] - BEIJING, Aug. 9, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) ('Fang' or the 'Company'), the leading real estate Internet portal in China, today announced that it would hold its 2016 annual ..."},{"title":"ETF’s with exposure to SouFun Holdings Ltd. : July 29, 2016","publication_date":"2016-07-29 17:52:39 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-soufun-holdings-ltd-july-29-2016/","summary":"ETF’s with exposure to SouFun Holdings Ltd. : July 29, 2016"},{"title":"After Hours Most Active for Jul 27, 2016 : EPD, FB, BWP, QQQ, AM, MPLX, GRPN, SFUN, EQR, GPRO, WFM, TLT","publication_date":"2016-07-27 21:09:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gSF8iwjF0ns/after-hours-most-active-for-jul-27-2016-epd-fb-bwp-qqq-am-mplx-grpn-sfun-eqr-gpro-wfm-tlt-cm655999","summary":"The NASDAQ 100 After Hours Indicator is up 19.12 to 4,722.01. The total After hours volume is currently 42,358,158 shares traded. The following are the most active stocks for the after hours session Enterprise Products Partners L.P. ( EPD"},{"title":"SouFun Filed 2015 Annual Report on Form 20-F","publication_date":"2016-07-20 07:00:00 +0000","url":"http://finance.yahoo.com/news/soufun-filed-2015-annual-report-070000821.html","summary":"[PR Newswire] - BEIJING, July 20, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) (\"Fang\" or the \"Company\"), the leading real estate Internet portal in China, today announced that it had ..."},{"title":"After Hours Most Active for Jul 19, 2016 : MU, MSFT, QQQ, SIRI, WCC, INTC, PFE, NLY, AAPL, SFUN, HLF, AVP","publication_date":"2016-07-19 21:08:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F-KCI8ZwQ3Y/after-hours-most-active-for-jul-19-2016-mu-msft-qqq-siri-wcc-intc-pfe-nly-aapl-sfun-hlf-avp-cm651600","summary":"The NASDAQ 100 After Hours Indicator is up 13.43 to 4,616.71. The total After hours volume is currently 36,960,044 shares traded. The following are the most active stocks for the after hours session Micron Technology, Inc. ( MU )"},{"title":"ETF’s with exposure to SouFun Holdings Ltd. : July 18, 2016","publication_date":"2016-07-18 18:18:00 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-soufun-holdings-ltd-july-18-2016/","summary":"ETF’s with exposure to SouFun Holdings Ltd. : July 18, 2016"},{"title":"FANG PROVIDES UPDATE ON RESTRUCTURING","publication_date":"2016-07-18 12:30:00 +0000","url":"http://finance.yahoo.com/news/fang-provides-restructuring-123000005.html","summary":"[PR Newswire] - BEIJING, July 18, 2016 /PRNewswire/ -- SouFun Holdings Limited (SFUN) (\"Fang\" or the \"Company\"), the leading real estate Internet portal in China, today provided a further update on its proposed acquisition of a controlling stake in Chongqing Wanli New Energy Co., Ltd. (\"Wanli\"), a company listed on the Shanghai Stock Exchange (\"SSE\") (stock code: 600847), and the sale of Wanli's assets (such transactions, collectively, the \"Restructuring\"). On July 18, 2016, the Company announced that Wanli had advised the Company that it had submitted an application for withdrawal of the application materials on the Restructuring to the China Securities Regulatory Commission (\"CSRC\"), considering that the relevant parties were unable to submit the required supplementary materials to the CSRC in a timely manner due to the workload."},{"title":"Fang Announced Appointment of New President And New COO","publication_date":"2016-07-12 14:20:00 +0000","url":"http://finance.yahoo.com/news/fang-announced-appointment-president-coo-141900750.html","summary":"[PR Newswire] - BEIJING, July 12, 2016 /PRNewswire/ -- SouFun Holdings Limited (SFUN) (\"Fang\" or the \"Company\"), the leading real estate Internet portal in China, today announced the appointment of new President, Mr. Jian Liu and the New Chief Operating Officer, Ms. Zhihong Zhang. Mr. Liu joined Fang in 2000 and most recently has served as the Company's Chief Operating Officer since 2007. Mr. Liu also served as the Chief Information Officer of the Company from 2004 to 2006."},{"title":"After Hours Most Active for Jul 8, 2016 : FLEX, CMCSA, PLCM, QQQ, NWSA, S, MU, BAC, MRO, SFUN, RF, VER","publication_date":"2016-07-08 21:02:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pxMMJb9-q4o/after-hours-most-active-for-jul-8-2016-flex-cmcsa-plcm-qqq-nwsa-s-mu-bac-mro-sfun-rf-ver-cm646659","summary":"The NASDAQ 100 After Hours Indicator is down 1.87 to 4,526.49. The total After hours volume is currently 57,862,306 shares traded. The following are the most active stocks for the after hours session Flextronics International Ltd. ( FLEX )"},{"title":"ETF’s with exposure to SouFun Holdings Ltd. : July 7, 2016","publication_date":"2016-07-07 19:06:35 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-soufun-holdings-ltd-july-7-2016/","summary":"ETF’s with exposure to SouFun Holdings Ltd. : July 7, 2016"},{"title":"Zacks Industry Outlook Highlights: Western Union, MoneyGram International, SouFun Holdings and Everi Holdings","publication_date":"2016-06-27 16:54:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TgGGs7AgRXk/zacks-industry-outlook-highlights-western-union-moneygram-international-soufun-holdings-and-everi-holdings-cm641410","summary":"For Immediate ReleaseChicago, IL June 27, 2016 Today, Zacks Equity Research discusses the Business Services (Part 3), including Western Union Company ( WU ), MoneyGram International Inc. ( MGI ), SouFun Holdings Ltd ( SFUN ) and Everi Holdings"},{"title":"Business Services Suffer High Costs, Stiff Competition","publication_date":"2016-06-27 12:30:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/__wvonMhh3M/business-services-suffer-high-costs-stiff-competition-cm640723","summary":"Despite having its hands full of positives, the Business Services sector is nevertheless faced with a number of headwinds that tend to partially offset the positive impact of the catalysts mentioned in \"Business Services Well Poised to Create Employment"},{"title":"ETF’s with exposure to SouFun Holdings Ltd. : June 23, 2016","publication_date":"2016-06-23 17:53:42 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-soufun-holdings-ltd-june-23-2016/","summary":"ETF’s with exposure to SouFun Holdings Ltd. : June 23, 2016"},{"title":"SouFun Holdings Ltd. :SFUN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016","publication_date":"2016-06-22 16:40:52 +0000","url":"http://www.capitalcube.com/blog/index.php/soufun-holdings-ltd-sfun-us-earnings-analysis-q1-2016-by-the-numbers-june-22-2016/","summary":"SouFun Holdings Ltd. :SFUN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016"},{"title":"Interesting SFUN Put And Call Options For February 2017","publication_date":"2016-06-20 18:07:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/43iSedm9Scw/interesting-sfun-put-and-call-options-for-february-2017-cm637916","summary":"Investors in SouFun Holdings Ltd (Symbol SFUN) saw new options become available today, for the February 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time"},{"title":"Noteworthy ETF Inflows: MCHI, WUBA, XRS, SFUN","publication_date":"2016-06-20 17:06:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oLibCsHBwb4/noteworthy-etf-inflows-mchi-wuba-xrs-sfun-cm637847","summary":"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the iShares MSCI China ETF (Symbol MCHI) where we have detected an approximate $81.6 million dollar inflow"},{"title":"Jon owns SouFun Holdings","publication_date":"2016-06-14 16:59:00 +0000","url":"http://finance.yahoo.com/video/jon-owns-soufun-holdings-165900471.html","summary":"Jon owns SouFun Holdings"},{"title":"Trending Now: SFUN","publication_date":"2016-06-14 06:16:22 +0000","url":"http://finance.yahoo.com/video/trending-now-sfun-013219301.html","summary":"Trending Now: SFUN"},{"title":"How The Parts Add Up: XITK Headed For $65","publication_date":"2016-06-07 14:03:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pfjoRExCfqI/how-the-parts-add-up-xitk-headed-for-65-cm631405","summary":"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"},{"title":"General Atlantic Hires Former Carlyle Deal Maker Zhang","publication_date":"2016-06-05 20:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yFVFMKVACe0/general-atlantic-hires-former-carlyle-deal-maker-zhang-20160605-00061","summary":"General Atlantic Hires Former Carlyle Deal Maker Zhang"},{"title":"SouFun (SFUN) Q1 Loss Wider Than Expected, View Raised","publication_date":"2016-06-05 06:10:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EtJJwMccexU/soufun-sfun-q1-loss-wider-than-expected-view-raised-cm630176","summary":"SouFun Holdings Ltd.SFUN reported operating net loss of 24 cents per share in the first quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 7 cents. The company had earned 2 cents per share in"},{"title":"Why SouFun Holdings Ltd (SFUN), Citigroup Inc (C) and Immunomedics, Inc. (IMMU) Are Three of Today’s Worst Stocks","publication_date":"2016-06-04 23:04:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lRkHT0FWf1I/why-soufun-holdings-ltd-sfun-citigroup-inc-c-and-immunomedics-inc-immu-are-three-of-todays-worst-stocks-cm630515","summary":"In the grand scheme of things, it could have been worse. At one point, weak employment growth for May had the S&P 500 down by"},{"title":"SouFun (SFUN) Stock Plunging on Q2 Net Loss","publication_date":"2016-06-03 18:05:00 +0000","url":"https://www.thestreet.com/story/13596101/1/soufun-sfun-stock-plunging-on-q2-net-loss.html?puc=yahoo&cm_ven=YAHOO","summary":"SouFun (SFUN) Stock Plunging on Q2 Net Loss"},{"title":"SouFun (SFUN) Q1 Loss Wider Than Expected, View Raised","publication_date":"2016-06-03 13:20:01 +0000","url":"http://finance.yahoo.com/news/soufun-sfun-q1-loss-wider-132001993.html","summary":"SouFun (SFUN) Q1 Loss Wider Than Expected, View Raised"},{"title":"Financial Sector Update for 06/02/2016: SFUN,AHT,DEA","publication_date":"2016-06-02 20:28:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g1SIO6cHTC4/financial-sector-update-for-06022016-sfunahtdea-cm629818","summary":"Top Financial Stocks JPM +0.06% BAC +0.50% WFC +0.06% C 0.05% USB +0.08% Financial stocks were ending little changed, paring their earlier losses, with the NYSE Financial Sector Index down less than 0.1% while financial companies in the S&P"},{"title":"A Look at Five Stocks on the Move on Thursday","publication_date":"2016-06-02 18:07:44 +0000","url":"http://www.insidermonkey.com/blog/a-look-at-five-stocks-on-the-move-on-thursday-457409/","summary":"A Look at Five Stocks on the Move on Thursday"},{"title":"Edited Transcript of SFUN earnings conference call or presentation 2-Jun-16 12:00pm GMT","publication_date":"2016-06-02 17:12:22 +0000","url":"http://finance.yahoo.com/news/edited-transcript-sfun-earnings-conference-171222662.html","summary":"Edited Transcript of SFUN earnings conference call or presentation 2-Jun-16 12:00pm GMT"},{"title":"Asian ADRs Move Lower in Thursday Trading","publication_date":"2016-06-02 15:08:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OIjp0ro7-Rs/asian-adrs-move-lower-in-thursday-trading-cm629531","summary":"American depository receipts of Asian stocks were trading 0.6% lower at 130.87 on the Bank of New York Mellon Asia ADR Index on Thursday. In North Asia, the gainers were led by Baozun ( BZUN ), which provides e"},{"title":"SouFun (SFUN) Stock Climbs on Q1 Revenue Beat","publication_date":"2016-06-02 14:16:00 +0000","url":"https://www.thestreet.com/story/13594059/1/soufun-sfun-stock-climbs-on-q1-revenue-beat.html?puc=yahoo&cm_ven=YAHOO","summary":"SouFun (SFUN) Stock Climbs on Q1 Revenue Beat"},{"title":"SouFun reports 1Q loss","publication_date":"2016-06-02 12:31:20 +0000","url":"http://sg.finance.yahoo.com/news/soufun-reports-1q-loss-123120840.html","summary":"SouFun reports 1Q loss"},{"title":"Fang Announces First Quarter 2016 Results","publication_date":"2016-06-02 12:01:00 +0000","url":"http://finance.yahoo.com/news/fang-announces-first-quarter-2016-120100307.html","summary":"[PR Newswire] - BEIJING, June 2, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) (\"we,\" \"our,\" or \"Fang\" ), the leading real estate Internet portal in China, announced today its ..."},{"title":"SouFun Holdings Ltd Earnings Call scheduled for 8:00 am ET today","publication_date":"2016-06-02 12:00:00 +0000","url":"http://biz.yahoo.com/cc/2/152262.html","summary":"SouFun Holdings Ltd Earnings Call scheduled for 8:00 am ET today"},{"title":"Q1 2016 SouFun Holdings Ltd Earnings Release - Before Market Open","publication_date":"2016-06-02 11:07:01 +0000","url":"http://biz.yahoo.com/research/earncal/20160602.html?t=sfun","summary":"Q1 2016 SouFun Holdings Ltd Earnings Release - Before Market Open"},{"title":"Earnings Reaction History: SouFun Holdings Limited, 30.0% Follow-Through Indicator, 4.6% Sensitive","publication_date":"2016-06-02 10:51:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9AeD2jewXk0/earnings-reaction-history-soufun-holdings-limited-300-follow-through-indicator-46-sensitive-cm629371","summary":"Expected Earnings Release 06 02 2016, Premarket Avg. Extended Hours Dollar Volume $789,487 SouFun Holdings Limited ( SFUN ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can expect"},{"title":"SouFun Increases FY16 Revenue Guidance; Posts Loss In Q1, Revenue Up 62.3%","publication_date":"2016-06-02 08:36:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TXGyHFeKsB0/soufun-increases-fy16-revenue-guidance-posts-loss-in-q1-revenue-up-623-20160602-00434","summary":"SouFun Increases FY16 Revenue Guidance; Posts Loss In Q1, Revenue Up 62.3%"},{"title":"SouFun Holdings Q1 16 Earnings Conference Call At 8:00 AM ET","publication_date":"2016-06-02 07:00:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-W-rVbgaciU/soufun-holdings-q1-16-earnings-conference-call-at-800-am-et-20160602-00223","summary":"SouFun Holdings Q1 16 Earnings Conference Call At 8:00 AM ET"},{"title":"Pre-Market Earnings Report for June 2, 2016 : DCI, WUBA, CIEN, JOY, SFUN, AMWD, CONN","publication_date":"2016-06-01 20:21:05 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KA-RqYWbuSA/pre-market-earnings-report-for-june-2-2016-dci-wuba-cien-joy-sfun-amwd-conn-cm629250","summary":"The following companies are expected to report earnings prior to market open on 06 02 2016. Visit our Earnings Calendar for a full list of expected earnings releases. Donaldson Company, Inc. ( DCI ) is reporting"},{"title":"After Hours Most Active for May 31, 2016 : JD, BRCD, VIPS, CTRP, NXPI, BABA, WCN, CDNS, SFUN, HTZ, BIDU, NI","publication_date":"2016-05-31 21:04:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3ozDzYjLZuI/after-hours-most-active-for-may-31-2016-jd-brcd-vips-ctrp-nxpi-baba-wcn-cdns-sfun-htz-bidu-ni-cm628654","summary":"The NASDAQ 100 After Hours Indicator is down 4.73 to 4,519.16. The total After hours volume is currently 215,508,685 shares traded. The following are the most active stocks for the after hours session JD.com, Inc. ( JD ) is"},{"title":"SouFun Holdings Limited to Report First Quarter 2016 Financial Results on June 2, 2016","publication_date":"2016-05-27 11:07:01 +0000","url":"http://www.publicnow.com/view/6A12E05BF27C200F59712D016558A9CA4F76B41F","summary":"[at noodls] - BEIJING, May 27, 2016 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN, 'Fang' or 'we'), the leading real estate internet portal in China, will report its unaudited first quarter 2016 financial results ..."},{"title":"Fang Reaches Definitive Agreements with Wanli","publication_date":"2016-01-20 12:15:08 +0000","url":"http://www.noodls.com/view/9F598A2FBEF934934AE3CAC942693E9112409F56","summary":"[at noodls] - , /PRNewswire/ -- (NYSE: SFUN) ('Fang' or the 'Company'), the leading real estate Internet portal in , today announced that it had made significant progress on its acquisition of a controlling stake in ..."},{"title":"SouFun(Fang) to Attend Upcoming Conferences in January 2016","publication_date":"2016-01-04 11:58:04 +0000","url":"http://www.noodls.com/view/FA8C961956D4BFF3CA2242F8134F502193AC50D0","summary":"[at noodls] - , /PRNewswire/ -- (NYSE: SFUN)('Fang' or the 'Company'), the leading real estate Internet portal in , today announced that it will meet with institutional investors at the following upcoming investor conferences ..."},{"title":"SOUFUN (FANG) Enhances Management Team with New CFO","publication_date":"2016-01-04 10:18:22 +0000","url":"http://www.noodls.com/view/6502E8E5DA36E8769032CCB5B2A991F8F1F9A89B","summary":"[at noodls] - , /PRNewswire/ -- (NYSE: SFUN) ('Fang' or the 'Company'), the leading real estate Internet portal in , today announced that it has strengthened its management team with the appointment of Mr. Kent (Cangsang) ..."},{"title":"SouFun Announces Third Quarter 2015 Results","publication_date":"2015-11-18 11:40:20 +0000","url":"http://www.noodls.com/view/9990EEF2D1646C2FF941ADA5AF10D803D443521C","summary":"[at noodls] - SouFun Announces Third Quarter 2015 Results"},{"title":"SouFun to Acquire a Controlling Stake in Wanli, a PRC Publicly Traded Company, to Further Tap into the PRC Domestic Capital Markets","publication_date":"2015-11-13 10:26:11 +0000","url":"http://www.noodls.com/view/0CF3B9D287A54F4392EBC976B458CB7B3A758115","summary":"[at noodls] - BEIJING, Nov. 13, 2015 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN, 'SouFun' or the 'Company'), the leading real estate Internet platform in China, today announced that it had entered into a framework ..."},{"title":"SouFun Holdings Limited to Report Third Quarter 2015 Financial Results on November 18, 2015","publication_date":"2015-11-06 08:24:11 +0000","url":"http://www.noodls.com/view/1524DCB7CBB8A12DA9CA037F9AE4B17E61DBD70A","summary":"[at noodls] - BEIJING, Nov. 6, 2015 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN, 'SouFun' or 'we'), the leading real estate internet portal in China, will report its unaudited third quarter 2015 financial results ..."},{"title":"SouFun Management Comments on Strengthening its New Ecommerce Businesses","publication_date":"2015-10-28 13:57:13 +0000","url":"http://www.noodls.com/view/DE782C8A4C711CA2FB9AA921137D65E26A64E5FF","summary":"[at noodls] - BEIJING, Oct 28, 2015 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN), ('SouFun', the 'Company'), the leading real estate Internet portal in China, commented on strengthening its new ecommerce businesses ..."},{"title":"SouFun Announces Investment from IDG, Carlyle and Management Members","publication_date":"2015-09-18 10:46:18 +0000","url":"http://www.noodls.com/view/605F36B131BD741AA77D0537E4C06924CF02AAB9","summary":"[at noodls] - BEIJING, Sept. 18, 2015 /PRNewswire/ -- SouFun Holdings Limited (NYSE: SFUN) ('SouFun'), the leading real estate Internet portal in China, announced today it entered into (i) a subscription agreement ( ..."}],"result_count":130,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1},"timeStamp": 1491053735,"trigger": "MARK AT OR ABOVE 3.30","triggerPrice":3.30,"alertStatus": "Active", "chart":[{"values":[ {"x":"1490967000","y":"2.69"},{"x":"1490967300","y":"2.745"},{"x":"1490967600","y":"2.7962"},{"x":"1490967900","y":"2.8449999999999998"},{"x":"1490968200","y":"2.94"},{"x":"1490968500","y":"3.08"},{"x":"1490968800","y":"3.0866"},{"x":"1490969100","y":"3.1"},{"x":"1490969400","y":"3.02"},{"x":"1490969700","y":"3.0699"},{"x":"1490970000","y":"3.08"},{"x":"1490970300","y":"3.1"},{"x":"1490970600","y":"3.105"},{"x":"1490970900","y":"3.1"},{"x":"1490971200","y":"3.1"},{"x":"1490971500","y":"3.11"},{"x":"1490971800","y":"3.1"},{"x":"1490972100","y":"3.1299"},{"x":"1490972400","y":"3.1101"},{"x":"1490972700","y":"3.11"},{"x":"1490973000","y":"3.12"},{"x":"1490973300","y":"3.175"},{"x":"1490973600","y":"3.15"},{"x":"1490973900","y":"3.16"},{"x":"1490974200","y":"3.15"},{"x":"1490974500","y":"3.125"},{"x":"1490974800","y":"3.155"},{"x":"1490975100","y":"3.15"},{"x":"1490975400","y":"3.15"},{"x":"1490975700","y":"3.17"},{"x":"1490976000","y":"3.16"},{"x":"1490976300","y":"3.155"},{"x":"1490976600","y":"3.16"},{"x":"1490976900","y":"3.16"},{"x":"1490977200","y":"3.14"},{"x":"1490977500","y":"3.1592000000000002"},{"x":"1490977800","y":"3.15"},{"x":"1490978100","y":"3.15"},{"x":"1490978400","y":"3.17"},{"x":"1490978700","y":"3.19"},{"x":"1490979000","y":"3.17"},{"x":"1490979300","y":"3.16"},{"x":"1490979600","y":"3.16"},{"x":"1490979900","y":"3.15"},{"x":"1490980200","y":"3.155"},{"x":"1490980500","y":"3.18"},{"x":"1490980800","y":"3.1899"},{"x":"1490981100","y":"3.2"},{"x":"1490981400","y":"3.1975"},{"x":"1490981700","y":"3.2"},{"x":"1490982000","y":"3.2"},{"x":"1490982300","y":"3.205"},{"x":"1490982600","y":"3.21"},{"x":"1490982900","y":"3.22"},{"x":"1490983200","y":"3.205"},{"x":"1490983500","y":"3.205"},{"x":"1490983800","y":"3.21"},{"x":"1490984100","y":"3.2199"},{"x":"1490984400","y":"3.2113"},{"x":"1490984700","y":"3.22"},{"x":"1490985000","y":"3.21"},{"x":"1490985300","y":"3.22"},{"x":"1490985600","y":"3.21"},{"x":"1490985900","y":"3.21"},{"x":"1490986200","y":"3.22"},{"x":"1490986500","y":"3.2195"},{"x":"1490986800","y":"3.24"},{"x":"1490987100","y":"3.24"},{"x":"1490987400","y":"3.26"},{"x":"1490987700","y":"3.255"},{"x":"1490988000","y":"3.27"},{"x":"1490988300","y":"3.27"},{"x":"1490988600","y":"3.265"},{"x":"1490988900","y":"3.26"},{"x":"1490989200","y":"3.255"},{"x":"1490989500","y":"3.26"},{"x":"1490989800","y":"3.265"},{"x":"1490990100","y":"3.25"},{"x":"1490990400","y":"3.26"},{"x":"1490990700","y":"3.24"},{"x":"1490991600","y":"3.21"},{"x":"1490991900","y":"3.22"},{"x":"1490992200","y":"3.22"},{"x":"1490992800","y":"3.22"},{"x":"1490997300","y":"3.25"},{"x":"1491001800","y":"3.22"},{"x":"1491003900","y":"3.25"},{"x":"1491004200","y":"3.2"},{"x":"1491004500","y":"3.2"} ], "color":"#03a9f4"}]}
]
